货号:A938719 同义名: N-Ethyl-N-sulfopropylaniline sodium salt
ALPS is a bio-chemical reagents/chromogenic reagent.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | Opioid receptor ↓ ↑ | ORL1 ↓ ↑ | μ-opioid receptor ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Racecadotril | ✔ | 98% | |||||||||||||||||
JTC-801 |
++
Opioid receptor-like1 (ORL1), IC50: 94 nM |
98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | ALPS is a bio-chemical reagents/chromogenic reagent. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03359174 | Cholangitis, Sclerosing | Phase 2 | Recruiting | January 1, 2021 | United States, Connecticut ... 展开 >> Yale University Recruiting New Haven, Connecticut, United States, 06510 收起 << |
NCT01098500 | - | Completed | - | - | |
NCT03351491 | - | Completed | - | France ... 展开 >> Dr Ronflet Chabons, France, 38690 Centre de santé de l'abbaye Grenoble, France, 38000 Dr CROS Grenoble, France, 38000 Dr Grasset Grenoble, France, 38000 Dr Riehl La Côte-Saint-André, France, 38260 Dr Fuentes Meylan, France, 38240 Maison médicale Moirans Moirans, France, 38430 Dr PARADIS Montmelian, France, 73800 Dr Chatellard Saint-Martin-d'Hères, France, 38400 Dr Moulis Saint-Martin-d'Hères, France, 38400 Maison médicale Saint Martin d'Hères Saint-Martin-d'Hères, France, 38400 Maison Médicale de Tullins Tullins, France, 38210 Dr Bichon Villard de Lans, France, 38250 收起 << | |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.77mL 0.75mL 0.38mL |
18.85mL 3.77mL 1.88mL |
37.69mL 7.54mL 3.77mL |
CAS号 | 82611-85-6 |
分子式 | C11H16NNaO3S |
分子量 | 265.304 |
别名 | N-Ethyl-N-sulfopropylaniline sodium salt |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Room Temperature |
溶解度 |
DMSO: 250 mg/mL(942.31 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
Tags: ALPS | 82611-85-6 | N-Ethyl-N-sulfopropylaniline | Fluorescent Dye | 仅供科研使用 | AmBeed-信号通路专用抑制剂 | ALPS 纯度/质量文件 | ALPS 亚型比较 | ALPS 生物活性 | ALPS 临床数据 | ALPS 实验方案 | ALPS 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT03359174 | Cholangitis, Sclerosing | Phase 2 | Recruiting | January 1, 2021 | United States, Connecticut ... 展开 >> Yale University Recruiting New Haven, Connecticut, United States, 06510 收起 << |
NCT01098500 | - | Completed | - | - | |
NCT03351491 | - | Completed | - | France ... 展开 >> Dr Ronflet Chabons, France, 38690 Centre de santé de l'abbaye Grenoble, France, 38000 Dr CROS Grenoble, France, 38000 Dr Grasset Grenoble, France, 38000 Dr Riehl La Côte-Saint-André, France, 38260 Dr Fuentes Meylan, France, 38240 Maison médicale Moirans Moirans, France, 38430 Dr PARADIS Montmelian, France, 73800 Dr Chatellard Saint-Martin-d'Hères, France, 38400 Dr Moulis Saint-Martin-d'Hères, France, 38400 Maison médicale Saint Martin d'Hères Saint-Martin-d'Hères, France, 38400 Maison Médicale de Tullins Tullins, France, 38210 Dr Bichon Villard de Lans, France, 38250 收起 << | |
NCT03092765 | Primary Biliary Cholangitis | Phase 2 | Active, not recruiting | October 2018 | Japan ... 展开 >> EA Pharma trial site Nagoya, Aichi, Japan EA Pharma trial site Matsudo, Chiba, Japan EA Pharma trial site Touon, Ehime, Japan EA Pharma trial site Yoshida, Fukui, Japan EA Pharma trial site Kurume, Fukuoka, Japan EA Pharma trial site Maebashi, Gunma, Japan EA Pharma trial site #1 Sapporo, Hokkaido, Japan EA Pharma trial site #2 Sapporo, Hokkaido, Japan EA Pharma trial site Kobe, Hyogo, Japan EA Pharma trial site Nishinomiya, Hyogo, Japan EA Pharma trial site Inashiki, Ibaraki, Japan EA Pharma trial site Morioka, Iwate, Japan EA Pharma trial site Kita, Kagawa, Japan EA Pharma trial site Takamatsu, Kagawa, Japan EA Pharma trial site #1 Yokohama, Kanagawa, Japan EA Pharma trial site #2 Yokohama, Kanagawa, Japan EA Pharma trial site Sendai, Miyagi, Japan EA Pharma trial site Matsumoto, Nagano, Japan EA Pharma trial site Oomura, Nagasaki, Japan EA Pharma trial site Kashihara, Nara, Japan EA Pharma trial site Nakagami, Okinawa, Japan EA Pharma trial site Hirakata, Osaka, Japan EA Pharma trial site #1 Suita, Osaka, Japan EA Pharma trial site #2 Suita, Osaka, Japan EA Pharma trial site Ageo, Saitama, Japan EA Pharma trial site Iruma, Saitama, Japan EA Pharma trial site Shimotsuga, Tochigi, Japan EA Pharma trial site Bunkyo, Tokyo, Japan EA Pharma trial site Itabashi, Tokyo, Japan EA Pharma trial site #1 Minato, Tokyo, Japan EA Pharma trial site #2 Minato, Tokyo, Japan EA Pharma trial site Musashino, Tokyo, Japan EA Pharma trial site Shinjuku, Tokyo, Japan EA Pharma trial site #1 Fukuoka, Japan EA Pharma trial site #2 Fukuoka, Japan EA Pharma trial site Fukushima, Japan EA Pharma trial site #1 Hiroshima, Japan EA Pharma trial site #2 Hiroshima, Japan EA Pharma trial site Kagoshima, Japan EA Pharma trial site Kumamoto, Japan EA Pharma trial site Kyoto, Japan EA Pharma trial site Niigata, Japan EA Pharma trial site Okayama, Japan EA Pharma trial site Osaka, Japan EA Pharma trial site Saga, Japan EA Pharma trial site Yamagata, Japan 收起 << |
NCT01688375 | Obstructive Jaundice | Phase 2 | Unknown | December 2013 | Serbia ... 展开 >> University clinical centre of Kosovo, Department of general surgery Not yet recruiting Pristina, Kosovo, Serbia, 10000 Contact: Enver H Fekaj, PhD student 37744279296 enverfekaj@hotmail.com Principal Investigator: Enver H Fekaj, PhD student University clinical centre of Kosovo Pristina, Kosovo, Serbia, 10000 University clinical centre of Kosovo Not yet recruiting Pristina, Kosovo, Serbia, 10000 Contact: Enver H Fekaj, PhD student 37744279296 enverfekaj@hotmail.com 收起 << |
NCT01163149 | Hypophosphatasia | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Shriner's Hospital for Children Saint Louis, Missouri, United States, 63131 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Canada, Manitoba Health Sciences Centre Winnipeg, University of Manitoba Winnipeg, Manitoba, Canada, R3A 1S1 收起 << |
NCT00051636 | Paget's Disease of Bone | Phase 3 | Completed | - | - |
NCT01176266 | Hypophosphatasia | Phase 2 Phase 3 | Completed | - | - |
NCT01176266 | - | Completed | - | - | |
NCT02496689 | - | - | - | United States, Colorado ... 展开 >> Colorado Center for Bone Research Lakewood, Colorado, United States, 80227 United States, Pennsylvania Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 France Hôpital Bicêtre Le Kremlin-Bicêtre, France, 94275 Hôpital Necker - Enfants Malades Paris, France, 75015 Hôpital des Enfants Toulouse Cedex 9, France, 31259 收起 << | |
NCT01163149 | - | Completed | - | - | |
NCT01098500 | - | Completed | - | - | |
NCT02531867 | - | Completed | - | - | |
NCT01205152 | Hypophosphatasia | Phase 2 | Completed | - | United States, Delaware ... 展开 >> Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States, 19803 United States, Missouri St. John's Medical Research Institute Springfield, Missouri, United States, 65807 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Wisconsin St. Vincent Hospital Green Bay, Wisconsin, United States, 54301 United Arab Emirates Tawam Hospital Al Ain, Abu-Dhabi, United Arab Emirates United Kingdom Royal Maternity Hospital, Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, Bt126BB Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TH 收起 << |
NCT02531867 | Hypophosphatasia | Phase 4 | Completed | - | - |
NCT00051636 | - | Completed | - | - | |
NCT01205152 | - | Completed | - | - | |
NCT03722576 | Primary Sclerosing Cholangitis | Phase 2 | Not yet recruiting | November 2020 | United States, Arizona ... 展开 >> Keith D. Lindor, MD Not yet recruiting Phoenix, Arizona, United States, 85004 Contact: Elizabeth Carey, MD 480-515-6296 carey.elizabeth@mayo.edu Contact: Nicholas F LaRusso 507-284-1006 larusso.nicholas@mayo.edu 收起 << |
NCT01446068 | Nutritional Intervention ... 展开 >> Nutritional and Metabolic Diseases Obesity 收起 << | Early Phase 1 | Completed | - | Switzerland ... 展开 >> Agroscope Liebefeld-Posieux ALP Research Station Berne, Switzerland, 3003 University Hospital Inselspital, Berne Berne, Switzerland, 3010 收起 << |
NCT01249092 | Primary Biliary Cirrhosis | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Cleveland, Ohio, United States, 44195 收起 << |
NCT01249092 | - | Completed | - | - | |
NCT03039062 | - | Recruiting | July 2017 | China, Beijing ... 展开 >> Cancer Hospital, ChineseAMS Recruiting Beijing, Beijing, China, 100021 Contact: Qiao LI, MD 86-10-87788120 liqiaopumc@yahoo.cn Contact: Binghe XU, MD, PHD 86-10-87788495 xubinghe@medmail.com.cn 收起 << | |
NCT02323477 | Chronic Ischemic Cardiomyopath... 展开 >>y Coronary Artery Bypass Surgery 收起 << | Phase 1 Phase 2 | Recruiting | February 2018 | Turkey ... 展开 >> Alp Can Recruiting Ankara, Turkey, 06100 Contact: Alp Can, M.D., Ph.D. +903125958169 alpcan@medicine.ankara.edu.tr Contact: A. Tulga Ulus, M.D. +903123054344 uluss@yahoo.com 收起 << |
NCT03127293 | - | Completed | - | - | |
NCT02944773 | Stress | Not Applicable | Completed | - | Spain ... 展开 >> Silvia Vicente Pérez Castelldefels, Barcelona, Spain, 08860 收起 << |
NCT02724306 | Colon Polyps ... 展开 >>Colon Adenomas 收起 << | Not Applicable | Completed | - | - |
NCT01662973 | Primary Biliary Cirrhosis | Phase 1 Phase 2 | Unknown | October 2013 | China, Beijing ... 展开 >> Beijing 302 Hospital Recruiting Beijing, Beijing, China, 100039 Contact: Fu-Sheng Wang, professor 86-10-63879735 ext 2015.12 fswang302@163.com Contact: Lifeng Wang, Doctor 86-10-63879735 ext 2015.12 wanglf76@gmail.com Principal Investigator: Fu-Sheng Wang, Professor 收起 << |
NCT01885416 | Inflammation ... 展开 >>Obesity Nutritional Intervention 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital, Inselspital Berne Bern, Switzerland, 3010 收起 << |
NCT03333928 | Primary Sclerosing Cholangitis... 展开 >> (PSC) 收起 << | Phase 2 | Recruiting | April 30, 2019 | United States, California ... 展开 >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Laura Sarmiento, CCRP 310-423-4295 Laura.sarmiento@cshs.org Contact: Jenny Park, CCRP 310-423-8762 Jenny.Park@cshs.org United States, Colorado University of Colorado, Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Jada Boyd 303-724-1866 jada.boyd@ucdenver.edu Contact: Lisa Forman, MD 720-848-2292 lisa.forman@ucdenver.edu Principal Investigator: Lisa Forman, MD United States, Connecticut Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Marina Silveira, MD 203-737-6060 marina.silveira@yale.edu Contact: Laura Cusack 203-737-6839 laura.cusack@yale.edu Principal Investigator: Marina Silveira, MD United States, Florida Florida Research Institute Recruiting Lakewood Ranch, Florida, United States, 34211 Contact: Tracy L Balentine, RN, MS, CCRC 941-727-7772 tracy.balentine@fdhs.com Contact: Johanna Valentin, MBA 941-727-7772 Johanna.valentin@fdhs.com University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Cynthia Levy, MD 305-243-4615 clevy@med.miami.edu Contact: Tiffannia T Grant 305-243-4649 t.grant11@med.miami.edu Principal Investigator: Cynthia Levy, MD United States, Kentucky University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Karen Beatty, RN 502-852-3383 Karen.beatty@louisville.edu Contact: Matthew Cave, MD 502-852-6189 matt.cave@louisville.edu Principal Investigator: Matthew C. Cave, MD United States, Maryland Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Dawn M Torres, MD 301-295-4451 dawn.m.torres2.mil@mail.mil Contact: Jeffrey Bloch, MS 301-319-8713 jeffrey.bloch.ctr@mail.mil United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Michael Klebert, PhD 314-454-0058 mklebert@wustl.edu Contact: Kevin Korenblat, MD 314-454-8141 korenblatk@wustl.edu Principal Investigator: Kevin Korenblat, MD United States, New York Mount Sinai - Icahn School of Medicine Recruiting New York, New York, United States, 10029 Contact: Jawad Ahmad, MD 212-241-0255 Jawad.Ahmad@mountsinai.org Contact: Brandy Haydel 212-241-0255 Brandy.Haydel@mountsinai.org United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Dee W. Faust 336-713-1442 delannin@wakehealth.edu Contact: Sean R. Rudnick, MD 336-713-7381 srudnick@wakehealth.edu Principal Investigator: Sean R. Rudnick, MD United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37212 Contact: Mary C. Vozar, RN, BSN, MSN 615-936-1745 mary.c.vozar@vumc.org Contact: Tina C. Higginbotham, MPA 615-322-4643 tina.higginbotham@vumc.org Principal Investigator: Michael Porayko, MD United States, Texas Pinnacle Clinical Research Recruiting Austin, Texas, United States, 78746 Contact: Nadege Gunn, MD 512-384-4560 ngunn@pinnacleresearch.com Pinnacle Clinical Research Recruiting San Antonio, Texas, United States, 78229 Contact: Leslie M DeHart, MSN, FNP-C 210-982-0320 ext 1451 ldehart@pinnacleresearch.com Contact: James Varner, PAC 210-982-0320 ext 1441 jvarner@pinnacleresearch.com United States, Washington Swedish Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Brook A Quist, CRC 206-386-2427 Brook.quist@swedish.org Contact: Jodie Davila, RN 206-215-4384 Jodie.davila@swedish.org Principal Investigator: Kris V. Kowdley, MD University of Washington Recruiting Seattle, Washington, United States, 98104 Contact: Lynn Gemmell, MBA, CRC 206-744-7063 lgemmell@medicine.washington.edu Contact: Peter Nguyen 206-744-3402 hnguyen@medicine.washington.edu Principal Investigator: Charles Landis, MD, PhD 收起 << |
NCT01142323 | Primary Sclerosing Cholangitis | Phase 1 Phase 2 | Terminated | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32608 University of Miami Miami, Florida, United States, 33136 收起 << |
NCT01634256 | - | Completed | - | - | |
NCT01142323 | - | Terminated | - | - | |
NCT03155932 | Primary Biliary Cholangitis | Phase 2 | Recruiting | December 2019 | United States, California ... 展开 >> Gastroenterology and Hepatology, UC Davis Medical Center Not yet recruiting Sacramento, California, United States, 95817 Principal Investigator: Chris Bowlus, MD United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Principal Investigator: John Vierling, MD Texas Liver Institute Recruiting San Antonio, Texas, United States, 78215 Principal Investigator: Eric Lawitz, MD United States, Washington Swedish Medical Center Not yet recruiting Seattle, Washington, United States, 98104 Principal Investigator: Kris Kowdley, MD Australia, New South Wales Royal Prince Alfred Hospital Recruiting Camperdown, New South Wales, Australia Contact: Simone Strasser, Prof Australia, Queensland Sunshine Coast University Hospital Recruiting Birtinya, Queensland, Australia Contact: James OBeirne, Prof Australia, Victoria Alfred Health Recruiting Melbourne, Victoria, Australia, 3004 Contact: William Kemp, Prof New Zealand Auckland City Hospital Recruiting Grafton, Auckland, New Zealand Contact: Dominic Ray-Chaudhuri, Dr Christchurch Clinical Studies Trust Recruiting Christchurch, New Zealand Contact: Jeffrey Ngu, Dr 收起 << |
NCT03260803 | Osteopenia | Phase 3 | Active, not recruiting | November 5, 2018 | Iran, Islamic Republic of ... 展开 >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 0098 Tehran University of Medical Sciences Tehrān, Iran, Islamic Republic of, 0098 收起 << |
NCT01152086 | Suicide Hopel... 展开 >>essness 收起 << | Phase 4 | Completed | - | - |
NCT03476993 | Liver Cirrhosis, Biliary | Phase 2 | Recruiting | December 2021 | Russian Federation ... 展开 >> State Budgetary Higher Vocational Education Institution I.M. Sechenov First Moscow State Medical University Recruiting Moscow, Russian Federation North-Western State Medical University named after I.I. Mechnikov Not yet recruiting Saint Petersburg, Russian Federation Smolensk state medical university Recruiting Smolensk, Russian Federation 收起 << |
NCT00392951 | Autoimmune Pancytopenia ... 展开 >> Autoimmune Lymphoproliferative Syndrome (ALPS) Evans Syndrome Idiopathic Thrombocytopenic Purpura Anemia, Hemolytic, Autoimmune Autoimmune Neutropenia Lupus Erythematosus, Systemic Inflammatory Bowel Disease Rheumatoid Arthritis 收起 << | Phase 1 Phase 2 | Active, not recruiting | February 2020 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00392951 | - | Active, not recruiting | - | - | |
NCT00575042 | Primary Biliary Cirrhosis | Phase 2 | Completed | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT03201380 | - | Active, not recruiting | December 1, 2017 | - | |
NCT01634256 | Mild Hepatic Injury | Phase 2 Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 收起 << |
NCT01585909 | Critical Illness ... 展开 >> Septic Shock SIRS 收起 << | Not Applicable | Completed | - | Austria ... 展开 >> Medical University Vienna Vienna, Austria, 1090 收起 << |
NCT03148847 | - | Recruiting | December 2019 | France ... 展开 >> CH Annecy Genevois Recruiting Pringy, France, F-74374 Contact: Pascale CONY-MAKHOUL, MD pconymakhoul@ch-annecygenevois.fr Contact: Claire MORVAN cmorvan@ch-annecygenevois.fr Principal Investigator: Loic E BELLE, MD 收起 << | |
NCT00575042 | - | Completed | - | - | |
NCT00882908 | - | Completed | - | - | |
NCT03160430 | Kidney Failure, Chronic | Phase 1 Phase 2 | Not yet recruiting | March 15, 2020 | - |
NCT02366988 | Chronic Pancreatitis | Not Applicable | Terminated(sponsor decision no... 展开 >>t enough inclusion) 收起 << | - | France ... 展开 >> Centre hospitalier Béthune, France Centre hospitalier Dunkerque, France Centre Hospitalier Dr Schaffner Lens, France Clinique de la Louvière Lille, France Hôpital St Philibert Lomme, France Centre hospitalier Roubaix, France Centre hospitalier Valencienne, France 收起 << |
NCT00882908 | Hepatitis C | Phase 2 | Completed | - | - |
NCT00774020 | Paget's Disease of Bone | Phase 4 | Completed | - | China ... 展开 >> Novartis Investigative Site Beijing, China Novartis Investigative site Guangzhou, China Novartis Investigative site Nanjing, China Novartis Investigative site Shanghai, China 收起 << |
NCT00511186 | Sepsis Bacter... 展开 >>ial Infections and Mycoses 收起 << | Phase 2 | Terminated(sufficient POC to s... 展开 >>witch development from bovine AP to recombinant AP) 收起 << | - | Belgium ... 展开 >> University Medical Center Antwerp (UZA) Antwerp, Belgium Cliniques Universitaires Saint Luc-UCL Brussels, Belgium ULB Hopital Erasme Brussels, Belgium Universitair Ziekenhuis Brussel Brussels, Belgium Netherlands UMC Nijmegen University Medical Center St Radboud Nijmegen, Gelderland, Netherlands, 6500 HB Isala Clinics Zwolle, Overijssel, Netherlands, 8011 JW Jeroen Bosch Ziekenhuis lokatie GZG 's-Hertogenbosch, Netherlands VU University Medical Center Amsterdam, Netherlands Canisius Wilhelmina Ziekenhuis Nijmegen, Netherlands 收起 << |
NCT01473524 | Primary Biliary Cirrhosis | Phase 3 | Active, not recruiting | June 2018 | - |
NCT01473524 | - | Active, not recruiting | - | - | |
NCT00005569 | Healthy Wound... 展开 >> Healing 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Dental And Craniofacial Research (NIDCR) Bethesda, Maryland, United States, 20892 收起 << |
NCT02733549 | - | Completed | - | Turkey ... 展开 >> Adiyaman University Research Hospital Adiyaman, Central, Turkey, 02000 收起 << | |
NCT01456468 | Cholangitis, Sclerosing | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine - 333 Cedar St - 1080 LMP New Haven, Connecticut, United States, 06520 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT02212327 | - | Recruiting | December 2019 | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Aseel Alsouqi, MD 615-343-6225 aseel.alsouqi@vanderbilt.edu Principal Investigator: Alp Ikizler, MD 收起 << | |
NCT03104166 | Vascular Calcification | Not Applicable | Not yet recruiting | December 31, 2018 | - |
NCT03375073 | Positive Communication ... 展开 >> Clinical Performance Anaesthesiology High Fidelity Simulation 收起 << | Not Applicable | Recruiting | September 2018 | France ... 展开 >> University Grenoble Alps Recruiting La Tronche, France, 38700 Contact: Pierre Albaladejo, M.D. Ph.D. +33 (0) 4 76 76 92 88 palbaladejo@chu-grenoble.fr Contact: Julien Picard, M.D. +33 (0) 4 76 76 92 88 jpicard@chu-grenoble.fr Principal Investigator: Jean-Noel Evain, M.D. 收起 << |
NCT02378870 | Prostate Cancer Metastatic | Phase 2 | Terminated(Poor patient recrui... 展开 >>tment) 收起 << | - | Sweden ... 展开 >> Oncology clinic, Norrlands Universitetssjukhus Umeå, Sweden, 901 85 收起 << |
NCT00952484 | Hypophosphatasia (HPP) | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Shriners Hospital for Children St. Louis, Missouri, United States, 63131 Canada, Manitoba The University of Manitoba Health Services Centre Winnipeg, Manitoba, Canada, R3A 1S1 收起 << |
NCT00570765 | Liver Cirrhosis, Biliary | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Henry Ford Novi, Michigan, United States, 39450 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Virginia McGuire DVAMC Richmond, Virginia, United States, 23219 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Austria Karls-Franzens University Graz, Austria, A8036 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario University of Toronto Toronto, Ontario, Canada, M5T 2S8 Canada, Quebec Centre de Recherche du CHUM / University of Montreal Montreal, Quebec, Canada, H2X 1P1 France Hopital de l'Hotel Dieu Lyon, France, 69288 Hopital Saint-Antoine Paris, France, 75012 Germany Johann Wolfgang Goethe University Frankfurt, Germany, 60590 University Medical Centre Hamburg-Eppendorf Hamburg, Germany, D20246 Medical School of Hannover Hannover, Germany, 30623 University of Munich Munich, Germany, D81377 Spain Hospital Clinic i Provincial Barcelona, Spain, 08036 United Kingdom Queen Elizabeth Medical Center Edgbaston, Birmingham, United Kingdom, B15 2TH Royal Free Hospital Hampstead, London, United Kingdom, NW3 2QG John Radcliffe Hospital Headington, Oxford, United Kingdom, OX3 9DU Royal Infirmary Edinburgh, United Kingdom, EH16 4SA University Upon Tyne/Newcastle Newcastle Upon Tyne, United Kingdom, NE2 4HH 收起 << |
NCT03442361 | - | Completed | - | - | |
NCT02204943 | Bone Metastatic Castration-Res... 展开 >>istant Prostate Cancer 收起 << | Early Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02825628 | Prostate Cancer Metastatic | Phase 2 | Active, not recruiting | October 2020 | Estonia ... 展开 >> East Tallinn Central Hospital Tallinn, Estonia, 10138 Tartu University Hospital Tartu, Estonia, 51014 Finland Tampere University Hospital, Urology Clinic Tampere, Finland, 33520 Latvia Latgales Urology Center Daugavpils, Latvia, 5401 Pauls Strandins Clinical University Hospital Riga, Latvia, 1002 Sweden Urology Clinic, Sodersjukhuset AB Stockholm, Sweden, 118 83 Oncology Clinic, Norrlands Universitetssjukhus Umeå, Sweden, 901 85 Örebro University Hospital Örebro, Sweden, 70185 收起 << |
NCT00952484 | - | Completed | - | - | |
NCT00894075 | Hypophosphatasia | Phase 2 | Withdrawn(Withdrawn pending fu... 展开 >>rther review of clinical design.) 收起 << | December 2014 | - |
NCT03668145 | Primary Biliary Cirrhosis | Not Applicable | Recruiting | December 31, 2020 | China, Shaanxi ... 展开 >> Changcun Guo Recruiting Xi'an, Shaanxi, China, 710032 Contact: Changcun Guo 13991900180 guochc@sina.com 收起 << |
NCT01203826 | Hypophosphatasia (HPP) | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Shriners Hospital for Children Saint Louis, Missouri, United States, 63110 Canada, Manitoba Children's Hospital Health Sciences Centre Winnipeg, Manitoba, Canada, R3A 1S1 收起 << |
NCT03226067 | Primary Biliary Cirrhosis | Phase 2 | Active, not recruiting | September 26, 2019 | - |
NCT01203826 | - | Completed | - | - | |
NCT00005465 | - | Completed | - | - | |
NCT03742973 | Primary Biliary Cholangitis | Phase 2 | Not yet recruiting | October 15, 2020 | United States, California ... 展开 >> Southern California GI and Liver Centers (SCLC) Not yet recruiting Coronado, California, United States, 92118 Contact 619-522-0399 Principal Investigator: Tarek Hassanein Cedars-Sinai Comprehensive Transplant Center Not yet recruiting Los Angeles, California, United States, 90048 Contact 310-423-6000 Principal Investigator: Vinay Sundaram UC Davis Transplant Research Not yet recruiting Sacramento, California, United States, 95816 Contact 916-734-0779 Principal Investigator: Christopher Bowlus United States, Colorado University of Colorado School of Medicine Not yet recruiting Aurora, Colorado, United States, 80045 Contact 728-848-2292 Principal Investigator: Lisa Forman United States, Florida Florida Digestive Health Specialists Not yet recruiting Lakewood Ranch, Florida, United States, 34211 Contact 941-727-7772 Principal Investigator: Guy W Neff Schiff Center for Liver Diseases/University of Miami Not yet recruiting Miami, Florida, United States, 33136 Contact 305-243-4615 Principal Investigator: Cynthia Levy United States, Louisiana Tulane University School of Medicine Not yet recruiting New Orleans, Louisiana, United States, 70112 Contact 504-988-5344 Principal Investigator: Fredric Regenstein United States, Maryland The Institute for Digestive Health and Liver Disease at Mercy Not yet recruiting Baltimore, Maryland, United States, 21202 Contact 410-332-9356 Principal Investigator: Paul Thuluvath United States, Michigan Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact 313-916-9465 Principal Investigator: Stuart Gordon United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact 507-284-3917 Principal Investigator: John Eaton United States, Missouri St Louis University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63104 Contact 314-577-8764 Principal Investigator: Bruce Bacon United States, Ohio UH Cleveland Medical Center Not yet recruiting Cleveland, Ohio, United States, 44106 Contact 216-844-5387 Principal Investigator: Anthony Post United States, Texas Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact 713-798-1966 Principal Investigator: John Vierling Italy Azienda Ospedaliera San Gerardo Not yet recruiting Monza, Milano, Italy, 20052 Contact 390392333673 Principal Investigator: Pietro Invernizzi Istituto Clinico Humanitas Not yet recruiting Rozzano, Milano, Italy, 20089 Contact 390282244556 Principal Investigator: Ana Lleo De Nalda Azienda Ospedaliera Umberto I Not yet recruiting Ancona, Italy, 60124 Contact 390715963377 Principal Investigator: Marco Marzioni Puerto Rico Klinical Investigations Group, LLC Not yet recruiting San Juan, Puerto Rico, 00909 Contact 7879197865 Principal Investigator: Federico Rodriguez University of Puerto Rico, Medical Sciences Campus Not yet recruiting San Juan, Puerto Rico, 00936 Contact 7877540101 Principal Investigator: Esther A. Torres 收起 << |
NCT00739505 | Hypophosphatasia (HPP) | Phase 1 | Completed | - | United States, Missouri ... 展开 >> Barnes Jewish Hospital- Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Canada, Manitoba Department of Pediatrics & Child Health, Health Sciences Centre Winnipeg, University of Manitoba Winnipeg, Manitoba, Canada, R3A 1S1 收起 << |
NCT02200029 | Intrahepatic Cholestasis Assoc... 展开 >>iated With Alcoholic Liver Disease 收起 << | Phase 3 | Completed | - | Russian Federation ... 展开 >> Research facility ORG-000962 Moscow, Russian Federation, 107014 Research facility ORG-000957 Moscow, Russian Federation, 117292 Research facility ORG-000961 Moscow, Russian Federation, 119435 Research facility ID ORG-000960 Moscow, Russian Federation, 119992 Research facility ID ORG-000726 Moscow, Russian Federation, 125284 Research facility ORG-000967 St. Petersburg, Russian Federation, 117630 Research facility ORG-000966 St. Petersburg, Russian Federation, 191015 Research facility ORG-000968 St. Petersburg, Russian Federation, 195257 Research facility ORG-000965 St. Petersburg, Russian Federation, 197022 Research facility ORG-000970 St. Petersburg, Russian Federation, 198216 Research facility ORG-000958 Troitsk, Russian Federation, 142190 Research facility ORG-000969 Yaroslavl, Russian Federation, 150003 收起 << |
NCT03112681 | Primary Biliary Cirrhosis | Phase 2 | Recruiting | March 2019 | United States, California ... 展开 >> California Liver Research Institute Recruiting Pasadena, California, United States, 91105 Contact: Stephanie Tang 626-795-5769 stephanie.tang@caliverresearch.org Principal Investigator: Edward Mena, MD United States, Indiana Indiana University School of Medicine Recruiting Indianapolis, Indiana, United States, 46202 Contact: Raj Vuppalanchi, MD Principal Investigator: Raj Vuppalanchi, MD United States, New Jersey Rutgers NJ Medical School Recruiting Newark, New Jersey, United States, 07101 Contact: Nick Pyrsopoulos, MD Principal Investigator: Nick Pyrsopoulos, MD United States, New York Sandra Atlas Bass Center for Liver Diseases- Northwell Health Withdrawn Manhasset, New York, United States, 11030 Mount Sinai Withdrawn New York, New York, United States, 10029 NY Presbyterian-Columbia Withdrawn New York, New York, United States, 10032 Center for Liver Diseases; New York Methodist Hospital Withdrawn New York, New York, United States, 11215 United States, North Carolina The University of North Carolina at Chapel Hill Withdrawn Chapel Hill, North Carolina, United States, 27599 Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28204 Contact: Andrew deLemos, MD Contact: Elise Duffield 704-446-4835 Principal Investigator: Andrew deLemos, MD United States, Pennsylvania Hospital of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: David Goldberg, MD Contact: Maureen McCauley 215-746-2575 Principal Investigator: David Goldberg, MD Einstein Medical Center Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19141 Contact: Simona Rossi, MD Principal Investigator: Simona Rossi, MD 收起 << |
NCT00550862 | Liver Cirrhosis, Biliary | Phase 2 | Completed | - | - |
NCT00570765 | - | Completed | - | - | |
NCT03599544 | Stroke Cerebr... 展开 >>ovascular Accident 收起 << | Not Applicable | Recruiting | November 2019 | United States, Massachusetts ... 展开 >> MGH Institute of Health Professions Recruiting Boston, Massachusetts, United States, 02129 Contact: Susan E Fasoli, ScD 617-643-4777 sfasoli@mghihp.edu Spaulding Rehabilitation Hospital Recruiting Boston, Massachusetts, United States, 02129 Contact: Susan E. Fasoli, ScD 617-643-4777 sfasoli@mghihp.edu Contact: Catherine Adans-Dester 617-952-6321 cadans-dester@partners.org Principal Investigator: Susan E. Fasoli, ScD Sub-Investigator: Paolo Bonato, PhD 收起 << |
NCT01144611 | Inflammation | Phase 3 | Completed | - | Netherlands ... 展开 >> Catharina Ziekenhuis, Dept. CardioThoracic Surgery Eindhoven, Netherlands, 5623 EJ 收起 << |
NCT02796885 | - | Recruiting | December 2018 | United Kingdom ... 展开 >> Nuffield Orthopaedic Research Not yet recruiting Oxford, United Kingdom, OX3 7HE Contact: Kassim Javaid 01865737871 kassim.javaid@ndorms.ox.ac.uk University of Sheffield Recruiting Sheffield, United Kingdom, S10 2TN Contact: Jennifer S Walsh, MBChB PhD +44 0114 2714705 j.walsh@sheffield.ac.uk Contact: Richard Eastell, MB MD +44 0114 2714705 r.eastell@sheffield.ac.uk 收起 << | |
NCT02177136 | - | Completed | - | - | |
NCT02177136 | Primary Sclerosing Cholangitis... 展开 >> (PSC) 收起 << | Phase 2 | Completed | - | - |
NCT00574639 | Type 1 Diabetes | Early Phase 1 | Completed | - | United States, Maryland ... 展开 >> University of Maryland, Baltimore Baltimore, Maryland, United States, 21201 收起 << |
NCT01389973 | Primary Biliary Cirrhosis | Phase 2 | Completed | - | United States, Florida ... 展开 >> Jacksonville, Florida, United States Miami, Florida, United States Naples, Florida, United States United States, Mississippi Tupelo, Mississippi, United States United States, New York New York, New York, United States United States, Texas Houston, Texas, United States Canada, British Columbia Vancouver, British Columbia, Canada Canada, Nova Scotia Halifax, Nova Scotia, Canada Canada, Ontario Toronto, Ontario, Canada Canada, Quebec Montreal, Quebec, Canada 收起 << |
NCT00550862 | - | Completed | - | - | |
NCT03561584 | Primary Sclerosing Cholangitis | Phase 2 | Recruiting | April 1, 2020 | United States, California ... 展开 >> University of California, Davis Recruiting Davis, California, United States, 95616 Contact: Sandeep Dhaliwal Principal Investigator: Chris Bowlus, MD United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Andrea Elibero Principal Investigator: Cynthia Levy, MD Sub-Investigator: Diane Sabogal, MD United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Fernanda Quevedo 617-732-9676 squevedo@bwh.harvard.edu Principal Investigator: Joshua Korzenik, MD United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Donna Rush Principal Investigator: Stuart Gordon, MD United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Stacey Smith Principal Investigator: Andrew Muir United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Maureen Mccauley Principal Investigator: David Goldberg, MD 收起 << |
NCT01389973 | - | Completed | - | - | |
NCT01829698 | Cholestatic Liver Disease | Phase 3 | Completed | - | China, Beijing ... 展开 >> Liver Research Center,Beijing Friendship Hospital Beijing, Beijing, China, 100050 收起 << |
NCT02653625 | Primary Sclerosing Cholangitis | Phase 2 | Completed | - | United States, California ... 展开 >> Scripps Clinic La Jolla, California, United States, 92037 University of California, Davis Medical Center Sacramento, California, United States, 95817 Sutter Health, California Pacific Medical Center San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, New York Icahn School of Medicine New York, New York, United States, 10029 Canada, Alberta University of Calgary, Liver Unit Calgary, Alberta, Canada, T2N 4Z6 University of Alberta, Zeidler Ledcor Centre Edmonton, Alberta, Canada, T6G 2X8 Canada, Manitoba University of Manitoba Winnipeg, Manitoba, Canada, R3E 3P4 Canada, Ontario Toronto University Health Center Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT03602976 | Hepatic Sarcoidosis, Elevated ... 展开 >>Alkaline Phosphatase 收起 << | Phase 2 | Recruiting | July 1, 2020 | United States, Pennsylvania ... 展开 >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kelly A Borges 215-615-3755 kelly.borges@uphs.upenn.edu Principal Investigator: Ethan M Weinberg, MD, MS Principal Investigator: K. Rajender Reddy, MD 收起 << |
NCT02653625 | - | Completed | - | - | |
NCT00430859 | Sepsis Multip... 展开 >>le Organ Dysfunction Syndrome 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> University Hospital Vrije Universiteit Brussel Brussel, Brussels Hoofdstedelijk Gewest, Belgium, B-1090 Hospital Network Antwerpen - Middelheim Antwerpen, Belgium, B-2020 University Hospital Antwerpen Antwerpen, Belgium, B-2650 Netherlands Medical Centre Leeuwarden Leeuwarden, Friesland, Netherlands, 8934 AD University Medical Centre St. Radboud Nijmegen, Gelderland, Netherlands, 6500 HB St. Elisabeth Hospital Tilburg, N-Brabant, Netherlands, 5022 GC Isala Clinics Zwolle, Overijssel, Netherlands, 8011 JW Erasmus Medical Centre Rotterdam, Z-Holland, Netherlands, 3015 GD University Medical Centre Groningen Groningen, Netherlands, 9700 RB University Medical Centre Utrecht Utrecht, Netherlands, 3508 GA 收起 << |
NCT00294567 | Hypertension ... 展开 >>Coronary Atherosclerosis 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Department of Cardiology, Juntendo University School of Medicine Tokyo, Japan 收起 << |
NCT03124108 | Primary Biliary Cholangitis (P... 展开 >>BC) 收起 << | Phase 2 | Recruiting | April 2018 | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Recruiting Phoenix, Arizona, United States, 85054 Contact: Elizabeth J. Carey, MD 480-342-2000 United States, Florida Schiff Center for Liver Diseases Recruiting Miami, Florida, United States, 33136 Contact: Cynthia Levy, MD 305-243-4615 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Daniel Pratt, MD 617-724-3836 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Alan Bonder, MD 617-632-1086 United States, New York Northwell Health - Sandra Atlas Bass Center for Liver Disease Recruiting Manhasset, New York, United States, 11030 Contact: Henry C. Bodenheimer, MD 516-562-4664 United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Marlyn Mayo, MD 214-648-2725 Baylor College of Medicine - Advanced Liver Therapies Recruiting Houston, Texas, United States, 77030 Contact: John M. Vierling, MD 832-355-8966 United States, Virginia University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Stephen H. Caldwell, MD 434-924-2626 Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Contact: Velimir Luketic, MD 804-828-4060 United States, Washington Swedish Organ Transplant and Liver Center Recruiting Seattle, Washington, United States, 98104 Contact: Kris Kowdley, MD 206-386-3880 Germany Clinic for Gastroenterology and Hepatology Recruiting Köln, Germany, 50937 Contact: Münevver Demir, MD +49 (0)2214 787334 Johannes Gutenberg University Recruiting Mainz, Germany, 55131 Contact: Jorn M Schattenberg, MD +49 (0)6131 176831 Spain Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Adolfo Gallego Moya, MD +34 932 919-000 Liver Unit, University of Barcelona Recruiting Barcelona, Spain, 08036 Contact: Albert Pares, MD +34 932 275-753 United Kingdom Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2GW Contact: Gideon Hirschfield, MD +44 (0)121 415-8700 Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: George Mells, MD +44 (0)122 324-5151 The Royal Liverpool University Hospital Recruiting Liverpool, United Kingdom, L7 8XP Contact: Imran Patanwala, MD +44 (0)151 706-2000 Royal Free London NHS Foundation Trust Not yet recruiting London, United Kingdom, NW3 2QG Contact: Douglas Thorburn, MD +44 (0)207 794-0500 Institute of Liver Studies, King's College Hospital Recruiting London, United Kingdom, SE5 9RS Contact: Michael Heneghan, MD +44 (0)203 299-7615 Royal Victoria Infirmary Recruiting Newcastle upon Tyne, United Kingdom, NE1 4LP Contact: David Jones, MD +44 (0)191 222-8335 收起 << |
NCT01790984 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Completed | - | United Kingdom ... 展开 >> University of Surrey Guildford, Surrey, United Kingdom, GU2 7XH 收起 << |
NCT03724383 | Atrial Fibrillation Paroxysmal | Not Applicable | Recruiting | April 2020 | Canada, British Columbia ... 展开 >> Richmond Hospital Cardiac Rehabilitation Not yet recruiting Richmond, British Columbia, Canada, V6X 1A2 Contact: Andrew Jakubowski, MD 6042731555 atjakubowski@gmail.com Richmond Health Services Not yet recruiting Richmond, British Columbia, Canada, V6Y 3T6 Contact: Christina Salgado, RN 6042335614 chris.salgado@vch.ca Garratt Wellness Centre Not yet recruiting Richmond, British Columbia, Canada, V7C 3S9 Contact (604) 204-2007 Richmond Cardiology Clinic Recruiting Richmond, British Columbia, Canada, V7C 5L9 Contact: Teddi Orenstein Lyall, MD 6042731555 teddi.orenstein@vch.ca Gordon and Leslie Diamond Health Care Centre Not yet recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Live Well Clinic Not yet recruiting Vancouver, British Columbia, Canada, V6M 3W6 Contact: Ali Zentner, MD 6042693705 St. Paul's Healthy Heart Program Not yet recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Saul Isserow, MD 6048227955 saul.isserow@vch.ca 收起 << |
NCT00874900 | Asthma | Not Applicable | Unknown | May 2013 | United States, Washington ... 展开 >> Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 收起 << |
NCT02427139 | Labor Pain Ob... 展开 >>stetric Pain 收起 << | Not Applicable | Unknown | September 2016 | India ... 展开 >> Fortis Hospital Recruiting Bangalore, Karnataka, India, 560 076 Contact: Gayathri D Kamath, M.D. 91-80-6621 4444 enquiries@fortishealthcare.com Contact: Jithesh R P, M.B.A. 917708931316 r.p.jithesh@dyansys.com 收起 << |
NCT01672918 | - | Withdrawn | - | - | |
NCT00727324 | Ulcerative Colitis | Phase 2 | Completed | - | Czech Republic ... 展开 >> Internal Clinic, Vitkovice Hospital Ostrava Ostrava, Vitkovice, Czech Republic, 703 84 Teaching Hospital Olomouc, Dep. Internal Clinic Olomouc, Czech Republic, 775 20 Center of Gastroenterology at General Teaching Hospital Prague, Czech Republic, 120 00 Institute of Clinical and Preventive Medicine (IKEM), Clinic of Hepatogastroenterology Prague, Czech Republic, 40 21 Italy Università di Ancona - Nuovo Complesso Didattico, Facoltà di Medicina e Chirurgia, Clinica di Gastroenterologia Ancona, Torrette, Italy, 60020 University of Bologna, Dept of Internal Medicine and Gastroenterology Bologna, Italy, I-40138 Ospedale di Marsciano, Ambulatorio Gastroenterologia Marsciano, Italy, 06055 Ospedale Santa Maria delle Croci, Servizio di Gastroenterologia e Endoscopia Digestiva Ravenna, Italy, 48100 Università Cattolica di Roma, Dipartimento di Medicina Interna Roma, Italy, 00168 Azienda Ospedaliera S. Camillo - Forlanini Roma, Italy, I-00152 Ospedale Mauriziano, UOA Gastroenterologia Torino, Italy, 10128 收起 << |
NCT00457613 | Severe Septic... 展开 >> Shock 收起 << | Phase 2 | Completed | - | Netherlands ... 展开 >> Radboud University Medical Centre Nijmegen, Gelderland, Netherlands 收起 << |
NCT02182440 | Acute Kidney Injury | Phase 2 | Completed | - | - |
NCT01889147 | Healthy | Early Phase 1 | Completed | - | Netherlands ... 展开 >> Centre for Human Drug Research Leiden, South-Holland, Netherlands, 2333CL 收起 << |
NCT00013689 | Autoimmune Disease ... 展开 >> Lymphoproliferative Disorder 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT02668120 | - | Completed | - | France ... 展开 >> CHRU,Hôpital Jeanne de Flandres Lille, France 收起 << | |
NCT00065390 | Autoimmune Disease ... 展开 >> Lymphatic Disease Lymphoproliferative Disorder 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 收起 << |
NCT01401647 | Cardiac Arrest | Phase 3 | Completed | - | United States, Alabama ... 展开 >> Alabama Resuscitation Center Birmingham, Alabama, United States, 35294 United States, California UCSD-San Diego Resuscitation Center San Diego, California, United States, 92103 United States, Oregon Portland Resuscitation Outcomes Consortium, Oregon Health & Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania The Pittsburgh Resuscitation Network, University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Dallas Center for Resuscitation Research, University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Washington Seattle-King County Center for Resuscitation Research, University of Washington Seattle, Washington, United States, 98195 United States, Wisconsin Milwaukee Resuscitation Network, Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario University of Ottawa/University of British Columbia Collaborative RCC, Ottawa Health Research Ottawa, Ontario, Canada Toronto Regional Resuscitation Research Out-of-Hospital Network, University of Toronto Toronto, Ontario, Canada 收起 << |
NCT03050476 | Systemic Inflammation ... 展开 >> Cardiopulmonary-bypass 收起 << | Phase 2 Phase 3 | Recruiting | September 2022 | Austria ... 展开 >> MedUniWien / AKH-Wien Recruiting Wien, Austria, 1090 Contact: Dominik Wiedemann, Prof. Dr. +43-1-40400-6966 dominik.wiedemann@meduniwien.ac.at Contact: Günther Laufer, Univ. Prof. Dr guenther.laufer@meduniwien.ac.at Belgium Hospital ZOL Not yet recruiting Genk, Belgium, 3600 Contact: Tom Fret, MD +32 89 - 32 50 05 TomFret@mac.com Germany Klinik für Herzchirurgie, Universitätsklinik Suspended Leipzig, Germany, 04289 Italy Policlinico Gemelli, Institute Cardiology Not yet recruiting Roma, Italy, 00168 Contact: Massimo Massetti, Prof.MD +39 06 - 3015 - 8762 Massimo.Massetti@unicatt.it Malaysia Institut Jantung Negara (IJN , Natl. Heart Inst.) Not yet recruiting Kuala Lumpur, Malaysia, 50400 Contact: Pau Kiew Kong, Dr. +603 2617 8200 paukk@ijn.com.my Contact: Jeffrey Jeswant Dillon, Prof Dr. jeswant@ijn.com.my Netherlands Catharina Ziekenhuis, Cathreine R&D, Heartcentre Recruiting Eindhoven, Netherlands, 5623 EJ Contact: M.E.S.H. Tan, MD +31 40 ‐ 239 8360 erwin.tan@catharinaziekenhuis.nl Contact: Esther van Dooren Esther.v.Dooren@catharinaziekenhuis.nl Portugal Hospital de Santa Marta Not yet recruiting Lisboa, Portugal, 1169-024 Contact: José Fragata, Prof. MD, PhD +351 21 359 41 06 jigFragata@gmail.com Contact: Pedro Coelho, MD pedropirescoelho@gmail.com Russian Federation Almazov Heart Center Not yet recruiting St Petersburg, Russian Federation, 197341 Contact: Alexandra Konradi, Prof dr +7 812 702-68-16 konradi@almazovcentre.ru Contact: Olga Bolsakova, Prof +7 (812) 702-37-41 oobolshakova@yahoo.com Singapore National University Hospital (NUH), Recruiting Singapore, Singapore, 119228 Contact: Theodoros Kofidis, Prof.Dr. +65 677 - 22059 Theodoros@nuhs.edu.sg Contact: Ram Ramanathan Ram_Ramanathan@nuhs.edu.sg 收起 << |
NCT01887600 | Anemia in Chronic Kidney Disea... 展开 >>se in Non-dialysis Patients 收起 << | Phase 3 | Completed | - | - |
NCT00068146 | - | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << | |
NCT01416493 | Acute Rheumatoid Arthritis | Phase 1 Phase 2 | Completed | - | United Kingdom ... 展开 >> Maidstone Hospital, Dept. Rheumatology Maidstone, Kent, United Kingdom, ME16 9QQ 收起 << |
NCT03187938 | - | Recruiting | May 2019 | United States, Ohio ... 展开 >> Good Samaritan TriHealth Hospital Recruiting Cincinnati, Ohio, United States, 45220 Contact: Ganga Devaiah, MS 513-862-2341 ganga_devaiah@trihealth.com Contact: Pam Plummer, MSN, RN 513-862-6918 pam_plummer@trihealth.com 收起 << | |
NCT01401647 | - | Completed | - | - | |
NCT02943161 | Asthma | Not Applicable | Recruiting | April 2019 | United States, Colorado ... 展开 >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Fernando Holguin 303-724-6095 fernando.holguin@ucdenver.edu United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27708 Contact: Heather Kuehn 919-479-0719 heather.kuehn@duke.edu Principal Investigator: Loretta Que, MD 收起 << |
NCT02747433 | Stroke | Not Applicable | Recruiting | June 2018 | United States, Massachusetts ... 展开 >> Spaulding Rehabilitation Hospital Recruiting Boston, Massachusetts, United States, 02129 Contact: Susan E. Fasoli, ScD 617-643-4777 sfasoli@mghihp.edu Contact: Catherine Adans-Dester 617-952-6321 cadans-dester@partners.org Principal Investigator: Susan E. Fasoli, ScD Sub-Investigator: Paolo Bonato, PhD 收起 << |
NCT03076775 | Pregnancy Preterm ... 展开 >> Neonatal Hypoglycemia Hyperglycemia Drug Induced 收起 << | Not Applicable | Recruiting | May 30, 2020 | United States, North Carolina ... 展开 >> University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Ashley N Battarbee, MD 收起 << |
NCT03520738 | Chronic Kidney Disease | Not Applicable | Not yet recruiting | June 1, 2021 | France ... 展开 >> CHU d'Angers - Service de Dermatologie Not yet recruiting Angers, France Contact: MARTIN Ludovic, Pr LuMartin@chu-angers.fr Principal Investigator: MARTIN Ludovic, Pr Service de Médecine Vacsulaire - CHU d'ANGERS Not yet recruiting Angers, France Contact: Samir HENNI, Dr Samir.henni@chu-angers.fr Principal Investigator: Samir HENNI, Dr CHU de Nice Not yet recruiting Nice, France Contact: Guillaume FAVRE, Dr 4 92 03 88 24 ext +33 favre.g@chu-nice.fr Principal Investigator: Guillaume FAVRE, Dr Sub-Investigator: Florence CHALMIN, Dr Sub-Investigator: Véronique BREUIL, Pr Sub-Investigator: Laetitia ALBANO, Dr Sub-Investigator: Sandor VIDO, Dr Sub-Investigator: Vincent ESNAULT, Pr Sub-Investigator: Georges LEFTHERIOTIS, Pr Service de Rhumatologie - Hôpital Cochin Not yet recruiting Paris, France Contact: Christian ROUX, Pr Christian.roux@aphp.fr Principal Investigator: Christian ROUX, Pr 收起 << |
NCT00001350 | - | Recruiting | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 << | |
NCT00605657 | - | Completed | - | - | |
NCT03328650 | Proximal Humeral Fracture ... 展开 >> Osteoporosis Risk 收起 << | Not Applicable | Recruiting | August 1, 2022 | United States, Tennessee ... 展开 >> Vanderbilt Orthopaedics Recruiting Nashville, Tennessee, United States, 37232 Contact: Julie M Daniels 615-322-4506 Julie.M.Daniels@Vanderbilt.edu Principal Investigator: Mihir J Desai, MD 收起 << |
NCT01222247 | Pregnancy Res... 展开 >>piratory Distress Syndrome Pregnancy Outcomes Preterm Birth 收起 << | Phase 3 | Active, not recruiting | May 2022 | United States, Alabama ... 展开 >> University of Alabama - Birmingham Birmingham, Alabama, United States, 35233 United States, California Stanford University Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80045 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Ohio State University Columbus, Ohio, United States, 43210 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pittsburgh Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Rhode Island Brown University Providence, Rhode Island, United States, 02905 United States, Texas University of Texas - Southwest Dallas, Texas, United States, 75235 University of Texas - Galveston Galveston, Texas, United States, 77555 University of Texas - Houston Houston, Texas, United States, 77030 United States, Utah University of Utah Medical Center Salt Lake City, Utah, United States, 84132 收起 << |
NCT00605657 | ALPS Hyperspl... 展开 >>enism Lymphadenopathy 收起 << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01612299 | Renal Transplant | Not Applicable | Withdrawn(Funding was withdraw... 展开 >>n for this study by the sponsor.) 收起 << | - | United States, Kentucky ... 展开 >> University of Kentucky Lexington, Kentucky, United States, 40536 收起 << |
NCT00125281 | Liver Cirrhosis, Biliary | Phase 2 | Terminated | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00460057 | Osteoporosis | Phase 4 | Completed | - | - |
NCT03648528 | Vitamin D Deficiency ... 展开 >> Hemodialysis Patient 收起 << | Phase 4 | Completed | - | - |
NCT01443572 | Kasai Operation ... 展开 >> Biliary Atresia 收起 << | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
NCT03201016 | - | Recruiting | December 2018 | Spain ... 展开 >> Corporació Sanitària i Universitària Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Jordi Sánchez-Delgado, M.D. PhD 937231010 ext 29803 jsanchezd@tauli.cat Sub-Investigator: Enrique Casado Burgos, M.D Sub-Investigator: Joaquim Profitós Font, M.D 收起 << | |
NCT01735799 | - | Unknown | - | Israel ... 展开 >> Liver Clinic, ZIv Medical Center Not yet recruiting Safed, Israel, 13100 Contact: Nimer Assy, MD +972-4-6828445 assy.n@ziv.health.gov.il 收起 << | |
NCT01839383 | Mineral-bone Metabolism | Not Applicable | Unknown | - | China, Beijing ... 展开 >> Beijing Friendship hospital Not yet recruiting Beijing, Beijing, China, 100050 Contact: Wenhu Liu, Doctor +86-01-63139144 liuwh2002@yahoo.cn Principal Investigator: Wenhu Liu, Doctor 收起 << |
NCT01073202 | Liver Transplantation ... 展开 >> Ischemia-reperfusion Injury Cholestasis 收起 << | Not Applicable | Completed | - | China, Shanghai ... 展开 >> Shanghai First People's Hospital Shanghai, Shanghai, China, 200080 收起 << |
NCT01504802 | - | Completed | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Florida Nemours Children Clinic Jacksonville, Florida, United States, 32207 收起 << | |
NCT02325895 | Bone Diseases, Metabolic | Not Applicable | Completed | - | - |
NCT01698840 | Premature Infants | Not Applicable | Completed | - | United States, Texas ... 展开 >> Baylor College of Medicine / Texas Children's Hospital Houston, Texas, United States, 77030 收起 << |
NCT01420874 | Colorectal Cancer ... 展开 >> Cancer of Pancreas Pancreatic Neoplasm Malignant Neoplasm of Large Intestine Malignant Tumor of Colon Colon Carcinoma Cancer of Colon Pancreatic Cancer 收起 << | Phase 1 | Active, not recruiting | June 2019 | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48601 收起 << |
NCT01861236 | - | Completed | - | Argentina ... 展开 >> Hospital de Trauma y Emergencia Dr Federico Abete Ingeniero Pablo Nogués, Buenos Aires, Argentina 收起 << | |
NCT03602573 | - | Recruiting | July 31, 2019 | Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Yi-Cheng Chen, MD 886-3-3281200 ext 8107 yichengliver@gmail.com Sub-Investigator: Rong-Nan Chien 收起 << | |
NCT01361165 | - | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << | |
NCT02477462 | - | Recruiting | May 2019 | United States, California ... 展开 >> University of California Davis Medical Center Recruiting Sacramento, California, United States, 95817 Contact: Sandeep Dhaliwal, MD 916-734-8696 sandhaliwal@ucdavis.edu Principal Investigator: Christopher L Bowlus, MD 收起 << | |
NCT01792648 | Dyslipidemia ... 展开 >>Obesity, Abdominal 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Cholesterol Research Center Berkeley, California, United States, 94705 收起 << |
NCT00179192 | End-Stage Renal Disease | Phase 2 | Withdrawn(non-enrollment) | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT03198325 | HIV Seropositivity | Not Applicable | Recruiting | April 2018 | Italy ... 展开 >> Ospedale San Raffaele Scientific Institute Recruiting Milan, Italy, 20127 Contact: Elisabetta Carini 0039022643 ext 7934 carini.elisabetta@hsr.it 收起 << |
NCT00878969 | Oxidative Stress ... 展开 >> Endothelial Dysfunction 收起 << | Phase 3 | Terminated(insufficient enroll... 展开 >>ment and retention) 收起 << | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 收起 << |
NCT02664857 | Postoperative Pain | Phase 4 | Recruiting | September 2018 | Turkey ... 展开 >> Cukurova University Recruiting Adana, Turkey, 01380 Contact: Ebru Biricik, MD 05052420223 ebrubiricik@mynet.com Contact: Nilgün Alpay 05324964955 nilgunalpay@yahoo.com 收起 << |
NCT03211520 | - | Completed | - | United States, Connecticut ... 展开 >> Connecticut Childrens Medical Center Hartford, Connecticut, United States, 06106 收起 << | |
NCT00878969 | - | Terminated(insufficient enroll... 展开 >>ment and retention) 收起 << | - | - | |
NCT03310554 | Bile Duct Stricture | Not Applicable | Active, not recruiting | October 31, 2020 | China, Beijing ... 展开 >> Peking University Third Hospital Beijing, Beijing, China, 100000 收起 << |
NCT02735200 | Vitamin D Deficiency | Phase 2 | Completed | - | Saudi Arabia ... 展开 >> King Fahd Hospital of the University AlKhobar, Saudi Arabia, 31952 收起 << |
NCT01359488 | Growth Hormone Deficiency | Phase 1 | Completed | - | United States, Texas ... 展开 >> Diabetes and Glandular Disease Clinic San Antonio, Texas, United States, 78229 收起 << |
NCT02735200 | - | Completed | - | - | |
NCT02472509 | Hemolytic Disorders ... 展开 >> Gallstones 收起 << | Phase 4 | Terminated(Study not feasible ... 展开 >>- very low recruitment rate) 收起 << | - | Israel ... 展开 >> Shaare Zedek Medical Center Jerusalem, Israel, 91031 收起 << |
NCT02751801 | - | Recruiting | August 2018 | United Kingdom ... 展开 >> Academic Unit of Bone Metabolism (Sheffield) Recruiting Sheffield, South Yorks, United Kingdom, S5 7AU Contact: Jennifer S Walsh, PhD 0114 2266941 jennifer.walsh2@sth.nhs.uk Contact: Tracey S Higginbottom 0114 2715238 Tracey.Higginbottom@sth.nhs.uk Principal Investigator: Jennifer S Walsh, PhD 收起 << | |
NCT02291497 | - | Completed | - | Germany ... 展开 >> Clinical Trial Unit, Orthopaedische Klinik Koenig-Ludwig-Haus, Lehrstuhl der Universitaet Wuerzburg Wuerzburg, Bavaria, Germany, 97074 收起 << | |
NCT03531593 | - | Completed | - | United States, Missouri ... 展开 >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 收起 << | |
NCT02106455 | - | Completed | - | Japan ... 展开 >> Osaka, Japan Tokyo, Japan 收起 << | |
NCT03440164 | - | Completed | - | - | |
NCT03040765 | Thalassemia Majors (Beta-Thala... 展开 >>ssemia Major) Osteoporosis 收起 << | Phase 3 | Recruiting | July 2019 | Qatar ... 展开 >> National Center for Cancer Care & Research (NCCCR) Recruiting Doha, Qatar Contact: Abdulqadir Nashwan 收起 << |
NCT00301353 | Osteoporosis | Not Applicable | Completed | - | France ... 展开 >> Institute National de la Recherche Agronomique Saint-Genes Champanelle, France, 63122 Italy National Institute for Research on Food an Nutrition Rome, Italy, 00178 Netherlands TNO Quality of Life Zeist, Netherlands, 3700 AJ 收起 << |
NCT02143323 | Healthy | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Jieon Lee Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 << |
NCT02215213 | Pregnancy | Not Applicable | Completed | - | Pakistan ... 展开 >> Aga Khan University Karachi, Sindh, Pakistan, 75300 收起 << |
NCT00378820 | Metabolic Syndrome ... 展开 >> Obesity 收起 << | Not Applicable | Unknown | - | Denmark ... 展开 >> Institute of Human Nutrition, Rolighedsvej 30 Frederiksberg C, Denmark, 1958 收起 << |
NCT03266146 | Drug-induced Liver Injury,Chro... 展开 >>nic 收起 << | Phase 1 Phase 2 | Recruiting | August 27, 2021 | China ... 展开 >> Beijing 302 hospital Recruiting Beijing, China, 100039 Contact: Zhengsheng Zou, Dr. +8601066933424 zszou302@163.com Principal Investigator: Zhengsheng Zou, Dr. 收起 << |
NCT01802996 | Neoplasms Liv... 展开 >>er Injury 收起 << | Phase 4 | Unknown | August 2014 | - |
NCT02247011 | Osteoporotic Fractures ... 展开 >> Osteoporosis, Postmenopausal 收起 << | Not Applicable | Completed | - | China, Beijing ... 展开 >> Department of Endocrinology, Peking Union Medical College Hospital Beijing, Beijing, China, 100730 收起 << |
NCT02237625 | - | Recruiting | September 2026 | United States, North Carolina ... 展开 >> Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Priya Kishnani, MD 919-681-1939 kishn001@mc.duke.edu Contact: Stephanie DeArmey, PA-C (919) 681-1946 dearm001@mc.duke.edu 收起 << | |
NCT02247011 | - | Completed | - | - | |
NCT03322943 | - | Recruiting | December 1, 2018 | China, Sichuan ... 展开 >> West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Li Yang, MD +8618980601276 yangli_hx@scu.edu.cn 收起 << | |
NCT02078882 | Primary Biliary Cirrhosis | Phase 4 | Completed | - | United States, California ... 展开 >> Univeristy of California Davis Medical Center Sacramento, California, United States, 95817 收起 << |
NCT03679572 | Renal Cancer | Not Applicable | Recruiting | March 1, 2020 | France ... 展开 >> University Hospital Grenoble-Alps (CHU-GA) Recruiting La Tronche, France, 38700 Contact: Jean-Alexandre Long, MD,PhD jalong@chu-grenoble.fr Contact: Emilie Chipon, PhD echipon@chu-grenoble.fr Sub-Investigator: Cécilia Lanchon, MD Sub-Investigator: Gaelle Fiard, MD,PhD Sub-Investigator: Jean-Luc Descotes, MD,PhD 收起 << |
NCT01765465 | Postcholecystectomy Syndrome | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> DongGuk University Ilsan Hospital Goyang, Gyeonggi, Korea, Republic of, 410-773 Chung-Ang University Hospital Seoul, Korea, Republic of, 156-755 收起 << |
NCT01402115 | - | Completed | - | - | |
NCT01402115 | Bone Health in Perimenopausal ... 展开 >>Women 收起 << | Phase 2 Phase 3 | Completed | - | Korea, Republic of ... 展开 >> Healthcare claims and management; Chonbuk National university Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 收起 << |
NCT00479037 | Osteoporosis | Phase 4 | Completed | - | Denmark ... 展开 >> Nycomed Roskilde, Denmark, 4000 收起 << |
NCT01765465 | - | Completed | - | - | |
NCT01268943 | - | Completed | - | - | |
NCT01587768 | - | Completed | - | - | |
NCT00479037 | - | Completed | - | - | |
NCT01268943 | Rectal Neoplasms | Phase 1 | Completed | - | China, Beijing ... 展开 >> radiation department, Cancer Hospital, CAMS Beijing, Beijing, China, 100021 收起 << |
NCT01703065 | Adenocarcinoma of the Prostate... 展开 >> Castration-resistant Prostate Cancer Recurrent Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer 收起 << | Phase 2 | Terminated(Closed 2017 for low... 展开 >> accrual. Last data for primary outcome on 02Feb2015.) 收起 << | - | United States, Washington ... 展开 >> Seattle Cancer Care Alliance/University of Washington Seattle, Washington, United States, 98109 收起 << |
NCT01703065 | - | Terminated(Closed 2017 for low... 展开 >> accrual. Last data for primary outcome on 02Feb2015.) 收起 << | - | - | |
NCT03537066 | Sleep Apnea, Obstructive | Not Applicable | Recruiting | October 31, 2020 | France ... 展开 >> Grenoble Alps University Hospital Recruiting Grenoble, Rhône Alpes, France, 38000 Contact: Jean-Louis PEPIN, MD, PhD 04.76.76.87.66 JPepin@chu-grenoble.fr Contact: Marie Joyeux-Faure, PharmD, PhD 04.76.76.71.66 MJoyeuxfaure@chu-grenoble.fr 收起 << |
NCT03066089 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | India ... 展开 >> Gian Sagar Medical College & Hospital Rajpura, Punjab, India, 140601 收起 << |
NCT02474446 | Vitamin D Status | Not Applicable | Completed | - | United Kingdom ... 展开 >> Sheffield Children's NHS Foundation Trust Sheffield, Sheffield (South Yorkshire district), United Kingdom, S10 2TH 收起 << |
NCT01224717 | Post-menopausal Osteoporosis | Phase 1 | Completed | - | Denmark ... 展开 >> Novartis Investigative Site Aalborg, Denmark Novartis Investigative Site Ballerup, Denmark Germany Novartis Investigative Site Berlin, Germany Novartis Investigative Site Munich, Germany 收起 << |
NCT00848471 | Healthy Obesi... 展开 >>ty 收起 << | Not Applicable | Unknown | December 2009 | France ... 展开 >> Centre de Recherche en Nutrition Rhône Alpes, Hôpital Edouard Herriot Recruiting Lyon, Rhone-Alps, France, 69424 收起 << |
NCT03150459 | Cirrhoses, Liver | Phase 2 | Completed | - | France ... 展开 >> Beajuon Hospital Clichy, Paris, France, 92110 Germany Universitatsklinikum Bonn Bonn, Germany, 53127 Italy Bologna University Hospital Bologna, Italy Padova University Hospital Padova, Italy, 35128 San Giovanni Battista Hospital Torino, Italy, 10129 Netherlands Academic Medical Centre Amsterdam, Netherlands, 1105 AZ Spain Hospital Universitari Vall d'Hebrón Barcelona, Spain, 08035 Hospital Clínic de Barcelona Barcelona, Spain, 08036 United Kingdom Royal Free Hospital London, United Kingdom, NW3 2QG 收起 << |
NCT01385085 | - | Unknown | - | - | |
NCT02997878 | Cholangitis, Sclerosing ... 展开 >> Hepatitis, Autoimmune 收起 << | Phase 1 Phase 2 | Not yet recruiting | December 2021 | - |
NCT01584544 | Rectal Neoplasms | Phase 1 | Completed | - | China, Beijing ... 展开 >> radiation department, Cancer Hospital, CAMS Beijing, Beijing, China, 100021 收起 << |
NCT01584544 | - | Completed | - | - | |
NCT03571438 | Kidney Cancer | Not Applicable | Recruiting | September 30, 2024 | France ... 展开 >> Grenoble Alps Hospital Recruiting Grenoble, France, 38043 Contact: Jean-Luc Descotes, PU-PH 收起 << |
NCT00562770 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03710122 | Primary Sclerosing Cholangitis | Phase 2 Phase 3 | Recruiting | November 2022 | United States, Arizona ... 展开 >> Mayo Clinic Arizona Recruiting Phoenix, Arizona, United States, 85259 Contact: Elizabeth Carey, MD United States, Florida Mayo Clinic Florida Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Denise M Harnois, DO United States, Minnesota Mayo Clinic Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Nichlas F LaRusso, MD 收起 << |
NCT01578239 | Carcinoid Tumor of the Small B... 展开 >>owel Neuroendocrine Tumour 收起 << | Phase 3 | Active, not recruiting | February 2021 | - |
NCT00325013 | Primary Sclerosing Cholangitis... 展开 >> Colitis 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01563484 | - | Unknown | September 2012 | China, Jiangsu ... 展开 >> Zhongda Hospital, Southeast University Nanjing, Jiangsu, China, 210009 收起 << | |
NCT01578239 | - | Active, not recruiting | - | - | |
NCT02605213 | Primary Sclerosing Cholangitis | Phase 4 | Unknown | February 2016 | Iran, Islamic Republic of ... 展开 >> Imam khomeini Hospital Complex Recruiting Tehran, Iran, Islamic Republic of, 1419733141 Contact: Naser Ebrahimi Daryani, Professor +989121104517 nasere@yahoo.com 收起 << |
NCT00710970 | Urinary Bladder Neoplasms | Phase 2 | Completed | - | United States, Texas ... 展开 >> Baylor College Of Medicine Houston, Texas, United States, 77030 Italy San Camillo and Forlanini Hospitals Rome, Italy 收起 << |
NCT00393185 | Primary Biliary Cirrhosis | Phase 1 | Withdrawn | - | - |
NCT00710970 | - | Completed | - | - | |
NCT00181558 | Prostate Cancer ... 展开 >> Adenocarcinoma of the Prostate 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01318304 | - | Completed | - | United States, Massachusetts ... 展开 >> Boston University Medical Center Boston, Massachusetts, United States, 02118 收起 << | |
NCT01100567 | Anorexia Nervosa | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT01100567 | - | Completed | - | - | |
NCT00740129 | Paget's Disease of the Bone | Phase 4 | Completed | - | Belgium ... 展开 >> Novartis Investigative site Brussels, Belgium Canada Novartis Investigative site Montreal, Canada Novartis Investigative site Quebec, Canada New Zealand Novartis Investigative site Aukland, New Zealand South Africa Novartis Investigative site Cape Town, South Africa Spain Novartis Investigative site Barcelona, Spain Novartis Investigative site Madrid, Spain Novartis Investigative site Salamanca, Spain Novartis Investigative site Valencia, Spain United Kingdom Novartis Investigative site Nottingham, United Kingdom Novartis Investigative site Oxford, United Kingdom 收起 << |
NCT02193360 | Primary Biliary Cirrhosis | Phase 1 Phase 2 | Unknown | December 2017 | Netherlands ... 展开 >> Amsterdam Medical Center Active, not recruiting Amsterdam, Netherlands, 1100 DD Erasmus University Medical Center Recruiting Rotterdam, Netherlands Contact: H R van Buuren, MD mdlpoli@erasmusmc.nl Principal Investigator: H R van Buuren, MD United Kingdom University Hospital Birmingham Recruiting Birmingham, United Kingdom Contact: G Hirschfield, MD G.Hirschfield@bham.ac.uk Royal Free Hospital Recruiting London, United Kingdom Contact: D Thorburn, MD douglas.thorburn@nhs.net Newcastle upon Tyne Hospitals Recruiting Newcastle upon Tyne, United Kingdom Contact: D Jones, MD 0191 213 7210 收起 << |
NCT00494104 | Vitamin D Deficiency | Not Applicable | Completed | - | United States, Iowa ... 展开 >> MTF, 2501 Crosspark Rd Coralville, Iowa, United States, 52241-8802 收起 << |
NCT00563914 | Malaria | Phase 1 Phase 2 | Completed | - | Gabon ... 展开 >> Sanofi-Aventis Administrative Office Lambaréné, Gabon Kenya Sanofi-Aventis Administrative Office Nairobi, Kenya 收起 << |
NCT00244478 | Osteoporosis ... 展开 >>Obesity 收起 << | Not Applicable | Completed | - | United States, Georgia ... 展开 >> The University of Georgia Athens, Georgia, United States, 30602 收起 << |
NCT01462552 | - | Completed | - | - | |
NCT00103740 | - | Completed | - | - | |
NCT00103740 | Paget's Disease of Bone | Phase 3 | Completed | - | - |
NCT00480662 | Paget's Disease of Bone | Phase 3 | Completed | - | - |
NCT03655041 | Sports Nutritional Physiologic... 展开 >>al Phenomena 收起 << | Not Applicable | Completed | - | - |
NCT03646162 | Prostate Cancer Metastatic | Phase 2 | Recruiting | March 18, 2019 | United States, Colorado ... 展开 >> The Urology Center of Colorado Recruiting Denver, Colorado, United States, 80211 Contact: Robin Dorsey 303-762-7155 Foothills Urology Recruiting Golden, Colorado, United States, 80401 Contact: Deborah Aggers 303-985-2550 United States, Idaho North Idaho Urology Recruiting Coeur d'Alene, Idaho, United States, 83814 Contact: Chris Weber 208-415-1749 United States, Indiana First Urology Recruiting Jeffersonville, Indiana, United States, 47130 Contact: Debbie Johnson 812-206-8161 United States, Maryland Chesapeake Urology Recruiting Towson, Maryland, United States, 21204 Contact: Jessica Harras 410-825-5454 United States, New Jersey Premier Urology Group Recruiting Edison, New Jersey, United States, 08837 Contact: Haleema Abdul Hameed 732-494-9400 United States, Pennsylvania Urologic Consultants Recruiting Bala-Cynwyd, Pennsylvania, United States, 19004 Contact: Kelly Liberatore 610-667-0485 United States, Texas Mary Crowley Cancer Research Recruiting Dallas, Texas, United States, 75230 Contact: Alisha Myers 972-566-3000 Urology San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Manuel Hernandez 210-617-4116 United States, Virginia Urology of Virginia Recruiting Virginia Beach, Virginia, United States, 23462 Contact: Laurie Jackson 757-452-3461 收起 << |
NCT03571191 | Bone Diseases ... 展开 >> Pain 收起 << | Phase 2 | Enrolling by invitation | January 31, 2019 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Bethesda, Maryland, United States, 20892 收起 << |
NCT02499081 | Multiple Myeloma | Phase 2 | Active, not recruiting | May 2021 | United States, Arkansas ... 展开 >> University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 收起 << |
NCT01237769 | Metabolic Syndrome | Phase 4 | Unknown | March 2012 | Greece ... 展开 >> Outpatient Lipid Clinic, University Hospital of Ioannina Recruiting Ioannina, Greece, 45 110 Contact: Moses Elisaf, MD +302651007509 egepi@cc.uoi.gr Sub-Investigator: Evangelos Liberopoulos, MD Sub-Investigator: Stefania Makariou, MD Sub-Investigator: Anna Challa, PhD 收起 << |
NCT00541710 | Metabolic Syndrome | Phase 2 Phase 3 | Completed | - | Italy ... 展开 >> University of Magnia Graecia Catanzaro, Italy Azienda Policlinico Universitario, G. Martino Messina, Italy, 090 University of Palermo Palermo, Italy, 90129 收起 << |
NCT03666312 | - | Recruiting | August 30, 2021 | Italy ... 展开 >> IRCCS San Raffaele Active, not recruiting Milan, Italy, 20132 Azienda Ospedaliero, Universitaria Pisana Recruiting Pisa, Italy Contact: Paola Carrai Azienda Ospedaliera Città della Salute e della Scienza di Torino Recruiting Torino, Italy Contact: Renato Romagnoli, MD 收起 << | |
NCT02256241 | - | Recruiting | July 2019 | Israel ... 展开 >> Rambam MC Recruiting Haifa, Israel Contact: Rostislav Novak, MD/PhD +972502061188 n_rosti@rambam.health.gov.il Contact: Amir M Orian, MD/PhD +97248295448/9 mdoryan@tx.technion.ac.il Principal Investigator: David Nikomarov, MD Sub-Investigator: Rostislav Novak, MD/PhD Sub-Investigator: Amir Oryan (Orian), MD/PhD 收起 << | |
NCT01565278 | Total Parenteral Nutrition-ind... 展开 >>uced Cholestasis 收起 << | Phase 3 | Terminated(No more eligible pa... 展开 >>tients could be identified.) 收起 << | - | Canada, Alberta ... 展开 >> Foothills Medical Center Calgary, Alberta, Canada, T2N 4Z6 University of Alberta Edmonton, Alberta, Canada, T5H 3V9 Canada, Manitoba St Boniface Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Canada, Ontario University Health Network Toronto, Ontario, Canada, M5G 2N2 收起 << |
NCT01402635 | Crowding | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT01946360 | Acute Liver Failure ... 展开 >> Acute on Chronic Liver Failure 收起 << | Not Applicable | Completed | - | India ... 展开 >> Institute of Liver & Biliary Sciences New Delhi, Delhi, India, 110070 收起 << |
NCT02950740 | - | Completed | - | - | |
NCT00004842 | Cholangitis, Sclerosing ... 展开 >> Liver Cirrhosis, Biliary 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01007656 | Healthy | Not Applicable | Completed | - | Taiwan ... 展开 >> PingTung Christian Hospital Pingtung, Taiwan 收起 << |
NCT01007656 | - | Completed | - | - | |
NCT01738282 | Alcohol Dependence | Phase 3 | Completed | - | France ... 展开 >> Angers, France Bron, France Clermont de l'Oise, France CHU Clermont Ferrand, France Hopital Beaujon Clichy, France Dax, France Centre hospitalier Dijon, France Centre hospitalier Erstein, France L'Arbresle, France Centre hospitalier La Membrolle sur Choisille, France Hopital Michallon La Tronche, France Centre hospitalier Le Mans, France CHRU Lille, France CSAPA Lille, France Limoges, France Hopital de la Croix Rousse Lyon, France Hopital Sainte Marguerite Marseille, France Centre hospitalier Montauban, France Morlaix, France Hopital Villemin Nancy, France CHU Nantes, France Centre hospitalier Nice, France CHRU Nimes, France Hopital Bichat Claude Bernard Paris, France Hopital Cochin Paris, France Hopital Fernand Widal Paris, France Hopital Saint Anne Paris, France Centre hospitalier Perpignan, France Centre hospitalier Pont du Casse, France Reims, France Hopital Pontchaillou Rennes, France Hopital de la Fraternité Roubaix, France Saint Egreve, France Hopital René Muret Sevran, France CSAPA Seynod, France Centre hospitalier intercommunal Toulon, France Hopital Brabois Vandoeuvre les Nancy, France Hopital Paul Brousse Villejuif, France 收起 << |
NCT01370941 | Osteoporosis ... 展开 >>Osteopenia 收起 << | Phase 1 | Completed | - | Denmark ... 展开 >> Ward 900, Osteporosis clinic, Aarhus University Hospital, THG Aarhus, Jutland, Denmark, 8000 收起 << |
NCT01380366 | - | Completed | - | - | |
NCT02967042 | Chronic Kidney Disease | Not Applicable | Recruiting | December 2020 | Finland ... 展开 >> TYKS/nefrologia ja dialyysihoidot Recruiting Turku, Finland Contact: Louise Aaltonen, LL 023138003 louise.aaltonen@tyks.fi Principal Investigator: Louise Aaltonen, LL 收起 << |
NCT00459654 | Prostate Cancer ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | Sweden ... 展开 >> Linköping, Sweden Sundsvall, Sweden United Kingdom Nottingham, United Kingdom 收起 << |
NCT01380366 | Short Bowel Syndrome | Phase 4 | Completed | - | United States, Illinois ... 展开 >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 收起 << |
NCT02788344 | - | Recruiting | December 2018 | France ... 展开 >> RENAU network Recruiting Metz-Tessy, France, 74374 Contact: Claire Morvan Contact: Pascale Cony-Makhoul 收起 << | |
NCT02430285 | Acute Biliary Pancreatitis | Not Applicable | Completed | - | Italy ... 展开 >> Endoscopy Unit, Gastroenterology Department, Humanitas Research Hospital Rozzano, Milan, Italy, 20089 收起 << |
NCT02299739 | - | Completed | - | Korea, Republic of ... 展开 >> Jaseng Hospital of Korean Medicine Seoul, Gangnam-Gu, Korea, Republic of, 135-896 收起 << | |
NCT00978718 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT00095147 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01387672 | Osteoporosis | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Women's College Research Institute/Women's College Hospital Toronto, Ontario, Canada, M5G 1N8 收起 << |
NCT00095147 | - | Completed | - | - | |
NCT00673257 | Unspecified Childhood Solid Tu... 展开 >>mor, Protocol Specific 收起 << | Not Applicable | Unknown | - | - |
NCT01126671 | Vitamin D Supplementation | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT01126671 | - | Completed | - | - | |
NCT02330276 | Pre-diabetes | Phase 1 | Completed | - | United States, California ... 展开 >> VA San Diego Healthcare System San Diego, California, United States, 92161 收起 << |
NCT02330276 | - | Completed | - | - | |
NCT00673257 | - | Unknown | - | - | |
NCT01511523 | Non Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Unknown | October 2012 | United States, North Carolina ... 展开 >> Cumberland Research Associates, LLC Fayetteville, North Carolina, United States, 28304 收起 << |
NCT01903460 | Alagille Syndrome | Phase 2 | Completed | - | United Kingdom ... 展开 >> Birmingham Children's Hospital Birmingham, West Midlands, United Kingdom, B4 6NH Leeds Teaching Hospitals Leeds, West Yorkshire, United Kingdom, LS9 7TF Kings College Hospital London, United Kingdom, SE5 9RS 收起 << |
NCT01903460 | - | Completed | - | - | |
NCT01387672 | - | Completed | - | - | |
NCT02177331 | Hypertension | Phase 3 | Completed | - | - |
NCT01563068 | Psoriasis | Phase 1 | Completed | - | United States, California ... 展开 >> Investigational Site San Diego, California, United States, 92123 United States, Florida Investigational Site Ormond Beach, Florida, United States, 32174 Investigational Site Tampa, Florida, United States, 33609 United States, Georgia Investigational Site Marietta, Georgia, United States, 30060 United States, Illinois Investigational Site Chicago, Illinois, United States, 60611 United States, Indiana Investigational Site Indianapolis, Indiana, United States, 46256 United States, Kentucky Investigational Site Louisville, Kentucky, United States, 40217 United States, Pennsylvania Investigational Site Philadelphia, Pennsylvania, United States, 19103 United States, Texas Investigational Site Houston, Texas, United States, 77030 收起 << |
NCT01422850 | Hormone-refractory Prostate Ca... 展开 >>ncer 收起 << | Phase 1 | Completed | - | Denmark ... 展开 >> Department of Urology Frederikssund, Denmark, DK-3600 收起 << |
NCT01422850 | - | Completed | - | - | |
NCT02187757 | Hyperlipidemia | Phase 3 | Completed | - | India ... 展开 >> Division of Clinical & Preventive Cardiology, Heart Institute Gurgaon, Delhi, India, 122001 Life Care Institute of Medical Science & Research Ahmedabad, Gujarat, India, 380014 Bhatia Hospital Medical Research Society Mumbai, Maharashtra, India, 400007 Dr. Vikas Govind Pai Clinical Research Foundation Pune, Maharashtra, India, 411005 Fortis Escorts Hospital Jaipur, Rajasthan, India, 302017 Pace Clinical Research Center Bangalore, Tamil Nadu, India, 560043 Singvi Health Centre Chennai, Tamil Nadu, India, 600079 Rangammal Hospital Tiruvannamalai, Tamil Nadu, India, 606003 收起 << |
NCT01216293 | Homeostasis B... 展开 >>one and Bones 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> San Diego, California, United States Walnut Creek, California, United States United States, Colorado Lakewood, Colorado, United States United States, Florida Hialeah, Florida, United States Jupiter, Florida, United States United States, Maryland Bethesda, Maryland, United States United States, New Mexico Albuquerque, New Mexico, United States United States, South Carolina Spartanburg, South Carolina, United States United States, Texas Austin, Texas, United States San Antonio, Texas, United States United States, Washington Seattle, Washington, United States United States, Wisconsin Madison, Wisconsin, United States 收起 << |
NCT00489905 | Prostatic Neoplasms ... 展开 >> Bone Density 收起 << | Not Applicable | Completed | - | China ... 展开 >> Department of Urology, Prince of Wales Hospital Hong Kong, China 收起 << |
NCT02731820 | Osteopenia Bo... 展开 >>ne Disease, Metabolic 收起 << | Not Applicable | Completed | - | Italy ... 展开 >> Istituto Ortopedico Rizzoli Bologna, Italy, 40136 收起 << |
NCT03244774 | Gastric Adenocarcinoma | Phase 1 | Recruiting | June 30, 2019 | China, Fujian ... 展开 >> Rongbo Lin Recruiting Fuzhou, Fujian, China, 350014 Contact: Rongbo Lin, MD 86+13705919382 rongbo_lin@163.com 收起 << |
NCT02035111 | Migraine | Phase 4 | Completed | - | China, Anhui ... 展开 >> The People's Hospital,Huaibei Huaibei, Anhui, China, 235000 China, Beijing Chinese PLA General Hospital Beijing, Beijing, China, 100039 Daxing hospital of Traditional Chinese Medicine Beijing, Beijing, China, 102600 China, Fujian Quanzhou First Hospita Quanzhou, Fujian, China, 362002 SanMing First Hospital Sanming, Fujian, China, 365000 China, Hebei The People's Hospital,Cangzhou Cangzhou, Hebei, China, 061000 Langfang hospital of Traditional Chinese Medicine Langfang, Hebei, China, 065000 The two six zero hospital of Chinese people's Liberation Army Shijiazhuang, Hebei, China, 050000 Tangshan TCM Hospital Tangshan, Hebei, China, 063000 China, Henan Kaifeng hospital of Traditional Chinese Medicine Kaifeng, Henan, China, 475000 Luohe hospital of Traditional Chinese Medicine Luohe, Henan, China, 462000 China, Hubei Wuhan sixth hospital Wuhan, Hubei, China, 430000 China, Hunan Yiyang central hospital Yiyang, Hunan, China, 413000 China, Jilin The Affiliated Hospital of Changchun University of Chinese medicine Changchun, Jilin, China, 130117 Jilin brain hospital Siping, Jilin, China, 136000 China, Shandong Jinan hospital of traditional Chinese Medicine Jinan, Shandong, China, 250000 The second affiliated hospital of Shandong Traditional Chinese Medicine University Jinan, Shandong, China, 250000 Affiliated Hospital of Jining Medical University Jining, Shandong, China, 272000 Jining First Hospital Jining, Shandong, China, 272000 China, Shanxi Xi An Hospital of Traditional Chinese Medicine Xian, Shanxi, China, 710021 收起 << |
NCT00067600 | Osteoporosis | Phase 1 | Completed | - | United States, Oregon ... 展开 >> Kaiser Permanente Center for Health Research Portland, Oregon, United States, 97227 收起 << |
NCT03602027 | Non-squamous Non-small Cell Lu... 展开 >>ng Cancer 收起 << | Not Applicable | Not yet recruiting | February 1, 2019 | - |
NCT02651350 | Drug-induced Liver Injury,Chro... 展开 >>nic 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2019 | China, Beijing ... 展开 >> Beijing 302 hospital,China Beijing, Beijing, China, 100039 收起 << |
NCT02561182 | - | Recruiting | December 2020 | United States, Minnesota ... 展开 >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55901 Contact: Henry Nguyen, MD Nguyen.Henry@mayo.edu Principal Investigator: Megha M Tollefson, MD 收起 << | |
NCT00657618 | Leishmaniasis | Phase 1 Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Walter Reed National Military Medical Center Washington, District of Columbia, United States, 20307 收起 << |
NCT02023411 | Diabetic Neuropathic Arthropat... 展开 >>hy 收起 << | Phase 2 | Active, not recruiting | December 2018 | India ... 展开 >> Deptt of Endocrinology Chandigarh, India, 160012 PGIMER Chandigarh, India, 160012 收起 << |
NCT00657618 | - | Completed | - | - | |
NCT01845870 | - | Completed | - | China, Tianjin ... 展开 >> General Hospital of Tianjin Medical University Tianjin, Tianjin, China, 300052 收起 << | |
NCT00282308 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02943746 | Premature Infants | Not Applicable | Recruiting | December 2019 | United States, Texas ... 展开 >> Baylor College of Medicine / Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Amy B Hair, MD 832-826-3719 abhair@texaschildrens.org Principal Investigator: Amy B Hair, MD 收起 << |
NCT03453047 | - | Recruiting | December 20, 2018 | Turkey ... 展开 >> Akdeniz University Medical Faculty Department of Anesthesiology and Reanimation Recruiting Antalya, Turkey, 07059 Contact: BORA DINC, ASSIST. PROF. +905323865600 drboradinc@gmail.com Contact: ILKER ONGUC AYCAN, ASSOC. PROF +905056702335 ilkeraycan@gmail.com Principal Investigator: BORA DINC, ASSIST. PROF Sub-Investigator: ILKER ONGUC AYCAN, ASSOC. PROF. 收起 << | |
NCT03712592 | Muscle Fatigue | Not Applicable | Completed | - | France ... 展开 >> CHU Grenoble-Alpes Grenoble, France, 38043 收起 << |
NCT03169088 | Healthy | Not Applicable | Active, not recruiting | September 1, 2019 | France ... 展开 >> University Hospital Grenoble Grenoble, France, 38043 收起 << |
NCT01213823 | - | Terminated(The study was termi... 展开 >>nated on May 5, 2011, due to methodological issues. The decision to terminate the study was not based on any safety or efficacy concerns.) 收起 << | - | - | |
NCT02195895 | Spinal Cord Injury ... 展开 >> Bone Loss Osteoporosis 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT02195895 | - | Completed | - | - | |
NCT01213823 | - | Terminated(The study was termi... 展开 >>nated on May 5, 2011, due to methodological issues. The decision to terminate the study was not based on any safety or efficacy concerns.) 收起 << | - | - | |
NCT03202407 | Hyperphosphatemia | Phase 3 | Not yet recruiting | December 1, 2018 | - |
NCT03024008 | Bone Fracture | Phase 1 Phase 2 | Recruiting | August 2019 | Israel ... 展开 >> Emek Medical Center Recruiting `Afula, Israel, 1834111 Contact: Nimrod Rozen, MD, PhD 04-6494201 nimrod_rozen@hotmail.com Contact: Inbal Reish, Ph.D 972-52-8877977 Inbal_la@clalit.org.il 收起 << |
NCT01527110 | Influenza, Human | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 816-0864 GSK Investigational Site Kanagawa, Japan, 247-8533 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 985-8506 GSK Investigational Site Okayama, Japan, 700-8557 GSK Investigational Site Osaka, Japan, 581-0011 GSK Investigational Site Shizuoka, Japan, 432-8002 收起 << |
NCT01717820 | Obesity | Not Applicable | Completed | - | United States, Texas ... 展开 >> Institute for Women's Health, Texas Woman's University Denton, Texas, United States, 76204-5876 收起 << |
NCT01527110 | - | Completed | - | - | |
NCT03416959 | - | Recruiting | December 31, 2019 | Italy ... 展开 >> Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Costantino Errani, MD, PhD 0039 051 6366103 costantino.errani@ior.it Contact: Davide Donati, MD 0039 051 6366012 davidemaria.donati@ior.it 收起 << | |
NCT02202200 | Melanoma BRAF V600E/K Mutated ... 展开 >> CDNKN2A Loss Defined 收起 << | Phase 1 Phase 2 | Unknown | August 2018 | France ... 展开 >> Saint-Louis Hospital Recruiting Paris, France, 75010 Contact: Celeste Lebbe, MDPHD +33 1 42 49 49 49 celeste.lebbe@sls.aphp.fr Principal Investigator: celeste lebbe, MD-PHD 收起 << |
NCT02178839 | Non Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Unknown | - | Iran, Islamic Republic of ... 展开 >> Shekh-al- rais Clinic Not yet recruiting Tabriz, Iran, Islamic Republic of Contact: Navideh Youshari, MSc. Student navideh_youshari@yahoo.co.uk Principal Investigator: Mohammad Alizadeh, PhD Principal Investigator: Mehrangiz Ebrahimi Mameghani, PhD 收起 << |
NCT03566576 | Non-squamous Non-small Cell Lu... 展开 >>ng Cancer 收起 << | Not Applicable | Not yet recruiting | October 1, 2018 | - |
NCT02897700 | Breast Cancer | Phase 1 | Recruiting | December 2020 | China, Jiangxi ... 展开 >> Ganzhou City People's Hospital Recruiting Ganzhou, Jiangxi, China, 341000 Contact: Xiao-Ming Zhong, M.D 86-18160779919 jxthrz@qq.com China, Jilin China-Japan Union Hospital, Jilin University Recruiting Changchun, Jilin, China, 130033 Contact: Xian-Ling Cong, M.D 86-0431-89876626 congxl888@hotmail.com China Shanghai 10th People's Hospital, Tongji University School of Medicine Recruiting Shanghai, China, 200072 Contact: Da Fu, Ph.D 86-15921527578 fu800da900@126.com 收起 << |
NCT00282308 | - | Completed | - | - | |
NCT00364819 | - | Completed | - | - | |
NCT00924833 | Hypoxia Altit... 展开 >>ude Heart Failure 收起 << | Phase 4 | Completed | - | Italy ... 展开 >> Laboratorio Ricerche Cardiologiche. Istituto Auxologico Italiano. Ospedale S. Luca. Via Spagnoletto, 3. Regina Margherita Hut (Monte Rosa, Italian Alps, 4559 m) Milan, Italy, 20148 收起 << |
NCT00924833 | - | Completed | - | - | |
NCT01384253 | Breast Neoplasms ... 展开 >> Peritoneal Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Stomach Neoplasms 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University Of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California UCSD Moores Cancer Center San Diego, California, United States 收起 << |
NCT02097303 | Prostate Cancer | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Chesapeake urology Research Associates Towson, Maryland, United States, 21204 United States, Nebraska Urology Cancer Center and GU Research Network Omaha, Nebraska, United States, 68130 United States, New York Associated Medical Professionals Syracuse, New York, United States, 13210 United States, Oregon Oregon Urology Institute Springfield, Oregon, United States, 97477 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 收起 << |
NCT03011281 | - | Recruiting | December 2021 | Korea, Republic of ... 展开 >> Hanyang University Recruiting Seoul, Korea, Republic of, 04763 Contact: Yoon-kyoung Sung, MD, PhD, MPH 82-2-2290-9250 sungyk@hanyang.ac.kr 收起 << | |
NCT02097303 | - | Completed | - | - | |
NCT00364819 | Primary Biliary Cirrhosis | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University of California Davis Medical Center Sacramento, California, United States, 95817 收起 << |
NCT00699751 | Hormone Refractory Prostate Ca... 展开 >>ncer Bone Metastases 收起 << | Phase 3 | Completed | - | - |
NCT01744769 | - | Unknown | May 2013 | Korea, Republic of ... 展开 >> Konkuk University Medical Center Recruiting Seoul, Korea, Republic of, 143-729 Contact: Jee Hyun An 82-10-9089-4655 jeehyunan@gmail.com Principal Investigator: Suk Kyoung Kim, MD, PhD Sub-Investigator: Jee Hyun An, MD, PhD Sub-Investigator: Ki Ho Song, MD, PhD Sub-Investigator: Dong Lim Kim, MD, PhD 收起 << | |
NCT00325468 | Low Bone Mineral Density | Phase 3 | Completed | - | - |
NCT03693807 | Colorectal Cancer ... 展开 >> Cholangiocarcinoma 收起 << | Phase 2 | Recruiting | September 2020 | United States, New Jersey ... 展开 >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Nancy Kemeny, MD 646-888-4180 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Nancy Kemeny, MD 646-888-4180 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Nancy Kemeny, MD 646-888-4180 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Nancy Kemeny, MD, PhD 646-888-4180 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Nancy Kemeny, MD 646-888-4180 Principal Investigator: Nancy Kemeny, MD Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nancy Kemeny, MD 646-888-4180 Principal Investigator: Nancy Kemeny, MD Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Nancy Kemeny, MD 646-888-4180 收起 << |
NCT00325468 | - | Completed | - | - | |
NCT00773448 | Venous Thromboembolism ... 展开 >> Deep Vein Thrombosis Pulmonary Embolism 收起 << | Not Applicable | Completed | - | Canada, Manitoba ... 展开 >> St. Boniface Hospital Winnipeg, Manitoba, Canada Canada, Nova Scotia Capital Health Centre for Research Halifax, Nova Scotia, Canada Canada, Ontario St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada London Health Sciences Center London, Ontario, Canada Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Montreal General Hospital Montreal, Quebec, Canada Sacre-Coeur Hospital Montreal, Quebec, Canada Sir Mortimer B. Davis Jewish General Hospital Montreal, Quebec, Canada St. Mary's Hospital Center Montreal, Quebec, Canada 收起 << |
NCT03693612 | Neoplasms | Phase 1 Phase 2 | Recruiting | June 16, 2022 | United States, Massachusetts ... 展开 >> GSK Investigational Site Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Not yet recruiting New York, New York, United States, 10016- Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Oklahoma GSK Investigational Site Not yet recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Recruiting San Antonio, Texas, United States, 78240 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Principal Investigator: Anthony Tolcher Australia, New South Wales GSK Investigational Site Not yet recruiting Darlinghurst, New South Wales, Australia, 2010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Not yet recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Not yet recruiting Ottawa, Ontario, Canada, K1H 8L Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Toronto, Ontario, Canada, M5G 2M Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Centre 877-379-3718 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03660748 | Obesity | Early Phase 1 | Recruiting | September 1, 2019 | Canada, Ontario ... 展开 >> GI Labs Recruiting Toronto, Ontario, Canada, M5C2N8 Contact: Adish Ezatagha, MSc 416 861-9782 ext 208 aezatagha@gilabs.com Contact: Alexandra L Jenkins, PhD / RN 416 861-9782 ext 200 alexandrajenkins@gilabs.com 收起 << |
NCT01846117 | Oxidative Stress ... 展开 >> Inflammation Aging Pain 收起 << | Phase 1 Phase 2 | Completed | - | Canada, Saskatchewan ... 展开 >> Saskatoon Centre for Patient-Oriented Research Saskatoon, Saskatchewan, Canada, S7K 0M7 收起 << |
NCT00625391 | Osteoporosis | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 收起 << |
NCT01668017 | Advanced Solid Tumors ... 展开 >> Hepatocellular Carcinoma 收起 << | Phase 1 | Terminated(The sponsor decided... 展开 >> not to conduct the expansion part of trial (part 2)) 收起 << | - | Japan ... 展开 >> Please contact Merck Serono Co., Ltd for recruiting locations in, Japan 收起 << |
NCT03089697 | Staphylococcus Aureus Bacterem... 展开 >>ia Anti-Bacterial Agents 收起 << | Phase 2 | Recruiting | April 2020 | Korea, Republic of ... 展开 >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 Contact: Hong Bin Kim, M.D, PhD +82-31-787-7021 hbkimmd@snu.ac.kr Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Wan Beom Park, M.D, PhD +82-2-2072-2114 wbpark1@snu.ac.kr 收起 << |
NCT00699751 | - | Completed | - | - | |
NCT01668017 | - | Terminated(The sponsor decided... 展开 >> not to conduct the expansion part of trial (part 2)) 收起 << | - | - | |
NCT03665402 | Tuberculosis ... 展开 >>Drug-Induced Liver Injury Adverse Drug Event 收起 << | Not Applicable | Recruiting | March 31, 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Clinical Trials Center Recruiting Seoul, Korea, Republic of, 110-744 Contact: In-Jin Jang, MD +82-2-2072-1930 ijjang@snu.ac.kr 收起 << |
NCT00625391 | - | Completed | - | - | |
NCT02941159 | Good Health | Phase 1 | Recruiting | February 2018 | Zambia ... 展开 >> Tropical Diseases Resaerch Centre Recruiting Ndola, Copperbelt, Zambia, 71769 Contact: Modest Mulenga, MD; PhD +260-212-620737 mulengam@tdrc.org.zm Contact: Shepherd Khondowe, MPH +260-212-620737 khondowes@tdrc.org.zm Principal Investigator: Ray Handema, PhD Sub-Investigator: Alasford Ngwengwe, PhD Sub-Investigator: Victor Mwanakasale, MD; PhD 收起 << |
NCT00964119 | - | Terminated(Principal Investiga... 展开 >>tor has left Sponsoring Instiution) 收起 << | - | United States, Wisconsin ... 展开 >> University of Wisconsin, Madison Madison, Wisconsin, United States, 53715 收起 << | |
NCT00119678 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT01594125 | Carcinoma, Hepatocellular | Phase 1 | Completed | - | Japan ... 展开 >> 1199.120.001 Boehringer Ingelheim Investigational Site Chuo-ku, Tokyo, Japan 1199.120.005 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1199.120.002 Boehringer Ingelheim Investigational Site Kashiwa, Chiba, Japan 1199.120.003 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1199.120.004 Boehringer Ingelheim Investigational Site Saga, Saga, Japan 收起 << |
NCT01594125 | - | Completed | - | - | |
NCT00964119 | - | Terminated(Principal Investiga... 展开 >>tor has left Sponsoring Instiution) 收起 << | - | - | |
NCT02341222 | Hernia | Early Phase 1 | Unknown | December 2015 | Italy ... 展开 >> National Health Institute (ISS Istituto Superiore di Sanità), Viale Regina Elena 299 Rome, Roma, Italy, 00161 收起 << |
NCT02147184 | - | Completed | - | United States, Iowa ... 展开 >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 收起 << | |
NCT00119678 | - | Completed | - | - | |
NCT00577720 | Postmenopausal Women | Phase 2 | Completed | - | United States, California ... 展开 >> Research Facility Costa Mesa, California, United States, 92626 United States, Florida Research Facility Gainsville, Florida, United States, 32608 Research Facility Miami, Florida, United States, 33126 United States, Hawaii Research Facility Honolulu, Hawaii, United States, 86813 United States, Texas Research Site Dallas, Texas, United States, 75247 Research Facility San Antonio, Texas, United States, 78229 收起 << |
NCT00983346 | - | Terminated(Lab Staff that was ... 展开 >>required left the institution, therefore accrual closed prematurely) 收起 << | - | - | |
NCT00983346 | Cancer Myelom... 展开 >>a Multiple Myeloma 收起 << | Phase 2 | Terminated(Lab Staff that was ... 展开 >>required left the institution, therefore accrual closed prematurely) 收起 << | - | United States, Utah ... 展开 >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 收起 << |
NCT03461562 | Nonalcoholic Fatty Liver Disea... 展开 >>se 收起 << | Not Applicable | Completed | - | Turkey ... 展开 >> Marmara University Istanbul, Turkey, 34000 收起 << |
NCT00222872 | Osteoporosis ... 展开 >>Osteoporosis, Postmenopausal 收起 << | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT00577720 | - | Completed | - | - | |
NCT00414271 | Stage T3-4NxM0 Gastric Cancer | Phase 2 | Unknown | - | Singapore ... 展开 >> Johns Hopkins Singapore International Medical Center Singapore, Singapore, 308433 收起 << |
NCT01466803 | Healthy | Phase 1 | Completed | - | Finland ... 展开 >> Turku University Hospital Turku, Finland, 20500 收起 << |
NCT00479973 | Type 2 Diabetes ... 展开 >> Hypercholesterolemia 收起 << | Phase 2 | Unknown | May 2008 | Canada, Ontario ... 展开 >> Canadian College of Naturopathic Medicine Recruiting Toronto, Ontario, Canada, m2k 1E2 Principal Investigator: Jean-Jacques Dugoua, NDPhD (cand) UHN - Toronto Western Hospital Recruiting Toronto, Ontario, Canada, M5T 2S8 Principal Investigator: Rowena Ridout, MD 收起 << |
NCT02147184 | - | Completed | - | - | |
NCT00238316 | Breast Cancer | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115-6084 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Hamilton Osteoporosis Diagnostic Services Hamilton, Ontario, Canada, L8N 1Y2 Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 St. Catharines General Hospital at Niagara Health System St. Catharines, Ontario, Canada, L2R 5K3 Toronto Sunnybrook Regional Cancer Centre at Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 收起 << |
NCT01829503 | Acute Myeloid Leukemia | Phase 2 | Active, not recruiting | October 2017 | United States, Pennsylvania ... 展开 >> University of PIttsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 收起 << |
NCT01829503 | - | Active, not recruiting | - | - | |
NCT01801397 | Low Bone Mass in Anorexia Nerv... 展开 >>osa Patients 收起 << | Phase 3 | Unknown | December 2016 | Switzerland ... 展开 >> University Hospital Zurich, Department of Psychiatry Recruiting Zurich, ZH, Switzerland, 8091 University Hospital Zurich, Rheumatology Department Recruiting Zurich, ZH, Switzerland, 8091 Contact: Diana P Frey, MD diana.frey@usz.ch Sub-Investigator: Diana P Frey, MD 收起 << |
NCT01779882 | Myeloid Leukemia ... 展开 >> Precursor Myeloid Neoplasms Lymphoid Neoplasms 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> University Hospital, Basel Basel, Switzerland, 4031 University Hospital Geneva Geneva, Switzerland, 1205 University Hospital Zurich Zurich, Switzerland, 8091 收起 << |
NCT00943176 | Fatigue Prima... 展开 >>ry Biliary Cirrhosis 收起 << | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00560300 | Secondary Hyperparathyroidism ... 展开 >> Renal Osteodystrophy 收起 << | Phase 2 | Completed | - | - |
NCT00723762 | - | Completed | - | United States, Ohio ... 展开 >> Hattie Larlham Center for Children with Disabilities Mantua, Ohio, United States, 44255 收起 << | |
NCT00986063 | Nevirapine Induced Rash ... 展开 >> Nevirapine Induced Hepatitis HIV Adverse Side Effects AIDS HIV Infections 收起 << | Phase 4 | Completed | - | Thailand ... 展开 >> Division of Infectious Diseases, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University Bangkok, Thailand, 10400 收起 << |
NCT01367808 | Pharmacokinetics and Pharmacod... 展开 >>ynamics of Sublingual Buprenorphine 收起 << | Phase 1 | Completed | - | Finland ... 展开 >> Department of Anaesthesiology & Intensive Care Turku, Finland, 21500 收起 << |
NCT01419821 | Vitamin D Deficiency | Not Applicable | Unknown | September 2016 | Israel ... 展开 >> Clalit Health services Not yet recruiting Beitar Elit, Israel Contact: Clalit 972-2-588-7000 收起 << |
NCT00935012 | TTR-CM | Phase 3 | Active, not recruiting | December 2021 | United States, Illinois ... 展开 >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, New York Clinical Cardiovascular Research Lab for the Elderly (CCRLE) Columbia Universtiy New York, New York, United States, 10034 收起 << |
NCT00366860 | Osteoporosis ... 展开 >>Cardiovascular Diseases 收起 << | Phase 1 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Ann Arbor, Michigan, United States, 48109 收起 << |
NCT00188617 | LUNG CANCER | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT02239211 | Primary Sclerosing Cholangitis | Phase 2 | Recruiting | March 2019 | United Kingdom ... 展开 >> Queens Medical Centre Recruiting Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Principal Investigator: Guruprasad Aithal, MD University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Principal Investigator: Gideon Hirschfield, MD Sub-Investigator: Prof David Adams, MD Royal Victoria Infirmary Recruiting Newcastle, United Kingdom Principal Investigator: Mark Hudson, MD John Radcliffe Recruiting Oxford, United Kingdom Principal Investigator: Ellie Barnes, MD 收起 << |
NCT00665860 | Osteoporosis | Not Applicable | Completed | - | United States, California ... 展开 >> University of California Davis, California, United States, 95616 United States, Georgia University of Georgia Athens, Georgia, United States, 30602 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT01038011 | Ankylosing Spondylitis | Phase 2 | Completed | - | Switzerland ... 展开 >> Zurich, Switzerland 收起 << |
NCT00004429 | Kidney Failure, Chronic | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-2516 收起 << |
NCT02531750 | - | Completed | - | Denmark ... 展开 >> Copenhagen University Hospital Hvidovre Hvidovre, Denmark, 2650 收起 << | |
NCT02573662 | - | Unknown | June 2016 | Denmark ... 展开 >> Amager University Hospital Recruiting Copenhagen, Denmark, 2300 Contact: Steen B Haugaard, MD, DMSc +45 53555066 sbhau@dadlnet.dk 收起 << | |
NCT00469599 | Secondary Hyperparathyroidism ... 展开 >> Chronic Kidney Disease Vitamin D Deficiency 收起 << | Not Applicable | Terminated(Terminated after 86... 展开 >> pt included, because of recruitment problems) 收起 << | - | Denmark ... 展开 >> Aalborg University Hospital Aalborg, Denmark, 4000 Århus University Hospital Skejby Aarhus, Denmark, 4000 Hospital of Southwest Denmark Esbjerg Esbjerg, Denmark, 6700 Holbæk County Hospital Holbæk, Denmark, 4300 Holstebro County Hospital Holstebro, Denmark, 7500 Odense University Hospital Odense, Denmark, 5000 Roskilde County Hospital Roskilde, Denmark, 4000 Viborg County Hospital Viborg, Denmark, 8800 收起 << |
NCT00820287 | Testicular Cancer | Not Applicable | Terminated | - | France ... 展开 >> CHU de Nice Nice, France, 06000 收起 << |
NCT00999349 | Beta-thalassemia Major ... 展开 >> Iron Overload 收起 << | Phase 2 Phase 3 | Unknown | - | Iran, Islamic Republic of ... 展开 >> Isfahan University of Medical Sciences Isfahan, Iran, Islamic Republic of, 81744-176 收起 << |
NCT01909063 | Vitamin D Deficiency ... 展开 >> Hypovitaminosis A Vitamin E Deficiency 收起 << | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
NCT01038596 | - | Completed | - | Germany ... 展开 >> University Hospital Dresden, Orthopaedic Department Dresden, Germany, 01307 收起 << | |
NCT01648140 | Hepatitis C, Chronic | Phase 2 | Completed | - | - |
NCT03428516 | Sleep Apnea Syndromes | Not Applicable | Recruiting | March 1, 2019 | France ... 展开 >> CHU Grenoble Alpes Recruiting Grenoble, France, 38000 Contact: Renaud Tamisier 收起 << |
NCT01648140 | - | Completed | - | - | |
NCT01696448 | Metabolic Syndrome | Not Applicable | Completed | - | United States, Georgia ... 展开 >> Atlanta Vascular Research Foundation Atlanta, Georgia, United States, 30342 收起 << |
NCT03286660 | Evaluations R... 展开 >>ehabilitation COPD 收起 << | Not Applicable | Completed | - | France ... 展开 >> Centre Hospitalier Universitaire Grenoble, France Hôpital Calmette, CHRU Lille, France 收起 << |
NCT00633282 | Nonalcoholic Fatty Liver Disea... 展开 >>se 收起 << | Phase 2 | Completed | - | China, Shanghai ... 展开 >> Endocrinology and Metabolism Department, Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China, 200032 Department of Endocrinology and Metabolism,Shanghai Clinical Center of Diabetes,Shanghai Institute of Diabetes,The sixth people's Hospital Affiliated to Shanghai Jiaotong University Shanghai, Shanghai, China, 200233 Department of Endocrinology and Metabolism,The Fifth People's Hospital,Fudan University Shanghai, Shanghai, China, 200240 收起 << |
NCT03283683 | - | Active, not recruiting | September 2018 | United Kingdom ... 展开 >> Royal Surrey County Hospital Guildford, Surrey, United Kingdom, GU2 7XX 收起 << | |
NCT01225055 | Spinal Cord Injury ... 展开 >> Bone Loss Osteoporosis 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Edward Hines, Jr, VA Hospital Maywood, Illinois, United States, 60153 收起 << |
NCT01250314 | Osteoporosis | Not Applicable | Completed | - | France ... 展开 >> Fédération de Rhumatologie - Hôpital LARIBOISIERE Paris, France, 75010 收起 << |
NCT01225055 | - | Completed | - | - | |
NCT02300571 | - | Recruiting | January 2018 | Italy ... 展开 >> Fondazione del Piemonte per l'Oncologia Recruiting Candiolo, Italy, 10060 Contact: Luisa Gioeni, PharmD +39011993 ext 3959 luisa.gioeni@ircc.it Sub-Investigator: Fabrizio Carnevale Schianca, MD Sub-Investigator: Daniela Caravelli, MD Sub-Investigator: Dario Sangiolo, MD Sub-Investigator: Susanna Gallo, MD Sub-Investigator: Valentina Coha, MD Sub-Investigator: Giovanni Grignani, MD Sub-Investigator: Delia Rota Scalabrini, MD Sub-Investigator: Marco Fizzotti, MD Ospedale Regina Margherita Not yet recruiting Torino, Italy, 10126 Contact: Massimo Berger, MD +39011.313 ext 5360 massimoberger@gmail.com Principal Investigator: Franca Fagioli, MD Sub-Investigator: Elena Vassallo, MD Sub-Investigator: Massimo Berger, MD Sub-Investigator: Francesca Nesi, MD Sub-Investigator: Paola Quarello, MD 收起 << | |
NCT01191177 | Liver Disease ... 展开 >> Short Bowel Syndrome 收起 << | Phase 1 Phase 2 | Withdrawn(no subjects recruite... 展开 >>d) 收起 << | January 2012 | United States, Massachusetts ... 展开 >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 收起 << |
NCT01828528 | - | Completed | - | Israel ... 展开 >> Liver Disease Center, Sheba Medical Center, Tel-Hashomer Ramat-Gan, Israel, 52621 收起 << | |
NCT02507570 | Prostate Carcinoma Metastatic ... 展开 >>to the Bone 收起 << | Phase 2 | Active, not recruiting | - | United States, Maryland ... 展开 >> Chesapeake Urology Research Associates Towson, Maryland, United States, 21204 United States, New York Associated Medical Professionals Syracuse, New York, United States, 13210 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Urology of Virginia, PLLC Virginia Beach, Virginia, United States, 23462 收起 << |
NCT02903160 | Prostate Cancer | Phase 2 | Recruiting | October 2019 | United States, New York ... 展开 >> Mount Sinai Beth Israel Recruiting New York, New York, United States, 10011 Contact: Bobby Liaw, MD 212-604-6010 bobby.liaw@mountsinai.org Principal Investigator: Bobby Liaw, MD Mount Sinai West Withdrawn New York, New York, United States, 10019 Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10028 Contact: William Oh, MD 212-659-5549 william.oh@mssm.edu Principal Investigator: William Oh, MD 收起 << |
NCT01101113 | Secondary Hyperparathyroidism | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Korea, Republic of, 110-744 Kyungpook National University Daegu, Korea, Republic of Gil Hospital Incheon, Korea, Republic of Hallym University Sacred Hospital Pyungchon, Korea, Republic of Seoul National University Bundang Hospital Seongnam, Korea, Republic of Eulji University Seoul, Korea, Republic of Samsung Medical Center Seoul, Korea, Republic of 收起 << |
NCT02837094 | Type 1 Diabetes | Phase 1 | Recruiting | December 31, 2018 | United Kingdom ... 展开 >> Cardiff and Vale University Health Board Recruiting Cardiff, United Kingdom, CF14 4XW Contact: Alexandra Howell +44 (0)29 20746710 ext 46710 HowellA4@cardiff.ac.uk 收起 << |
NCT02568787 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> University of Miami Miller School of Medicine, Soffer Clinical Research Center, Department of Psychiatry & Behavioral Sciences Miami, Florida, United States, 33136-2107 收起 << |
NCT01855048 | Healthy Volunteers ... 展开 >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus 收起 << | Phase 1 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02829268 | Wolfram Syndrome ... 展开 >> Diabetes Mellitus Optic Nerve Atrophy Ataxia 收起 << | Phase 1 Phase 2 | Recruiting | March 2021 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ashley Simpson, RN, BSN, CPN 314-286-1550 ashley.simpson@wustl.edu Contact: Fumihiko Urano, MD 314-362-8683 urano@wustl.edu Principal Investigator: Fumihiko Urano, MD 收起 << |
NCT00010439 | Osteoporosis | Phase 2 | Completed | - | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 << |
NCT01847976 | Pain | Phase 2 | Active, not recruiting | November 2017 | Canada, Ontario ... 展开 >> The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 收起 << |
NCT00010439 | - | Completed | - | - | |
NCT01293682 | Breast Cancer | Phase 2 | Active, not recruiting | October 2019 | United States, New York ... 展开 >> University of Rochester Rochester, New York, United States, 14642 收起 << |
NCT02579265 | Hospitalized Neonates and Infa... 展开 >>nts, Expected to Require Parenteral Nutrition for 28 Days 收起 << | Phase 3 | Recruiting | October 2019 | United States, California ... 展开 >> Lucile Packard Children's Hospital Recruiting Palo Alto, California, United States, 94304 Contact: Katherine McCallie, MD UC San Diego Medical Center Recruiting San Diego, California, United States, 92103 Contact: Jae H Kim, MD, PhD Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Brian Lane, MD United States, Connecticut Yale - New Haven Children's Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Orly Levit, MD United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2991 Contact: Daniel T Robinson, MD United States, Massachusetts Boston Children's Hospital Withdrawn Boston, Massachusetts, United States, 02115 United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-1205 Contact: Ann Anderson Berry, MD, PhD United States, New York Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Contact: Joanne Lai, MD Steven & Alexandra Cohen Children's Medical Center of NY Active, not recruiting New York, New York, United States, 11040 United States, Oklahoma The Children's Hospital at OU Medical Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Kimberly Ernst, MD United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Maria R Mascarenhas, MBBS Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jeffrey A Rudolph, MD United States, Tennessee Vanderbilt Children's Hospital Recruiting Nashville, Tennessee, United States, 37345 Contact: William Walsh, MD United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Amy B Hair, MD 收起 << |
NCT00730639 | Metastatic Castration-resistan... 展开 >>t Prostrate Cancer Renal Cell Carcinoma Metastatic Melanoma Non-small Cell Lung Cancer 收起 << | Phase 1 | Active, not recruiting | May 14, 2019 | United States, Arizona ... 展开 >> Pinnacle Oncology Hematology Scottsdale, Arizona, United States, 85258 United States, Connecticut Yale University School Of Medicine New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612-9497 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan University Of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Biooncology Institute Huntersville, North Carolina, United States, 28078 United States, Ohio Christ Hospital Cincinnati, Ohio, United States, 45219 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt-Ingram Cancer Ctr Nashville, Tennessee, United States, 37232 收起 << |
NCT03593460 | Hepatitis, Autoimmune | Phase 2 | Not yet recruiting | December 31, 2019 | - |
NCT01525225 | - | Terminated(Release of Post Mar... 展开 >>keting Requirement for this study. Terminated November 2013.) 收起 << | - | - | |
NCT02175654 | Colorectal Neoplasms ... 展开 >> Metastatic Disease 收起 << | Phase 2 | Terminated(The trial was prema... 展开 >>turely closed due to lack of accrual) 收起 << | - | Spain ... 展开 >> Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain, 28046 收起 << |
NCT01525225 | Type 2 Diabetes Mellitus | Phase 1 | Terminated(Release of Post Mar... 展开 >>keting Requirement for this study. Terminated November 2013.) 收起 << | - | United States, Arkansas ... 展开 >> Osborne Research Center Little Rock, Arkansas, United States, 72201 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Missouri The Children'S Mercy Hospital And Clinics Kansas City, Missouri, United States, 64108 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Promedica Toledo Childrens Hospital Toledo, Ohio, United States, 43606 United States, Pennsylvania Childrens Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 收起 << |
NCT00377234 | Post Menopausal Osteoporosis | Phase 4 | Completed | - | - |
NCT00005906 | Lymphangioleiomyomatosis ... 展开 >> Lymphangiomyomas Pleural Effusions Ascites 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00377234 | - | Completed | - | - | |
NCT00005906 | - | Completed | - | - | |
NCT03415477 | Bone Cyst Aneurysmal ... 展开 >> Pathological Fracture Recurrent Disease Refractory Tumor 收起 << | Phase 1 Phase 2 | Completed | - | - |
NCT01378494 | - | Completed | - | United States, Alabama ... 展开 >> UAB Birmingham, Alabama, United States, 35242 收起 << | |
NCT00124982 | - | Completed | - | - | |
NCT00730639 | - | Active, not recruiting | - | - | |
NCT01209078 | Skin Infections, Bacterial | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, California GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site Oceanside, California, United States, 92056 United States, Hawaii GSK Investigational Site Honolulu, Hawaii, United States, 96813 United States, Pennsylvania GSK Investigational Site West Reading, Pennsylvania, United States, 19611 收起 << |
NCT01679899 | Type 2 Diabetes Mellitus ... 展开 >> Menopause Osteoporosis Osteopenia 收起 << | Phase 4 | Completed | - | Brazil ... 展开 >> Centro de Diabetes Curitiba Curitiba, Parana, Brazil, 80810040 收起 << |
NCT00124982 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02647671 | Colonic Cancer | Phase 1 | Active, not recruiting | March 2019 | United States, Michigan ... 展开 >> University of Michigan Hospital Ann Arbor, Michigan, United States, 48109 收起 << |
NCT01348269 | Bone Marrow Edema | Phase 3 | Completed | - | Germany ... 展开 >> Orthopedic Center for Musculoskeletal Research, Orthopedic Department, University of Wuerzburg Wuerzburg, Bavaria, Germany, 97074 Department of trauma, hand, reconstructive and plastic, University of Wuerzburg Wuerzburg, Bavaria, Germany, 97080 收起 << |
NCT02065245 | Aging Frailty | Phase 1 Phase 2 | Active, not recruiting | December 2020 | United States, Florida ... 展开 >> ISCI/University of Miami Miller School of Medicine Miami, Florida, United States, 33136 收起 << |
NCT00043719 | Osteoporosis ... 展开 >>Osteopenia 收起 << | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> UMDNJ-Robert Wood Johnson Medical School, Department of Medicine, Division of Endocrinology New Brunswick, New Jersey, United States, 08903-0019 收起 << |
NCT01209078 | - | Completed | - | - | |
NCT01831791 | Alopecia | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Osaka, Japan, 530-0057 GSK Investigational Site Osaka, Japan, 532-0003 GSK Investigational Site Tokyo, Japan, 103-0028 GSK Investigational Site Tokyo, Japan, 160-0022 收起 << |
NCT01899859 | Non-Alcoholic Steatohepatitis ... 展开 >>(NASH) 收起 << | Phase 1 | Completed | - | United States, Texas ... 展开 >> Brooke Army Medical Ctr. San Antonio, Texas, United States, 78234 收起 << |
NCT01831791 | - | Completed | - | - | |
NCT02791555 | - | Terminated(Study was terminate... 展开 >>d early due to low enrollment numbers.) 收起 << | - | United States, Connecticut ... 展开 >> University of Connecticut Health Center Farmington, Connecticut, United States, 06030 收起 << | |
NCT01808313 | - | Completed | - | - | |
NCT01808313 | Vascular Disease | Phase 3 | Completed | - | China, Heilongjiang ... 展开 >> GSK Investigational Site Harbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430022 China, Hunan GSK Investigational Site Hunan, Hunan, China, 410008 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130021 China, Shaanxi GSK Investigational Site Xian, Shaanxi, China, 710032 China, Shandong GSK Investigational Site Jinan, Shandong, China, 250012 China GSK Investigational Site Beijing, China, 100032 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100037 GSK Investigational Site Beijing, China, 100038 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200433 收起 << |
NCT01339078 | Biliary Strictures Post Liver ... 展开 >>Transplantation. 收起 << | Not Applicable | Unknown | December 2015 | Belgium ... 展开 >> University Hospital, Ghent Recruiting Ghent, Belgium Contact: Hans Van Vlierberghe, Ph.D. , M.D. Hans.Vanvlierberghe@ugent.be Principal Investigator: Hans Van Vlierberghe, Ph.D. , M.D. 收起 << |
NCT01833520 | Sarcoma | Phase 1 Phase 2 | Active, not recruiting | October 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00656292 | - | Completed | - | - | |
NCT03177395 | Paracetamol Overdose | Phase 1 | Enrolling by invitation | December 31, 2018 | United Kingdom ... 展开 >> Royal Infirmary of Edinburgh Edinburgh, City Of Edinburgh, United Kingdom, EH16 4SA 收起 << |
NCT02516605 | Primary Biliary Cholangitis | Phase 2 | Completed | - | - |
NCT02629874 | Endotoxemia S... 展开 >>ystemic Inflammatory Response 收起 << | Phase 1 | Completed | - | Netherlands ... 展开 >> Intensive care, research unit, Radboud University Medical Centre Nijmegen, Gelderland, Netherlands, 6525 GA 收起 << |
NCT02345161 | - | Completed | - | - | |
NCT02345161 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00615485 | - | Completed | - | United States, New York ... 展开 >> SUNY Upstate Medical University Syracuse, New York, United States, 13202 收起 << | |
NCT01587898 | Anaemia | Phase 2 | Completed | - | - |
NCT01334242 | Healthy | Phase 1 | Completed | - | United States, Texas ... 展开 >> Lexicon Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT00656292 | Perioperative Inflammatory Res... 展开 >>ponse 收起 << | Phase 4 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT03324633 | - | Active, not recruiting | December 2018 | - | |
NCT01587898 | - | Completed | - | - | |
NCT01234506 | Oxidative Stress ... 展开 >> Inflammation Aging Dementia Pain 收起 << | Phase 2 | Completed | - | Canada, Saskatchewan ... 展开 >> Saskatoon Health Region Saskatoon, Saskatchewan, Canada, S7K 5T6 收起 << |
NCT01769469 | - | Completed | - | United States, California ... 展开 >> Children's Hopsital of Los Angeles Los Angeles, California, United States, 90027 United States, Colorado Children's Hospital of Denver Aurora, Colorado, United States, 80045 United States, Florida University of Miami Miami, Florida, United States, 33101 University of South Florida Tampa, Florida, United States, 33606 United States, Illinois Stroger Hospital and the CORE Center Chicago, Illinois, United States, 60612 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Fenway Institute Boston, Massachusetts, United States, 02215 United States, Michigan Wayne State University Detroit, Michigan, United States, 48201 United States, Pennsylvania Children's Hopsital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee St. Jude Childrens Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 收起 << | |
NCT01935804 | Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders 收起 << | Phase 2 | Completed | - | Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 收起 << |
NCT03345589 | Primary Biliary Cholangitis | Phase 4 | Recruiting | January 1, 2019 | China, Sichuan ... 展开 >> West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Li Yang +8618980601276 yangli_hx@scu.edu.cn 收起 << |
NCT02636348 | Nutrition Status ... 展开 >> Bone Health 收起 << | Not Applicable | Completed | - | United States, South Carolina ... 展开 >> Marine Corps Recruit Depot Parris Island Parris Island, South Carolina, United States, 29905 收起 << |
NCT02426229 | Scleroderma I... 展开 >>nterstitial Lung Disease 收起 << | Phase 1 | Completed | - | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 << |
NCT01089361 | Sepsis | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01076179 | - | Completed | - | - | |
NCT01089361 | - | Completed | - | - | |
NCT00128921 | - | Terminated(study terminated du... 展开 >>e to low accrual) 收起 << | - | - | |
NCT02802384 | - | Recruiting | June 2019 | United States, Maryland ... 展开 >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21205 Contact: Janet Crane, M.D. 410-502-6425 jcrane2@jhmi.edu Contact: Xiao Wang, Ph.D. 410-502-6425 xwang113@jhmi.edu 收起 << | |
NCT00346242 | Thalassemia | Phase 4 | Completed | - | Greece ... 展开 >> Novartis Investigative Site Athens, Greece 收起 << |
NCT00052884 | Drug/Agent Toxicity by Tissue/... 展开 >>Organ Multiple Myeloma and Plasma Cell Neoplasm 收起 << | Phase 1 | Terminated(Slow accrual and ch... 展开 >>anges in clinical practice) 收起 << | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Minnesota Fairview Ridges Hospital Burnsville, Minnesota, United States, 55337 Mercy and Unity Cancer Center at Mercy Hospital Coon Rapids, Minnesota, United States, 55433 Fairview Southdale Hospital Edina, Minnesota, United States, 55435 Mercy and Unity Cancer Center at Unity Hospital Fridley, Minnesota, United States, 55432 Minnesota Oncology Hematology, PA - Maplewood Maplewood, Minnesota, United States, 55109 Virginia Piper Cancer Institute at Abbott - Northwestern Hospital Minneapolis, Minnesota, United States, 55407 Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center Robbinsdale, Minnesota, United States, 55422-2900 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 Park Nicollet Cancer Center St. Louis Park, Minnesota, United States, 55416 United Hospital St. Paul, Minnesota, United States, 55102 Ridgeview Medical Center Waconia, Minnesota, United States, 55387 Minnesota Oncology Hematology, PA - Woodbury Woodbury, Minnesota, United States, 55125 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT00151437 | Acromegaly | Phase 4 | Completed | - | Canada, Alberta ... 展开 >> Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Pfizer Investigational Site Edmonton, Alberta, Canada, T6G 2S2 Canada, Nova Scotia Pfizer Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario Pfizer Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec Pfizer Investigational Site Montreal, Quebec, Canada, H2L 2W5 收起 << |
NCT00128921 | Multiple Myeloma | Phase 2 | Terminated(study terminated du... 展开 >>e to low accrual) 收起 << | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 << |
NCT00459186 | Metastatic, Androgen Independe... 展开 >>nt Prostate Cancer Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Oregon Oregon Health Science University Portland, Oregon, United States 收起 << |
NCT00459186 | - | Completed | - | - | |
NCT01291407 | Gastrointestinal Neoplasms ... 展开 >> Gastric Cancer 收起 << | Phase 1 | Completed | - | China ... 展开 >> Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, China, 100021 收起 << |
NCT01076179 | - | Completed | - | - | |
NCT01363167 | Infant, Very Low Birth Weight ... 展开 >> Calcium Deficiency Vitamin D Deficiency 收起 << | Not Applicable | Completed | - | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425-8750 Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 << |
NCT00982865 | Solid Tumors ... 展开 >>Cancer 收起 << | Phase 1 | Completed | - | Australia ... 展开 >> Westmead Hospital Westmead, Australia Belgium Jules Bordet Institute Brussels, Belgium, B-1000 Ghent University Hospital Ghent, Belgium France Institute Bergonié Bordeaux, France Hôpital Beaujon Paris, France, 92118 Hopital Saint Louis Paris, France Centre Eugène Marquis Rennes, France Institute Claudius Regaud Toulouse, France, 03 31052 Netherlands Netherlands Cancer Institute - Antonie van Leeuwenhoek Hospital Amsterdam, Netherlands 收起 << |
NCT03163550 | Healthy Volunteers | Phase 1 | Completed | - | Australia ... 展开 >> Clinical Site Perth, Australia 收起 << |
NCT01378585 | Healthy | Not Applicable | Completed | - | Indonesia ... 展开 >> PT Equilab International Jakarta, Indonesia, 12430 收起 << |
NCT00933322 | Healthy | Not Applicable | Terminated(Recruitment problem... 展开 >>s) 收起 << | - | Switzerland ... 展开 >> Cardiovascular Prevention and Rehabilitation, Bern University Hospital Bern, Switzerland, 3010 收起 << |
NCT02808013 | Lower Urinary Tract Symptoms | Phase 2 | Unknown | - | - |
NCT00963417 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Not Applicable | Active, not recruiting | December 2018 | Australia ... 展开 >> Royal Brisbane and Women's Hospital Brisbane, Australia Peter MacCallum Cancer Center East Melbourne, Australia Box Hill Hospital Melbourne, Australia Maroondah Hospital Melbourne, Australia Royal Perth Hospital Perth, Australia Belgium Centre Hospitalier Regional de Huy Huy, Belgium UZ Leuven Leuven, Belgium C.H.U. Sart Tilman Liège, Belgium CHR Citadelle Liège, Belgium C.H.P.L.T. de Verviers Verviers, Belgium Switzerland Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland Kantonsspital St.Gallen St.Gallen, Switzerland 收起 << |
NCT01153295 | Irritable Bowel Syndrome | Not Applicable | Completed | - | Denmark ... 展开 >> Research Unit for General Practice, Department of gastroenterology, Odense University hospital Odense, Denmark, 5000 收起 << |
NCT00800358 | Hyperparathyroidism ... 展开 >> Kidney Disease 收起 << | Not Applicable | Completed | - | Malaysia ... 展开 >> Hospital Sultanah Bahiyah Haemodialysis Unit KM 6 Jalan Langgar Alor Star, Kedah, Malaysia, 05460 Hemodialysis Unit, Raja Perempuan Zainab II Hospital Kota Bahru, Kelantan, Malaysia, 15586 Hemodialysis Unit, Tengku Ampuan Afzan Hospital Kuantan, Pahang, Malaysia, 25100 Clinical Research Centre, Penang Hospital Georgetown, Penang, Malaysia, 10990 Haemodialysis Unit, Seberang Jaya Hospital Seberang jaya, Penang, Malaysia, 13700 Hemodialysis Unit, Taiping Hospital Taiping, Perak, Malaysia, 34000 Nephrology Department, Tengku Ampuan Rahimah Hospital Klang, Selangor, Malaysia, 41200 Hemodialysis Unit, Kuala Lumpur Hospital Kuala Lumpur, Selangor, Malaysia, 50586 Haemodialysis Unit, Serdang Hospital Serdang, Selangor, Malaysia, 43000 Hemodialysis Unit, Tuanku Ja'afar Seremban Hospital Seremban, Selangor, Malaysia, 70300 Haemodialysis Unit, Melaka Hospital Melaka, Malaysia, 75400 收起 << |
NCT00464399 | De Novo Renal Transplantation | Phase 3 | Completed | - | Norway ... 展开 >> Novartis Investigative Site, Oslo, Norway 收起 << |
NCT00752739 | Prostate Cancer | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 收起 << |
NCT03331536 | - | Recruiting | October 2, 2020 | United States, Alabama ... 展开 >> UAB Kirklin Clinic Digestive Health Center Recruiting Birmingham, Alabama, United States, 35233 Contact: Amandiy N Liwo, MD,MSPH 205-996-5186 amandiyliwo@uabmc.edu Contact: Katey Feng, MPH 205-934-3612 kateyfeng@uabmc.edu 收起 << | |
NCT02289066 | - | Completed | - | United States, Nevada ... 展开 >> University of Nevada School of Medicine Las Vegas, Nevada, United States, 89102 收起 << | |
NCT00982865 | - | Completed | - | - | |
NCT01374568 | Type 2 Diabetes Mellitus | Phase 4 | Terminated(Study closed by spo... 展开 >>nsor. Funding ended.) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 收起 << |
NCT01374568 | - | Terminated(Study closed by spo... 展开 >>nsor. Funding ended.) 收起 << | - | - | |
NCT01876017 | Chronic Renal Failure | Phase 1 Phase 2 | Unknown | December 2016 | India ... 展开 >> Chaitanya Hospital Recruiting Pune,, Maharashtra, India, 411009 Contact: Sachin P Jamadar, D ORTHO +918888788880 sac2751982@gmail.com Principal Investigator: Anant E Bagul, MS,Ortho 收起 << |
NCT01335568 | Liver Cirrhosis ... 展开 >> Liver Insufficiency Chronic Liver Disease 收起 << | Phase 1 | Unknown | December 2012 | Indonesia ... 展开 >> R.S. Gading Pluit Recruiting Jakarta, Indonesia, 14250 Sub-Investigator: Suryadi The, MD 收起 << |
NCT00428935 | Duchenne Muscular Dystrophy | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Columbus Children's Hospital Columbus, Ohio, United States, 43205 收起 << |
NCT01802034 | - | Recruiting | August 2022 | United States, New York ... 展开 >> The Rogosin Institute Recruiting New York, New York, United States, 10021 Contact: Betty-Jane Sloan, M.A. 646-317-0701 bjsloan@nyp.org Principal Investigator: Alan S Perlman, MD Sub-Investigator: Nathaniel Berman, MD Sub-Investigator: James M Chevalier, MD Sub-Investigator: Choli Hartono, MD Sub-Investigator: Surya V Seshan, MD Sub-Investigator: Manikkam Suthanthiran, MD Sub-Investigator: John CL Wang, MD Sub-Investigator: Thomas S Parker, PhD Sub-Investigator: Daniel M Levine, PhD Sub-Investigator: David Serur, MD Sub-Investigator: Jun Lee, MD Sub-Investigator: Liu M Frank, MD Sub-Investigator: Meredith J Aull, PharmD 收起 << | |
NCT00996892 | Solid Tumors | Phase 1 | Terminated(A recommended Phase... 展开 >> 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.) 收起 << | - | United States, Maryland ... 展开 >> Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 United States, Michigan Detroit, Michigan, United States, 48201 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Nashville, Tennessee, United States, 37203 收起 << |
NCT02230345 | Inflammation ... 展开 >>Dyslipidemia 收起 << | Not Applicable | Completed | - | Switzerland ... 展开 >> Clinical research center, Lausanne University hospital Lausanne, Vaud, Switzerland, 1011 收起 << |
NCT02993796 | - | Recruiting | August 2019 | United States, New York ... 展开 >> State University of New York at Buffalo Recruiting Buffalo, New York, United States, 14203 Contact: Thomas J. Langan, MD 716-888-4732 tjlangan@buffalo.edu 收起 << | |
NCT03194893 | Neoplasms | Phase 3 | Recruiting | June 12, 2024 | - |
NCT02937012 | Primary Biliary Cirrhosis | Phase 3 | Recruiting | December 2019 | Mexico ... 展开 >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Mexico, 14000 Contact: Edgardo Eric Lopez Mendez, MD (01)(55) 54870900 ext 2710 ericlopezmendez@yahoo.com.mx Contact: Sergio Gabriel Munoz Martinez, MD (01)(55) 54870900 ext 2710 sergio_sg@hotmail.com Principal Investigator: Edgardo Eric Lopez Martinez, MD Sub-Investigator: Sergio Gabriel Munoz Martinez, MD Sub-Investigator: Ignacio Garcia Juarez, MD Sub-Investigator: Ernesto Marquez Guillen, MD Sub-Investigator: Carlos Moctezuma Velazquez, MD Sub-Investigator: Alejandra Tepox Padron, MD 收起 << |
NCT03130920 | Liver Metastases | Not Applicable | Completed | - | Croatia ... 展开 >> University Hospital Dubrava Zagreb, Croatia, 10000 收起 << |
NCT02705560 | Healthy | Not Applicable | Unknown | May 2018 | Switzerland ... 展开 >> Service of Endocrinology, Diabetes and Metabolism, University Hospital, CHUV Recruiting Lausanne, VD, Switzerland, 1011 Contact: François Pralong, MD 004121 314 05 96 francois.pralong@chuv.ch 收起 << |
NCT00435123 | Malnutrition ... 展开 >>ESRD 收起 << | Not Applicable | Terminated(Increased use of co... 展开 >>mmercial product; less eligible patients & poor enrollment.) 收起 << | - | United States, Kansas ... 展开 >> Kansas Nephrology Physicians, PA Wichita, Kansas, United States, 67214 United States, Massachusetts Western New England Renal Transplant Associates Springfield, Massachusetts, United States, 01107 United States, Mississippi Nephrology Associates Columbus, Mississippi, United States, 39705 United States, Missouri Metro Hypertension & Kidney Center, LLC. St. Louis, Missouri, United States, 63136 Midwest Nephrology Associates St. Peters, Missouri, United States, 63376 United States, Pennsylvania Lankenau Center for Medical Research Wynnewood, Pennsylvania, United States, 19096 收起 << |
NCT01825785 | Postmenopausal ... 展开 >> Osteopenia 收起 << | Phase 1 | Completed | - | - |
NCT01101048 | Osteopenia | Phase 1 | Completed | - | - |
NCT02160782 | Alagille Syndrome | Phase 2 | Active, not recruiting | June 28, 2019 | Australia, New South Wales ... 展开 >> Children's Hospital Westmead Westmead, New South Wales, Australia, 2145 Australia, Victoria The Royal Children's Hospital Melbourne Parkville, Victoria, Australia, 3052 Belgium Cliniques Universitaires Saint-Luc Brussels, Belgium France Hopital Femme Mere Enfant De Lyon Bron, France, 69677 Hopital Necker-Enfants Malades Paris, France, 75015 Hopital Kremlin Bicetre Paris, France, 94275 Poland The Children's Memorial Health Institute Warsaw, Poland, 04-730 Spain Hospital Universitario La Paz- Hospital Materno Infantil Madrid, Spain, 261 United Kingdom Paediatric Liver Center, Kings College Hospital London, United Kingdom, SE5 9RS 收起 << |
NCT03489889 | Ursodeoxycholic Acid ... 展开 >> Primary Biliary Cirrhosis 收起 << | Not Applicable | Completed | - | Brazil ... 展开 >> Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo São Paulo, Brazil, 05403-000 收起 << |
NCT02540538 | Hepatitis B | Phase 1 | Completed | - | Netherlands ... 展开 >> Maastricht UMC Maastricht, Netherlands, 6202 AZ 收起 << |
NCT02540538 | - | Completed | - | - | |
NCT03386981 | - | Recruiting | February 4, 2019 | Italy ... 展开 >> Istituto Ortopedico Galeazzi Recruiting Milano, Italy, 20161 Contact: Giovanni Lombardi, PhD 00390216621 ext 4068 giovanni.lombardi@grupposandonato.it Contact: Elena Cittera, MSc 00390216621 ext 4057 elena.cittera@grupposandonato.it 收起 << | |
NCT01786759 | Preterm Infants | Phase 4 | Unknown | July 2013 | China, Shanghai ... 展开 >> Xinhua hospital Recruiting Shanghai, Shanghai, China, 200092 Contact: Yexuan Tao, PhD 13818334664 taoyexuan@hotmail.cm Principal Investigator: Wei Cai, PhD Principal Investigator: Ying Wang, PhD Sub-Investigator: Kejun Zhou, PhD Sub-Investigator: Qingya Tang, MD Sub-Investigator: Lina Lu, PhD 收起 << |
NCT02422875 | - | Enrolling by invitation | June 2020 | United States, Georgia ... 展开 >> Emory University Hospital (CIN/ACTSI) Atlanta, Georgia, United States, 30322 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << | |
NCT02404311 | HIV Infection | Phase 1 Phase 2 | Unknown | January 2017 | South Africa ... 展开 >> CAPRISA eThekwini CRS Durban, KwaZulu-Natal, South Africa, 4001 Isipingo CRS Durban, KwaZulu-Natal, South Africa, 4133 Emavundleni Desmond Tutu HIV Centre CRS Cape Town, Western Cape, South Africa, 7750 Aurum Institute for Health Research Klerksdorp, South Africa, 2570 Perinatal HIV Research Unit Soweto, South Africa, 2013 收起 << |
NCT01654731 | PBC | Phase 3 | Completed | - | France ... 展开 >> Hepatology department - Hopital Saint Antoine Paris, France, 75012 收起 << |
NCT01331525 | Extensive Stage Small Cell Lun... 展开 >>g Cancer 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Leeds Teaching Hospitals NHS Foundation Trust Leeds, United Kingdom, LS9 7TF Barts and The London NHS Trust London, United Kingdom, EC1M 6BQ Nottingham University Hospitals NHS Trust Nottingham, United Kingdom, NG5 1PB Weston Park Clinical Trials Centre Sheffield, United Kingdom, S10 2SJ Southampton University Hospitals NHS Trust Southampton, United Kingdom, SO16 6YD The Clatterbridge Cancer Centre NHS Foundation Trust Wirral, United Kingdom, CH63 4JY 收起 << |
NCT00996892 | - | Terminated(A recommended Phase... 展开 >> 2 dose and schedule was not identified and the study was terminated before initiation of Stage 2B.) 收起 << | - | - | |
NCT02586155 | Diabetes Mellitus, Type 2 ... 展开 >> Coronary Artery Disease Cardiovascular Diseases 收起 << | Phase 3 | Recruiting | October 2018 | Israel ... 展开 >> Lady Davis Carmel Medical Center Recruiting Haifa, Israel, 34362 Contact: Basil Lewis, MD 收起 << |
NCT03648658 | SMA II Cerebr... 展开 >>al Palsy 收起 << | Phase 4 | Not yet recruiting | July 2021 | - |
NCT02029066 | Actinic Keratosis | Phase 1 | Completed | - | Taiwan ... 展开 >> National Cheng Kung University Hospital Tainan, Taiwan, 70403 收起 << |
NCT02431247 | Immunodeficiency Virus Type 1,... 展开 >> Human 收起 << | Phase 3 | Active, not recruiting | April 5, 2020 | - |
NCT03354507 | Epilepsy Meta... 展开 >>bolic Acidosis Tubular Acidosis; Renal 收起 << | Not Applicable | Not yet recruiting | December 2018 | Canada, Ontario ... 展开 >> McMaster Children's Hospital Not yet recruiting Hamilton, Ontario, Canada, L8N 3Z5 Contact: Mandeep Sidhu, MD 9055212100 ext 6924 mandeep.sidhu@medportal.ca Contact: Surejini Tharmaradinam, MD 9055212100 ext 6760 surejini.tharmaradinam@medportal.ca Principal Investigator: Vladimir Belostotsky, MD Sub-Investigator: Brandon Meaney, MD 收起 << |
NCT02122146 | Neoplasms | Phase 1 | Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 << | - | United States, California ... 展开 >> Keck Hospital of USC Los Angeles, California, United States, 90033 LAC&USC Medical Center Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center / Investigational Drug Services Los Angeles, California, United States, 90033 USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver CTO (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Washington Swedish Medical Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 << |
NCT01148771 | Healthy | Phase 4 | Completed | - | United States, Connecticut ... 展开 >> Hartford Hospital Hartford, Connecticut, United States, 06102 收起 << |
NCT01148771 | - | Completed | - | - | |
NCT02122146 | - | Terminated(The study was prema... 展开 >>turely discontinued due to a business-related decision on 09-FEB-2016. The decision to terminate the trial was based on the overall results.) 收起 << | - | - | |
NCT02274402 | - | Completed | - | France ... 展开 >> AP-HP Cochin Paris, France, 75015 收起 << | |
NCT02594878 | Immune System Disease ... 展开 >> Musculoskeletal Disease 收起 << | Phase 2 | Unknown | August 2018 | Denmark ... 展开 >> Universityhospital of Aarhus, Denmark Recruiting Aarhus, Denmark, 8000 Contact: Caroline Marie Andreasen, MD +4578464252 carand@rm.dk 收起 << |
NCT02632266 | Complication of Prematurity | Phase 4 | Recruiting | July 2019 | United States, Kansas ... 展开 >> University of Kansas Medical Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Amie Slaughter 913-588-6350 AGRIMM@kumc.edu 收起 << |
NCT00939991 | - | Completed | - | - | |
NCT02431247 | - | Active, not recruiting | - | - | |
NCT00547521 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT03676231 | Nonalcoholic Steatohepatitis | Phase 2 | Not yet recruiting | November 2019 | United States, Arizona ... 展开 >> Second Genome Clinical Site 405 Not yet recruiting Chandler, Arizona, United States, 85224 Second Genome Clinical Site 406 Not yet recruiting Tucson, Arizona, United States, 85641 United States, California Second Genome Clinical Site 403 Not yet recruiting Los Angeles, California, United States, 90008 United States, Florida Second Genome Clinical Site 409 Not yet recruiting Lakewood Ranch, Florida, United States, 34202 United States, Mississippi Second Genome Clinical Site 410 Not yet recruiting Jackson, Mississippi, United States, 39205 United States, Missouri Second Genome Clinical Site 404 Not yet recruiting Kansas City, Missouri, United States, 64030 United States, North Carolina Second Genome Clinical Site 408 Not yet recruiting Fayetteville, North Carolina, United States, 28301 United States, Tennessee Second Genome Clinical Site 407 Not yet recruiting Clarksville, Tennessee, United States, 37040 United States, Texas Second Genome Clinical Site 402 Not yet recruiting Austin, Texas, United States, 78710 Second Genome Clinical Site 401 Not yet recruiting San Antonio, Texas, United States, 78220 收起 << |
NCT00939991 | Brain Tumor G... 展开 >>lioblastoma 收起 << | Phase 1 Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02370238 | Metastatic Breast Cancer | Phase 2 | Active, not recruiting | February 2019 | - |
NCT03058562 | Tourette Syndrome ... 展开 >> Chronic Motor Tic Disorder 收起 << | Phase 1 | Completed | - | Germany ... 展开 >> Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 收起 << |
NCT03664596 | Non-alcoholic Steatohepatitis | Not Applicable | Recruiting | June 2019 | Kazakhstan ... 展开 >> Medical Centre Hospital of the President's Affairs Administration Recruiting Astana, Kazakhstan, 010000 Contact: Bakytzhan Bimbetov, MD, PhD +7701 383 6072 bimbetov2010@mail.ru Sub-Investigator: Abay Zhangabylov, MD, PhD Sub-Investigator: Marzhan Rakhimzhanova, MD, MPH 收起 << |
NCT00764309 | - | Completed | - | - | |
NCT00261443 | Bipolar Disorder | Phase 4 | Completed | - | - |
NCT02715193 | Type 1 Diabetes Mellitus ... 展开 >> Diabetes 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> San Diego, California, United States United States, Missouri St. Louis, Missouri, United States 收起 << |
NCT00764309 | Scleroderma | Phase 1 Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85259 United States, California Ucla Division Of Rheumatology Los Angeles, California, United States, 90095 United States, Connecticut University Of Connecticut Health Center Farmington, Connecticut, United States, 06030 United States, District of Columbia Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, Massachusetts Boston University School Of Medicine Boston, Massachusetts, United States, 02118 United States, Michigan University Of Michigan Ann Arbor, Michigan, United States, 48106 West Michigan Rheumatology Grand Rapids, Michigan, United States, 49546 United States, New Jersey Umdnj Clinical Research Center New Brunswick, New Jersey, United States, 08903 United States, New York Hospital For Special Surgery New York, New York, United States, 10021 United States, Pennsylvania University Of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02905 United States, South Carolina Medical University Of South Carolina Charleston, South Carolina, United States, 29425 收起 << |
NCT01899703 | Cholestasis, Intrahepatic | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Birmingham, West Midlands, United Kingdom, B15 2WB GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT00547521 | - | Completed | - | - | |
NCT03301506 | Primary Biliary Cirrhosis | Phase 2 Phase 3 | Recruiting | March 2022 | - |
NCT01098487 | Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 << | Phase 4 | Completed | - | - |
NCT01098487 | - | Completed | - | - | |
NCT00960934 | Osteoporosis | Phase 2 | Terminated | - | - |
NCT02351284 | - | Not yet recruiting | December 2019 | Spain ... 展开 >> Ramon y Cajal Hospital Active, not recruiting Madrid, Spain, 28034 收起 << | |
NCT01861054 | Breast Cancer | Phase 2 | Terminated(Enrollment target n... 展开 >>ot reached) 收起 << | - | United States, Indiana ... 展开 >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Kansas University of Kansas Cancer Center, 4350 Shawnee Mission Pkwy, Suite 1500, Mailstop 6004 Fairway, Kansas, United States, 66205 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 Montefiore Medical Center, MMC Medical Park at Eastchester The Bronx, New York, United States, 10461 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Magee-Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Sara Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The Methodist Hospital Research Institute Houston, Texas, United States, 77030 收起 << |
NCT00960934 | - | Terminated | - | - | |
NCT00996801 | Osteoporosis ... 展开 >>Postmenopausal Osteoporosis 收起 << | Phase 2 | Completed | - | - |
NCT00320710 | Breast Cancer | Phase 3 | Completed | - | - |
NCT03405818 | Onychomycosis ... 展开 >> Tinea Unguium 收起 << | Phase 4 | Completed | - | United States, California ... 展开 >> Madera Family Medical Group Madera, California, United States, 93637 Stanford University School of Medicine Palo Alto, California, United States, 94304 United States, District of Columbia MedStar Health Research Institute - MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20016 United States, Florida Doctors Research Network South Miami, Florida, United States, 33143 United States, New York University Hospital, SUNY Downstate Medical Center Brooklyn, New York, United States, 11203 Skin Specialty Dermatology New York, New York, United States, 10155 United States, Oregon Cyn3rgy Research Gresham, Oregon, United States, 97030 Oregon Dermatology & Research Center Portland, Oregon, United States, 97210 United States, Texas West Houston Clinical Research Services LLC Houston, Texas, United States, 77055 Texas Dermatology and Laser Specialists San Antonio, Texas, United States, 78218 United States, Utah Jordan Valley Dermatology Center West Jordan, Utah, United States, 84088 United States, Virginia PI Coor Clinical Research, LLC Burke, Virginia, United States, 22015 收起 << |
NCT03405818 | - | Completed | - | - | |
NCT00885170 | Osteoporosis | Phase 2 | Completed | - | - |
NCT00320710 | - | Completed | - | - | |
NCT00996801 | - | Completed | - | - | |
NCT00261443 | - | Completed | - | - | |
NCT00885170 | - | Completed | - | - | |
NCT02237534 | Renal Insufficiency, Chronic ... 展开 >> Hyperphosphatemia Bone Diseases, Metabolic 收起 << | Phase 4 | Enrolling by invitation | June 2021 | Japan ... 展开 >> Osaka University Hospital Suita, Osaka, Japan, 565-0871 收起 << |
NCT03558711 | Prostate Cancer | Phase 1 | Completed | - | Belgium ... 展开 >> university hospital, Ghent Gent, Belgium 收起 << |
NCT00623194 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01736475 | Hemophilia A | Phase 2 Phase 3 | Completed | - | - |
NCT00623194 | - | Completed | - | - | |
NCT00489489 | Multiple Sclerosis | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-Aventis Administrative Office Laval, Canada Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy Spain Sanofi-Aventis Administrative Office Barcelona, Spain 收起 << |
NCT01437540 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00494312 | Diabetes Mellitus ... 展开 >> Liver 收起 << | Phase 4 | Completed | - | - |
NCT01747330 | Pancreatic Exocrine Insufficie... 展开 >>ncy 收起 << | Phase 3 | Completed | - | Russian Federation ... 展开 >> Site Reference ID/Investigator# 80716 Barnaul, Russian Federation, 656019 Site Reference ID/Investigator# 80693 Moscow, Russian Federation, 117997 Site Reference ID/Investigator# 80698 Novosibirsk, Russian Federation, 630091 Site Reference ID/Investigator# 80713 Novosibirsk, Russian Federation Site Reference ID/Investigator# 80715 Orenburg, Russian Federation, 460000 Site Reference ID/Investigator# 80694 St. Petersburg, Russian Federation, 194156 Site Reference ID/Investigator# 80714 Tomsk, Russian Federation, 634050 Site Reference ID/Investigator# 80697 Voronezh, Russian Federation, 394036 Site Reference ID/Investigator# 80696 Yaroslavl, Russian Federation, 150003 收起 << |
NCT01437540 | - | Completed | - | - | |
NCT01736475 | - | Completed | - | - | |
NCT00489489 | - | Completed | - | - | |
NCT01747330 | - | Completed | - | - | |
NCT03377283 | Organ Preservation Solutions | Phase 4 | Completed | - | - |
NCT02118766 | Dermatitis, Atopic | Phase 3 | Completed | - | United States, Georgia ... 展开 >> Anacor Investigational Site Stockbridge, Georgia, United States 收起 << |
NCT00475865 | Multiple Sclerosis | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Austria Sanofi-Aventis Administrative Office Vienna, Austria Canada Sanofi-Aventis Administrative Office Laval, Canada Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milan, Italy United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom 收起 << |
NCT01231321 | Rheumatoid Arthritis | Phase 3 | Completed | - | Russian Federation ... 展开 >> Site Ref # / Investigator 17682 Kazan, Russian Federation, 420095 Site Ref # / Investigator 7417 Moscow, Russian Federation, 115522 Site Ref # / Investigator 17681 Moscow, Russian Federation, 117513 Site Ref # / Investigator 7401 Moscow, Russian Federation, 119049 Site Ref # / Investigator 18081 Saint Petersburg, Russian Federation, 191015 收起 << |
NCT03658213 | Breast Cancer | Phase 3 | Not yet recruiting | December 31, 2020 | China, Beijing ... 展开 >> The 307th hospital of Chinese People's Liberation Army Not yet recruiting Beijing, Beijing, China Contact: Zefei JIANG 收起 << |
NCT02118766 | - | Completed | - | - | |
NCT01916239 | Colorectal Cancer | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> Hospital General Universitario Reina Sofía Murcia, Spain, 30003 收起 << |
NCT01231321 | - | Completed | - | - | |
NCT02421783 | - | Recruiting | June 2019 | Italy ... 展开 >> Antonio Carroccio Recruiting Sciacca, Agrigento, Italy Pasquale Mansueto Recruiting Palermo, Italy, 90127 收起 << | |
NCT01340599 | Stage I Prostate Cancer ... 展开 >> Stage IIA Prostate Cancer Stage IIB Prostate Cancer 收起 << | Phase 2 | Terminated(Slow accrual) | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT01241292 | - | Completed | - | - | |
NCT00478738 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 South Africa GSK Investigational Site Bloemfontein, South Africa, 9301 GSK Investigational Site George, South Africa, 6530 GSK Investigational Site Mowbray, South Africa, 7700 收起 << |
NCT03771170 | Peritonitis I... 展开 >>ntoxication 收起 << | Phase 4 | Recruiting | January 31, 2020 | Georgia ... 展开 >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Kahaber Kishibadje, MD Principal Investigator: Kahaber Kishibadje, MD Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: David Tevdoradze Principal Investigator: David Tevdoradze JSC EVEX/LTD Traumatology Recruiting Tbilisi, Georgia Contact: Jano Vashadze, MD Principal Investigator: Jano Vashadze, MD Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Beliy, MD Principal Investigator: Adrian Beliy, MD Municipal Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Silvia Agop, MD Principal Investigator: Silvia Agop, MD Republican Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru, MD Principal Investigator: Viktor Kogokaru Ukraine Institute of General and Urgent Surgery of the National Academy of Medical Sciences of Ukraine Recruiting Kharkov, Ukraine Contact: Peev Stanislav, MD Principal Investigator: Peev Stanislav, MD Kyiv City Clinical Hospital No.4; National Medical University named after O.O. Bogomolets Recruiting Kyiv, Ukraine Contact: Igor Kolosovich, MD Principal Investigator: Igor Kolosovich, MD HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Ligonenko, MD Principal Investigator: Alexey Ligonenko, MD Vinnytsa Regional Clinical Hospital Active, not recruiting Vinnitsa, Ukraine Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Visolat Sharipova, MD Principal Investigator: Visolat Sharipova, MD 收起 << |
NCT02720081 | Asthma | Phase 2 | Completed | - | - |
NCT01780948 | Difference of 12-hour AUC | Not Applicable | Completed | - | Thailand ... 展开 >> King Chulalongkorn Memorial Hospital Bangkok, Thailand, 10330 收起 << |
NCT02708342 | - | Completed | - | - | |
NCT02930434 | Vitamin D Deficiency | Not Applicable | Completed | - | - |
NCT03426995 | Arthritis, Rheumatoid | Phase 1 | Recruiting | July 29, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00417612 | Hypophosphatemia, Familial ... 展开 >> Hyperparathyroidism 收起 << | Phase 3 | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT01218113 | AIDS | Phase 2 | Completed | - | - |
NCT00417612 | - | Completed | - | - | |
NCT03236259 | Cognitive Impairment ... 展开 >> Overweight and Obesity 收起 << | Phase 2 | Completed | - | Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Netherlands 收起 << |
NCT01428258 | Phenylketonuria | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Children's Hospital of Boston Boston, Massachusetts, United States, 02115 United States, Wisconsin University of Wisconsin-Madison Madison, Wisconsin, United States, 53706 收起 << |
NCT02691325 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01603719 | Infections St... 展开 >>ool Flora Stool Biochemistry Constipation Food Intolerance 收起 << | Not Applicable | Active, not recruiting | December 2018 | Germany ... 展开 >> Evangelisches Waldkrankenhaus Spandau Berlin, Germany, 13589 收起 << |
NCT01220128 | Neoplasms, Breast | Phase 2 | Terminated(Study termination d... 展开 >>ue to negative Ph III of another study product from same technology platform.) 收起 << | - | - |
NCT01589523 | Bile Acid Synthesis Defect ... 展开 >> Inborn Error of Bile Acid Metabolism Inborn Error of Bile Acid Conjugation 收起 << | Phase 3 | Enrolling by invitation | December 2020 | United States, Ohio ... 展开 >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 收起 << |
NCT01428258 | - | Completed | - | - | |
NCT03472157 | Surgery Obesi... 展开 >>ty NASH - Nonalcoholic Steatohepatitis Cirrhosis 收起 << | Not Applicable | Recruiting | March 2023 | France ... 展开 >> Hôpital Claude Huriez, CHRU Recruiting Lille, France Principal Investigator: Guillaume Lassailly, MD 收起 << |
NCT01220128 | - | Terminated(Study termination d... 展开 >>ue to negative Ph III of another study product from same technology platform.) 收起 << | - | - | |
NCT00049452 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | United States, Connecticut ... 展开 >> Carl and Dorothy Bennett Cancer Center at Stamford Hospital Stamford, Connecticut, United States, 06904 United States, New Jersey Valley Hospital - Paramus Paramus, New Jersey, United States, 07652-2509 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 收起 << |
NCT01218113 | - | Completed | - | - | |
NCT02101151 | Type 2 Diabetes Mellitus ... 展开 >> Obesity Hypovitaminosis D 收起 << | Not Applicable | Completed | - | United Arab Emirates ... 展开 >> Rashid Centre for Diabetes and Research Ajman, United Arab Emirates 收起 << |
NCT01335698 | HIV | Phase 3 | Completed | - | - |
NCT03044639 | Liver Failure | Phase 4 | Completed | - | Poland ... 展开 >> Stanley Dudrick's Memorial Hospital Skawina, Poland, 32-050 收起 << |
NCT02721277 | Cholestasis J... 展开 >>aundice, Obstructive 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Florida ... 展开 >> University of Florida Gainesville, Florida, United States, 32610 收起 << |
NCT01335698 | - | Completed | - | - | |
NCT00302952 | - | Completed | - | - | |
NCT00302952 | Rheumatoid Arthritis | Phase 2 | Completed | - | United States, Alabama ... 展开 >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Aurora, Colorado, United States, 80095 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Michigan Justus J. Fiechtner, MD, PLLC Lansing, Michigan, United States, 48910 United States, New York Feinstein Institute for Medical Research NS-LIJ Health System Manhasset, New York, United States, 11030 University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Carolina Bone and Joint Charlotte, North Carolina, United States, 29425 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Altoona Center for Clinical Research Duncansville, Pennsylvania, United States, 16635 University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15261 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Baylor Research Institute Dallas, Texas, United States, 75231 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 收起 << |
NCT02462759 | Spinal Muscular Atrophy | Phase 2 | Active, not recruiting | April 9, 2019 | United States, California ... 展开 >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095-8344 United States, Connecticut Connecticut Childrens Medical Hartford, Connecticut, United States, 06106 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Minnesota Gillette Children's Specialty Healthcare Saint Paul, Minnesota, United States, 55101 United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States, 75235 United States, Washington Seattle Children's Research Institute Seattle, Washington, United States, 98105 Germany LMU-Campus Innenstadt Muenchen, Germany, 80337 收起 << |
NCT00932373 | Metastatic Breast Cancer | Phase 1 | Completed | - | - |
NCT00932373 | - | Completed | - | - | |
NCT01099579 | HIV Infections | Phase 3 | Completed | - | Brazil ... 展开 >> Local Institution Sao Paolo, SAO Paulo, Brazil, 01246-900 Chile Local Institution Santiago, Metropolitana, Chile, 8380418 Local Institution Santiago, Metropolitana, Chile Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44160 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Oaxaca, Mexico, 71256 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru South Africa Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Coronationville, Gauteng, South Africa, 2092 Local Institution Soweto, Gauteng, South Africa, 2001 Local Institution Congella, KWA ZULU Natal, South Africa, 4013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 收起 << |
NCT03613649 | Electrocardiogram Repolarisati... 展开 >>on Abnormality Gonococcal Infection 收起 << | Phase 1 | Active, not recruiting | January 6, 2019 | United States, Kansas ... 展开 >> Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 << |
NCT02721277 | - | Terminated | - | - | |
NCT00048932 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT01068717 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Texas ... 展开 >> Ppd Development, Lp Austin, Texas, United States, 78744 收起 << |
NCT03356522 | - | Completed | - | France ... 展开 >> Rennes University Hospital Rennes, Britain, France, 35033 收起 << | |
NCT00961831 | Neoplasm | Phase 1 | Completed | - | Germany ... 展开 >> Ulm, Baden-Württemberg, Germany, 89081 München, Bayern, Germany, 81675 收起 << |
NCT00048932 | - | Completed | - | - | |
NCT02751424 | Infections, Bacterial | Phase 1 | Terminated(Study data is curre... 展开 >>ntly under review.) 收起 << | - | Australia, South Australia ... 展开 >> GSK Investigational Site Adelaide, South Australia, Australia, 5000 收起 << |
NCT03685591 | Hormone Receptor Positive Adva... 展开 >>nced Breast Cancer Metastatic Breast Cancer Human Epidermal Receptor 2 Negative Advanced Breast Cancer Castration Resistant Prostate Cancer 收起 << | Phase 1 | Recruiting | August 24, 2023 | United States, Texas ... 展开 >> The University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030-4009 The University of Texas - MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 NEXT Oncology Recruiting San Antonio, Texas, United States, 78240 收起 << |
NCT00100893 | Breast Cancer | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 收起 << |
NCT01099579 | - | Completed | - | - | |
NCT02552901 | Hepatic Failure ... 展开 >> Liver Failure 收起 << | Phase 3 | Withdrawn | May 2016 | United States, Ohio ... 展开 >> The Ohio State University Wexner Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT01068717 | - | Completed | - | - | |
NCT01393964 | Multiple Myeloma | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States, 46260 United States, Iowa University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States, 52242 United States, Maryland University Of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School Of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10021 Mount Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Tennessee Oncology, Pllc Nashville, Tennessee, United States, 37203 United States, Texas The University Of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Va Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 << |
NCT02289027 | Ebola Vaccines | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> Clinical Trial Unit Lausanne Lausanne, Switzerland, 1011 收起 << |
NCT01293487 | Osteopenia Os... 展开 >>teoporosis Bone Disease 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Pfizer Investigational Site Miami, Florida, United States, 33126 Pfizer Investigational Site Miami, Florida, United States, 33134 Pfizer Investigational Site Miami, Florida, United States, 33143 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 收起 << |
NCT01593046 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Daytona Beach, Florida, United States, 32117 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01925287 | Pharmacokinetics of Novel Curc... 展开 >>umin Formulations Safety of Novel Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Germany, 70599 收起 << |
NCT02751424 | - | Terminated(Study data is curre... 展开 >>ntly under review.) 收起 << | - | - | |
NCT01243320 | Healthy | Phase 1 Phase 2 | Completed | - | United States, Utah ... 展开 >> University of Utah Hospital and Clinics Salt Lake City, Utah, United States, 84132 收起 << |
NCT02873559 | Muscle Weakness | Phase 2 Phase 3 | Recruiting | January 2019 | Denmark ... 展开 >> Karsten Overgaard Recruiting Hellerup, Danmark, Denmark, DK-2900 Contact: Karsten Overgaard, neurologist +45 2617 2611 karstenovergaard20@hotmail.com Contact: Rune Rasmussen, PhD neuropsy +45 2875 7500 rsr@sund.ku.dk Principal Investigator: Mette Midttun, M.D. DMSci Medical Dept. O, Geriatric Section Recruiting Herlev, Denmark, 2730 Contact: Mette Midttun, MD, DMSc +45 38689188 mette.midttun@regionh.dk Principal Investigator: Mette Midttun, MD, DMSc 收起 << |
NCT01405794 | Healthy | Phase 1 Phase 2 | Completed | - | United States, Utah ... 展开 >> University of Utah Salt Lake City, Utah, United States, 84112-5820 收起 << |
NCT00770445 | Diabetes Mellitus | Phase 4 | Completed | - | Germany ... 展开 >> Lichtenfels, Bavaria, Germany Frankfurt, Hessen, Germany Kassel, Hessen, Germany Wiesbaden, Hessen, Germany Bad Oeynhausen, North Rhine-Westphalia, Germany Dinslaken, North Rhine-Westphalia, Germany Duisburg, North Rhine-Westphalia, Germany Essen, North Rhine-Westphalia, Germany Münster, North Rhine-Westphalia, Germany Wuppertal, North Rhine-Westphalia, Germany Mainz, Rheinland-Pfalz, Germany Diez, Rhineland-Palatinate, Germany Landau, Rhineland-Palatinate, Germany Dresden, Saxony, Germany Leipzig, Saxony, Germany Jena, Thüringen, Germany Berlin, Germany Hamburg, Germany 收起 << |
NCT00664521 | Rheumatoid Arthritis | Phase 2 | Completed | - | France ... 展开 >> Research Site Nice, France Research Site Paris, France Research Site Strasbourg, France Netherlands Research Site Amsterdam, Netherlands Sweden Research Site Malmö, Sweden Research Site Stockholm, Sweden United Kingdom Research Site Newcastle, United Kingdom Research Site Norwich, United Kingdom 收起 << |
NCT01393964 | - | Completed | - | - | |
NCT01243320 | - | Completed | - | - | |
NCT02661334 | Physical Fitness | Not Applicable | Enrolling by invitation | December 2018 | United States, California ... 展开 >> David Grant Medical Center Fairfield, California, United States, 94535 收起 << |
NCT03170193 | Cardiovascular | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Research Site Overland Park, Kansas, United States, 66212 收起 << |
NCT00664521 | - | Completed | - | - | |
NCT02522390 | - | Active, not recruiting | January 2025 | Austria ... 展开 >> Medizinische Universität Graz Graz, Austria, A-8036 Belgium University of Leuven (KU Leuven) Leuven, Belgium Czechia Charles University Prague Prague, Czechia Denmark University of Copenhagen Copenhagen, Denmark Finland University of Eastern Finland Kuopio, Finland, FI-70210 France INRA - L'Institut Nationel de la Recherche Agronomique Clermont, France Ireland University College Dublin Dublin, Ireland Italy CRA-NUT - Centro di Ricerca per gli Alimenti e la Nutrizione Rome, Italy, 00178 Netherlands TNO Zeist, Gelderland, Netherlands Spain University of Barcelona Barcelona, Spain Switzerland Agroscope, Institute for Food Sciences Berne, Switzerland United Kingdom Newcastle University Newcastle, United Kingdom 收起 << | |
NCT01405794 | - | Completed | - | - | |
NCT00846963 | Cholestasis | Phase 2 Phase 3 | Completed | - | Canada, Quebec ... 展开 >> CHU Sainte-Justine Montréal, Quebec, Canada, H3T 1C5 收起 << |
NCT00533897 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03207243 | Asthma | Phase 2 | Recruiting | May 9, 2019 | - |
NCT02915016 | HIV Infections | Phase 1 Phase 2 | Active, not recruiting | - | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, Massachusetts Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States, 02115-6110 Fenway Health (FH) CRS Boston, Massachusetts, United States, 02215-4302 United States, New York Columbia P&S CRS New York, New York, United States, 10032-3732 New York Blood Center CRS New York, New York, United States, 10065 University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States, 14642 United States, Tennessee Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States, 37232-2582 United States, Washington Seattle Vaccine and Prevention CRS Seattle, Washington, United States, 98109-1024 South Africa Kliptown Soweto CRS Johannesburg, Gauteng, South Africa, 1409 Aurum Tembisa CRS Johannesburg, Gauteng, South Africa, 1632 Soweto HVTN CRS Johannesburg, Gauteng, South Africa, 1862 Setshaba Research Centre CRS Soshanguve, Gauteng, South Africa, 0152 CAPRISA eThekwini CRS Durban, Kwa Zulu Natal, South Africa, 4013 Qhakaza Mbokodo Research Clinic CRS Ladysmith, Kwa Zulu Natal, South Africa, 3370 Verulam CRS Verulam, Kwa Zulu Natal, South Africa, 4340 Aurum Institute Klerksdorp CRS Klerksdorp, North West Province, South Africa, 2571 Emavundleni CRS Cape Town, Western Cape, South Africa, 7750 收起 << |
NCT00533897 | - | Completed | - | - | |
NCT02997969 | HIV Infections | Phase 1 | Unknown | September 2017 | South Africa ... 展开 >> Aurum Tembisa CRS Recruiting Johannesburg, Gauteng, South Africa, 1632 Contact: Modulakgotla Sebe 27-87-1351645 msebe@auruminstitute.org Contact: Gladys Kobane 27-87-1351533 gkobane@auruminstitute.org Isipingo CRS Recruiting Westville, Kwa Zulu Natal, South Africa, 3630 Contact: Arendevi Pather 27-31-9027494 Arendevi.Pather@mrc.ac.za Contact: Girisha Kistnasami, BSc, DPM 27-31-9027494 girisha.kistnasami@mrc.ac.za Aurum Institute Klerksdorp CRS Recruiting Klerksdorp, North West Province, South Africa, 2571 Contact: Craig Innes 27-87-1351587 cinnes@auruminstitute.org Contact: Tania Adonis 27-87-1351587 tadonis@auruminstitute.org Tanzania National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS Recruiting Mbeya, Tanzania Contact: Nyanda Elias nelias@nimr-mmrc.org Contact: Lucas Maganga 255-25-2503364 lmaganga@nimr-mmrc.org Zambia Matero Reference Clinic CRS Recruiting Lusaka, Zambia Contact: Stewart Reid 260-966-747677 stewart.reid@cidrz.org Contact: Bupe N Sichalwe 260-966848889 bupe.sichalwe@cidrz.org 收起 << |
NCT00870740 | Relapsing-Remitting Multiple S... 展开 >>clerosis 收起 << | Phase 2 | Completed | - | - |
NCT00870740 | - | Completed | - | - | |
NCT01449110 | Cardiovascular Diseases | Phase 2 | Completed | - | Spain ... 展开 >> University Hospital Morales Meseguer Murcia, Spain, 30008 收起 << |
NCT00452673 | - | Completed | - | - | |
NCT00452673 | Advanced Breast Cancer | Phase 1 | Completed | - | United States, California ... 展开 >> City Of Hope National Medical Center Duarte, California, United States, 91010-3000 United States, Illinois Northwestern University Feinberg School Of Medicine Chicago, Illinois, United States, 60611 United States, New York New York Presbyterian Hospital New York, New York, United States, 10065 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Italy Local Institution Rozzano, Milano, Italy, 20089 Spain Local Institution Barcelona, Spain, 08035 Local Institution Sevilla, Spain, 41013 收起 << |
NCT01513902 | Juvenile Idiopathic Arthritis | Phase 1 | Completed | - | United States, Minnesota ... 展开 >> Explorer Clinic, University of Minnesota Children's Hospital Minneapolis, Minnesota, United States, 55454 Clinical and Translational Science Institute Masonic Clinical Research Unit (Administration Only) Minneapolis, Minnesota, United States, 55455 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Randall Children's Hospital at Legacy Emanuel Portland, Oregon, United States, 97227 Germany PRI - Pediatric Rheumatology Research Institute GmbH Bad Bramstedt, Germany, 24576 Hamburger Zentrum fuer Kinder-und Jugendrheumatologie SchoenKlinik Hamburg Eilbek Hamburg, Germany, 22081 Asklepios Klinik Sankt Augustin Gmbh St. Augustin, Germany, 53757 Poland Wojewodzki Specjalistyczny Szpital Dzieciecy im. Sw. Ludwika w Krakowie Krakow, Poland, 31-503 Klinika Kardiologii i Reumatologii Dzieciecej Lodz, Poland, 91-738 Slovakia Narodny ustav reumatickych chorob Piestany, Slovakia, 921 12 收起 << |
NCT03739710 | Neoplasms | Phase 2 | Not yet recruiting | February 9, 2022 | - |
NCT01513902 | - | Completed | - | - | |
NCT00857857 | Asthma | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT03024827 | Epileptic Encephalopathy | Phase 1 | Recruiting | December 2019 | Canada, British Columbia ... 展开 >> University of British Columbia Recruiting Vancouver, British Columbia, Canada, V6T1Z4 Contact: Vesna Popovska vpopovska@cw.bc.ca Principal Investigator: Linda Huh Canada, Manitoba University of Manitoba Recruiting Winnipeg, Manitoba, Canada, R3T 2N2 Contact: Lise Bourrier LBourrier@chrim.ca Principal Investigator: Edward Leung Canada, Quebec Universite de Montreal Recruiting Montreal, Quebec, Canada, H3T1J4 Contact: Jonathan Bitton jonathan.bitton@umontreal.ca Principal Investigator: Philippe Major Canada, Saskatchewan University of Saskatchewan Recruiting Saskatoon, Saskatchewan, Canada, S7N5C5 Contact: Doris Newmeyer 306-844-1208 doris.newmeyer@usask.ca Principal Investigator: Richard Huntsman Sub-Investigator: Blair Seifert Sub-Investigator: Jose Tellez-Zentino Sub-Investigator: Jane Alcorn Sub-Investigator: Bryan Acton Sub-Investigator: Andrew Lyon Sub-Investigator: June Lim Sub-Investigator: Simona Hasal 收起 << |
NCT00857857 | - | Completed | - | - | |
NCT01622231 | Rhinitis | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 272-0143 GSK Investigational Site Chiba, Japan, 277-0882 GSK Investigational Site Gifu, Japan, 501-3247 GSK Investigational Site Saitama, Japan, 355-0062 GSK Investigational Site Tokyo, Japan, 160-0017 GSK Investigational Site Tokyo, Japan, 170-0005 收起 << |
NCT01721317 | Seizures | Phase 4 | Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Fresno, California, United States, 93710 GSK Investigational Site Newport Beach, California, United States, 92658 GSK Investigational Site Newport Beach, California, United States, 92663 GSK Investigational Site Santa Monica, California, United States, 90404 United States, Colorado GSK Investigational Site Colorado Springs, Colorado, United States, 80907 United States, Florida GSK Investigational Site Pensacola, Florida, United States, 32514 GSK Investigational Site Port Charlotte, Florida, United States, 33952 United States, Illinois GSK Investigational Site Peoria, Illinois, United States, 61637 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20817 United States, Minnesota GSK Investigational Site Golden Valley, Minnesota, United States, 55422 United States, New Jersey GSK Investigational Site Hackensack, New Jersey, United States, 07601 GSK Investigational Site Livingston, New Jersey, United States, 07039 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76017 GSK Investigational Site Dallas, Texas, United States, 75251 GSK Investigational Site Kingwood, Texas, United States, 77339 GSK Investigational Site San Antonio, Texas, United States, 78229 GSK Investigational Site Temple, Texas, United States, 76508 United States, Washington GSK Investigational Site Spokane, Washington, United States, 99204 Greece GSK Investigational Site Athens, Greece, 10676 GSK Investigational Site Thessaloniki, Greece, 57010 收起 << |
NCT02780752 | Primary Sclerosing Cholangitis | Phase 1 Phase 2 | Not yet recruiting | September 2020 | United States, California ... 展开 >> Stanford University Not yet recruiting Palo Alto, California, United States, 94304 Contact: Adam Frymoyer, MD frymoyer@stanford.edu 收起 << |
NCT02360852 | Biliary Cirrhosis, Primary | Phase 2 | Terminated((Expected) side eff... 展开 >>ects) 收起 << | - | Sweden ... 展开 >> Sahlgrenska Academy Göteborg, Sweden 收起 << |
NCT01721317 | - | Terminated(After reevaluation ... 展开 >>of the benefit risk profile of ezogabine/retigabine, GSK does not believe the early adjunctive treatment study population is appropriate.) 收起 << | - | - | |
NCT02006628 | Schizophrenia ... 展开 >> Schizophrenia-related Psychotic Disorder 收起 << | Phase 2 | Completed | - | Poland ... 展开 >> Investigator 7 Bytomska, Poland Investigator 4 Gdansk, Poland Investigator 9 Katowice, Poland Investigator 5 Kielce, Poland Investigator 10 Lublin, Poland Investigator 8 Wrocław, Poland Romania Investigator 11 Bucharest, Romania Investigator 12 Bucharest, Romania Investigator 15 Bucharest, Romania Investigator 14 Sibiu, Romania Investigator 16 Targoviste, Romania Investigator 13 Targu Mures, Romania United Kingdom Investigator 2 Chertsey, United Kingdom Investigator 1 Coventry, United Kingdom Investigator 3 London, United Kingdom 收起 << |
NCT01622231 | - | Completed | - | - | |
NCT03420092 | Coronary Artery Disease | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 << |
NCT03640273 | Allergic Rhinitis ... 展开 >> Adverse Drug Event Quality of Life 收起 << | Phase 2 | Completed | - | Thailand ... 展开 >> Thammasat University Khlong Luang, Pathumthani, Thailand, 12120 收起 << |
NCT00697593 | Chronic Plaque Psoriasis | Phase 4 | Terminated(The study was termi... 展开 >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 << | - | Canada, Ontario ... 展开 >> Probity Medical Research City Waterloo, Ontario, Canada, N2J 1C4 收起 << |
NCT03395262 | Weight Loss | Not Applicable | Active, not recruiting | December 31, 2018 | United States, Texas ... 展开 >> Exercise & Sport Nutrition Lab - Human Clinical Research Facility College Station, Texas, United States, 77845 收起 << |
NCT01457950 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> GSK Investigational Site Busan, Korea, Republic of, 602-739 GSK Investigational Site Daegu, Korea, Republic of GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Seoul, Korea, Republic of, 100-380 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 GSK Investigational Site songpa-gu, Seoul, Korea, Republic of, 138-736 GSK Investigational Site Suwon, Korea, Republic of, 443-721 收起 << |
NCT00697593 | - | Terminated(The study was termi... 展开 >>nated after the European Medicines Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 << | - | - | |
NCT01939470 | - | Active, not recruiting | February 2019 | United States, Oklahoma ... 展开 >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73117 收起 << | |
NCT01457950 | - | Completed | - | - | |
NCT01578889 | HIV Infections | Phase 1 | Completed | - | United States, New York ... 展开 >> Columbia P&S CRS New York, New York, United States, 10032-3732 New York Blood Center CRS New York, New York, United States, 10065 University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States, 14642 United States, Pennsylvania Penn Prevention CRS Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States, 37232-2582 收起 << |
NCT02347319 | Chronic Liver Disease | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> The catholic university of korea, Bucheon ST. Mary's Hosipital Bucheon, Gyeonggi-do, Korea, Republic of, 420-717 收起 << |
NCT00593606 | Parkinson's Disease | Phase 3 | Completed | - | - |
NCT02562274 | Healthy | Phase 1 | Completed | - | Thailand ... 展开 >> Jitanaporn Wattanathorn Khon Kaen, Thailand, 40002 收起 << |
NCT02464072 | Hyperparathyroidism, Secondary | Not Applicable | Active, not recruiting | July 2019 | Brazil ... 展开 >> University of Sao Paulo General Hospital Sao Paulo, SP, Brazil 收起 << |
NCT02336932 | - | Active, not recruiting | July 2018 | Denmark ... 展开 >> Rigshospitalet/Hvidovre hospital Copenhagen, Denmark, 2100 收起 << | |
NCT03687476 | Niemann-Pick Disease, Type C | Phase 2 | Not yet recruiting | October 30, 2022 | - |
NCT02020616 | Type 2 Diabetes Mellitus | Phase 1 Phase 2 | Terminated(Lack of Efficacy) | - | United States, California ... 展开 >> Orange County Research Center Orange, California, United States, 92868 United States, Florida Miami Research Associates Miami, Florida, United States, 33143 Compass Research Orlando, Florida, United States, 32806 United States, New York Clinilabs, Inc (New York) New York, New York, United States, 10019 United States, Texas Dallas Diabetes Endocrine Center Dallas, Texas, United States, 75230 收起 << |
NCT00197145 | - | Terminated | - | - | |
NCT00593606 | - | Completed | - | - | |
NCT03333447 | - | Recruiting | December 2019 | France ... 展开 >> Beaujon Hospital Recruiting Clichy, France, 92110 Contact: BELMATOUG NADIA, DOCTOR +33 1 40 87 52 86 nadia.belmatoug@aphp.fr Contact: BENGHERBIA MONIA, CRA +33 1 71 11 46 08 monia.bengherbia@aphp.fr 收起 << | |
NCT00197145 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Terminated | - | - |
NCT03397888 | Hepatic Impairment | Phase 1 | Completed | - | United States, Florida ... 展开 >> Clinical Pharmacology of Miami Hialeah, Florida, United States, 33014 收起 << |
NCT03364738 | Hypoparathyroidism | Phase 3 | Recruiting | June 5, 2020 | United States, Louisiana ... 展开 >> Crescent City Clinical Research Center, LLC Recruiting Metairie, Louisiana, United States, 70006 Contact: Site Contact 504-494-1098 jwiaemd@gmail.com Principal Investigator: Jonathan Wise, MD United States, Nevada Northern Nevada Endocrinology - Lisa Abbott MD Recruiting Reno, Nevada, United States, 89511-2060 Contact: Site Contact 775-786-6770 lgabbott@sbcglobal.net Principal Investigator: Lisa Abott, MD United States, New York State University of New York Upstate Medical Center (SUNY) Recruiting Syracuse, New York, United States, 13210 Contact: Site Contact 315-464-9008 dhaliwar@upstate.edu Principal Investigator: Ruban Dhaliwal, MD United States, Pennsylvania Thomas Jefferson University, Jefferson Rheumatology Associates Recruiting Philadelphia, Pennsylvania, United States, 19107-6810 Contact: Site Contact 215-955-8405 intekhab.ahmed@jefferson.edu Principal Investigator: Intekhab Ahmed, MD Denmark Aarhus Universitetshospital Not yet recruiting Aarhus N, Denmark, 8200 Contact: Site Contact +45 23329135 lars.rejnmark@rm.dk Principal Investigator: Lars Rejnmark, Dr. Hungary Semmelweis Egyetem Not yet recruiting Budapest, Hungary, 1083 Contact: Site Contact +36 304746416 takacs.istvan@med.semmelweis-univ.hu Principal Investigator: Istvan Takacs, Dr. Pecsi Tudomanyegyetem, I. sz. Belgyogyaszati Klinika Not yet recruiting Pécs, Hungary, 7624 Contact: Site Contact +36 305654155 mezosi.emese@pte.hu Principal Investigator: Emese Mezosi, Prof. Dr. 收起 << |
NCT02020616 | - | Terminated(Lack of Efficacy) | - | - | |
NCT02130193 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Iowa GSK Investigational Site Iowa City, Iowa, United States, 52242 United States, Pennsylvania GSK Investigational Site Oaks, Pennsylvania, United States, 19456 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 United States, South Carolina GSK Investigational Site Spartanburg, South Carolina, United States, 29303 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Neu isenburg, Hessen, Germany, 63263 GSK Investigational Site Dueren, Nordrhein-Westfalen, Germany, 52349 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45359 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Leipzig, Sachsen, Germany, 04207 GSK Investigational Site Leipzig, Sachsen, Germany, 04275 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 10789 收起 << |
NCT01970449 | HIV Infections | Phase 1 | Withdrawn | - | - |
NCT00499811 | Adult Grade III Lymphomatoid G... 展开 >>ranulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Primary Central Nervous System Hodgkin Lymphoma Primary Central Nervous System Non-Hodgkin Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenström Macroglobulinemia 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 University of Southern California Los Angeles, California, United States, 90033 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland National Institutes of Health Bethesda, Maryland, United States, 20892 United States, Michigan Wayne State University-Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, West Virginia West Virginia University Healthcare Morgantown, West Virginia, United States, 26506 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT01438606 | HIV Infections | Phase 1 | Completed | - | United States, California ... 展开 >> Bridge HIV CRS San Francisco, California, United States, 94143 United States, Georgia The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States, 30030 United States, Pennsylvania Penn Prevention CRS Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States, 37232 收起 << |
NCT02130193 | - | Completed | - | - | |
NCT00848510 | Colorectal and Ovarian Cancer ... 展开 >>Patients With Liver Metastases 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Christie Hospital Manchester, United Kingdom 收起 << |
NCT02549521 | Unspecified Disorder of Bone D... 展开 >>ensity and Structure 收起 << | Phase 1 | Completed | - | - |
NCT03481894 | Malnutrition | Phase 4 | Recruiting | March 2021 | United States, Illinois ... 展开 >> The University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Timothy Sentongo, MD United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Joel D Lim, MD 收起 << |
NCT02656212 | Pre-diabetes | Phase 1 | Completed | - | United States, California ... 展开 >> CMR Center for Metabolic Research VASDHS San Diego, California, United States, 92161 VA San Diego Healthcare System San Diego, California, United States, 92161 收起 << |
NCT03636035 | Mild Knee Osteoarthritis | Not Applicable | Not yet recruiting | December 31, 2019 | - |
NCT00848510 | - | Completed | - | - | |
NCT00701805 | Secondary Hyperparathyroidism ... 展开 >> Hemodialysis 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Aichi, Japan Chiba, Japan Fukuoka, Japan Hokkaido, Japan Ibaragi, Japan Kanagawa, Japan Kumamoto, Japan Nagano, Japan Nagasaki, Japan Osaka, Japan Saitama, Japan Tokyo, Japan 收起 << |
NCT00679939 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00679939 | - | Completed | - | - | |
NCT02304367 | Tumor Induced Osteomalacia (TI... 展开 >>O) Epidermal Nevus Syndrome (ENS) 收起 << | Phase 2 | Active, not recruiting | December 31, 2019 | United States, Colorado ... 展开 >> Colorado Center for Bone Research Lakewood, Colorado, United States, 80227 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520-8064 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Texas Houston Methodist Research Institute Houston, Texas, United States, 77030 收起 << |
NCT02930161 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 2 | Recruiting | November 2020 | Russian Federation ... 展开 >> Company "Clinic of professor Gorbakov" Ltd. Recruiting Krasnogorsk, Russian Federation, 143405 City Hospital of the Holy Martyr Elizabeth Recruiting Saint-Petersburg, Russian Federation, 197706 Medical Company "Hepatologist" Ltd. Recruiting Samara, Russian Federation, 443063 收起 << |
NCT02476994 | - | Terminated(Based on feedback f... 展开 >>rom FDA) 收起 << | - | - | |
NCT03563222 | Malnutrition, Child | Phase 4 | Not yet recruiting | November 2020 | - |
NCT02553044 | Vitamin D Deficiency ... 展开 >> Osteoporosis 收起 << | Not Applicable | Active, not recruiting | December 2018 | United Kingdom ... 展开 >> Clinical Research Facility Sheffield, South Yorkshire, United Kingdom, S5 7AU 收起 << |
NCT03706690 | Carcinoma, Non-Small-Cell Lung | Phase 3 | Recruiting | January 31, 2025 | - |
NCT03732820 | Metastatic Castration-resistan... 展开 >>t Prostate Cancer 收起 << | Phase 3 | Recruiting | August 17, 2022 | - |
NCT00701805 | - | Completed | - | - | |
NCT00775437 | - | Completed | - | - | |
NCT02476994 | Essential Fatty Acid Deficienc... 展开 >>y (EFAD) 收起 << | Phase 4 | Terminated(Based on feedback f... 展开 >>rom FDA) 收起 << | - | United States, Illinois ... 展开 >> Advocate Children's Hospital Park Ridge, Illinois, United States, 60068 United States, Indiana Riley Hospital for Children at Indiana Health Indianapolis, Indiana, United States, 46202 United States, Ohio Ohio State University, Wexner Medical Center Columbus, Ohio, United States, 43210 United States, South Carolina Medical University of SC, Neonatology Charleston, South Carolina, United States, 29425 收起 << |
NCT03688711 | Hypoglycemia ... 展开 >>Diabetes Mellitus, Type 1 收起 << | Phase 3 | Recruiting | April 18, 2019 | United States, California ... 展开 >> ProSciento, Inc. Recruiting Chula Vista, California, United States, 91911 Contact: Julie Willard, MD AMCR Institute Recruiting Escondido, California, United States, 92025 Contact: Tim Bailey, MD United States, Washington Rainier Clinical Research, Inc. Recruiting Renton, Washington, United States, 98057 Contact: Leslie Klaff, MD, PhD 收起 << |
NCT02169063 | Hormone-resistant Prostate Can... 展开 >>cer Recurrent Prostate Cancer Stage IV Prostate Cancer 收起 << | Not Applicable | Withdrawn | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00775437 | Juvenile Idiopathic Arthritis | Phase 3 | Completed | - | - |
NCT02450227 | Ileostomy; Functional Disturba... 展开 >>nce Healthy 收起 << | Not Applicable | Terminated(It is considered no... 展开 >>n-achievable to recruit the target number of subjects in the short bowel group (n = 12). 10 participants were recruited.) 收起 << | - | Denmark ... 展开 >> Rigshospitalet, Department of Gastroenterology, CA-2121 Copenhagen Ø, Denmark, 2100 Department of Nutrition, Exercise and Sports, University of Copenhagen Frederiksberg C, Denmark, 1958 收起 << |
NCT01804374 | Metastatic Osteosarcoma ... 展开 >> Relapsed Osteosarcoma 收起 << | Phase 2 | Completed | - | Italy ... 展开 >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy, 10060 收起 << |
NCT02720081 | - | Completed | - | - | |
NCT01304927 | Male Infertility | Phase 2 Phase 3 | Completed | - | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT00376948 | - | Completed | - | - | |
NCT01432587 | - | Completed | - | Sweden ... 展开 >> Dept of Clinical Medicin, Ptieå Hospital Piteå, Sweden, SE-941 28 Dept of clinical medicin, Skellefteå Hospital Skellefteå, Sweden, SE-931 86 Dept of Clinical Medicine, Umeå University Hospital Umeå, Sweden, SE-90185 收起 << | |
NCT03764085 | Sepsis Intoxi... 展开 >>cation; Septic 收起 << | Phase 4 | Recruiting | October 31, 2019 | Georgia ... 展开 >> "Unimedi Adjara" LLC Recruiting Batumi, Georgia Contact: Sophio Beridze Kutaisi Referral Hospital Recruiting Kutaisi, Georgia Contact: Nino Babunashvili "Unimedi Kakheti" Ltd Recruiting Telavi, Georgia Contact: Maya Makkhetelashvili Kazakhstan Hospital of the Medical Center of the Administration of the President of the Republic of Kazakhstan Recruiting Astana, Kazakhstan Contact: Nasrulla Shanazarov Moldova, Republic of Institute of Ambulance Recruiting Chisinau, Moldova, Republic of Contact: Adrian Belyy State Clinical Hospital of Traumatology and Orthopedy Recruiting Chisinau, Moldova, Republic of Contact: Octavian Cherempey State Clinical Hospital Recruiting Chisinau, Moldova, Republic of Contact: Victor Cojocaru Ukraine Dnipro`s Medical Academy of Ministry of Health of Ukraine Recruiting Dnipro, Ukraine, 49005 Contact: Yurii Kobelyatsky Zaicev's Institute of general and urgent surgery NMA Ukraine Recruiting Kharkiv, Ukraine, 61018 Contact: Stanislav Peev HSEE of Ukraine "Ukrainian Medical Stomatological Academy"; Poltava Central District Hospital Recruiting Poltava, Ukraine Contact: Alexey Lyhonenko Zaporizka Medical Academy of postgraduate education, Zaporizkyi Clinical Hospital N9 Recruiting Zaporizhzhya, Ukraine, 69065 Contact: Volodymyr Koshlya Uzbekistan Republic Centre of Ambulance Recruiting Tashkent, Uzbekistan Contact: Vіsolat Sharipova 收起 << |
NCT02205476 | Hypertrophic Scars Resulting F... 展开 >>rom Prior Breast Scar Revision Surgery 收起 << | Phase 2 | Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 << | - | United States, Florida ... 展开 >> Stephan Baker MD PA Coral Gables, Florida, United States, 33146 Bayside Ambulatory Center Miami, Florida, United States, 33133 United States, Georgia Kavali Plastic Surgery and Skin Renewal Center Atlanta, Georgia, United States, 30328 Primeter outpatient surgery center Atlanta, Georgia, United States, 30328 United States, Missouri Body Aesthetic Research Center Saint Louis, Missouri, United States, 63141 收起 << |
NCT02205476 | - | Terminated(B5301001 study did ... 展开 >>not meet its predefined efficacy endpoints, the long term follow up study B5301012 was terminated in 1/6/2015. No safety concerns identified.) 收起 << | - | - | |
NCT03336983 | Prostate Cancer ... 展开 >> Bone Metastases 收起 << | Phase 2 | Recruiting | December 1, 2023 | Italy ... 展开 >> Azienda Ospedaliera Spedali Civili di Brescia Recruiting Brescia, Italy, 25123 收起 << |
NCT02319577 | Non Small Cell Lung Cancer | Phase 2 | Unknown | December 2015 | Italy ... 展开 >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genova, Italy, 16132 Contact: Francesco Grossi, MD +39 010 5600385 francesco.grossi@hsanmartino.it 收起 << |
NCT00376948 | Pancreatic Cancer | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 收起 << |
NCT01382212 | End-Stage Renal Disease ... 展开 >> Secondary Hyperparathyroidism 收起 << | Phase 3 | Completed | - | - |
NCT01241292 | Multiple Myeloma | Phase 1 | Completed | - | Japan ... 展开 >> Local Institution Nagoya-shi, Aichi, Japan, 4600001 Local Institution Nagoya-shi, Aichi, Japan, 4678602 Local Institution Niigata-shi, Niigata, Japan, 9518566 收起 << |
NCT01382212 | - | Completed | - | - | |
NCT02455011 | Type 2 Diabetes Mellitus ... 展开 >> Diabetes 收起 << | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> Miami, Florida, United States United States, Texas San Antonio, Texas, United States United States, Washington Renton, Washington, United States 收起 << |
NCT02706834 | Dose Finding Study | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Baltimore, Maryland, United States United States, Texas Austin, Texas, United States 收起 << |
NCT03123406 | Hyperparathyroidism; Secondary... 展开 >>, Renal 收起 << | Phase 4 | Recruiting | September 27, 2019 | China, Jiangsu ... 展开 >> Nanjing Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhihong Liu 收起 << |
NCT02798978 | Cancer | Phase 1 | Completed | - | Germany ... 展开 >> GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT02377427 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92123 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7310 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73112 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792-9988 Japan GSK Investigational Site Fukuoka, Japan, 811-1394 GSK Investigational Site Hiroshima, Japan, 720-8520 GSK Investigational Site Hiroshima, Japan, 721-8511 GSK Investigational Site Wakayama, Japan, 646-8558 Poland GSK Investigational Site Lodz, Poland, 90-329 GSK Investigational Site Tarnow, Poland, 33-100 GSK Investigational Site Wroclaw, Poland, 53-201 United Kingdom GSK Investigational Site Glasgow, United Kingdom, G514TF GSK Investigational Site Leicester, United Kingdom, LE27LX GSK Investigational Site Liverpool, United Kingdom, L12 2AP GSK Investigational Site London, United Kingdom, SE5 9RS GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site Oxford, United Kingdom, OX3 9DU GSK Investigational Site Sheffield, United Kingdom, S10 2TH 收起 << |
NCT03052062 | Obese | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique Clermont-Ferrand, France, 63000 收起 << |
NCT01147809 | - | Completed | - | - | |
NCT00408421 | Osteoarthritis Knee Pain | Phase 3 | Completed | - | United States, Arizona ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, California For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beverly Hills, California, United States, 90211 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northridge, California, United States, 91325 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Walnut Creek, California, United States, 94598 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fort Myers, Florida, United States, 33916 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S. Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stuart, Florida, United States, 34996 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States, 60611 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Morton Grove, Illinois, United States, 60053 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Billerica, Massachusetts, United States, 01821 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waltham, Massachusetts, United States, 02453 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Westborough, Massachusetts, United States, 01581 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reno, Nevada, United States, 89502 United States, New Jersey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edison, New Jersey, United States, 08817 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stratford, New Jersey, United States, 08084 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toms River, New Jersey, United States, 08755 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tulsa, Oklahoma, United States, 74135 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lake Jackson, Texas, United States, 77566 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Waco, Texas, United States, 76708 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita Falls, Texas, United States, 76309 Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hato Rey, Puerto Rico, 00917 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Juan, Puerto Rico, 00935 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brasov, Romania, 500365 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 70266 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cluj-Napoca, Romania, 400132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 700656 收起 << |
NCT01147809 | Thrombocytopaenia | Phase 2 | Completed | - | - |
NCT00795600 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Málaga, Spain, 29009 收起 << |
NCT02706834 | - | Completed | - | - | |
NCT00795600 | - | Completed | - | - | |
NCT01020123 | Type II Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT01135576 | Iron-deficiency Anemia | Not Applicable | Completed | - | - |
NCT01202253 | - | Completed | - | United Kingdom ... 展开 >> Pfizer Investigational Site London, United Kingdom, SE5 9RS 收起 << | |
NCT02796794 | Sepsis | Phase 4 | Unknown | September 2016 | Turkey ... 展开 >> Erciyes University Medical School Recruiting Kayseri, Turkey, 38039 Contact: Kudret Dogru, MD +90 352 207 6666 ext 20000 kdogru@erciyes.edu.tr Contact: Emine Alp, MD +90 352 207 6666 ext 20000 ealp@erciyes.edu.tr 收起 << |
NCT01202253 | - | Completed | - | - | |
NCT03087149 | Vitamin D Deficiency ... 展开 >> Osteopenia Nephrolithiasis Drug Overdose 收起 << | Not Applicable | Recruiting | May 31, 2020 | Poland ... 展开 >> Princess Anna Mazowiecka Hospital Recruiting Warsaw, Poland, 00-315 Contact: Maria K Borszewska-Kornacka, Professor 225966155 ext +48 mariak@szpitalkarowa.pl 收起 << |
NCT01069055 | Inguinal Hernia ... 展开 >> Postoperative Pain 收起 << | Phase 3 | Unknown | June 2010 | Turkey ... 展开 >> Diskapi Teaching and Research Hospital Not yet recruiting Ankara, Turkey Contact: Alp Alptekin, MD +90 312 5962370 alptekinmd@yahoo.com Contact: Hakan Kulacoglu, MD, FACS hakankulacoglu@hotmail.com 收起 << |
NCT02973412 | - | Recruiting | June 2021 | United Kingdom ... 展开 >> Leicester Diabetes Centre, Leicester General Hospital Recruiting Leicester, United Kingdom, LE5 4PW Contact: Lois Daniels 0116 258 8070 Lois.J.Daniels@uhl-tr.nhs.uk Contact: Emer Brady 0116 258 8959 Emer.Brady@uhl-tr.nhs.uk 收起 << | |
NCT03098537 | Enteral Nutrition ... 展开 >> Gastro Intestinal Bleeding Stress Ulcer Prophylaxis Proton Pump Inhibitor 收起 << | Not Applicable | Recruiting | December 1, 2017 | Turkey ... 展开 >> Erciyes University Medical School Recruiting Kayseri, Turkey, 38039 Contact: Kudret Dogru, MD +90 352 207 6666 ext 20000 kdogru@erciyes.edu.tr Contact: Emine Alp, MD +90 352 207 6666 ext 20000 ealp@erciyes.edu.tr 收起 << |
NCT02012985 | Primary Hyperoxaluria | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Hôpital Robert-Debré, Néphrologie Pédiatrique Paris, Cedex 19, France, 75945 Hôpital des Enfants, Centre de référence maladies rénales rares du Sud-Ouest (SORARE), CHU de Bordeaux Bordeaux, France, 33076 Hôpital Femme Mère Enfant, Lyon - Paediatric Dept Lyon, France, 69677 Bron Hôpital Necker-Enfants Malades,Centre de référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA) Paris, France, 75015 Germany Universitätsklinikum Bonn, Dept of Paediatric Nephrology Bonn, Germany, DE-53113 United Kingdom Birmingham Children's Hospital NHS Foundation Trust - Dept of Nephrology Birmingham, United Kingdom, B4 6NH Royal Free Hospital -UCL Centre for Nephrology London, United Kingdom, NW3 2QG Great Ormond Street Hospital for Children NHS Trust London, United Kingdom, WCIN 3JH 收起 << |
NCT01738776 | - | Completed | - | Norway ... 展开 >> University of Oslo, Institute of Clinical Medicine Oslo, Norway, 0424 收起 << | |
NCT02500186 | Diabetes Melltius, Type 2 | Not Applicable | Completed | - | - |
NCT01928940 | Solid Tumours | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Shizuoka, Japan, 411-8777 GSK Investigational Site Tokyo, Japan, 104-0045 收起 << |
NCT01097655 | - | Completed | - | - | |
NCT02926456 | - | Completed | - | - | |
NCT02214563 | Kidney Failure, Chronic ... 展开 >> Anemia Vitamin D Deficiency Bone Diseases, Metabolic 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Hyogo Prefectural Nishinomiya Hospital Nishinomiya, Hyogo, Japan, 662-0918 Higashikouri hospital Hirakata, Osaka, Japan, 573-0075 Department of Comprehensive Kidney Disease Research, Osaka University Graduate School of Medicine Suita, Osaka, Japan, 565-0871 Akebono clinic Kumamoto, Japan, 861-4112 Obi clinic Osaka, Japan, 543-0052 Nishi clinic Osaka, Japan, 552-0007 Futaba clinic Osaka, Japan, 559-0013 收起 << |
NCT00530790 | Restless Legs Syndrome | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 802-0084 GSK Investigational Site Fukuoka, Japan, 810-0044 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Hiroshima, Japan, 733-0031 GSK Investigational Site Kanagawa, Japan, 210-0024 GSK Investigational Site Osaka, Japan, 550-0004 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 599-8263 GSK Investigational Site Tochigi, Japan, 321-0293 GSK Investigational Site Tokyo, Japan, 151-0053 GSK Investigational Site Tokyo, Japan, 187-0041 收起 << |
NCT03598283 | - | Recruiting | June 30, 2020 | United States, Texas ... 展开 >> University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77550 Contact: Christian Tapking, MD 409-770-6964 chtapkin@utmb.edu 收起 << | |
NCT01928940 | - | Completed | - | - | |
NCT02431767 | HIV Infections | Phase 1 | Completed | - | United States, Georgia ... 展开 >> The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States, 30030 United States, New York University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States, 14642 United States, Tennessee Vanderbilt Vaccine (VV) CRS Nashville, Tennessee, United States, 37232-2582 United States, Washington Seattle Vaccine and Prevention CRS Seattle, Washington, United States, 98109-1024 收起 << |
NCT01097655 | - | Completed | - | - | |
NCT01165203 | - | Completed | - | - | |
NCT00530790 | - | Completed | - | - | |
NCT01165203 | Herpes Zoster | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Long Beach, California, United States, 90813 GSK Investigational Site San Francisco, California, United States, 94115 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32803 United States, New Mexico GSK Investigational Site Santa Fe, New Mexico, United States, 87505 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40237 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Berlin, Germany, 13353 GSK Investigational Site Hamburg, Germany, 20146 United Kingdom GSK Investigational Site Woolwich, London, London, United Kingdom, SE18 4QH GSK Investigational Site London, United Kingdom, E1 1BB GSK Investigational Site London, United Kingdom, NW3 2QG GSK Investigational Site London, United Kingdom, SW10 9TH 收起 << |
NCT00337155 | Prostate Cancer ... 展开 >> Neoplasm Metastasis 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Sutton, Surrey, United Kingdom, SM2 5RT 收起 << |
NCT02181335 | Asthma | Phase 3 | Completed | - | - |
NCT03544281 | Multiple Myeloma | Phase 2 | Recruiting | November 28, 2022 | United States, Alabama ... 展开 >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02189005 | Diabetes Mellitus ... 展开 >> Pre-Diabetes Hyperglycemia Metabolic Syndrome 收起 << | Phase 3 | Completed | - | India ... 展开 >> Dia Care- Diabetes Care and Hormone Clinic Ahmedabad, Gujarat, India, 380015 St. Johns College and Hospital Bangalore, Karnataka, India, 560034 Totall Diabetes and Hormone Institution Indore, Madhya Pradesh, India, 452010 Bhatia Hospital Mumbai, Maharashtra, India, 411007 Inamdar Multispeciality Hospital Pune, Maharashtra, India, 411040 Diabetes Care Centre Jaipur, Rajasthan, India, 302018 收起 << |
NCT02972905 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 << |
NCT02729142 | Organ Transplant | Not Applicable | Recruiting | June 2020 | France ... 展开 >> Hopital Edouard Herriot Recruiting Lyon, France Contact: Charlène Lévi, MD 收起 << |
NCT02817620 | Metabolic Syndrome | Not Applicable | Completed | - | France ... 展开 >> Biofortis Mérieux NutriSciences Clinical Investigation Center Saint Herblain, France, 44800 收起 << |
NCT03196557 | Immunoscience | Phase 1 | Completed | - | United States, Texas ... 展开 >> Local Institution Austin, Texas, United States, 78759 收起 << |
NCT01020123 | - | Completed | - | - | |
NCT02790489 | Overweight | Phase 1 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique Clermont-Ferrand, France, 63000 收起 << |
NCT00172198 | Critical Ill Patients in SICU | Phase 4 | Unknown | - | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Hong-Shiee Lai, M.D., Ph.D. 886-2-23123456 ext 5112 hslai@ha.mc.ntu.edu.tw 收起 << |
NCT03422172 | HIV Infections | Phase 1 | Active, not recruiting | April 28, 2020 | China, Zhejiang ... 展开 >> GSK Investigational Site Hangzhou, Zhejiang, China, 310000 China GSK Investigational Site Beijing, China, 100069 GSK Investigational Site Shanghai, China, 201508 收起 << |
NCT02117713 | Alagille Syndrome | Phase 2 | Active, not recruiting | June 28, 2019 | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 University of California at San Francisco Children's Hospital San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19147 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine/Texas Children's Hospital Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84113 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT01173120 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT01001832 | Rheumatoid Arthritis | Phase 2 Phase 3 | Completed | - | Japan ... 展开 >> Local Institution Narita-Shi, Chiba, Japan, 2868523 Local Institution Fukuoka-Shi, Fukuoka, Japan, 8108563 Local Institution Kitakyushu-Shi, Fukuoka, Japan, 8078555 Local Institution Kurume-Shi, Fukuoka, Japan, 8308543 Local Institution Maebashi-Shi, Gunma, Japan, 3718511 Local Institution Takasaki-Shi, Gunma, Japan, 3700053 Local Institution Higashi-Hiroshima-Shi, Hiroshima, Japan, 7390002 Local Institution Sapporo-Shi, Hokkaido, Japan, 0608604 Local Institution Sapporo-Shi, Hokkaido, Japan, 0608648 Local Institution Sapporo-Shi, Hokkaido, Japan, 0630811 Local Institution Sapporo, Hokkaido, Japan, 0630005 Local Institution Kanzaki-Gun, Hyogo, Japan, 6792414 Local Institution Kato-Shi, Hyogo, Japan, 6731462 Local Institution Kobe-Shi, Hyogo, Japan, 6500001 Local Institution Hitachi-Shi, Ibaraki, Japan, 3160035 Local Institution Kagoshima-Shi, Kagoshima, Japan, 8900067 Local Institution Sagamihara-Shi, Kanagawa, Japan, 2520392 Local Institution Yokohama-Shi, Kanagawa, Japan, 2220036 Local Institution Yokohama-Shi, Kanagawa, Japan, 2360037 Local Institution Nagano-Shi, Nagano, Japan, 3808582 Local Institution Kurashiki-Shi, Okayama, Japan, 7128044 Local Institution Hannan-Shi, Osaka, Japan, 5990212 Local Institution Iruma-Gun, Saitama, Japan, 3500495 Local Institution Kawagoe-Shi, Saitama, Japan, 3508550 Local Institution Kitamoto-Shi, Saitama, Japan, 3640026 Local Institution Tokorozawa-Shi, Saitama, Japan, 3591111 Local Institution Hamamatsu-Shi, Shizuoka, Japan, 4308558 Local Institution Shizuoka-Shi, Shizuoka, Japan, 4208623 Local Institution Shimotsuke-Shi, Tochigi, Japan, 3290498 Local Institution Utsunomiya-Shi, Tochigi, Japan, 3291193 Local Institution Bunkyo-Ku, Tokyo, Japan, 1138519 Local Institution Nakano-Ku, Tokyo, Japan, 1648541 Local Institution Shinjuku-Ku, Tokyo, Japan, 1608582 收起 << |
NCT03550508 | Bone Metastases | Phase 1 | Recruiting | December 1, 2019 | China ... 展开 >> Shanghai East Hospital Recruiting Shanghai, China, 200123 Contact: Jin Li, MD 86-21-38804518 lijin@csco.org.cn 收起 << |
NCT01001832 | - | Completed | - | - | |
NCT03109678 | Airway Management ... 展开 >> Laryngeal Mask Airway Fibreoptic Intubation 收起 << | Not Applicable | Completed | - | - |
NCT01173120 | - | Completed | - | - | |
NCT03004547 | - | Completed | - | Canada, Ontario ... 展开 >> London Health Sciences Centre London, Ontario, Canada 收起 << | |
NCT00725712 | Neoplasms, Gastrointestinal Tr... 展开 >>act 收起 << | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, Arizona GSK Investigational Site Scottsdale, Arizona, United States, 85258 United States, California GSK Investigational Site Los Angeles, California, United States, 90024 GSK Investigational Site Stanford, California, United States, 94305 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20007 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30309 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Montana GSK Investigational Site Billings, Montana, United States, 59101 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87131 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10021 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 United States, Wisconsin GSK Investigational Site Madison, Wisconsin, United States, 53792 收起 << |
NCT03623529 | Catecholamine-resistant Hypote... 展开 >>nsion (CRH) Distributive Shock High Output Shock Septic Shock 收起 << | Phase 2 | Recruiting | April 2023 | Belgium ... 展开 >> Investigational Site Not yet recruiting Brussels, Belgium Lithuania Investigational Site Recruiting Vilnius, Lithuania, 08406 收起 << |
NCT02733484 | Obesity | Not Applicable | Recruiting | December 2017 | China, Shanghai ... 展开 >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD 18817951953 1263856671@qq.com Contact: Renyuan Gao, MD renyuangao@126.com Principal Investigator: Huanlong Qin, PhD Principal Investigator: Shen Qu, PhD 收起 << |
NCT00725712 | - | Completed | - | - | |
NCT02728414 | Diabetes Mellitus, Type 2 | Not Applicable | Recruiting | December 2017 | China, Shanghai ... 展开 >> Shanghai 10th People's Hospital Recruiting Shanghai, Shanghai, China, 200072 Contact: Cuiling Zhu, MD 18817951953l 1263856671@qq.com Principal Investigator: Renyuan Gao, MD 收起 << |
NCT00048035 | Anemia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Birmingham, Alabama, United States, 35211 United States, California Los Angeles, California, United States, 90095 United States, Illinois Maywood, Illinois, United States, 60153 United States, Kentucky Louisville, Kentucky, United States, 40202-1718 United States, Michigan Detroit, Michigan, United States, 48202-2689 Detroit, Michigan, United States, 48236 United States, Minnesota Brooklyn Center, Minnesota, United States, 55430 United States, Nevada Las Vegas, Nevada, United States, 89106 United States, New Jersey Paterson, New Jersey, United States, 07503 United States, New York Brooklyn, New York, United States, 11203 Mineola, New York, United States, 11501 New York, New York, United States, 10128 United States, Tennessee Nashville, Tennessee, United States, 37232 United States, West Virginia Morgantown, West Virginia, United States, 26506 收起 << |
NCT00048035 | - | Completed | - | - | |
NCT01265498 | Nonalcoholic Fatty Liver Disea... 展开 >>se (NAFLD) Nonalcoholic Steatohepatitis (NASH) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63104 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 收起 << |
NCT00626769 | - | Completed | - | - | |
NCT02680847 | - | Terminated(The trial was termi... 展开 >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) 收起 << | - | - | |
NCT03678480 | Primary Sclerosing Cholangitis... 展开 >> Cholangitis Cholangitis, Sclerosing Bile Duct Diseases Biliary Tract Diseases Digestive System Diseases Adolescent 收起 << | Phase 2 | Not yet recruiting | November 4, 2019 | - |
NCT00408421 | - | Completed | - | - | |
NCT03520231 | Urothelial Carcinoma ... 展开 >> Kidney Cancer Ureter Cancer Bladder Cancer 收起 << | Phase 2 | Recruiting | June 1, 2020 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Srikala Sridhar, M.D. 416-946-4501 ext 2662 srikala.sridhar@uhn.ca Principal Investigator: Srikala Sridhar, M.D. 收起 << |
NCT01369550 | Healthy Volunteers ... 展开 >> Markers of Cardiovascular Risk 收起 << | Not Applicable | Completed | - | United States, Florida ... 展开 >> Meridien Research St. Petersburg, Florida, United States, 33709 United States, Illinois Provident Clinical Research & Consulting, Inc. Addison, Illinois, United States 收起 << |
NCT03549494 | Stomach Neoplasm ... 展开 >> Gastrointestinal Neoplasms Digestive System Neoplasm Esophageal Neoplasms Head and Neck Neoplasms Gastrointestinal Disease Digestive System Disease Esophageal Diseases Stomach Diseases Esophagogastric Junction Disorder 收起 << | Phase 2 | Not yet recruiting | October 1, 2019 | Cuba ... 展开 >> National Institute of Oncology and Radiobiology (INOR) Not yet recruiting Havana, La Habana, Cuba, 10400 Contact: Luis E. Alsina Tul, Dr. +53-78388589 lealsina@infomed.sld.cu Principal Investigator: Luis E. Alsina Tul, Dr. Sub-Investigator: Yanelys Mir Espinosa, Dr. Sub-Investigator: Giselle Álvarez Pérez, BSc Sub-Investigator: Karelia Silvera Candó, BSc Sub-Investigator: Zaida Lastre Sosa, BSc Sub-Investigator: Janet Lamadrid García, Dr. Sub-Investigator: Danay Corrales Otero, Dr. Sub-Investigator: Marta Lugioyo Lugo, BSc Sub-Investigator: Juan J. Lence Anta, Dr. 收起 << |
NCT01265498 | - | Completed | - | - | |
NCT02680847 | Moderate-severe Pain | Phase 4 | Terminated(The trial was termi... 展开 >>nated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.) 收起 << | - | United States, California ... 展开 >> Research Center For Clinical Studies-West, Inc. Lancaster, California, United States, 93534 Children's Hopsital Los Angeles Los Angeles, California, United States, 90027 Children's Hospital Of Los Angeles - University Of Southern California School Of Medicine Los Angeles, California, United States, 90027 Shriners Hospitals For Children Northern California Sacramento, California, United States, 95817 UC Davis Health Attn: Peter Trovitch, PharmD Sacramento, California, United States, 95817 University of California Davis Sacramento, California, United States, 95817 United States, Illinois University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences Systems Chicago, Illinois, United States, 60612 University of Illinois Hospital at the Medical Center Chicago, Illinois, United States, 60612 United States, North Carolina East Carolina University Brody School of Medicine(ECU) Greenville, North Carolina, United States, 27834 Leo Jenkins Cancer Center Pharmacy Greenville, North Carolina, United States, 27834 United States, South Carolina Medical University of South Carolina Children's Hospital Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Investigational Drugs Services Charleston, South Carolina, United States, 29425 Medical University of South Carolina, Rutledge Tower, Pediatric Clinic Charleston, South Carolina, United States, 29425 Medical University of South Carolina, SCTR Research Nexus Charleston, South Carolina, United States, 29425 United States, Texas Road Runner Research, Ltd San Antonio, Texas, United States, 78249 收起 << |
NCT01900171 | Essential Hypertension | Phase 1 | Completed | - | France ... 展开 >> Biotrial PARIS Rueil-Malmaison, France, 92502 收起 << |
NCT00310388 | Epilepsy | Phase 3 | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - |
NCT00431808 | Malaria | Phase 1 | Unknown | June 2008 | Mali ... 展开 >> Malaria Research and Training Center Recruiting Bandiagara, Mali Contact: Mahamadou A Thera, MD MPH +223 221 6361 mthera@mrtcbko.org Contact: Ogobara K Doumbo, MD PhD +223 222 8109 okd@ikatelnet.net Sub-Investigator: Drissa Coulibaly, MD Principal Investigator: Mahamadou A Thera, MD MPH 收起 << |
NCT03593707 | Healthy Volunteers | Phase 1 | Suspended(Sponsor elected to v... 展开 >>oluntarily pause study.) 收起 << | February 12, 2019 | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT00374907 | Type 2 Diabetes | Phase 3 | Completed | - | United States, California ... 展开 >> Va San Diego Healthcare System San Diego, California, United States, 92161 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, Texas Diabetes & Glandular Disease Research Assoc,, Inc. San Antonio, Texas, United States, 78229 收起 << |
NCT00531206 | - | Completed | - | - | |
NCT00531206 | - | Completed | - | Germany ... 展开 >> Boehringer Ingelheim Investigational Site Aachen, Germany Boehringer Ingelheim Investigational Site Berlin, Germany Boehringer Ingelheim Investigational Site Bremen, Germany Boehringer Ingelheim Investigational Site Dortmund, Germany Boehringer Ingelheim Investigational Site Düsseldorf, Germany Boehringer Ingelheim Investigational Site Erlangen, Germany Boehringer Ingelheim Investigational Site Frankfurt/Main, Germany Boehringer Ingelheim Investigational Site Freiburg, Germany Boehringer Ingelheim Investigational Site Gießen, Germany Boehringer Ingelheim Investigational Site Halle/Saale, Germany Boehringer Ingelheim Investigational Site Hamburg, Germany Boehringer Ingelheim Investigational Site Hannover, Germany Boehringer Ingelheim Investigational Site Homburg/Saar, Germany Boehringer Ingelheim Investigational Site Karlsruhe, Germany Boehringer Ingelheim Investigational Site Krefeld, Germany Boehringer Ingelheim Investigational Site Köln, Germany Boehringer Ingelheim Investigational Site Leipzig, Germany Boehringer Ingelheim Investigational Site Magdeburg, Germany Boehringer Ingelheim Investigational Site Mainz, Germany Boehringer Ingelheim Investigational Site München, Germany Boehringer Ingelheim Investigational Site Münster, Germany Boehringer Ingelheim Investigational Site Nürnberg, Germany Boehringer Ingelheim Investigational Site Oldenburg, Germany Boehringer Ingelheim Investigational Site Osnabrück, Germany Boehringer Ingelheim Investigational Site Saarbrücken, Germany Boehringer Ingelheim Investigational Site Stuttgart, Germany Boehringer Ingelheim Investigational Site Wuppertal, Germany 收起 << | |
NCT00374907 | - | Completed | - | - | |
NCT02433717 | Schizophrenia ... 展开 >> Schizoaffective Disorder 收起 << | Phase 4 | Unknown | February 2016 | Taiwan ... 展开 >> Department of Psychiatry, National Taiwan University Hospital Not yet recruiting Taipei, Test2, Taiwan, test3 Contact: Yi-Ting Lin +886-972-653-797 p98421013@ntu.edu.tw Sub-Investigator: Ming H. Hsieh Sub-Investigator: Yi-Lin Chien Sub-Investigator: Chih-Min Liu Sub-Investigator: Tzung-Jeng Hwang Sub-Investigator: Chen-Chung Liu National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yi-Ting Lin, MD +886-2-23123456 ext 67990 p98421013@ntu.edu.tw Principal Investigator: Yi-Ting Lin, MD Sub-Investigator: Chin-Min Liu, MD, PhD Sub-Investigator: Ming H Hsieh, MD, PhD Sub-Investigator: Tzung-Jeng Hwang, MD, PhD Sub-Investigator: Chen-Chung Liu, MD, PhD Principal Investigator: Yi-Ling Chien, MD, PhD 收起 << |
NCT01900184 | Essential Hypertension | Phase 1 | Completed | - | France ... 展开 >> Biotrial PARIS Rueil-Malmaison, France, 92502 收起 << |
NCT00216060 | - | Terminated(Terminated due to l... 展开 >>ow accrual) 收起 << | - | - | |
NCT01397227 | Malaria | Phase 1 Phase 2 | Completed | - | United States, Washington ... 展开 >> Malaria Clinical Trials Center at Seattle Biomedical Research Institute Seattle, Washington, United States, 98109 收起 << |
NCT01556633 | Healthy Volunteer | Phase 1 | Completed | - | New Zealand ... 展开 >> Christchurch, New Zealand, 8011 Grafton, New Zealand, 1010 收起 << |
NCT00310388 | - | Terminated(No longer any benef... 展开 >>it in collecting data since retigabine has been withdrawn from market.) 收起 << | - | - | |
NCT01556633 | - | Completed | - | - | |
NCT01142726 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03473925 | Solid Tumors ... 展开 >>Non-small Cell Lung Cancer Castration Resistant Prostate Cancer Microsatellite Stable Colorectal Cancer 收起 << | Phase 2 | Recruiting | August 9, 2019 | United States, Arizona ... 展开 >> Honor Health ( Site 0005) Recruiting Scottsdale, Arizona, United States, 85258 Contact: Study Coordinator 623-238-7685 United States, Florida Florida Cancer Specialists ( Site 0003) Recruiting Sarasota, Florida, United States, 34232 Contact: Study Coordinator 941-377-9993 United States, Michigan Henry Ford Health System ( Site 0006) Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator 313-916-1784 United States, North Carolina Duke University Medical Center ( Site 0004) Recruiting Durham, North Carolina, United States, 27710 Contact: Study Coordinator 919-668-8797 Australia, New South Wales Scientia Clinical Research ( Site 0021) Recruiting Sydney, New South Wales, Australia, 2031 Contact: Study Coordinator +61293825807 Australia, Victoria Peter MacCallum Cancer Centre ( Site 0023) Recruiting Melbourne, Victoria, Australia, 3000 Contact: Study Coordinator +61385595000 Canada, Ontario Princess Margaret Cancer Centre ( Site 0031) Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Study Coordinator 41694645015634 Canada, Quebec Jewish General Hospital ( Site 0032) Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Study Coordinator 5143408222 Israel Sourasky Medical Center ( Site 0012) Recruiting Tel Aviv, Israel, 6423906 Contact: Study Coordinator +97236973082 Korea, Republic of Severance Hospital Yonsei University Health System ( Site 0041) Recruiting Seoul, Korea, Republic of, 03722 Contact: Study Coordinator +82222288132 收起 << |
NCT00216060 | Metastatic Prostate Cancer | Phase 3 | Terminated(Terminated due to l... 展开 >>ow accrual) 收起 << | - | - |
NCT00564889 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT02893891 | Grade III Obesity ... 展开 >> Type 2 Diabetes Mellitus 收起 << | Not Applicable | Completed | - | Czechia ... 展开 >> Vítkovice Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia, 703 00 University Hospital Ostrava Ostrava, Moravian-Silesian Region, Czechia, 708 52 收起 << |
NCT02936596 | Hepatitis, Autoimmune ... 展开 >> Cholangitis Liver Cirrhosis, Biliary Cholestasis 收起 << | Not Applicable | Recruiting | August 2018 | China, Sichuan ... 展开 >> West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Xiaoli Fan, MM +8618008028017 13980433451@163.com Contact: Li Yang, MD yangli_hx@scu.edu.cn 收起 << |
NCT01142726 | - | Completed | - | - | |
NCT01798680 | HIV Infection | Phase 3 | Active, not recruiting | March 2019 | Tanzania ... 展开 >> Management and Development for Health (MDH) Dar es Salaam, Tanzania 收起 << |
NCT02312687 | X-Linked Hypophosphatemia | Phase 2 | Active, not recruiting | November 24, 2018 | United States, California ... 展开 >> University California San Francisco Hospital San Francisco, California, United States, 94143 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520-8064 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 United States, Texas Houston Methodist Reasearch Institute Houston, Texas, United States, 77030 收起 << |
NCT00564889 | - | Completed | - | - | |
NCT02615301 | Osteoporosis | Not Applicable | Completed | - | Norway ... 展开 >> NIFES Bergen, Norway, 5817 收起 << |
NCT01572545 | Postmenopausal Osteoporosis | Not Applicable | Completed | - | Greece ... 展开 >> 251 Hellenic Air Force Hospital Athens, Attikis, Greece 424 General Military Hospital Thessaloniki, Greece Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital Thessaloniki, Greece 收起 << |
NCT00583362 | Systemic Lupus Erythematosus | Phase 2 | Completed | - | - |
NCT02654080 | HIV Infections | Phase 1 | Active, not recruiting | - | United States, Ohio ... 展开 >> Case Clinical Research Site Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn Prevention CRS Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT03694197 | Heterozygous Familial Hypercho... 展开 >>lesterolemia Non-familial Hypercholesterolemia 收起 << | Phase 4 | Enrolling by invitation | November 24, 2023 | United States, Texas ... 展开 >> Regeneron Research Site Schertz, Texas, United States, 78154 收起 << |
NCT00583362 | - | Completed | - | - | |
NCT01222078 | - | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | - | |
NCT03251014 | Thrombosis | Not Applicable | Completed | - | - |
NCT01222078 | Diabetes Mellitus, Type 1 | Phase 2 | Terminated(A Phase 3 study rec... 展开 >>ently reported and demonstrated that the dose of otelixizumab in OTX113390 is not effective.) 收起 << | - | France ... 展开 >> GSK Investigational Site Paris Cedex 18, France, 75877 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT02046577 | Acute Respiratory Tract Infect... 展开 >>ions 收起 << | Phase 2 | Completed | - | Chile ... 展开 >> Hospital de Punta Arenas Punta Arenas, Magallanes, Chile Pontificia Universidad Católica de Chile Santiago, Región Metropolitana, Chile Hospital Las Higueras Talcahuano, VIII Región, Chile 收起 << |
NCT03282955 | Patients Requiring Home Parent... 展开 >>eral Nutrition 收起 << | Phase 4 | Recruiting | September 1, 2019 | France ... 展开 >> Hospices Civiles de Lyon - Centre hospitalier Lyon Sud Recruiting Pierre-Bénite, France Contact: Cécile Chambrier, Dr. Italy Department of Medical and Surgical Science, University of Bologna, Center for Chronic Intestinal Failure, Department of Digestive System, St. Orsola-Malpighi Hospital Recruiting Bologna, Italy Contact: Loris Pironi, Prof. Netherlands Radboud university medical center Recruiting Nijmegen, Netherlands Contact: Geert Wanten, Dr. Poland Stanley Dudrick`s Memorial Hospital Recruiting Skawina, Poland Contact: Stanislaw Klek, Prof. Principal Investigator: Stanislaw Klek, Prof. Samodzielny Publiczny Szpital Kliniczny, im. prof. dr W. Orlowskiego, Centrum Medycznego Ksztalcenia Podyplomowego, Oddzial Kliniczny Zywienia i Chirurgii Recruiting Warszawa, Poland Contact: Jacek Sobocki, Dr. Wojewódzkim Specjalistycznym Szpitalem im. M. Pirogowa w Łodzi , Oddział Chirurgii Ogólnej i Naczyniowej Recruiting Łódź, Poland Contact: Marek Kunecki, Dr. United Kingdom University of East Anglia, Faculty of Medicine and Health Sciences Not yet recruiting Norwich, United Kingdom Contact: Alastair Forbes, Prof. 收起 << |
NCT00449462 | Healthy | Not Applicable | Completed | - | Netherlands ... 展开 >> VU University Amsterdam, Institute for Health Sciences Amsterdam, Netherlands Wageningen University, Division of Human Nutrition Wageningen, Netherlands 收起 << |
NCT01636778 | - | Completed | - | - | |
NCT02304276 | Heart; Complications, Valve, P... 展开 >>rosthesis 收起 << | Not Applicable | Enrolling by invitation | January 2021 | - |
NCT01134952 | - | Completed | - | - | |
NCT01134952 | Hepatitis C | Phase 4 | Completed | - | Canada, Ontario ... 展开 >> London Health Sciences Centre London, Ontario, Canada, N6A5A5 收起 << |
NCT00146328 | HIV Infections | Phase 2 Phase 3 | Completed | - | - |
NCT03233126 | X-linked Hypophosphatemic Rick... 展开 >>ets/Osteomalacia 收起 << | Phase 3 | Active, not recruiting | December 2019 | Japan ... 展开 >> Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center Yokohama, Kanagwa, Japan National University Corporation Osaka University Hospital Suita, Osaka, Japan Osaka Hospital, Japan Community Healthcare Organization (JCHO) Ōsaka, Osaka, Japan Okayama Saiseikai General Hospital Outpatient Center Okayama, Japan 收起 << |
NCT01636778 | Hepatitis C, Chronic | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 467-8602 GSK Investigational Site Fukui, Japan, 918-8503 GSK Investigational Site Fukuoka, Japan, 803-8505 GSK Investigational Site Fukuoka, Japan, 830-0011 GSK Investigational Site Gunma, Japan, 370-0829 GSK Investigational Site Hyogo, Japan, 663-8501 GSK Investigational Site Ibaraki, Japan, 317-0077 GSK Investigational Site Kagawa, Japan, 760-0017 GSK Investigational Site Kagawa, Japan, 760-8557 GSK Investigational Site Kagoshima, Japan, 899-5112 GSK Investigational Site Kanagawa, Japan, 213-8587 GSK Investigational Site Nagasaki, Japan, 856-8562 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 540-0006 GSK Investigational Site Tokyo, Japan, 105-8470 GSK Investigational Site Wakayama, Japan, 646-8558 收起 << |
NCT01582295 | Multiple Myeloma | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT01266967 | Melanoma and Brain Metastases | Phase 2 | Completed | - | - |
NCT01266967 | - | Completed | - | - | |
NCT00991354 | HIV Infections | Phase 1 | Completed | - | United States, New York ... 展开 >> Univ. of Rochester HVTN CRS Rochester, New York, United States, 14642-0001 United States, Pennsylvania 3535 Market Street CRS Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Vaccine CRS Nashville, Tennessee, United States, 37232 收起 << |
NCT02916862 | Osteoporosis | Phase 2 Phase 3 | Withdrawn(Principal Investigat... 展开 >>or moved to another institution, grant could not be moved) 收起 << | June 2020 | - |
NCT00146328 | - | Completed | - | - | |
NCT00474955 | - | Completed | - | - | |
NCT00474955 | Hepatitis C, Chronic | Phase 4 | Completed | - | Russian Federation ... 展开 >> Chita, Russian Federation, 672090 Irkutsk, Russian Federation, 664047 Khabarovsk, Russian Federation, 680009 Khabarovsk, Russian Federation, 680022 Orenburg, Russian Federation, 460040 收起 << |
NCT01222026 | Primary Hyperparathyroidism ... 展开 >> Osteopenia Osteoporosis 收起 << | Phase 4 | Completed | - | Austria ... 展开 >> Medical University Vienna, General Hospital Vienna (AKH Wien) Vienna, Austria, 1090 收起 << |
NCT03563846 | Lactose Intolerance | Phase 1 | Completed | - | United States, Florida ... 展开 >> Syneos Health Miami, Florida, United States, 33136 收起 << |
NCT00394953 | Anemia | Phase 3 | Completed | - | - |
NCT00394953 | - | Completed | - | - | |
NCT02999152 | Bone Metastasis ... 展开 >> Malignant Hemopathy 收起 << | Not Applicable | Recruiting | December 31, 2019 | France ... 展开 >> Institut de Cancérologie Lucien Neuwirth Recruiting Saint-Priest en Jarez, France, 42270 Principal Investigator: Nicolas Magné, PhD Sub-Investigator: Guy De Laroche, MD Sub-Investigator: Grégoire Pigne, MD Sub-Investigator: Denis Guyotat, PhD Sub-Investigator: Jérôme Cornillon, MD Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Valentine Martin, MD Principal Investigator: Valentine Martin, MD Sub-Investigator: Angela Boros, MD 收起 << |
NCT02613910 | - | Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 << | - | - | |
NCT01106352 | Bone Metastases ... 展开 >> Castration-Resistant Prostate Cancer 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> San Francisco, California, United States, 94115 United States, Illinois Evanston, Illinois, United States, 60201 United States, Maryland Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston, Massachusetts, United States, 02115-6013 United States, New York New York, New York, United States, 10065 United States, Washington Seattle, Washington, United States, 98109 France Villejuif Cedex, France, 94805 收起 << |
NCT00736099 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00644904 | Multiple Sclerosis | Phase 1 Phase 2 | Completed | - | Canada, Ontario ... 展开 >> St. Michael's Hospital Toronto, Ontario, Canada, M5B 1W8 收起 << |
NCT00255190 | Gastroesophageal Reflux Diseas... 展开 >>e 收起 << | Phase 3 | Completed | - | - |
NCT00736099 | - | Completed | - | - | |
NCT01106352 | - | Completed | - | - | |
NCT00742508 | Heart Failure, Congestive | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 296-8602 GSK Investigational Site Ehime, Japan, 794-0006 GSK Investigational Site Hiroshima, Japan, 737-0023 GSK Investigational Site Hokkaido, Japan, 060-0033 GSK Investigational Site Hokkaido, Japan, 063-0005 GSK Investigational Site Kanagawa, Japan, 210-0852 GSK Investigational Site Kanagawa, Japan, 238-8558 GSK Investigational Site Mie, Japan, 511-0068 GSK Investigational Site Nagano, Japan, 397-8555 GSK Investigational Site Nagasaki, Japan, 859-3615 GSK Investigational Site Oita, Japan, 879-5593 GSK Investigational Site Osaka, Japan, 565-8565 GSK Investigational Site Saga, Japan, 843-0393 GSK Investigational Site Saitama, Japan, 364-8501 GSK Investigational Site Shizuoka, Japan, 410-2295 GSK Investigational Site Shizuoka, Japan, 411-8611 GSK Investigational Site Shizuoka, Japan, 427-8502 GSK Investigational Site Shizuoka, Japan, 430-8502 GSK Investigational Site Tokyo, Japan, 141-0001 GSK Investigational Site Tokyo, Japan, 142-8666 GSK Investigational Site Tokyo, Japan, 153-8515 GSK Investigational Site Tokyo, Japan, 196-0003 GSK Investigational Site Wakayama, Japan, 640-8158 收起 << |
NCT01665651 | Renal Insufficiency, Chronic ... 展开 >> Renal Osteodystrophy 收起 << | Phase 2 | Withdrawn(Hard to enroll parti... 展开 >>cipants) 收起 << | - | China, Anhui ... 展开 >> The first affiliated hospital of Anhui University of TCM Hefei, Anhui, China, 230031 China, Shanghai Huadong hospital affiliated to Fudan University Shanghai, Shanghai, China, 200000 Longhua Hospital affiliated to Shanghai Uni of TCM Shanghai, Shanghai, China, 200032 收起 << |
NCT00255190 | - | Completed | - | - | |
NCT02956408 | Obesity, Pediatric ... 展开 >> Obesity, Childhood Obesity, Morbid Vitamin D Deficiency 收起 << | Phase 4 | Enrolling by invitation | November 2019 | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02613910 | Pemphigus | Phase 3 | Terminated(Novartis has acquir... 展开 >>ed the rights to ofatumumab and terminated the OPV116910 and OPV117059 studies. This decision is not linked to any safety consideration.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90045 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48103 收起 << |
NCT00742508 | - | Completed | - | - | |
NCT00753688 | Sarcoma, Soft Tissue | Phase 3 | Completed | - | - |
NCT02915705 | X-Linked Hypophosphatemia | Phase 3 | Active, not recruiting | September 2019 | - |
NCT02377427 | - | Completed | - | - | |
NCT00753688 | - | Completed | - | - | |
NCT03299049 | HIV Infections | Phase 3 | Active, not recruiting | March 11, 2022 | - |
NCT00767520 | Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Compassionate Cancer Care Medical Group, Inc Fountain Valley, California, United States, 92708 Compassionate Cancer Care Medical Group Inc Riverside, California, United States, 92501 United States, Pennsylvania Pennsylvania Oncology/Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Czech Republic Local Institution Hradec Kralove, Czech Republic, 500 05 Local Institution Prague 5, Czech Republic, 150 06 France Local Institution Lille, France, 59000 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint-Cloud Cedex, France, 92211 Ireland Local Institution Dublin, Ireland, 24 Poland Local Institution Gdansk, Poland, 80-462 Local Institution Gdansk, Poland, 80-952 Local Institution Lodz, Poland, 93-509 Local Institution Opole, Poland, 45-060 Spain Local Institution Madrid, Spain, 28033 Local Institution Madrid, Spain, 28041 Local Institution Torrevieja, Spain, 03186 Sweden Local Institution Vasteras, Sweden, 72189 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution London, Greater London, United Kingdom, NW1 2BU Local Institution Coventry, Warwickshire, United Kingdom, CV22DX 收起 << |
NCT02363946 | Alpha-1 Antitrypsin Deficiency | Phase 1 | Terminated(Company decision to... 展开 >> terminate the trial) 收起 << | - | Australia, Victoria ... 展开 >> Nucleus Network Ltd Melbourne, Victoria, Australia, 3004 Germany Universitatsklinikum des Saarlandes Homburg, Germany Netherlands Leiden University Medical Center Leiden, Netherlands, 2333ZA United Kingdom Queen Elizabeth Hospital Edgbaston, Birmingham, United Kingdom, B15 2WB 收起 << |
NCT01370720 | Irritable Bowel Syndrome | Phase 2 | Unknown | January 2013 | Italy
... 展开 >> Dept Internal Medicine and Gastroenterology, Policlinico Sant'Orsola-Malpighi
Recruiting
Bologna, Italy, I-40138
Contact: Vincenzo Stanghellini, MD +39 051 6364101 Prof. Vincenzo Stanghellini |
NCT00132808 | Osteopenia | Phase 3 | Completed | - | United States, New Jersey ... 展开 >> For information regarding facilities, please contact the Central Contact E. Hanover, New Jersey, United States, 07936 收起 << |
NCT00767520 | - | Completed | - | - | |
NCT01222949 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 Nucleus Network Limited Melbourne, Australia, VIC 3004 收起 << |
NCT00132808 | - | Completed | - | - | |
NCT01222962 | Malaria, Falciparum | Phase 1 | Completed | - | Australia ... 展开 >> CMAX, a division of IDT Australia Limited Adelaide, Australia, SA 5000 收起 << |
NCT00516139 | Epilepsy | Phase 3 | Completed | - | - |
NCT01244984 | - | Completed | - | - | |
NCT00655824 | Arthritis, Rheumatoid | Phase 2 | Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33334 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 Denmark GSK Investigational Site Glostrup, Denmark, 2600 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Koebenhavn, Denmark, 2100 Hungary GSK Investigational Site Szombathely, Hungary, 9700 Poland GSK Investigational Site Warszawa, Poland, 02-256 United Kingdom GSK Investigational Site Ipswich, United Kingdom, IP4 5PD 收起 << |
NCT00516139 | - | Completed | - | - | |
NCT00573794 | - | Completed | - | - | |
NCT01244984 | Asthma | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Chiba, Japan, 277-0863 GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Fukuoka, Japan, 816-0813 GSK Investigational Site Gifu, Japan, 501-6062 GSK Investigational Site Gunma, Japan, 373-0021 GSK Investigational Site Hiroshima, Japan, 730-0844 GSK Investigational Site Hiroshima, Japan, 732-0062 GSK Investigational Site Hiroshima, Japan, 739-0402 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0046 GSK Investigational Site Hyogo, Japan, 672-8064 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Kanagawa, Japan, 231-8682 GSK Investigational Site Kanagawa, Japan, 253-0041 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Miyagi, Japan, 983-8520 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-8510 GSK Investigational Site Okayama, Japan, 700-0862 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Okayama, Japan, 714-0081 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 569-1192 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Toyama, Japan, 937-0066 收起 << |
NCT01301456 | Diabetes Mellitus ... 展开 >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Nebraska ICON Clinical Pharmacology, LLC Omaha, Nebraska, United States, 68154 United States, Pennsylvania CRI Worldwide, LLC Philadelphia, Pennsylvania, United States, 19139 United States, Texas Healthcare Discoveries LLC d/b/a ICON Development Solutions San Antonio, Texas, United States, 78209 收起 << |
NCT00573794 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT00383708 | - | Completed | - | - | |
NCT00655824 | - | Terminated(The clinical develo... 展开 >>pment of intravenously administered ofatumumab in RA will no longer be pursued, so this study was prematurely terminated by the Sponsor.) 收起 << | - | - | |
NCT02000440 | - | Completed | - | - | |
NCT02763280 | Osteopenia | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Clinical Trial Center for Functional Foods; Chonbuk National University Hospital Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 收起 << |
NCT02363946 | - | Terminated(Company decision to... 展开 >> terminate the trial) 收起 << | - | - | |
NCT00383708 | Acromegaly | Phase 3 | Completed | - | Czechia ... 展开 >> University Hospital, Charles University Hradec Kralove, Czechia, 500 05 Charles University Prague, Czechia, 120 00 PRAHA 2 Denmark Aarhus Kommunehospital Aarhus, Denmark France Groupe Hospitalier Henri Mondor- Albert Chenevier Créteil Cedex, France Hôpital Bicêtre Le Kremlin-Bicêtre, France, 94275 Clinique Marc Linquette Lille Cedex, France, 59037 Hôpital de la Timone Marseille Cedex, France, 13385 CHU de Rangueil Toulouse, France, 31054 Germany Charite Campus Mitte Berlin, Germany, 10117 Klinikum Johann Wolfgang Goethe-Universität Frankfurt, Germany, 605090 Medizinische Klinik Innenstadt Munchen, Germany, 80336 Greece Anticancer Hospital Metaxa Piraeus Piraeus, Greece, 18537 Italy Universitá degli Studi di Milano Milano, Italy, 20122 University Federico II Napoli, Italy, 80131 Universitá di Torino Torino, Italy, 10126 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 RC Dept. of Internal Medicine Erasmus MC Rotterdam, Netherlands, 3015 GD Spain Hospital General de Alicante Alicante, Spain, 03012 Clínica Puerta de Hierro Madrid, Spain, 28035 Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, Spain, 15706 Sweden Sahlgrenska University Hospital Göteborg, Sweden, 413 45 Uppsala University Hospital Uppsala, Sweden, 75185 United Kingdom Christie Hospital and Holt Radium Institute Manchester, United Kingdom, M20 4BX Royal Hallamshire Hospital Sheffield, United Kingdom 收起 << |
NCT02000440 | Glomerulosclerosis, Focal Segm... 展开 >>ental 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site Stanford, California, United States, 94304 United States, Louisiana GSK Investigational Site New Orleans, Louisiana, United States, 70112 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599-7155 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44109 GSK Investigational Site Columbus, Ohio, United States, 43210 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19140 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4N 3M5 GSK Investigational Site Toronto, Ontario, Canada, M5G 2C4 收起 << |
NCT02760095 | - | Active, not recruiting | June 2019 | United States, Colorado ... 展开 >> University of Colorado Denver School of Medicine Aurora, Colorado, United States, 80045 Bangladesh icddr,b (International Centre for Diarrheal Disease Research, Bangladesh Dhaka, Bangladesh 收起 << | |
NCT00536809 | - | Completed | - | - | |
NCT01301456 | - | Completed | - | - | |
NCT03298373 | Healthy Men M... 展开 >>ale Contraception 收起 << | Phase 1 | Recruiting | December 2018 | United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Christina Wang, MD 310-222-2503 wang@labiomed.org United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu 收起 << |
NCT02187029 | Gout | Phase 1 | Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 << | - | United States, Florida ... 展开 >> MRA Clinical Research, LLC Miami, Florida, United States, 33143 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 United States, Kansas Vince and Associates Clinical Research Inc. Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research, Inc. Overland Park, Kansas, United States, 66212 收起 << |
NCT00536809 | Neoplasms, Colorectal | Phase 1 | Completed | - | United States, Wisconsin ... 展开 >> GSK Investigational Site Madison, Wisconsin, United States, 53792 收起 << |
NCT00510146 | Depression, Bipolar | Phase 3 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100088 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changsha, China, 410008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chengdu, China, 610041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510370 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kunming, China, 650032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200030 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Xi'An, China, 710032 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hiroshima, Japan, 731-0501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shiga, Japan, 525-0037 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 170-0002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seongnam-Si, Korea, Republic of, 463-707 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 收起 << |
NCT00050011 | Breast Neoplasms ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | - |
NCT00247273 | Postmenopausal Osteoporosis | Phase 3 | Completed | - | - |
NCT02187029 | - | Terminated(B7911002 was premat... 展开 >>urely discontinued due to a safety concern that led to decision to terminate the study on 10 Nov 2014) 收起 << | - | - | |
NCT00510146 | - | Completed | - | - | |
NCT00536471 | Major Depressive Disorder | Phase 4 | Completed | - | - |
NCT00247273 | - | Completed | - | - | |
NCT00050011 | - | Completed | - | - | |
NCT02852005 | HIV Infections | Phase 1 | Active, not recruiting | October 28, 2019 | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California Bridge HIV CRS San Francisco, California, United States, 94143 United States, Georgia The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States, 30030 United States, Massachusetts Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States, 02115-6110 United States, New York Columbia P&S CRS New York, New York, United States, 10032-3732 University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States, 14642 United States, Washington Seattle Vaccine and Prevention CRS Seattle, Washington, United States, 98109-1024 Peru ACSA CRS Iquitos, Maynas, Peru, 1 Barranco CRS Lima, Peru, 04 - 15063 收起 << |
NCT00619957 | Other Osteoporosis | Phase 3 | Completed | - | - |
NCT01520909 | Idiopathic Thrombocytopenic Pu... 展开 >>rpura 收起 << | Phase 3 | Completed | - | - |
NCT00619957 | - | Completed | - | - | |
NCT03569826 | - | Recruiting | December 2025 | Canada, Alberta ... 展开 >> University of Alberta Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Andrew Mason, MD (780) 492-8176 am16@ualberta.ca Canada, Ontario Toronto General Hospital Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Bettina Hansen, PhD 416-340-5157 bettina.hansen@utoronto.ca Principal Investigator: Bettina Hansen, PhD 收起 << | |
NCT00408876 | Back Pain Without Radiation | Phase 3 | Completed | - | United States, Florida ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Fort Myers, Florida, United States, 33912 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Orlando, Florida, United States, 32806 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Miami, Florida, United States, 33143 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Tampa, Florida, United States, 33606 收起 << |
NCT00620113 | Osteoporosis Postmenopausal | Phase 2 | Completed | - | - |
NCT01520909 | - | Completed | - | - | |
NCT00536471 | - | Completed | - | - | |
NCT00386100 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00918749 | Postmenopausal Osteoporosis | Phase 2 | Completed | - | United States, Florida ... 展开 >> Research Site Daytona, Florida, United States, 32117 Research Site Ft. Myers, Florida, United States, 33901 United States, Hawaii Research Site Honolulu, Hawaii, United States, 96821 United States, Indiana Research Site Evansville, Indiana, United States, 47711 United States, Texas Research Site Austin, Texas, United States, 78727 Research Site Dallas, Texas, United States, 75247 收起 << |
NCT02296541 | HIV Infections | Phase 1 | Active, not recruiting | September 8, 2020 | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California Bridge HIV CRS San Francisco, California, United States, 94143 United States, Georgia The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States, 30030 United States, Massachusetts Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States, 02115-6110 Fenway Health (FH) CRS Boston, Massachusetts, United States, 02215-4302 United States, Washington Seattle Vaccine and Prevention CRS Seattle, Washington, United States, 98109-1024 Switzerland Lausanne Vaccine and Immunotherapy Center CRS Lausanne, Vaud, Switzerland, 1011 收起 << |
NCT00620113 | - | Completed | - | - | |
NCT00408876 | - | Completed | - | - | |
NCT00903201 | Cystic Fibrosis | Phase 2 | Completed | - | - |
NCT00903201 | - | Completed | - | - | |
NCT00793195 | Short Bowel Syndrome ... 展开 >> Intestinal Failure Gastrointestinal Motility Disorder Mucosal Enteropathy 收起 << | Phase 2 | Unknown | January 2012 | Canada, Alberta ... 展开 >> Alberta Children's Hospital Calgary, Alberta, Canada Foothills Medical Center Calgary, Alberta, Canada Stollery Children's Hospital Edmonton, Alberta, Canada Canada, Ontario Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 The Hospital for Sick Children Toronto, Ontario, Canada 收起 << |
NCT00386100 | - | Completed | - | - | |
NCT01890746 | Leukaemia, Acute | Phase 2 | Completed | - | - |
NCT00918749 | - | Completed | - | - | |
NCT02061098 | Overweight | Phase 1 Phase 2 | Completed | - | Spain ... 展开 >> UCAM (San Antonio Catholic University from Murcia) Murcia, Spain, 30107 收起 << |
NCT02550912 | Autism | Phase 2 | Completed | - | Egypt ... 展开 >> Faculty of Pharmacy AinShams University Cairo, Egypt, 02 收起 << |
NCT01890746 | - | Completed | - | - | |
NCT02564055 | Dermatitis, Atopic | Phase 2 | Completed | - | - |
NCT00339144 | Tumors | Phase 1 | Completed | - | Japan ... 展开 >> Local Institution Osakasayama City, Osaka, Japan, 589-0014 Local Institution Koto-Ku, Tokyo, Japan, 135-0063 收起 << |
NCT00339144 | - | Completed | - | - | |
NCT01120600 | Osteoporosis | Phase 3 | Completed | - | - |
NCT01939977 | - | Completed | - | - | |
NCT02089997 | - | Completed | - | Japan ... 展开 >> Osaka, Japan Tokyo, Japan 收起 << | |
NCT01285492 | Chronic Obstructive Pulmonary ... 展开 >>Disease (COPD) 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Anjo, Aichi, Japan, 446-8602 Novartis Investigative Site Nagoya, Aichi, Japan, 457-8511 Novartis Investigative Site Nishio-city, Aichi, Japan, 445-8510 Novartis Investigative Site Kasuga-city, Fukuoka, Japan, 816-0813 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Kanazawa, Ishikawa, Japan, 920-8610 Novartis Investigative Site Takamatsu, Kagawa, Japan, 760-8538 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Koshi-city, Kumamoto, Japan, 861-1196 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Ueda, Nagano, Japan, 386-8610 Novartis Investigative Site Osaka-city, Osaka, Japan, 545-8586 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1192 Novartis Investigative Site Toyonaka, Osaka, Japan, 560-8552 Novartis Investigative Site Kawaguhi-city, Saitama, Japan, 333-0833 Novartis Investigative Site Hamamatsu, Shizuoka, Japan, 430-8525 Novartis Investigative Site Fuchu, Tokyo, Japan, 183-8524 Novartis Investigative Site Meguro, Tokyo, Japan, 152-8902 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Akita, Japan, 010-0933 Novartis Investigative Site Fukuoka, Japan, 811-0213 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Fukuoka, Japan, 815-8588 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 558-8558 Novartis Investigative Site Wakayama, Japan, 641-8510 收起 << |
NCT01939977 | Secondary Hyperparathyroidism ... 展开 >>Due to Renal Causes 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Universitari Germans Trias I Pujol de Badalona Badalona, Barcelona, Spain, 08916 Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Del Mar Barcelona, Spain, 08003 Fundació Puigvert-Iuna Barcelona, Spain, 08025 Hospital Universitari Vall D'Hebron Barcelona, Spain, 08035 Hospital Puerta Del Mar Cádiz, Spain, 11009 Hospital Reina Sofía Córdoba, Spain, 14004 Complexo Hospitalario Universitario A Coruna La Coruna, Spain, 15006 Complejo Hospitalario Universitario de Canarias Las Palmas De Gran Canaria, Spain, 38320 Hospital Ramón Y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Complejo Hospitalario Regional de Málaga Málaga, Spain, 29010 Hospital Virgen Del Rocío Sevilla, Spain, 41013 Hospital Universitari I Politècnic La Fe Valencia, Spain, 46026 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 收起 << |
NCT01285492 | - | Completed | - | - | |
NCT01197300 | Osteoporosis | Phase 3 | Active, not recruiting | April 15, 2019 | Australia, New South Wales ... 展开 >> Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V6H 3V4 Canada, Ontario Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L1 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3H 1P3 Novartis Investigative Site Montreal, Quebec, Canada, H3T 1C5 Hungary Novartis Investigative Site Budapest, Hungary, 1085 Russian Federation Novartis Investigative Site Saint-Petersburg, Russian Federation, 195067 South Africa Novartis Investigative Site Soweto, Gauteng, South Africa, 2013 Turkey Novartis Investigative Site Izmir, Turkey, 35040 Novartis Investigative Site Pendik / Istanbul, Turkey, 34899 United Kingdom Novartis Investigative Site West Midlands, Birmingham, United Kingdom, B4 6NH 收起 << |
NCT02089997 | - | Completed | - | - | |
NCT00849875 | Melanoma | Phase 2 | Terminated(Early end of trial ... 展开 >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) 收起 << | - | Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Brussel, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1180 GSK Investigational Site Liège, Belgium, 4000 GSK Investigational Site Roeselare, Belgium, 8800 GSK Investigational Site Yvoir, Belgium, 5530 France GSK Investigational Site Caen, France, 14033 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Nantes, France, 44093 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Paris, France, 75018 GSK Investigational Site Reims, France, 51092 GSK Investigational Site Villejuif, France, 94805 收起 << |
NCT01120600 | - | Completed | - | - | |
NCT02853435 | Infections, Bacterial | Phase 1 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Anaheim, California, United States, 92801 United States, Texas GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT00849875 | - | Terminated(Early end of trial ... 展开 >>notification after termination of long term follow up due to lack of scientific justification to continue collect information.) 收起 << | - | - | |
NCT02564055 | - | Completed | - | - | |
NCT01892644 | Hemochromatosis ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 2 | Terminated(Failure to recruit ... 展开 >>patients with hemochromatosis to the Deferasirox arm) 收起 << | - | Norway ... 展开 >> Haukeland University Hospital, Clinical Trial Unit Bergen, Norway, 5021 收起 << |
NCT01231620 | Influenza, Human | Phase 3 | Completed | - | - |
NCT02853435 | - | Completed | - | - | |
NCT00942162 | Melanoma | Phase 2 | Completed | - | - |
NCT00942162 | - | Completed | - | - | |
NCT01231620 | - | Completed | - | - | |
NCT03031496 | Hypertension | Phase 1 | Completed | - | South Africa ... 展开 >> GSK Investigational Site Bloemfontein, South Africa, 9301 收起 << |
NCT02063854 | Involutional Osteoporosis | Phase 2 Phase 3 | Completed | - | Japan ... 展开 >> Nagoya-shi, Aichi, Japan Chiba-shi, Chiba, Japan Narashino-shi, Chiba, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Onga-gun, Fukuoka, Japan Ebetsu-shi, Hokkaido, Japan Sapporo-shi, Hokkaido, Japan Kako-gun, Hyogo, Japan Morioka-shi, Iwate, Japan Atsugi-shi, Kanagawa, Japan Kawasaki-shi, Kanagawa, Japan Yokohama-shi, Kanagawa, Japan Zushi-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Tamana-shi, Kumamoto, Japan Sendai-shi, Miyagi, Japan Tagajo-shi, Miyagi, Japan Miyazaki-shi, Miyazaki, Japan Saito-shi, Miyazaki, Japan Higashi Osaka-shi, Osaka, Japan Saitama-shi, Saitama, Japan Daito-ku, Tokyo, Japan Setagaya-ku, Tokyo, Japan Wakayama-shi, Wakayama, Japan 收起 << |
NCT01133665 | Squamous Cell Carcinoma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT02063854 | - | Completed | - | - | |
NCT00896532 | Low Bone Mineral Density ... 展开 >> Postmenopausal Osteoporosis 收起 << | Phase 2 | Completed | - | - |
NCT01494584 | Epilepsy | Phase 2 | Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 << |
NCT00261950 | Secondary Hyperparathyroidism | Phase 2 | Completed | - | - |
NCT01133665 | - | Completed | - | - | |
NCT01227629 | Atrial Fibrillation | Phase 2 | Completed | - | - |
NCT01494584 | - | Terminated(Terminated after pl... 展开 >>acing the study on hold at the request of the FDA) 收起 << | - | - | |
NCT03031496 | - | Completed | - | - | |
NCT00261950 | - | Completed | - | - | |
NCT01227629 | - | Completed | - | - | |
NCT00767806 | Chronic Low Back Pain | Phase 3 | Completed | - | United States, Arizona ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandler, Arizona, United States, 85225 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deland, Florida, United States, 32720 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jacksonville, Florida, United States, 32216 United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brighton, Massachusetts, United States, 02135 United States, Oklahoma For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oklahoma City, Oklahoma, United States, 73109 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97210 Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sa Coma, Brazil, 04230000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil, 04026-000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aalen, Germany, 73430 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alzenau, Germany, 63755 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10629 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ellwangen, Germany, 73479 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20255 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wiesbaden, Germany, 65189 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3039 BD Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Krakow, Poland, 30-349 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lublin, Poland, 20-093 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 61-289 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Szczecin, Poland, 70-376 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 119992 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08025 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bilboa, Spain, 48013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Getafe, Spain, 28905 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28009 收起 << |
NCT01376388 | - | Completed | - | - | |
NCT01702363 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-1347 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 302-0022 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Miyagi, Japan, 983-0824 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 530-0001 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 153-8934 GSK Investigational Site Tokyo, Japan, 192-0903 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT01376388 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 802-0083 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 080-0805 GSK Investigational Site Hyogo, Japan, 665-0827 GSK Investigational Site Hyogo, Japan, 670-0849 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Osaka, Japan, 590-0064 GSK Investigational Site Shizuoka, Japan, 436-0022 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT00711009 | Human Immunodeficiency Virus I... 展开 >>nfection 收起 << | Phase 3 | Completed | - | - |
NCT00924560 | Bone Mineral Density | Phase 2 | Completed | - | - |
NCT01702363 | - | Completed | - | - | |
NCT03706482 | Osteogenesis Imperfecta | Phase 1 Phase 2 | Not yet recruiting | January 1, 2033 | - |
NCT00711009 | - | Completed | - | - | |
NCT01702740 | Lupus Erythematosus, Cutaneous... 展开 >> Lupus Erythematosus, Systemic 收起 << | Phase 1 | Completed | - | - |
NCT01144377 | Osteoporosis | Phase 2 | Completed | - | United States, Georgia ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States, 30501 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bethesda, Maryland, United States, 20817 Denmark For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hvidovre, Denmark, 2650 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vejle, Denmark, 7100 Estonia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tallinn, Estonia, 10128 Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 386-0493 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 166-0003 Lithuania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vilnius, Lithuania, 10323 收起 << |
NCT00896532 | - | Completed | - | - | |
NCT00303485 | Post Menopausal Osteoporosis | Phase 4 | Completed | - | United States, California ... 展开 >> Beverly Hills, California, United States, 90211 La Jolla, California, United States, 92093 United States, Georgia Augusta, Georgia, United States, 30904 United States, Minnesota Woodbury, Minnesota, United States, 55125 United States, New York Bronx, New York, United States, 10461 United States, Pennsylvania Hopwood, Pennsylvania, United States, 15445 United States, Wisconsin Madison, Wisconsin, United States, 53705 Puerto Rico Ponce, Puerto Rico, 00717-1318 San Juan, Puerto Rico, 00927 San Juan, Puerto Rico, 00935 收起 << |
NCT01144377 | - | Completed | - | - | |
NCT00924560 | - | Completed | - | - | |
NCT00303485 | - | Completed | - | - | |
NCT00972543 | Chronic Plaque Psoriasis | Phase 4 | Terminated(The study was termi... 展开 >>nated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 << | - | - |
NCT03603665 | Botulism | Phase 1 | Recruiting | September 7, 2019 | United States, North Carolina ... 展开 >> Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit Recruiting Durham, North Carolina, United States, 27710-4000 收起 << |
NCT00972543 | - | Terminated(The study was termi... 展开 >>nated after the European Medicines Evaluation Agency recommended to suspend the marketing authorisation of Raptiva in the European Union) 收起 << | - | - | |
NCT01803607 | Osteoporosis | Phase 3 | Terminated(Study halted premat... 展开 >>urely due to low enrollment.) 收起 << | - | - |
NCT00767806 | - | Completed | - | - | |
NCT01494610 | Asthma | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Wellington, New Zealand, 6021 收起 << |
NCT01803607 | - | Terminated(Study halted premat... 展开 >>urely due to low enrollment.) 收起 << | - | - | |
NCT01898312 | Women With Mutations in the Br... 展开 >>east Cancer Susceptibility Genes BRCA1,2 收起 << | Phase 2 | Recruiting | December 2018 | Sweden ... 展开 >> Department of Woman and Child Health Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Sub-Investigator: Angelique Flöter Rådestad, MD PhD 收起 << |
NCT01623453 | - | Terminated(Difficulty recruiti... 展开 >>ng subjects) 收起 << | - | Korea, Republic of ... 展开 >> DaeHang Hospital Seoul, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of 收起 << | |
NCT00445146 | - | Completed | - | - | |
NCT02473809 | Diabetes Complications ... 展开 >> Osteoporosis 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Endocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Aarhus C, Denmark, 8000 收起 << |
NCT00148915 | Osteoporosis | Phase 4 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Upland, California, United States, 91786 United States, Colorado GSK Investigational Site Boulder, Colorado, United States, 80304 GSK Investigational Site Lakewood, Colorado, United States, 80227 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Miami, Florida, United States, 33156 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 GSK Investigational Site Decatur, Georgia, United States, 30033 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maine GSK Investigational Site Bangor, Maine, United States, 04401 United States, Maryland GSK Investigational Site Bathesda, Maryland, United States, 20817 United States, Michigan GSK Investigational Site Flint, Michigan, United States, 48532 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87106 United States, New York GSK Investigational Site West Haverstraw, New York, United States, 10993 United States, Pennsylvania GSK Investigational Site Duncansville, Pennsylvania, United States, 16635 收起 << |
NCT01494610 | - | Completed | - | - | |
NCT03626662 | Cardiovascular Disease | Phase 1 | Recruiting | December 1, 2019 | United States, Florida ... 展开 >> Research Site Recruiting South Miami, Florida, United States, 33143 Australia, Western Australia Research Site Recruiting Nedlands, Western Australia, Australia, 6009 收起 << |
NCT00413699 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT00611455 | Arthritis, Rheumatoid | Phase 3 | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - |
NCT01172899 | Obesity, Morbid | Not Applicable | Recruiting | December 2020 | Netherlands ... 展开 >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6202ZA Contact: Givan F Paulus, PhD student +31625587074 research@givan.nl Contact: Yvonne Roebroek, PhD student +31433881574 y.roebroek@maastrichtuniversity.nl 收起 << |
NCT00413699 | - | Completed | - | - | |
NCT00445146 | HIV Infections | Phase 2 | Completed | - | - |
NCT00611455 | - | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - | |
NCT00168831 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00168831 | - | Completed | - | - | |
NCT02500706 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00168844 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00603525 | Arthritis, Rheumatoid | Phase 3 | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - |
NCT02500706 | - | Completed | - | - | |
NCT00168844 | - | Completed | - | - | |
NCT01519414 | Hormone-Resistant Prostate Can... 展开 >>cer Prostate Adenocarcinoma Recurrent Prostate Carcinoma Stage IV Prostate Cancer 收起 << | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 Michael Reese Hospital Chicago, Illinois, United States, 60616 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard Fort Wayne, Indiana, United States, 46804 Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 University of Maryland Saint Joseph Medical Center Towson, Maryland, United States, 21204 United States, Missouri Mercy Hospital Saint Louis Saint Louis, Missouri, United States, 63141 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT00603525 | - | Terminated(Ofatumumab IV trial... 展开 >>s in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.) 收起 << | - | - | |
NCT01519414 | - | Completed | - | - | |
NCT02014584 | Alopecia | Phase 3 | Completed | - | Chile ... 展开 >> GSK Investigational Site Santiago, Región Metro De Santiago, Chile, 7580206 Hong Kong GSK Investigational Site Pokfulam, Hong Kong GSK Investigational Site Shatin, Hong Kong Korea, Republic of GSK Investigational Site Chungcheongnam-do, Korea, Republic of GSK Investigational Site Daejeon, Korea, Republic of, 301-721 GSK Investigational Site Gwangju, Korea, Republic of, 501-757 GSK Investigational Site Gyeonggi-do, Korea, Republic of, 463-707 GSK Investigational Site Incheon, Korea, Republic of, 400-711 GSK Investigational Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 GSK Investigational Site Kangwon-Do, Korea, Republic of, 220-701 GSK Investigational Site Pusan, Korea, Republic of, 602-739 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 134-090 GSK Investigational Site Seoul, Korea, Republic of, 143-729 GSK Investigational Site Seoul, Korea, Republic of, 156-755 Singapore GSK Investigational Site Singapore, Singapore, 169608 Taiwan GSK Investigational Site Taipei, Taiwan, 106 GSK Investigational Site Taipei, Taiwan 收起 << |
NCT02652975 | Breast Neoplasms ... 展开 >> Endothelial Dysfunction Cardiovascular Disease Metabolic Syndrome 收起 << | Not Applicable | Active, not recruiting | October 2019 | Denmark ... 展开 >> Aarhus University Hospital Aarhus, Jutland, Denmark, 8000 收起 << |
NCT02014584 | - | Completed | - | - | |
NCT00532948 | Glioma | Phase 1 | Completed | - | United States, California ... 展开 >> San Francisco, California, United States, 94143-0780 United States, District of Columbia Washington, District of Columbia, United States, 20010 United States, Illinois Chicago, Illinois, United States, 60614 United States, Massachusetts Boston, Massachusetts, United States, 02115-6084 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98105 收起 << |
NCT00558272 | - | Completed | - | - | |
NCT00532948 | - | Completed | - | - | |
NCT00558272 | Breast Cancer ... 展开 >> Prostate Cancer Bone Neoplasms 收起 << | Phase 2 | Completed | - | - |
NCT00377312 | Osteoporosis ... 展开 >>Bone Diseases, Endocrine Hyperparathyroidism 收起 << | Early Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Medical Center Pittsburgh,, Pennsylvania, United States, 15213 收起 << |
NCT01736891 | Parkinson´s Disease | Phase 3 | Completed | - | China ... 展开 >> CN002 Chengdu, China, 610041 CN005 Chenzhou, China, 423000 CN007 Chongqing, China, 404000 CN003 Guilin, China, 541001 CN004 Lanzhou, China, 730050 CN006 Luzhou, China, 646000 CN008 Nanjing, China, 210029 CN001 Xi'an, China, 710032 收起 << |
NCT00940498 | Neoplasms | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Insitute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10022 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Research Institute, Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37203-1632 Spain Hospital General Vall D'Hebron Barcelona, Spain, 08035 United Kingdom King's College London London, England, United Kingdom, SE1 9RT 收起 << |
NCT00377312 | - | Completed | - | - | |
NCT03104569 | Cholangitis | Not Applicable | Recruiting | April 1, 2019 | China, Gansu ... 展开 >> The first hospital of Lanzhou university Recruiting Lanzhou, Gansu, China, 730000 Contact: Wence Zhou, M. D. +8609318356919 zhouwc129@163.com Contact: Wenbo Meng, M. D. +8609318356213 mengwb@lzu.edu.cn China, Shaanxi The first affiliated hospital of Xi 'an jiaotong university Not yet recruiting Xi'an, Shaanxi, China, 710061 Contact: Hao Sun, M. D. +86 13891813691 sunhaoxjfy@126.com China, Tianjin Tianjin Nankai Hospital Not yet recruiting Tianjin, Tianjin, China, 300100 Contact: Zhenyu Wang, M. D. +86 15302021661 Wangzytj@163.com 收起 << |
NCT02467413 | Alzheimer's Disease ... 展开 >> Vascular Dementia 收起 << | Phase 2 | Not yet recruiting | December 2021 | Taiwan ... 展开 >> National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Contact: Ming-Chyi Pai, PhD +886-6-2353535 ext 5534 pair@mail.ncku.edu.tw Principal Investigator: Ming-Chyi Pai, MD, PhD 收起 << |
NCT00580788 | Osteoporosis ... 展开 >>Humoral Hypercalcemia of Malignancy Hyperparathyroidism 收起 << | Early Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT01167088 | Non-alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 2 | Terminated(This study has been... 展开 >> terminated due to poor participant recruitment) 收起 << | July 2011 | United Kingdom ... 展开 >> Freeman Hospital Newcastle-upon-Tyne, United Kingdom, NE2 4HH 收起 << |
NCT03458650 | Healthy | Phase 1 | Completed | - | China, Shanghai ... 展开 >> Huashan Hospital, Fudan University Shanghai, Shanghai, China, 200040 收起 << |
NCT02201251 | Epilepsy | Phase 3 | Recruiting | November 30, 2021 | - |
NCT02929498 | Myelodysplastic Syndrome | Phase 2 | Recruiting | May 15, 2019 | United States, Pennsylvania ... 展开 >> GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02882659 | Colorectal Neoplasms ... 展开 >> Hepatocellular Carcinoma Neoplasm Metastasis 收起 << | Phase 1 | Unknown | December 2017 | - |
NCT00940498 | - | Completed | - | - | |
NCT02775162 | Liver Transplantation | Phase 3 | Recruiting | January 2020 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Devin Eckhoff, MD 205-975-7622 United States, Arizona Mayo Clinic - Phoenix Recruiting Phoenix, Arizona, United States, 85054 Contact: Andrew Singer, MD, PhD 480-342-3771 United States, California University of Southern California (USC) Recruiting Los Angeles, California, United States, 90033 Contact: Yuri Genyk, MD 323-442-5908 University of California - Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Hasan Yersiz, MD 310-267-9591 University of California-San Francisco (UCSF) Active, not recruiting San Francisco, California, United States, 94153 United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Rodrigo Vianna, MD 305-355-5315 United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Chandrashekhar Kubal, MD 317-312-2601 United States, Louisiana Ochsner Recruiting New Orleans, Louisiana, United States, 70121 Contact: Ari Cohen, MD 504-842-3925 United States, Maryland University of Maryland Recruiting Baltimore, Maryland, United States, 21201 Contact: Rolf Barth, MD 410-328-6020 Contact: Sheehan Wheeler 410-328-0303 United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Christopher Sonnenday, MD 734-936-5962 United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: William Chapman, MD 314-362-7792 United States, North Carolina Duke Recruiting Durham, North Carolina, United States, 27710 Contact: Deb Sudan, MD 919-668-2279 United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Abt Peter, MD 215-662-2094 United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Sophoclis Alexopoulos, MD 615-936-0420 United States, Wisconsin University of Wisconsin Madison Recruiting Madison, Wisconsin, United States, 53792 Contact: Anthony D'Alessandro, MD 608-263-9501 收起 << |
NCT01506947 | Moderate to Severe Secondary H... 展开 >>yperparathyroidism Stage 5 Chronic Kidney Diseases 收起 << | Phase 4 | Completed | - | - |
NCT03766399 | Asthma | Phase 1 | Recruiting | December 5, 2019 | United Kingdom ... 展开 >> Research Site Recruiting Harrow, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9GP 收起 << |
NCT00580788 | - | Completed | - | - | |
NCT01108029 | Parkinson's Disease ... 展开 >> Gait Disorders, Neurologic 收起 << | Phase 4 | Completed | - | France ... 展开 >> Devos Lille, France, 59037 收起 << |
NCT01506947 | - | Completed | - | - | |
NCT02321306 | Primary Biliary Cirrhosis | Phase 2 | Withdrawn(The study stopped ea... 展开 >>rly, before enrolling its first participant.) 收起 << | March 2018 | United States, California ... 展开 >> Scripps Clinic La Jolla, California, United States, 92037 University of California at Davis Sacramento, California, United States, 95817 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Minnesota Minnesota Gastroenterology St Paul, Minnesota, United States, 55114 United States, Missouri St. Louis University St. Louis, Missouri, United States, 63104 United States, New York Weill Cornell Medical College New York, New York, United States, 10021 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Virginia Liver Institute of Virginia Newport News, Virginia, United States, 23602 Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 United States, Washington University of Washington Harborview Medical Center Seattle, Washington, United States, 98104 United Kingdom University of Birmingham Birmingham, England, United Kingdom, B15 2TT Royal Liverpool & Broadgreen University Hospital Liverpool, England, United Kingdom, L7 8XP Newcastle University Newcastle Upon Tyne, England, United Kingdom, NE1 4LP Oxford University Hospitals (John Radcliffe) Oxford, England, United Kingdom, OX3 9DU Royal Free Hospital London, United Kingdom, NW3 2QG 收起 << |
NCT01348971 | Coronary Artery Disease | Phase 2 | Completed | - | Sweden ... 展开 >> Karolinska University Hospital Stockholm, Sweden, S-171 76 收起 << |
NCT02177812 | Leukaemia, Myelocytic, Acute | Phase 1 | Terminated(The risk benefit in... 展开 >> relapsed refractory AML does not favor continuation of the study.) 收起 << | - | United States, Georgia ... 展开 >> GSK Investigational Site Augusta, Georgia, United States, 30912 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site Bronx, New York, United States, 10467 GSK Investigational Site New York, New York, United States, 10065 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia, 3004 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 GSK Investigational Site Toronto, Ontario, Canada, M5G 2M 收起 << |
NCT02463799 | Prostate Cancer | Phase 2 | Recruiting | December 2020 | United States, California ... 展开 >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Edwin Posadas, MD 310-423-7600 edwin.posadas@csmc.edu United States, District of Columbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016 Contact: Channing Paller, MD 202-660-6500 cpaller1@jhmi.edu Contact: Ashley Bruns, RN 202-537-4000 abruns3@jhmi.edu Sub-Investigator: Channing Paller, MD United States, Louisiana Tulane Cancer Center Recruiting New Orleans, Louisiana, United States, 70112 Contact: Oliver Sartor, MD 504-988-7869 osartor@tulane.edu Principal Investigator: Oliver Sartor, MD United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21231 Contact: Emmanuel Antonarakis, MD 410-287-0553 eatona1@jhmi.edu Contact: Rana Sullivan, RN 410-614-6337 tomalra@jhmi.edu Principal Investigator: Emmanuel Antonarakis, MD United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Andrew Armstrong, MD 919-668-4667 andrew.armstrong@duke.edu Principal Investigator: Andrew Armstrong, MD 收起 << |
NCT02484339 | Prostate Carcinoma | Phase 2 | Unknown | December 2017 | Germany ... 展开 >> Universitätsklinikum "Carl Gustav Carus" der Technischen Universität Dresden Recruiting Dresden, Germany, 01307 Contact: Tobias Hölscher, Dr 0351 4580 Contact: Franziska Hessel, Dr 0351 4580 Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde Recruiting Freiburg, Germany, 79106 Contact: Ursula Nestle, Prof.Dr. alpha-radiotherapy@uniklinik-freiburg.de Contact: Daniel Schnell, Dr. alpha-radiotherapy@uniklinik-freiburg.de Universitätsmedizin Mainz, Klinik und Poliklinik für Nuklearmedizin Recruiting Mainz, Germany, 55131 Contact: Matthias Miederer, Prof. 06131 170 Contact: Mathias Schreckenberger, Prof. 06131 170 Sub-Investigator: Eva Holzhäuser, Dr.med Klinikum der Universität München Recruiting München, Germany, 81377 Contact: Ute Ganswindt, Prof 089 / 4400-0 Contact: Minglun Li, Dr 089 / 4400-0 Sub-Investigator: Harun Illhan, Dr Universitätsklinikum Tübingen Recruiting Tübingen, Germany, 72076 Contact: Arndt Ch Müller, Prof 07071 290 Contact: Daniel Zips, Prof 07071 290 Sub-Investigator: Helmut Dittmann, Dr Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Andreas K Buck, Prof 0931 2010 Contact: Ken Herrmann, PD 0931 2010 Sub-Investigator: Michaela Metz, Dr 收起 << |
NCT03613571 | Amyotrophic Lateral Sclerosis | Phase 2 | Enrolling by invitation | June 1, 2019 | Sweden ... 展开 >> Sahlgrenska University Hospital Gothenburg, Sweden 收起 << |
NCT00410410 | Ulcerative Colitis | Phase 3 | Completed | - | - |
NCT02526927 | Anorexia Nervosa | Not Applicable | Completed | - | France ... 展开 >> CHU de SAINT-ETIENNE Saint-etienne, France, 42000 收起 << |
NCT02014467 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | China, Sichuan ... 展开 >> GSK Investigational Site Chengdu, Sichuan, China, 610041 GSK Investigational Site Chengdu, Sichuan, China, 610072 China GSK Investigational Site Beijing, China, 100035 GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chengdu, China, 610083 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200233 收起 << |
NCT00410410 | - | Completed | - | - | |
NCT00385580 | - | Completed | - | - | |
NCT02014467 | - | Completed | - | - | |
NCT00256126 | Growth Hormone Deficiency ... 展开 >> Turner Syndrome 收起 << | Phase 4 | Completed | - | Argentina ... 展开 >> Local Medical Information Office Buenos Aires, Argentina Australia Local Medical Information Office Sydney, Australia Austria Local Medical Information Office Vienna, Austria Canada Local Medical Information Office Mississauga, Canada France Local Medical InformationOffice Paris, France Germany Local Medical Information Office Munich, Germany Italy Local Medical Information Office Rome, Italy Norway Local Medical Information Office Oslo, Norway Russian Federation Local Medical Information Office Russia, Russian Federation Singapore Local Medical Information Office Singapore, Singapore Spain Local Medical Information Office Madrid, Spain Sweden Local Medical Information Office Stockholm, Sweden United Kingdom Local Medical Information Office Feltham, United Kingdom 收起 << |
NCT00760370 | Multiple Myeloma ... 展开 >> Breast Cancer 收起 << | Phase 2 | Completed | - | Denmark ... 展开 >> Odense University Hospital Odense, Denmark, 5000 Vejle Hospital Vejle, Denmark, 7100 收起 << |
NCT00256126 | - | Completed | - | - | |
NCT00385580 | Prostate Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Illinois University Of Chicago Chicago, Illinois, United States, 60637 United States, Maryland The Bunting Blaustein Cancer Research Building Baltimore, Maryland, United States, 21231 United States, New York Memorial Sloan-Kettering Cancer Center-Sidney Kimmel Center New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 United States, Wisconsin University Of Wisconsin Paul P Carbone Comprehensive Ca Ctr Madison, Wisconsin, United States, 53792 France Local Institution Montpellier, France, 34298 Local Institution Paris, France, 75015 Local Institution Villejuif Cedex, France, 94800 Italy Local Institution Rome, Italy, 00152 收起 << |
NCT00623597 | - | Completed | - | - | |
NCT00623597 | HIV Infections | Phase 2 | Completed | - | Argentina ... 展开 >> Buenos Aires, Argentina, 1202 Buenos Aires, Argentina, 1425 Santa Fe, Argentina, 3000 Spain Madrid, Spain, 28046 Madrid, Spain, 28905 Valencia, Spain, 46009 Thailand Bangkok, Thailand, 10400 Khon Kaen, Thailand, 40002 Pathumwan, Thailand, 10330 Payathai, Thailand, 10400 收起 << |
NCT00371254 | - | Completed | - | - | |
NCT02299375 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | - |
NCT00371254 | Breast Cancer ... 展开 >> Metastasis 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Dana-Farber Cancer Inst Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, Texas University Of Texas Md Anderson Cancer Ctr Houston, Texas, United States, 77030 France Local Institution Paris, France, 75231 Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Modena, Italy, 41100 Spain Local Institution Barcelona, Spain, 08035 Local Institution Lleida, Spain, 25198 收起 << |
NCT00431444 | Osteoporosis | Phase 4 | Completed | - | United States, Arizona ... 展开 >> Women's Health Research Phoenix, Arizona, United States, 85015 United States, California Associated Pharma Research Center Buena Park, California, United States, 90620 United States, District of Columbia Washington, District of Columbia, United States, 20036 United States, Florida Jacksonville Center for Clinical Research Jacksonville, Florida, United States, 32216 Women's Physicians of Jacksonville Jacksonville, Florida, United States, 32256 Tampa Clinical Research Tampa, Florida, United States, 33624 United States, Illinois Springfield Clinic Springfield, Illinois, United States, 62703 United States, Missouri Consultants in Women's Health Care St Louis, Missouri, United States, 63131 United States, Nebraska Alegent Health Omaha, Nebraska, United States, 68152 United States, Nevada Specialty Medical and Research Center Pahrump, Nevada, United States, 89048 United States, New Jersey UMDNJ-Robert Wood Johnson Medical Center New Brunswick, New Jersey, United States, 08901 United States, New York Columbia University New York, New York, United States, 10032 United States, North Carolina Kernodle Clinic, Inc. Burlington, North Carolina, United States, 27215 United States, Oregon The Portland Clinic Portland, Oregon, United States, 97205 Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Texas Texas Institute for Clinical Research Fort Worth, Texas, United States, 76104 United States, Washington Valley Women's Health Clinic Renton, Washington, United States, 98055 收起 << |
NCT02299375 | - | Completed | - | - | |
NCT00431444 | - | Completed | - | - | |
NCT00787137 | - | Terminated(poor recruitment) | - | - | |
NCT00787137 | Arthritis, Psoriatic | Phase 1 | Terminated(poor recruitment) | - | Serbia ... 展开 >> Professor Nemanja Damjanov Belgrade, Serbia 收起 << |
NCT01010230 | - | Completed | - | - | |
NCT01010230 | Bone Mineral Density ... 展开 >> Bone Strength 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 收起 << |
NCT01883674 | Sarcopenia | Not Applicable | Completed | - | Canada, Quebec ... 展开 >> Centre de recherche sur le vieillissement Sherbrooke, Quebec, Canada, J1H 4C4 收起 << |
NCT02970331 | Psoriasis | Phase 2 | Not yet recruiting | August 2019 | - |
NCT02294682 | Gonorrhea | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site Los Angeles, California, United States, 90028 GSK Investigational Site Los Angeles, California, United States, 90069 GSK Investigational Site Palm Springs, California, United States, 92262 GSK Investigational Site San Francisco, California, United States, 94103 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32806 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30308 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Louisiana GSK Investigational Site New Orleans, Louisiana, United States, 70119 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68114 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44109 United States, Pennsylvania GSK Investigational Site Jenkintown, Pennsylvania, United States, 19046 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 United Kingdom GSK Investigational Site London, United Kingdom, SW10 9NH 收起 << |
NCT02294682 | - | Completed | - | - | |
NCT02598934 | Post Menopausal Osteoporosis | Phase 4 | Completed | - | - |
NCT01571960 | HIV Infections | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California Bridge HIV CRS San Francisco, California, United States, 94143 United States, Massachusetts Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States, 02115-6110 United States, New York University of Rochester Vaccines to Prevent HIV Infection CRS Rochester, New York, United States, 14642 收起 << |
NCT02579226 | Advanced Solid Tumours | Phase 1 | Recruiting | March 3, 2020 | United States, Colorado ... 展开 >> Research Site Recruiting Denver, Colorado, United States, 80218 United States, Florida Research Site Recruiting Sarasota, Florida, United States, 34232 United States, Tennessee Research Site Recruiting Nashville, Tennessee, United States, 37203 收起 << |
NCT01262898 | Gastroparesis | Phase 2 | Completed | - | - |
NCT00949832 | Nutritional Rickets | Phase 4 | Completed | - | Nigeria ... 展开 >> Jos University Teaching Hospital Jos, Plateau, Nigeria, 930001 收起 << |
NCT01788358 | - | Completed | - | - | |
NCT01252355 | Multiple Sclerosis Relapse | Phase 3 | Terminated(Sponsor decision to... 展开 >> prematurely stop the study, not linked to any safety concern.) 收起 << | - | - |
NCT01788358 | Hypertension | Phase 3 | Completed | - | - |
NCT02539576 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Glendale, California, United States, 91206 收起 << |
NCT02598934 | - | Completed | - | - | |
NCT01252355 | - | Terminated(Sponsor decision to... 展开 >> prematurely stop the study, not linked to any safety concern.) 收起 << | - | - | |
NCT01136408 | - | Completed | - | - | |
NCT03404167 | Gonorrhoea | Phase 1 | Completed | - | United States, Kansas ... 展开 >> Quintiles Phase I Services - Overland Park Overland Park, Kansas, United States, 66211-1553 收起 << |
NCT01447368 | Kidney Failure ... 展开 >> Secondary Hyperparathyroidism Vascular Diseases 收起 << | Not Applicable | Recruiting | December 2017 | Hong Kong ... 展开 >> Queen Mary Hospital and Tung Wah Hospital Recruiting Hong Kong, Hong Kong, 0000 Contact: Angela YM Wang, MD, PhD 852-22554949 aymwang@hku.hk Principal Investigator: Angela YM Wang, MD, PhD Sub-Investigator: Wai-Kei Lo, FRCP 收起 << |
NCT01262898 | - | Completed | - | - | |
NCT00634088 | Locally Advanced or Metastatic... 展开 >> Breast Cancer 收起 << | Phase 1 | Terminated(Slow Accrual) | - | United States, New Jersey ... 展开 >> The Cancer Institute Of New Jersey New Brunswick, New Jersey, United States, 08901 Australia, Queensland Local Institution Brisbane, Queensland, Australia, 4101 Italy Local Institution Modena, Italy, 41100 收起 << |
NCT01136408 | Atrial Fibrillation | Phase 2 | Completed | - | Japan ... 展开 >> 1160.49.024 Boehringer Ingelheim Investigational Site Aki-gun, Hiroshima, Japan 1160.49.025 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1160.49.026 Boehringer Ingelheim Investigational Site Fukuoka, Fukuoka, Japan 1160.49.021 Boehringer Ingelheim Investigational Site Himeji, Hyogo, Japan 1160.49.027 Boehringer Ingelheim Investigational Site Iizuka,Fukuoka, Japan 1160.49.013 Boehringer Ingelheim Investigational Site Kyoto, Kyoto, Japan 1160.49.011 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1160.49.012 Boehringer Ingelheim Investigational Site Nagoya, Aichi, Japan 1160.49.004 Boehringer Ingelheim Investigational Site Naka-gun, Ibaragi, Japan 1160.49.022 Boehringer Ingelheim Investigational Site Okayama, Okayama, Japan 1160.49.023 Boehringer Ingelheim Investigational Site Okayama, Okayama, Japan 1160.49.006 Boehringer Ingelheim Investigational Site Oota, Tokyo, Japan 1160.49.016 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1160.49.017 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1160.49.018 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1160.49.019 Boehringer Ingelheim Investigational Site Osaka, Osaka, Japan 1160.49.020 Boehringer Ingelheim Investigational Site Sakai, Osaka, Japan 1160.49.001 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1160.49.028 Boehringer Ingelheim Investigational Site Sapporo, Hokkaido, Japan 1160.49.002 Boehringer Ingelheim Investigational Site Sendai, Miyagi, Japan 1160.49.005 Boehringer Ingelheim Investigational Site Shinjuku, Tokyo, Japan 1160.49.014 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1160.49.015 Boehringer Ingelheim Investigational Site Suita, Osaka, Japan 1160.49.007 Boehringer Ingelheim Investigational Site Tokorozawa, Saitama, Japan 1160.49.009 Boehringer Ingelheim Investigational Site Toyama, Toyama, Japan 1160.49.003 Boehringer Ingelheim Investigational Site Tsuchiura, Ibaragi, Japan 1160.49.029 Nagano National Hospital Ueda, Nagano, Japan 1160.49.008 Boehringer Ingelheim Investigational Site Yokohama, Kanagawa, Japan 收起 << |
NCT03319238 | - | Recruiting | November 1, 2018 | France ... 展开 >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 04 73 75 11 95 placarin@chu-clermontferrand.fr Sub-Investigator: Thibault RIANT Sub-Investigator: Bruno RIOULT Sub-Investigator: Marc SOREL Sub-Investigator: Christian GOV Sub-Investigator: Franck LE CAER Sub-Investigator: Pascale VERGNE-SALLE Sub-Investigator: Maryline FEUILLET Sub-Investigator: Gilles ALLANO Sub-Investigator: Fadel MAAMAR Sub-Investigator: Véronique DIXNEUF Sub-Investigator: Julien ESNAULT Sub-Investigator: Jacques GAILLARD Sub-Investigator: Mario BARMAKI Sub-Investigator: Olivier COLLARD Sub-Investigator: Yves-Marie PLUCHON Sub-Investigator: Frédéric PLANTEVIN Sub-Investigator: Claire DELORME Sub-Investigator: Gilbert ANDRE Sub-Investigator: Caroline MAINDET Sub-Investigator: Xavier KIEFFER Sub-Investigator: Yannick PERIER Sub-Investigator: Jean-Marie AMODEO Sub-Investigator: Florence TIBERGHIEN Sub-Investigator: Mohammed EL AYADI Sub-Investigator: Sonia CIESLAK Sub-Investigator: Géraldine DEMONTGAZON Sub-Investigator: Erik VASSORT Sub-Investigator: Jean-Marie LE BORGNE Sub-Investigator: Caroline COLOMB Sub-Investigator: Rodrigue DELEENS Sub-Investigator: Virginie PIANO Sub-Investigator: Julien NIZARD 收起 << | |
NCT03717298 | Adenocarcinoma of the Pancreas... 展开 >> Pancreatic Cancer Advanced Cancer Digestive System Neoplasms Pancreatic Neoplasms Endocrine Gland Neoplasms Digestive System Diseases Endocrine System Diseases Pancreatic Diseases 收起 << | Phase 2 | Not yet recruiting | December 15, 2019 | Cuba ... 展开 >> "Hermanos Ameijeiras" Surgical Clinical Hospital Not yet recruiting La Habana, Cuba, 10300 Contact: Mayté Lima Pérez, Dr. mayte.lima@infomed.sld.cu Contact: Juan L. Soriano García, Dr. soriano@infomed.sld.cu Principal Investigator: Mayte Lima Pérez, Dr. Principal Investigator: Jorge L. Soriano García, Dr. Sub-Investigator: Vilma Fleites Calvo, Dr. Sub-Investigator: Jorge Ortiz, Dr. Sub-Investigator: María E. Suardiaz, MSc Sub-Investigator: Yolanda Hernández García, NP Sub-Investigator: Amarilis Grau Cascudo, NP Sub-Investigator: Ivelisse Fleites, BSc Sub-Investigator: Carlos Domínguez, Dr. Sub-Investigator: Robin García Diéguez, BSc Sub-Investigator: Angela Gutiérrez, Dr. 收起 << |
NCT00634088 | - | Terminated(Slow Accrual) | - | - | |
NCT00009737 | Colorectal Cancer | Phase 3 | Completed | - | - |
NCT00009737 | - | Completed | - | - | |
NCT01376323 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Anniston, Alabama, United States, 36207 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 GSK Investigational Site Miramar, Florida, United States, 33025 France GSK Investigational Site Nantes cedex 01, France, 44093 GSK Investigational Site Pierre-Bénite Cedex, France, 69495 GSK Investigational Site Rennes Cedex, France, 35046 GSK Investigational Site Rueil-Malmaison, France, 92502 Spain GSK Investigational Site Alicante, Spain, 03114 GSK Investigational Site Badalona, Spain, 08916 GSK Investigational Site Granada, Spain, 18004 GSK Investigational Site Madrid, Spain, 28046 United Kingdom GSK Investigational Site Edinburgh, Midlothian, United Kingdom, EH4 2XU GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site Coventry, United Kingdom, CV2 2DX GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 4LP 收起 << |
NCT00861614 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT02722798 | Tumor-Induced Osteomalacia or ... 展开 >>Epidermal Nevus Syndrome 收起 << | Phase 2 | Active, not recruiting | June 2019 | Japan ... 展开 >> Osaka, Japan Tokyo, Japan Korea, Republic of Seoul, Korea, Republic of 收起 << |
NCT01321567 | - | Completed | - | - | |
NCT02968810 | Cirrhosis | Phase 2 | Recruiting | January 1, 2020 | United States, California ... 展开 >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Marc T. Goodman 310-423-6188 marc.goodman@cshs.org Principal Investigator: Marc T. Goodman United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Seema A. Khan 312-503-4236 skhan@nm.org Principal Investigator: Seema A. Khan 收起 << |
NCT02109445 | Metastatic Cancer Pancreas | Phase 2 | Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 << | - | United States, Colorado ... 展开 >> Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 Drug Shipment: Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Cancer Center Aurora, Colorado, United States, 80045 University of Colorado Denver, CTO (CTRC) Aurora, Colorado, United States, 80045 United States, New York University of Rochester Investigational Drug Pharmacy Rochester, New York, United States, 14642 University of Rochester Rochester, New York, United States, 14642 收起 << |
NCT01376323 | - | Completed | - | - | |
NCT00861614 | - | Completed | - | - | |
NCT00972959 | - | Completed | - | - | |
NCT00972959 | Multiple Myeloma | Phase 2 | Completed | - | Greece ... 展开 >> Department of Clinical Therapeutics, University of Athens School of Medicine, "Alexandra" General Hospital Athens, Greece, 115 28 Department of Hematology & Medical Research, 251 General Air Force Hospital Athens, Greece, 11525 Department of Hematology, "Theagenion" Cancer Center Thessaloniki, Greece, 540 07 收起 << |
NCT03455868 | - | Recruiting | December 1, 2020 | Canada, Quebec ... 展开 >> The Research Institute of the McGill University Health Centre Not yet recruiting Montréal, Quebec, Canada, H3H 2R9 Contact: Vanessa Tardio, Dr vanessa.tardio@mail.mcgill.ca Principal Investigator: Vanessa Tardio, Dr Canada Centre de recherche du CHU de Québec - Université Laval Active, not recruiting Quebec, Canada, G1V 4G2 Centre de recherche de l'IUCPQ Recruiting Québec, Canada, G1V 4G5 Contact: Sarah Chouinard-Castonguay 4185254444 ext 48729 Sarah.Chouinard-Castonguay@crchudequebec.ulaval.ca Principal Investigator: Gagnon Claudia, Dr 收起 << | |
NCT03023748 | Endstage Renal Disease ... 展开 >> Secondary Hyperparathyroidism 收起 << | Phase 4 | Active, not recruiting | January 2018 | Hong Kong ... 展开 >> Queen Mary Hospital and Tung Wah Hospital Hong Kong, Hong Kong, 0000 收起 << |
NCT02970838 | Obesity Diabe... 展开 >>tes Type 2 Weight Loss 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University Medicine Greifswald Greifswald, Germany, 17475 收起 << |
NCT02090621 | Hepatic Insufficiency | Phase 2 | Completed | - | Spain ... 展开 >> Jose Antonio Pons, MD Murcia, El Palmar, Spain, 30120 收起 << |
NCT02482974 | - | Completed | - | Turkey ... 展开 >> Ege University Izmir, Turkey, 35100 收起 << | |
NCT02109445 | - | Terminated(The study was termi... 展开 >>nated on 24JUN15 due to change in strategy of PF-03084014 development.No safety/efficacy concerns were behind the reason of trial termination) 收起 << | - | - | |
NCT02024295 | Hepatitis, Alcoholic | Phase 4 | Unknown | December 2015 | China, Beijing ... 展开 >> Beijing Ditan Hospital Recruiting Beijing, Beijing, China, 100015 Contact: Jun Cheng 8610-84322566 jun.cheng.ditan@gmail.com Jun Cheng Recruiting Beijing, Beijing, China, 100015 Contact: Jun Cheng 收起 << |
NCT02295293 | Hyperlipidemias | Early Phase 1 | Completed | - | Iran, Islamic Republic of ... 展开 >> Shahid Motahhari Clinic, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of 收起 << |
NCT02581345 | Chronic Plaque Psoriasis ... 展开 >> Psoriasis 收起 << | Phase 3 | Completed | - | - |
NCT01754714 | Non Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 3 | Completed | - | France ... 展开 >> Site Reference ID 93914 Amiens, France, 80054 Site Reference ID 93895 Angers, France, 49933 Site Reference ID 93894 Bobigny, France, 93009 Site Reference ID 93913 Montpellier, France, 34295 Site Reference ID 93916 Nice, France, 06202 Site Reference ID 93915 Paris, France, 75012 Site Reference ID 93893 Paris, France, 75651 Site Reference ID 93896 Pessac, France, 33604 Germany Site Reference ID 93953 Bonn, Germany, 53127 Site Reference ID 93954 Frankfurt, Germany, 60594 Site Reference ID 93935 Freiburg, Germany, 79106 Site Reference ID 93955 Halle, Germany, 06120 Site Reference ID 93917 Hannover, Germany, 30625 Site Reference ID 93933 Homburg, Germany, 66424 Site Reference ID 94015 Leipzig, Germany, 04103 Site Reference ID 93918 Mainz, Germany, 55131 Site Reference ID 94014 Ulm, Germany, 89081 Poland Site reference ID/Investigator # 109455 Bydgoszcz, Poland, 85-030 Site Reference ID 93958 Chorzow, Poland, 41-500 Site Reference ID 93973 Krakow, Poland, 31-531 Site Reference ID 93956 Lodz, Poland, 91-347 Site Reference ID 93957 Myslowice, Poland, 41-400 Site Reference ID 93974 Warsaw, Poland, 02-507 Site Reference ID 93975 Wroclaw, Poland, 50-220 Russian Federation Site reference ID ORG-000905 Krasnoyarsk, Russian Federation, 660022 Site reference ID ORG-000906 Moscow, Russian Federation, 119435 Site reference ID ORG-000900 Nizhniy Novgorod, Russian Federation, 603126 Site reference ID ORG-000907 Novosibirsk, Russian Federation, 630084 Site reference ID ORG-000903 Omsk, Russian Federation, 644043 Site reference ID ORG-000920 Rostov-on-Don, Russian Federation, 344022 Site reference ID ORG-000904 Samara, Russian Federation, 443011 Site reference ID ORG-000901 Stavropol, Russian Federation, 355017 收起 << |
NCT00301756 | Fallopian Tube Carcinoma ... 展开 >> Primary Peritoneal Carcinoma Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor Recurrent Ovarian Carcinoma Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor Stage III Ovarian Cancer Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor Stage IV Ovarian Cancer 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Odette Cancer Centre- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 University Health Network Princess Margaret Cancer Center P2C Toronto, Ontario, Canada, M5G 2M9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT02581345 | - | Completed | - | - | |
NCT02749864 | - | Completed | - | Spain ... 展开 >> Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Clínico Universitario de Valencia Valencia, Comunidad Valenciana, Spain Hospital Universitario Puerta de Hierro-Majadahonda Madrid, Spain, 28222 收起 << | |
NCT01754714 | - | Completed | - | - | |
NCT00301756 | - | Completed | - | - | |
NCT00077766 | Anemia | Phase 3 | Completed | - | - |
NCT03214939 | Colorectal Cancer | Early Phase 1 | Recruiting | September 2019 | Russian Federation ... 展开 >> RIFCI Recruiting Novosibirsk, Russian Federation Contact: Sergey V. Sennikov, MD sennikov@gmail.com 收起 << |
NCT00575159 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92161 收起 << |
NCT03113019 | Breast Cancer | Early Phase 1 | Active, not recruiting | September 11, 2017 | - |
NCT03641872 | - | Recruiting | June 30, 2019 | China, Beijing ... 展开 >> Ditan Hospital of integrated traditional Chinese and Western Medicine Center Recruiting Beijing, Beijing, China, 100015 Contact: Xianbo Wang, Professor +86-13011001598 wangxianbo638@163.com China, Chongqing Southwest Hospital of Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: Baoyan Xu, Professor +86-13032396309 xby1977@126.com China, Guangdong Southern hospital infection department Recruiting Guangzhou, Guangdong, China, 510515 Contact: Jinjun Chen, Professor +86-13902246336 chjj@smu.edu.cn China, Henan Henan Provincial People's Hospital Recruiting Zhengzhou, Henan, China, 450003 Contact: Junping Liu, Professor China, Hubei Taihe Hospital Recruiting Shiyan, Hubei, China, 442000 Contact: Jizhong Meng, Professor +86-18971905757 zhongji.meng@163.com Wuhan Union Hospital of Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430022 Contact: Xin Zheng, Professor +86-18602724981 xin11@hotmail.com China, Hunan Xiangya hospital of Central South University Recruiting Changsha, Hunan, China, 410008 Contact: Yan Huang, Professor +86-13874854142 drhyan@163.com China, Jilin The First Affiliated Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Xiaoyu Wen, Professor +86-15804301609 wenxiaoyu328@aliyun.com China, Shanghai Renji hospital of Shanghai Jiao Tong University School of Medical Recruiting Shanghai, Shanghai, China, 200001 Contact: Hai Li +86-13818525494 haili_17@126.com Shanghai Public Health Clinical Center Recruiting Shanghai, Shanghai, China, 200083 Contact: Zhiping Qian, Professor +86-18916192210 qianzhiping@shaphc.org China, Xinjiang Infectious Disease Center, The First Teaching Hospital of Xinjiang Medical University Recruiting Ürümqi, Xinjiang, China, 830054 Contact: Xiaobo Lu, Professor luxiaobo1101@sina.com China, Zhejiang The First Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 收起 << | |
NCT02836184 | Hyperphosphatemia | Phase 4 | Unknown | September 2016 | China, Jiangxi ... 展开 >> Jiujiang NO.1 People's Hospital Recruiting Jiujiang, Jiangxi, China, 332000 收起 << |
NCT00575159 | - | Completed | - | - | |
NCT02453308 | Malaria, Falciparum | Phase 2 Phase 3 | Completed | - | Bangladesh ... 展开 >> College of Medicine Chittagong Ramu, Bangladesh Cambodia Pailin Pailin, Cambodia Preah Vihear Preah Vihear, Cambodia Pursat Pursat, Cambodia Ratanakiri Ratankiri, Cambodia Congo, The Democratic Republic of the Kinshasa Kinshasa, Congo, The Democratic Republic of the India Mohanpur Community health center Agartala, India Midnapore Midnapore, India Ispat General hospital Rourkela, India Lao People's Democratic Republic Sekong Sekong, Lao People's Democratic Republic Myanmar Ann Hospital Ann, Myanmar Pyay hospital Pyay, Myanmar Pyin oo Lwin hospital Pyin oo Lwin, Myanmar Thabeikkyin hospital Thabeikkyin, Myanmar Thailand Phusing hospital Phusing, Srisaket, Thailand Tha Song Yang hospital Tha Song Yang, Tak, Thailand Chumphon hospital Chumphon, Thailand Kunhan Hospital Si Sa Ket, Thailand Thanto Hospital Yala, Thailand Vietnam Binh Phuoc hospital Binh Phuoc, Vietnam 收起 << |
NCT02771756 | Breast Cancer ... 展开 >> Lung Cancer 收起 << | Not Applicable | Unknown | May 2016 | China, Beijing ... 展开 >> National Cancer Institute, Cancer Hospital Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Peng Yuan, MD 86-10-87788528 Yuanpeng01@hotmail.com 收起 << |
NCT02119260 | - | Completed | - | - | |
NCT02222493 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02119260 | Oedema, Pulmonary | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT02512900 | Asthma | Phase 1 | Completed | - | Poland ... 展开 >> Research Site Kielce, Poland, 25-040 Research Site Wrocław, Poland, 51-162 Research Site Wrocław, Poland, 53-201 Research Site Łódź, Poland, 71-329 收起 << |
NCT00077766 | - | Completed | - | - | |
NCT02512900 | - | Completed | - | - | |
NCT00661349 | HIV Infections | Phase 4 | Terminated(It has been impossi... 展开 >>ble to achieve the number of patients defined by protocol) 收起 << | - | Spain ... 展开 >> Hospital Son Dureta Palma de Mallorca, Baleares, Spain, 07014 H.U. Germans Trias i Pujol - Unitat VIH, Fundació Lluita contra la Sida Badalona, Barcelona, Spain, 08916 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario Príncipe de Asturias Madrid, Spain, 28005 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario la Paz Madrid, Spain, 28046 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Valme Sevilla, Spain, 41014 收起 << |
NCT02133079 | Liver Cancer ... 展开 >>Pancreatic Adenocarcinoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | November 2019 | China ... 展开 >> Cancer Insititute and Hospital,Chinese Academy of Medical Sciences Beijing, China, 100021 收起 << |
NCT03627494 | Muscular Dystrophies | Phase 1 | Recruiting | June 30, 2019 | United States, Maryland ... 展开 >> GSK Investigational Site Recruiting Baltimore, Maryland, United States, 21225 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01856595 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida MRA Clinical Research, LLC South Miami, Florida, United States, 33143 收起 << |
NCT02198703 | Moderate Hypercholesterolemia | Not Applicable | Completed | - | France ... 展开 >> Naturalpha Lille, France, 59020 Biofortis Saint-Herblain, France, 44800 收起 << |
NCT00430677 | Systemic Lupus Erythematosus | Phase 2 Phase 3 | Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 << | - | - |
NCT02073136 | Chronic Kidney Disease | Not Applicable | Completed | - | Denmark ... 展开 >> Herlev Hospital Herlev, Herlev Ringvej 75, Denmark, 2730 收起 << |
NCT02222493 | - | Completed | - | - | |
NCT00430677 | - | Terminated(Terminated due to f... 展开 >>ailure to meet the primary efficacy endpoint in the Short-term Period) 收起 << | - | - | |
NCT02492958 | Staphylococcal Infections | Phase 2 | Completed | - | Japan ... 展开 >> SOUSEIKAI Sumida Hospital (formerly Medical Co. LTA Sumida Hospital) Sumida-ku, Tokyo, Japan, 130-0004 SOUSEIKAI PS Clinic (formerly Medical Co. LTA PS Clinic) Fukuoka, Japan, 812-0025 收起 << |
NCT00910962 | - | Completed | - | - | |
NCT02492958 | - | Completed | - | - | |
NCT02603172 | Amyloidosis | Phase 1 | Terminated(A new study will be... 展开 >> initiated in order to specifically investigate cardiac safety) 收起 << | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 << |
NCT01856595 | - | Completed | - | - | |
NCT00734474 | Diabetes Mellitus, Type 2 | Phase 2 Phase 3 | Completed | - | - |
NCT00910962 | Acute Coronary Syndrome | Phase 2 | Completed | - | - |
NCT03632876 | Sickle Cell Anemia in Children... 展开 >> Vitamin A Deficiency in Children 收起 << | Not Applicable | Completed | - | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19146 收起 << |
NCT03414294 | Healthy | Phase 1 | Recruiting | February 27, 2020 | Australia, South Australia ... 展开 >> CMAX, Clinical Research Pty Ltd Recruiting Adelaide, South Australia, Australia, 5000 收起 << |
NCT00122382 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT03046056 | Small Bowel Crohn's Disease | Phase 2 | Recruiting | March 2020 | - |
NCT03470441 | Acute Myocardial Infarction ... 展开 >> STEMI 收起 << | Phase 2 | Not yet recruiting | December 2018 | - |
NCT00122382 | - | Completed | - | - | |
NCT00605267 | Breast Cancer | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Hakata, Fukuoka, Japan Research Site Kumamoto, Japan Research Site Nagoya, Japan Research Site Osaka, Japan 收起 << |
NCT00605267 | - | Completed | - | - | |
NCT00044278 | Epilepsy | Phase 2 | Completed | - | - |
NCT02824718 | Autosomal Dominant Hypocalcemi... 展开 >>a or OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment 收起 << | Phase 2 | Recruiting | August 2020 | France ... 展开 >> AP-HP hopital Bicetre Not yet recruiting Le Kremlin-Bicetre, Val-de-Marne, France, 94270 Contact: Agnes Linglart, MD agnes.linglart@aphp.fr AP-HP Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Anne Blanchard, MD anne.blanchard@aphp.fr 收起 << |
NCT00734474 | - | Completed | - | - | |
NCT00463294 | the Efficacy and Safety of Off... 展开 >>-pump CABG 收起 << | Phase 3 | Completed | - | - |
NCT03077412 | Fistulizing Crohn's Disease | Phase 2 | Recruiting | April 2020 | - |
NCT02778477 | Normal Healthy | Phase 1 | Terminated(Preliminary analysi... 展开 >>s of accrued data failed to indicate any meaningful pharmacodynamic response.) 收起 << | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT03562117 | Infections, Bacterial | Phase 1 | Recruiting | April 10, 2019 | United States, Florida ... 展开 >> GSK Investigational Site Recruiting Miami, Florida, United States, 33136 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Orlando, Florida, United States, 32809 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02706535 | Drug Interactions | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01313663 | Lung Cancer, Small Cell | Phase 2 | Terminated | - | - |
NCT03061799 | Postmenopausal Period | Not Applicable | Recruiting | December 2017 | Korea, Republic of ... 展开 >> Severance hospital, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Jae hoon Lee, M.D. +82-10-9985-4676 jhlee126@yuhs.ac Contact: Jisun Yun, M.D. +82-10-2622-5664 grimoire@yuhs.ac 收起 << |
NCT01313663 | - | Terminated | - | - | |
NCT02342548 | Huntington's Disease | Phase 2 | Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 << | - | - |
NCT01766011 | Pre-term Infants | Phase 2 Phase 3 | Completed | - | United States, Alabama ... 展开 >> University of South Alabama - Children's and Women's Hospital Mobile, Alabama, United States, 36604 United States, Indiana Memorial Hospital of South Bend South Bend, Indiana, United States, 46601 United States, Kansas Wesley Medical Center Wichita, Kansas, United States, 67214 United States, New York Maria Children's Hospital Westchester Medical Center Valhalla, New York, United States, 10595 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Lehigh Valley Hospital Allentown, Pennsylvania, United States, 18103 United States, Wisconsin Wheaton Franciscan Healthcare-St. Joseph Milwaukee, Wisconsin, United States, 53210 收起 << |
NCT02703753 | Overweight Ob... 展开 >>esity Pregnancy Complications 收起 << | Not Applicable | Recruiting | December 2021 | Netherlands ... 展开 >> Maastricht University Medical Center Recruiting Maastricht, Limburg, Netherlands, 6229HX Contact: Yvon Timmermans, Drs. +31433875521 yvon.timmermans@mumc.nl 收起 << |
NCT01889823 | Hypoxia Hyper... 展开 >>oxia 收起 << | Phase 1 | Completed | - | Netherlands ... 展开 >> Intensive Care Medicine, Radboud University Nijmegen Medical Centre Nijmegen, Nijmegen, Gelderland, Netherlands, 6500 HB 收起 << |
NCT02765776 | - | Completed | - | - | |
NCT02342548 | - | Terminated(Study terminated on... 展开 >> 15DEC2016 due to study A8241021 showing no significant difference on primary endpoint between PF-02545920 & placebo. No safety concerns.) 收起 << | - | - | |
NCT03032861 | Intestinal Diseases | Not Applicable | Completed | - | Brazil ... 展开 >> Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas Araraquara, Sao Paulo, Brazil, 14800-903 收起 << |
NCT03026569 | Chronic Infection | Not Applicable | Completed | - | Brazil ... 展开 >> Sao Paulo State University "Julio de Mesquita Filho" Araraquara, Sao Paulo, Brazil, 14800-903 收起 << |
NCT01978158 | Hypoxia Normo... 展开 >>xia Hyperoxia 收起 << | Phase 1 Phase 2 | Completed | - | Netherlands ... 展开 >> Intensive Care Medicine Nijmegen, Gelderland, Netherlands, 6500HB 收起 << |
NCT02914249 | Obesity | Not Applicable | Completed | - | - |
NCT00298272 | Rheumatoid Arthritis | Phase 2 | Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 << | - | United States, Alabama ... 展开 >> Research Site Huntsville, Alabama, United States, 35801 United States, Arizona Research Site Paradise Valley, Arizona, United States, 85253 United States, California Research Site Palm Desert, California, United States, 92260 United States, Florida Research Site Jupiter, Florida, United States, 33458 Research Site Sarasota, Florida, United States, 34239 United States, Idaho Research Site Boise, Idaho, United States, 83702 United States, Michigan Research Site Kalamazoo, Michigan, United States, 49048 United States, Missouri Research Site St. Louis, Missouri, United States, 63141 United States, Ohio Research site Chardon, Ohio, United States, 44024 Research Site Mayfield Village, Ohio, United States, 44143 United States, Oklahoma Research Site Oklahoma City, Oklahoma, United States, 73103 Research Site Tulsa, Oklahoma, United States, 74135 United States, Pennsylvania Research Site Duncansville, Pennsylvania, United States, 16635 United States, Texas Research Site Dallas, Texas, United States, 75231 Research Site Houston, Texas, United States, 77074 Research Site San Antonio, Texas, United States, 78217 United States, Utah Research Site Salt Lake City, Utah, United States, 84132 United States, Vermont Research Site Burlington, Vermont, United States, 05401 收起 << |
NCT00298272 | - | Terminated(Sponsor decided to ... 展开 >>end long term extension phase for business reasons unrelated to safety.) 收起 << | - | - | |
NCT03667144 | - | Not yet recruiting | June 1, 2019 | - | |
NCT03217604 | Healthy Volunteers | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT03215043 | Pre Diabetes | Not Applicable | Recruiting | June 28, 2019 | Brazil ... 展开 >> Sao Paulo State University "Julio de Mesquita Filho", Faculdade de Ciências Farmacêuticas Recruiting Araraquara, Sao Paulo, Brazil, 14800-903 Contact: Thais B Cesar, Ph.D. +55 16 3301-6927 tcesar@fcfar.unesp.br 收起 << |
NCT01506271 | Intra-abdominal Infections | Phase 2 | Completed | - | - |
NCT03516721 | Obesity Adole... 展开 >>scent Obesity 收起 << | Not Applicable | Completed | - | Belgium ... 展开 >> Jessa Ziekenhuis Hasselt, Belgium, 3500 收起 << |
NCT01934192 | Gastroparesis | Phase 2 | Terminated | - | United States, Colorado ... 展开 >> GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30909 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40202 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Southport, Queensland, Australia, 4215 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 GSK Investigational Site Woodville, South Australia, Australia, 5011 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T1Y 6J4 GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8L 2X2 GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 GSK Investigational Site Ottawa, Ontario, Canada, K1H 8L6 GSK Investigational Site Ottawa, Ontario, Canada, K1Y 4E9 GSK Investigational Site Toronto, Ontario, Canada, M5G 1X5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 3J4 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Canada GSK Investigational Site Quebec, Canada, G1J 1Z4 收起 << |
NCT01934192 | - | Terminated | - | - | |
NCT00988533 | Head Lice | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Children's Investigational Research Program Bentonville, Arkansas, United States, 72712 United States, California Universal BioPharma Research, Inc Dinuba, California, United States, 93618 Impact Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Lice Source Solutions Inc Plantation, Florida, United States, 33313 United States, Mississippi Spence Medical Research L.L.C Picayune, Mississippi, United States, 39466 收起 << |
NCT01439971 | Hemophilia A | Phase 1 | Completed | - | United States, California ... 展开 >> University of California San Diego Medical Center San Diego, California, United States, 92103-8651 United States, Connecticut New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 OHSU Investigational Pharmacy Portland, Oregon, United States, 97239 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania CTRC Philadelphia, Pennsylvania, United States, 19104 Penn Comprehensive Hemophilia Program - Center for Blood Disorders Philadelphia, Pennsylvania, United States, 19104 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, B-1070 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar/ I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Dipartimento di Medicina Clinica 1-Centro Regionale per le Malattie del Sangue Castelfranco Veneto (TV), Italy, 31033 Servizio Farmacia- Ospedale Castelfranco Veneto Castelfranco Veneto - Treviso, Italy, 31033 Centro Emofilia e Trombosi "Angelo Bianchi Bonomi" U.O.S. Dipartimentale per la Diagnosi e la Terapi Milano, Italy, 20122 Servizio Farmacia Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Milano, Italy, 20122 Centro Malattie Emorragiche e Trombotiche - Ematologia Vicenza, Italy, 36100 Farmacia Ospedaliera Ospedale San Bortolo Vicenza, Italy, 36100 New Zealand Christchurch Clinical Studies Trust Christchurch, New Zealand, 08011 South Africa Phoenix Pharma (Pty) Ltd Port Elizabeth, Eastern Cape, South Africa, 6001 Turkey Ege University Tip Fakultesi Izmir, Turkey, 35100 United Kingdom Royal Free Hampstead NHS Trust, Royal Free Hospital London, United Kingdom, NW3 2QG Haematology Department London, United Kingdom, W12 0HS Central Manchester Universtiy Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL 收起 << |
NCT02838121 | Prevention of BMD Loss After T... 展开 >>HR Serum Markers of Bone Turnover Functional Outcomes 收起 << | Phase 3 | Completed | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital Kweishan, Taoyuan, Taiwan, 333 收起 << |
NCT01505634 | Urinary Tract Infections ... 展开 >> Pyelonephritis 收起 << | Phase 2 | Completed | - | - |
NCT01439971 | - | Completed | - | - | |
NCT00988533 | - | Completed | - | - | |
NCT02689206 | Anaemia | Phase 2 | Completed | - | - |
NCT03287310 | Asthma | Phase 1 | Recruiting | September 24, 2019 | Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Berlin, Germany, 14050 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Harrow, Middlesex, United Kingdom, HA1 3UJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting London, United Kingdom, NW10 7EW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Manchester, United Kingdom, M23 9QZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT02000817 | Diabetes Mellitus, Type 1 | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Brussels, Belgium, 1090 GSK Investigational Site Bruxelles, Belgium, 1070 GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 收起 << |
NCT02689206 | - | Completed | - | - | |
NCT03468556 | NASH - Nonalcoholic Steatohepa... 展开 >>titis 收起 << | Phase 2 | Not yet recruiting | June 30, 2019 | - |
NCT00106028 | - | Completed | - | - | |
NCT02457637 | - | Unknown | December 2017 | China, Beijing ... 展开 >> Ditan Hospital of integrated traditional Chinese and Western Medicine Center Enrolling by invitation Beijing, Beijing, China, 100015 302ed Military Hospital of PLA Enrolling by invitation Beijing, Beijing, China, 100039 China, Chongqing Southwest Hospital of Third Military Medical University Recruiting Chongqing, Chongqing, China, 400038 Contact: Baoyan Xu +86-13032396309 xby1977@126.com China, Fujian Fuzhou general hospital of Xiamen university Active, not recruiting Fuzhou, Fujian, China, 350025 China, Guangdong Southern hospital infection department Recruiting Guangzhou, Guangdong, China, 510515 Contact: Jinjun Chen, Professor 13902246336 chjj@smu.edu.cn China, Hebei Affiliated Hospital of the Armed Police Logistics College Active, not recruiting Tianjing, Hebei, China, 300499 China, Hubei Taihe Hospital Enrolling by invitation Shiyan, Hubei, China, 442000 Wuhan Union Hospital of Huazhong University of Science and Technology Enrolling by invitation Wuhan, Hubei, China, 430022 China, Hunan Xiangya hospital of Central South University Enrolling by invitation Changsha, Hunan, China, 410008 China, Jilin The First Affiliated Hospital of Jilin University Enrolling by invitation Changchun, Jilin, China, 130021 China, Shandong The Second Hospital of Shandong University Enrolling by invitation Jinan, Shandong, China, 250033 China, Shanghai Renji hospital of Shanghai Jiao Tong University School of Medical Enrolling by invitation Shanghai, Shanghai, China, 200001 Shanghai Public Health Clinical Center Enrolling by invitation Shanghai, Shanghai, China, 200083 China, Sichuan West China Hospital of Sichuan University Completed Chengdu, Sichuan, China, 610041 China, Xinjiang The First Teaching Hospital of Xinjiang Medical University Enrolling by invitation Wulumuqi, Xinjiang, China, 830054 收起 << | |
NCT02927210 | Healthy Men M... 展开 >>ale Contraception 收起 << | Phase 1 | Recruiting | October 2019 | United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang, MD United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Kathy Winter 206-616-0484 klwinter@uw.edu Principal Investigator: Stephanie Page, MD, PhD 收起 << |
NCT02537431 | X-linked Hypophosphatemia | Phase 3 | Active, not recruiting | November 30, 2018 | United States, California ... 展开 >> UCSF Medical Center at Mission San Francisco, California, United States, 94158 United States, Connecticut Yale University School of Medicine - Yale New-Haven Hospital/Yale Center for Clinical Investigation New Haven, Connecticut, United States, 06510 United States, Indiana Indiana University Department of Medicine University Hospital Indianapolis, Indiana, United States, 46202 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Texas Houston Methodist Hospital Houston, Texas, United States, 77030 Canada, Ontario Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Canada, Quebec Shriners Hospital for Children Montreal, Quebec, Canada, H3G 1A6 Denmark Aarhus University Hospital-Dept of Endocrinology and Internal Medicine Aarhus, Denmark, 8000 France CHU de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction Le Kremlin-Bicêtre, France, 94275 CHU Paris Centre - Hôpital Cochin Paris, France, 75014 Japan Osaka University Hospital Osaka, Japan, 565-0871 Hokkaido University Hospital Sapporo, Japan, 060-8648 The University of Tokyo Hospital Tokyo, Japan, 113-8655 Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT00106028 | Osteogenesis Imperfecta | Phase 3 | Completed | - | - |
NCT01120717 | - | Completed | - | - | |
NCT02537431 | - | Active, not recruiting | - | - | |
NCT01120717 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT02020889 | Churg-Strauss Syndrome | Phase 3 | Completed | - | - |
NCT00434304 | Parkinson Disease | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 455-8530 GSK Investigational Site Aichi, Japan, 460-0008 GSK Investigational Site Chiba, Japan, 279-0021 GSK Investigational Site Ehime, Japan, 791-0295 GSK Investigational Site Hokkaido, Japan, 070-0901 GSK Investigational Site Iwate, Japan, 020-0878 GSK Investigational Site Kanagawa, Japan, 251-0038 GSK Investigational Site Kyoto, Japan, 600-8811 GSK Investigational Site Osaka, Japan, 570-8507 GSK Investigational Site Saitama, Japan, 343-0032 GSK Investigational Site Tokyo, Japan, 113-8431 GSK Investigational Site Tokyo, Japan, 136-0075 收起 << |
NCT00051558 | Osteoporosis | Phase 3 | Completed | - | United States, California ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Loma Linda, California, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Palo Alto, California, United States United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aurora, Colorado, United States United States, North Dakota For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fargo, North Dakota, United States For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Jamestown, North Dakota, United States United States, Wisconsin For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Milwaukee, Wisconsin, United States Austria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Graz, Austria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Vienna, Austria Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Brussels, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gent, Belgium For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Leuven, Belgium Denmark For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aarhus, Denmark Norway For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Oslo, Norway Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Carolina, Puerto Rico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ponce, Puerto Rico 收起 << |
NCT02758444 | Environmental Enteric Dysfunct... 展开 >>ion Zinc Deficiency 收起 << | Not Applicable | Active, not recruiting | February 2019 | United States, Colorado ... 展开 >> University of Colorado Denver Aurora, Colorado, United States, 80045 Bangladesh icddr,b (International Centre for Diarrheal Disease Research, Bangladesh Dhaka, Bangladesh 收起 << |
NCT03683225 | Idiopathic Parkinson Disease | Phase 2 | Not yet recruiting | March 1, 2020 | - |
NCT03720886 | Postmenopausal Osteoporosis | Phase 1 Phase 2 | Active, not recruiting | August 31, 2020 | China, Beijing ... 展开 >> Peking Union Medical College Hospital Beijing, Beijing, China, 100006 China, Chongqing Chongqing Three Gorges Central Hospital Wanzhou, Chongqing, China China, Jiangsu Nanjing Drum Tower Hospital Nanjing, Jiangsu, China Zhongda Hospital, Southeast University Nanjing, Jiangsu, China China, Shanghai Huadong Hospital Affiliated to Fudan University Shanghai, Shanghai, China, 200000 Shanghai Sixth People's Hospital Shanghai, Shanghai, China China, Sichuan The West China Second UniversityHospital of Sichuan University Chengdu, Sichuan, China West China Hospital,Sichuan University Chengdu, Sichuan, China China, Tianjin Tianjin Hospital Tianjin, Tianjin, China 收起 << |
NCT00281632 | Peritoneal Cancer ... 展开 >> Ovarian Cancer Neoplasms, Ovarian Fallopian Tube Cancer 收起 << | Phase 2 | Completed | - | United States, Georgia ... 展开 >> GSK Investigational Site Atlanta, Georgia, United States, 30342 United States, Texas GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Bedford, Texas, United States, 76022 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Fort Worth, Texas, United States, 76104 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4029 Australia GSK Investigational Site Melbourne, Australia, 3084 Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 229899 收起 << |
NCT00434304 | - | Completed | - | - | |
NCT00281632 | - | Completed | - | - | |
NCT02020889 | - | Completed | - | - | |
NCT00957528 | Hypogonadism | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas Medical Branch Galveston, Texas, United States, 77555 收起 << |
NCT00879814 | Meningitis, Meningococcal | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami Research Associates, Inc. South Miami, Florida, United States, 33143 收起 << |
NCT00957528 | - | Completed | - | - | |
NCT00051558 | - | Completed | - | - | |
NCT00796991 | Advanced Melanoma | Phase 1 | Completed | - | United States, California ... 展开 >> The Angeles Clinic & Research Inst. Los Angeles, California, United States, 90025 United States, Florida H Lee Moffit Cancer Cnt And Res Inst Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Blumenthal Cancer Center, Carolinas Medical Center Charlotte, North Carolina, United States, 28204 收起 << |
NCT00879814 | - | Completed | - | - | |
NCT03369457 | - | Not yet recruiting | June 14, 2020 | - | |
NCT01552590 | Hyponatremia and Extracellular... 展开 >> Fluid in Cirrhotic 收起 << | Phase 4 | Unknown | January 2013 | Korea, Republic of ... 展开 >> Hallym Univ. Chuncheon Sacred Heart Hospital Recruiting Bucheon, Korea, Republic of Contact: KiTae Suk, Assistant professor Principal Investigator: KiTae Suk, Assistant professor Soonchunhyang Univ. Bucheon Hospital Recruiting Bucheon, Korea, Republic of Contact: YoungSeok Kim, Associate professor Principal Investigator: YoungSeok Kim, Associate professor Wonju Christian Hospital Recruiting Wonju, Korea, Republic of Contact: SoonKoo Baik, Professor Principal Investigator: SoonKoo Baik, Professor 收起 << |
NCT00038467 | Breast Neoplasms | Phase 3 | Completed | - | - |
NCT00963833 | - | Completed | - | Austria ... 展开 >> Many Locations, Austria Belgium Many Locations, Belgium Finland Many Locations, Finland Germany Many Locations, Germany Israel Many Locations, Israel United Kingdom Many Locations, United Kingdom 收起 << | |
NCT00038467 | - | Completed | - | - | |
NCT00541658 | Postmenopausal Osteoporosis | Phase 3 | Completed | - | - |
NCT00502996 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00350727 | - | Completed | - | - | |
NCT03436316 | Asthma | Phase 1 | Recruiting | January 16, 2019 | Germany ... 展开 >> Research Site Recruiting Berlin, Germany, 14050 收起 << |
NCT00350727 | Glioma | Phase 2 | Completed | - | - |
NCT00796991 | - | Completed | - | - | |
NCT01378767 | Effects of Krill Oil on Human ... 展开 >>Health 收起 << | Not Applicable | Completed | - | United States, Tennessee ... 展开 >> Cardiorespiratory/Metabolic Laboratory Memphis, Tennessee, United States, 38152 收起 << |
NCT00502996 | - | Completed | - | - | |
NCT00696657 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 2 | Completed | - | - |
NCT02064985 | - | Completed | - | - | |
NCT01378910 | HIV | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Xeral de Vigo Santiago de Compostela, A Coruña, Spain, 15781 Hospital de Elche Elche, Alicante, Spain, 03203 Hospital Son Espases Palma de Mallorca, Baleares, Spain, 07011 H. U. Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 H. de Bellvitge Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital U. Marqués de Valdecilla Santander, Cantabria, Spain, 39011 Hospital Sta. Lucía/ H. Sta. Mª del Rosell Cartagena, Murcia, Spain, 30203 Hospital General de Castellón Castellón, Valencia, Spain, 12004 Hospital de Cruces Bilbao, Vizcaya, Spain, 48903 Hospital Gral. U. de Alicante Alicante, Spain, 03010 Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital de Mataró Barcelona, Spain, 08304 Hospital Virgen de las Nieves Granada, Spain, 18014 Hospital U. San Cecilio Granada, Spain, 28012 Hospital U. Gregorio Marañón Madrid, Spain, 28007 Hospital Carlos III Madrid, Spain, 28029 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Reina Sofía de Murcia Murcia, Spain, 30003 Hospital Sant Pau i Santa Tecla Tarragona, Spain, 43007 Hospital La Fe Valencia, Spain, 46009 Hospital Gral. U. de Valencia Valencia, Spain, 46014 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital U. Dr. Peset Valencia, Spain, 46017 收起 << |
NCT01927848 | Knee Related Walking Limitatio... 展开 >>ns 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> The Parker Institute, Frederiksberg Hospital Copenhagen, Denmark, 2000 收起 << |
NCT02064985 | Stable Coronary Heart Disease ... 展开 >>(CHD) 收起 << | Phase 4 | Completed | - | China ... 展开 >> Research Site Beijing, China 收起 << |
NCT00541658 | - | Completed | - | - | |
NCT01513733 | Prostate Cancer | Phase 1 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke Cancer Institute Durham, North Carolina, United States, 27710 收起 << |
NCT02776033 | Psoriasis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> GSK Investigational Site Markham, Ontario, Canada, L3P1X2 GSK Investigational Site Peterborough, Ontario, Canada, K9J 5K2 GSK Investigational Site Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 收起 << |
NCT01997749 | Acute Stroke | Phase 1 | Completed | - | Denmark ... 展开 >> Glostrup Hospital Glostrup, Copenhagen, Denmark, 2600 收起 << |
NCT03237689 | Hiv | Early Phase 1 | Recruiting | August 31, 2022 | United States, Maryland ... 展开 >> Johns Hopkins University School of Medicine Recruiting Baltimore, Maryland, United States, 21224 Contact: Leah Rubin lrubin1@jhu.edu 收起 << |
NCT01057810 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01057810 | - | Completed | - | - | |
NCT03184987 | Asthma | Phase 3 | Active, not recruiting | June 24, 2019 | Japan ... 展开 >> GSK Investigational Site Gifu, Japan, 509-6134 GSK Investigational Site Gunma, Japan, 372-0831 GSK Investigational Site Gunma, Japan, 373-0807 GSK Investigational Site Hiroshima, Japan, 732-0052 GSK Investigational Site Kagawa, Japan, 762-8550 GSK Investigational Site Kanagawa, Japan, 236-0004 GSK Investigational Site Kyoto, Japan, 607-8062 GSK Investigational Site Okinawa, Japan, 901-2121 GSK Investigational Site Tokyo, Japan, 103-0027 GSK Investigational Site Tokyo, Japan, 134-0083 GSK Investigational Site Tokyo, Japan, 157-0066 GSK Investigational Site Tokyo, Japan, 169-0073 GSK Investigational Site Toyama, Japan, 937-0042 收起 << |
NCT03318731 | Muscle Damage ... 展开 >> Inflammation 收起 << | Not Applicable | Recruiting | September 2018 | United States, Texas ... 展开 >> UMHB Human Performance Lab Recruiting Belton, Texas, United States, 76513 Contact: Stacie L Urbina, MsEd 254-295-4280 ext 4280 surbina@umhb.edu Contact: Lem W Taylor, PhD 254-295-4895 ext 4895 ltyalor@umhb.edu Sub-Investigator: Katelyn B Villa, B.S. Sub-Investigator: Allyson K Bermea Sub-Investigator: Torrey Boggs Sub-Investigator: Matthias R Tinnin, B.S. Sub-Investigator: Javier A Zaragoza Sub-Investigator: Seth M Bates Sub-Investigator: Colin D Wilborn, PhD Sub-Investigator: Cliffa Foster, EdD 收起 << |
NCT02293161 | Autoimmune Diseases | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 << |
NCT02846233 | Type 2 Diabetes Mellitus | Not Applicable | Recruiting | December 2018 | United States, California ... 展开 >> UCSF Fresno Recruiting Fresno, California, United States, 93701 Contact: SOE NAING snaing@fresno.ucsf.edu 收起 << |
NCT00622700 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT02652793 | Human Immunodeficiency Virus | Not Applicable | Unknown | December 2017 | Spain ... 展开 >> Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Jose Luis Blanco, MD +34 93 227 54 00 收起 << |
NCT03004846 | Psoriasis | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Hamburg, Germany, 20095 收起 << |
NCT01002872 | Metabolic Bone Disease | Not Applicable | Unknown | December 2012 | United States, Illinois ... 展开 >> NorthShore University HealthSystem Evanston, Illinois, United States, 60201 收起 << |
NCT03432416 | Healthy Women ... 展开 >> Female Contraception 收起 << | Phase 2 | Recruiting | June 20, 2020 | United States, California ... 展开 >> Essential Access Health Recruiting Los Angeles, California, United States, 30010 Contact: Kieumai Vo 213-386-5614 ext 4592 KVo@essentialaccess.org Contact: Ron Frezeries 213-386-5614 ext 4403 RFrezieres@essentialaccess.org Principal Investigator: Anita Nelson University of California, Davis Recruiting Sacramento, California, United States, 95817 Contact: Courtney Overstreet 916-734-6846 cboverstreet@ucdavis.edu Contact: Aubrey Blanton 916-734-6846 akblanton@ucdavis.edu Principal Investigator: Mitchell Creinin United States, Colorado University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Ines Crato 303-724-5559 INES.CRATO@UCDENVER.EDU Contact: Rebecca Seale 303-724-2013 REBECCA.SEALE@UCDENVER.EDU Principal Investigator: Stephanie Teal United States, Maryland Johns Hopkins Bayview Medical Center Recruiting Baltimore, Maryland, United States, 21224 Contact: Katrina Thaler 410-550-8506 kstouff3@jhmi.edu Contact: Lauren Beal 410-550-4825 lbeal2@jhu.edu Principal Investigator: Anne Burke United States, New York Bellevue Hospital Center Recruiting New York, New York, United States, 10016 Contact: Anna Davis 212-263-6253 anna.davis@nyumc.org Principal Investigator: Treasure Walker Columbia University Recruiting New York, New York, United States, 10032 Contact: Subrina Bisnauth 212-305-8031 Snb2147@cumc.columbia.edu Contact: Connie Colon 212-305-6098 cc3238@cumc.columbia.edu Principal Investigator: Carolyn Westhoff United States, Ohio University of Cincinnati Recruiting Cincinnati, Ohio, United States, 45267 Contact: Deborah Boerschig 513-584-4100 BOERSCDA@UCMAIL.UC.EDU Contact: Tiffany Rupert 513-584-4100 tiffany.rupert@uc.edu Principal Investigator: Michael Thomas United States, Oregon Oregon Health Science University Recruiting Portland, Oregon, United States, 97239 Contact: Ariela Schnyer 503-494-3173 schnyer@ohsu.edu Contact: Alison Edelman 503-494-5949 edelmana@ohsu.edu Principal Investigator: Jeffrey Jensen United States, Pennsylvania University of Pennsylvania School of Medicine Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Andrea Morley 215-615-4202 Andrea.morley@uphs.upenn.edu Contact: Kieran Alessi 215-615-3664 Kieran.Alessi@uphs.upenn.edu Principal Investigator: Kurt Barnhart United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Jasmin Alcantra 801-213-3796 jasmin.alcantara@hsc.utah.edu Contact: Amy Orr 801-213-2774 amy.orr@hsc.utah.edu Principal Investigator: David Turok United States, Virginia Eastern Virginia Medical School Recruiting Norfolk, Virginia, United States, 23507 Contact: Jackie Rocccazella 757-446-7161 roccazj@evms.edu Contact: Kim Pitts 757-446-8925 pittska@evms.edu Principal Investigator: David Archer 收起 << |
NCT00751881 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT02278185 | Adenocarcinoma of the Prostate... 展开 >> Recurrent Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer 收起 << | Phase 2 | Recruiting | December 2019 | United States, Colorado ... 展开 >> University of Colorado Cancer Center - Anschutz Cancer Pavilion Recruiting Aurora, Colorado, United States, 80045 Contact: Michael Wacker 720-848-3427 michael.wacker@ucdenver.edu Principal Investigator: Elizabeth R. Kessler, MD Sub-Investigator: Al Barqawi, MD Sub-Investigator: Thomas W Flaig, MD Sub-Investigator: Elaine T Lam, MD Sub-Investigator: Paul Maroni, MD Sub-Investigator: Shandra Wilson, MD University of Colorado Health - Poudre Valley Hospital Recruiting Fort Collins, Colorado, United States, 80524 Contact: Joanne O'Malia 970-297-6153 Joanne.omalia@uchealth.org Principal Investigator: Steven Schuster, MD 收起 << |
NCT00457002 | Venous Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT03101722 | Presbycusis T... 展开 >>innitus Cognitive Impairment 收起 << | Not Applicable | Enrolling by invitation | December 1, 2021 | China, Shanghai ... 展开 >> Huadong Hospital Shanghai, Shanghai, China, 200040 Jinshan Zhong Ren geriatric care hospital Shanghai, Shanghai, China, 200040 Jiuting Community Health Service Shanghai, Shanghai, China, 200040 收起 << |
NCT01489410 | Hepatocellular Carcinoma | Not Applicable | Withdrawn(Insufficient staff) | - | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00989235 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00457002 | - | Completed | - | - | |
NCT00989235 | - | Completed | - | - | |
NCT03567499 | Amyloidosis | Phase 1 | Withdrawn(The decision to end ... 展开 >>the study was made for GSK portfolio reasons. No subjects were randomised into the study.) 收起 << | May 3, 2019 | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT01714817 | Lupus Nephritis | Phase 3 | Completed | - | - |
NCT01714817 | - | Completed | - | - | |
NCT01104935 | Breast Cancer | Phase 3 | Active, not recruiting | April 30, 2018 | Japan ... 展开 >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 收起 << |
NCT03523455 | Iron-deficiency | Not Applicable | Terminated(Unable to recruit q... 展开 >>ualified participants) 收起 << | - | United States, Texas ... 展开 >> UMHB Human Performance Lab Belton, Texas, United States, 76513 收起 << |
NCT00705367 | Lupus Nephritis | Phase 1 | Completed | - | China, Shanghai ... 展开 >> Local Institution Shanghai, Shanghai, China, 200001 收起 << |
NCT02663089 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT03775538 | Parkinson Disease ... 展开 >> Movement Disorders Neuro-Degenerative Disease Nervous System Diseases Brain Diseases 收起 << | Phase 1 Phase 2 | Recruiting | September 30, 2020 | Finland ... 展开 >> Helsinki University Hospital Not yet recruiting Helsinki, Finland, 00029 Contact: Filip Scheperjans, Ph.D, MD +358 (0)50-4284113 parkinson.tutkimus@gmail.com Sweden Skåne University Hospital Not yet recruiting Lund, Sweden, 221 85 Contact: Håkan Widner, Ph.D, MD +46 (0)46-17 14 25 Hakan.Widner@med.lu.se Contact: Gesine Paul-Visse, Ph.D, MD +46 (0)46-17 77 66 Gesine.Paul-Visse@med.lu.se Karolinska University Hospital Recruiting Stockholm, Sweden, 14186 Contact: Per Svenningsson, Ph.D, MD +46 8 585 87271 per.svenningsson@ki.se Contact: Lisa Hainke +46 8 585 84710 lisa.hainke@sll.se 收起 << |
NCT00751881 | - | Completed | - | - | |
NCT00705367 | - | Completed | - | - | |
NCT01366521 | Asthma | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Estonia GSK Investigational Site Tallinn, Estonia, 13619 GSK Investigational Site Tartu, Estonia, 51014 France GSK Investigational Site Marseille cedex 20, France, 13915 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pessac Cedex, France, 33604 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60596 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT00370552 | - | Completed | - | - | |
NCT03776058 | Primary Hyperparathyroidism | Phase 2 | Completed | - | - |
NCT01366521 | - | Completed | - | - | |
NCT00622700 | - | Completed | - | - | |
NCT02226354 | Healthy | Phase 1 | Completed | - | Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 << |
NCT03754920 | Fasting | Not Applicable | Active, not recruiting | September 9, 2019 | China, Shanghai ... 展开 >> Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai, Shanghai, China, 200030 收起 << |
NCT03485365 | Pain, Inflammatory | Phase 1 | Recruiting | November 27, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00370552 | Metastatic Breast Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> East Valley Hematology And Oncology Medical Group Burbank, California, United States, 91505 Wilshire Oncology Medical Group, Inc. La Verne, California, United States, 91750 Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Iowa University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States, 52242 United States, Missouri Ellis Fischel Cancer Center Columbia, Missouri, United States, 65203 United States, New York Weill Medical College Of Cornell University New York, New York, United States, 10021 France Local Institution Besancon Cedex, France, 25030 Local Institution Clermont-Ferrand, France, 63000 Local Institution Marseille Cedex 9, France, 13273 Local Institution Paris Cedex 10, France, 75475 Local Institution Saint Herblain, France, 44805 Local Institution Strasbourg Cedex, France, 67085 Local Institution Tours Cedex, France, 37044 Italy Local Institution Cuneo, Italy, 12100 Local Institution Meldola Fc, Italy, 47014 Local Institution Milano, Italy, 20132 Local Institution Modena, Italy, 41100 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00161 Spain Local Institution Hospitalet De Llobregat, Spain, 08907 Local Institution Jaen, Spain, 23007 United Kingdom Local Institution Chelmsford, Essex, United Kingdom, CM1 7ET Local Institution Manchester, Greater Manchester, United Kingdom, M20 4BX Local Institution Nottingham, Nottinghamshire, United Kingdom, NG5 1PB Local Institution Merseyside, United Kingdom, CH63 4JY 收起 << |
NCT02398279 | Schizophrenia ... 展开 >> Schizoaffective Disorder 收起 << | Not Applicable | Completed | - | Turkey ... 展开 >> Hacettepe University Faculty of Medicine Department of Psychiatry Ankara, Turkey, 06100 收起 << |
NCT00048048 | Anemia | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Birmingham, Alabama, United States, 35211 United States, California San Diego, California, United States, 92103-8342 United States, Michigan Detroit, Michigan, United States, 48202-2689 Detroit, Michigan, United States, 48236 United States, Nevada Las Vegas, Nevada, United States, 89106 United States, Oregon Portland, Oregon, United States, 97201-2940 Canada, Alberta Edmonton, Alberta, Canada, T6G 2B7 Canada, British Columbia Vancouver, British Columbia, Canada, V6Z 1Y6 Mexico Mexico City, Mexico, 14000 Monterrey, Mexico, 64710 Poland Gdansk, Poland, 80-211 Krakow, Poland, 31-501 Wroclaw, Poland, 50-417 United Kingdom Belfast, United Kingdom, BT9 7LJ London, United Kingdom, SE22 8PT 收起 << |
NCT00277212 | Bipolar Disorder | Phase 4 | Completed | - | - |
NCT03002220 | Prostate Cancer | Phase 2 | Recruiting | July 2018 | Spain ... 展开 >> MedSIR Investigative site Recruiting Barcelona, Spain Principal Investigator: Joan Carles Galcerán MedSIR Investigative site Not yet recruiting Barcelona, Spain Principal Investigator: Begoña Mellado MedSIR investigative site Recruiting Barcelona, Spain Principal Investigator: Enrique Gallardo MedSIR investigative site Not yet recruiting Barcelona, Spain Principal Investigator: Josep Maria Piulats MedSIR Investigative site Recruiting Cáceres, Spain Principal Investigator: Pablo Borrega MedSIR Investigative site Not yet recruiting Córdoba, Spain Principal Investigator: Mª José Méndez MedSIR Investigative site Not yet recruiting Lugo, Spain Principal Investigator: Sergio Vázquez MedSIR Investigative site Recruiting Madrid, Spain Principal Investigator: Enrique Grande 收起 << |
NCT00048048 | - | Completed | - | - | |
NCT03446053 | Healthy Volunteers ... 展开 >> Anti-Bacterial Agents Methicillin-Resistant Staphylococcus Aureus Methicillin-Sensitive Staphylococcus Aureus Infection 收起 << | Phase 1 | Recruiting | October 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: In Jin Jang, M.D., Ph. D 82-2-740-8290 ijjang@snu.ac.kr Contact: Jun Gi Hwang Hwang, M.D 82-2-742-9252 hjk17@snu.ac.kr Principal Investigator: In Jin Jang, M.D., Ph. D Sub-Investigator: Jun Gi Hwang, M.D 收起 << |
NCT00559585 | Rheumatoid Arthritis (RA) | Phase 3 | Completed | - | - |
NCT00387764 | Carcinoma, Renal Cell | Phase 3 | Completed | - | - |
NCT00559585 | - | Completed | - | - | |
NCT00387764 | - | Completed | - | - | |
NCT03268005 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Active, not recruiting | January 29, 2019 | - |
NCT03490448 | Obesity, Childhood ... 展开 >> Vitamin D Deficiency 收起 << | Not Applicable | Completed | - | China, Shanghai ... 展开 >> Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China, 200092 收起 << |
NCT03323359 | Hepatectomy C... 展开 >>ancer, Metastatic Hemostasis 收起 << | Not Applicable | Recruiting | March 17, 2019 | Italy ... 展开 >> Policlinico Universitario Agostino Gemelli Recruiting Rome, Italy, 00168 Contact: Pacelli 00390630155133 ext 4477 fabio.pacelli@policlinicogemelli.it Principal Investigator: Fabio FP Pacelli, MD 收起 << |
NCT03305419 | Autoimmune Diseases | Phase 1 | Recruiting | October 22, 2018 | United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 2GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00277212 | - | Completed | - | - | |
NCT02122211 | Men Carrying 2 Minor Alleles f... 展开 >>or Choline Dehydrogenase rs12676 Male Infertility 收起 << | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> UNC Nutrition Research Institute Kannapolis, North Carolina, United States, 28081 收起 << |
NCT01136564 | Chronic Kidney Disease | Phase 2 | Completed | - | Denmark ... 展开 >> Department of Medical Research Holstebro, Denmark, 7500 收起 << |
NCT02540759 | Healthy | Phase 1 | Completed | - | Canada, New Brunswick ... 展开 >> Université de Moncton Moncton, New Brunswick, Canada, E1A 3E9 收起 << |
NCT01072175 | Cancer | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Los Angeles, California, United States, 90025 Novartis Investigative Site San Francisco, California, United States, 94115 United States, Colorado Novartis Investigative Site Aurora, Colorado, United States, 80045 United States, Connecticut Novartis Investigative Site New Haven, Connecticut, United States, 06520 United States, Florida Novartis Investigative Site Tampa, Florida, United States, 33612 United States, Maryland Novartis Investigative Site Lutherville-Timonium, Maryland, United States, 21093 United States, Massachusetts Novartis Investigative Site Boston, Massachusetts, United States, 02114 Novartis Investigative Site Boston, Massachusetts, United States, 02215 United States, Minnesota Novartis Investigative Site Rochester, Minnesota, United States, 55905 United States, Pennsylvania Novartis Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Novartis Investigative Site Nashville, Tennessee, United States, 37203 Novartis Investigative Site Nashville, Tennessee, United States, 37232 United States, Texas Novartis Investigative Site Houston, Texas, United States, 77030-4009 Australia, New South Wales Novartis Investigative Site Westmead, New South Wales, Australia, 2145 Australia, Victoria Novartis Investigative Site Heidelberg, Victoria, Australia, 3084 收起 << |
NCT00490646 | - | Completed | - | - | |
NCT01655953 | Low Grade Metabolic Acidosis | Not Applicable | Completed | - | Germany ... 展开 >> German Aerospace Center (DLR) Cologne, Germany, 51147 收起 << |
NCT03677076 | Prostate Cancer | Not Applicable | Not yet recruiting | December 29, 2020 | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 << |
NCT00364793 | - | Completed | - | - | |
NCT00859898 | - | Completed | - | - | |
NCT01072175 | - | Completed | - | - | |
NCT00859898 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT01848457 | Osteosarcoma ... 展开 >>Nephrotoxicity Ototoxicity 收起 << | Phase 2 | Active, not recruiting | January 2019 | United States, Pennsylvania ... 展开 >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT00736879 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00364793 | HIV Infections | Phase 1 Phase 2 | Completed | - | Argentina ... 展开 >> Local Institution Buenos Aires, Argentina, 1425 Local Institution Capital Federal, Argentina, 1425 Colombia Local Institution Cali, Colombia Mexico Local Institution Df, Distrito Federal, Mexico, 06720 Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Guadalajara, Jalisco, Mexico, 44520 Local Institution Morelia, Michioacan, Mexico, 58000 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Colima, Mexico, 28019 Local Institution Puebla, Mexico, 72000 Local Institution San Luis Potosi, Mexico, 78240 Panama Local Institution Ciudad De Panama, Panama, 0816-00383 South Africa Local Institution Bloemfontein, Free State, South Africa, 9301 Local Institution Westdene, Gauteng, South Africa, 2092 Local Institution Cape Town, Western Cape, South Africa, 7505 Thailand Local Institution Bangkok, Thailand, 10330 Local Institution Bangkok, Thailand, 10700 收起 << |
NCT02819219 | Healthy | Not Applicable | Completed | - | - |
NCT00490646 | Metastatic Breast Cancer | Phase 2 | Completed | - | France ... 展开 >> Local Institution Caen, France, F-14076 Local Institution Grenoble, France, 38028 Local Institution St Priest En Jarez, France, 42271 Local Institution Toulouse, France, 31300 Greece Local Institution Athens, Greece, 11522 Local Institution Athens, Greece, 12462 Local Institution Pireaus, Greece, 18537 Italy Local Institution Bologna, Italy, 40138 Local Institution Brescia, Italy, 25123 Local Institution Modena, Italy, 41100 Local Institution Napoli, Italy, 80131 Local Institution Roma, Italy, 00144 Local Institution Sora, Italy, 03039 Spain Local Institution Madrid, Spain, 28007 Local Institution Madrid, Spain, 28034 Turkey Local Institution Ankara, Turkey, 06100 Local Institution Ankara, Turkey, 06500 Local Institution Izmir, Turkey, 35100 Local Institution Izmir, Turkey, 35340 收起 << |
NCT00736879 | - | Completed | - | - | |
NCT01119937 | - | Completed | - | - | |
NCT02927457 | Lupus Erythematosus, Cutaneous | Phase 1 | Completed | - | Germany ... 展开 >> GSK Investigational Site Tuebingen, Baden-Wuerttemberg, Germany, 72076 GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Wuppertal, Nordrhein-Westfalen, Germany, 42283 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 10117 收起 << |
NCT02905539 | Anemia, Iron-Deficiency | Phase 4 | Recruiting | June 2019 | Germany ... 展开 >> Universitätsklinikum des Saarlandes Recruiting Homburg, Saarland, Germany, 66421 Contact: Fabio Lizzi +4968411621328 fabio.lizzi@uks.eu Contact: Insa Emrich, MD +4968411623556 insa.emrich@uks.eu Principal Investigator: Gunnar Heine, MD Sub-Investigator: Sarah Seiler-Mußler, MD 收起 << |
NCT02142348 | - | Unknown | December 2018 | China, Shanghai ... 展开 >> Longhua Hospital Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Xuejun Cui 13917715524@139.com Principal Investigator: Chenguang Li, Dr. Principal Investigator: Jing Wang, master 收起 << | |
NCT01119937 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novartis Investigative Site Iizuka, Fukuoka, Japan, 820-8505 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 802-0083 Novartis Investigative Site Kitakyushu, Fukuoka, Japan, 820-0052 Novartis Investigative Site Kurume, Fukuoka, Japan, 830-0011 Novartis Investigative Site Onojo, Fukuoka, Japan, 816-0931 Novartis Investigative Site Yanagawa, Fukuoka, Japan, 832-0059 Novartis Investigative Site Asahikawa, Hokkaido, Japan, 070-8644 Novartis Investigative Site Obihiro, Hokkaido, Japan, 080-0805 Novartis Investigative Site Sapporo, Hokkaido, Japan, 060-8648 Novartis Investigative Site Himeji-city, Hyogo, Japan, 672-8064 Novartis Investigative Site Takarazuka, Hyogo, Japan, 665-0827 Novartis Investigative Site Yabu, Hyogo, Japan, 667-8555 Novartis Investigative Site Inashiki-gun, Ibaraki, Japan, 300-0395 Novartis Investigative Site Naka-gun, Ibaraki, Japan, 319-1113 Novartis Investigative Site Sashima-gun, Ibaraki, Japan, 306-0433 Novartis Investigative Site Morioka, Iwate, Japan, 020-0055 Novartis Investigative Site Kawasaki, Kanagawa, Japan, 210-0852 Novartis Investigative Site Yokohama, Kanagawa, Japan, 232-0021 Novartis Investigative Site Yokohama, Kanagawa, Japan, 236-0051 Novartis Investigative Site Uji, Kyoto, Japan, 611-0042 Novartis Investigative Site Matsusaka-city, Mie, Japan, 515-8544 Novartis Investigative Site Sendai, Miyagi, Japan, 981-8563 Novartis Investigative Site Nagaoka-City, Niigata, Japan, 940-2085 Novartis Investigative Site Nagaoka, Niigata, Japan, 940-8653 Novartis Investigative Site Kasaoka, Okayama, Japan, 714-0081 Novartis Investigative Site Tsuyama, Okayama, Japan, 708-0841 Novartis Investigative Site Osakasayama, Osaka, Japan, 589-0022 Novartis Investigative Site Sakai, Osaka, Japan, 591-8555 Novartis Investigative Site Takatsuki, Osaka, Japan, 569-1096 Novartis Investigative Site Shimotsuka-gun, Tochigi, Japan, 321-0293 Novartis Investigative Site Bunkyo-ku, Tokyo, Japan, 113-8431 Novartis Investigative Site Nakano-ku, Tokyo, Japan, 164-0012 Novartis Investigative Site Ohta-ku, Tokyo, Japan, 140-0063 Novartis Investigative Site Yamagata city, Yamagata, Japan, 990-8533 Novartis Investigative Site Ube, Yamaguchi, Japan, 755-0241 Novartis Investigative Site Fukuoka, Japan, 812-0033 Novartis Investigative Site Kochi, Japan, 780-8077 Novartis Investigative Site Osaka, Japan, 530-0012 Novartis Investigative Site Osaka, Japan, 545-8586 Novartis Investigative Site Saitama, Japan, 337-0012 收起 << |
NCT03239756 | Breast Cancer | Phase 1 | Recruiting | August 2018 | China, Jiangsu ... 展开 >> the first affiliated hospital with Nanjing University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Yin Y M 13951842727 ym.yin@hotmail.com 收起 << |
NCT02625207 | - | Completed | - | - | |
NCT03242512 | Osteoporosis | Phase 1 | Enrolling by invitation | December 30, 2018 | China, Beijing ... 展开 >> Peking Union Medical College Hospital Beijing, Beijing, China 收起 << |
NCT01966822 | HIV-1 Infection | Phase 3 | Completed | - | Spain ... 展开 >> GermansTrias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clínico San Carlos Madrid, Spain, 28040 收起 << |
NCT00698841 | Advanced Cancer | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, Arizona Donald W. Hill, MD Casa Grande, Arizona, United States, 85222 United States, California Compassionate Cancer Care Medical Group, Inc Corona, California, United States, 92879 Compassionate Cancer Care Medical Group Inc Fountain Valley, California, United States, 92708 Pacific Shores Medical Group Long Beach, California, United States, 90813 Desert Hospital Comprehensive Cancer Center Palm Springs, California, United States, 92262 Compassionate Cancer Care Medical Group, Inc Riverside, California, United States, 92501 American Institute Research Whittier, California, United States, 90603 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida Baptist Cancer Institute Jacksonville, Florida, United States, 32207 Ocala Oncology Center Ocala, Florida, United States, 34471 United States, Louisiana Brinz, Burroff, Gurtler, & Russo Metairie, Louisiana, United States, 70006 United States, Oklahoma Cancer Specialists Of Oklahoma Oklahoma City, Oklahoma, United States, 73112 United States, Rhode Island Pharma Resource East Providence, Rhode Island, United States, 02915 United States, Texas Austin Cancer Centers Austin, Texas, United States, 78759 Puerto Rico Local Institution San Juan, Puerto Rico, 00910 收起 << |
NCT02625207 | Healthy Subjects | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01854463 | DIABETES MELLITUS | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Chuncheon Sacred Heart Hospital Chuncheon, Gangwon-do, Korea, Republic of, 200704 收起 << |
NCT02460159 | Hypercholesterolemia ... 展开 >> Heterozygous Familial Hypercholesterolemia 收起 << | Phase 3 | Completed | - | - |
NCT00698841 | - | Completed | - | - | |
NCT02460159 | - | Completed | - | - | |
NCT02550288 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02230930 | Parkinson's Disease ... 展开 >> Apomorphine-induced Skin Reactions 收起 << | Phase 2 | Recruiting | November 2017 | Netherlands ... 展开 >> Department of Neurology Recruiting Groningen, Netherlands, 9713GZ Contact: Robbert Borgemeester, MD +31 (0) 50-3611519 r.w.k.borgemeester@umcg.nl Sub-Investigator: Robbert Borgemeester, MD Principal Investigator: Teus van Laar, MD PhD 收起 << |
NCT03395405 | Gastroenteritis Norovirus | Phase 2 | Recruiting | May 22, 2021 | United States, Alabama ... 展开 >> University of Alabama Hospital - Infectious Diseases Not yet recruiting Birmingham, Alabama, United States, 35249-0001 United States, Illinois Northwestern University - Comprehensive Transplant Center Recruiting Chicago, Illinois, United States, 60611-2927 United States, Kansas University of Kansas Medical Center - Infectious Diseases Recruiting Kansas City, Kansas, United States, 66160-8500 United States, Maryland Johns Hopkins Hospital - Medicine - Infectious Diseases Not yet recruiting Baltimore, Maryland, United States, 21287-0005 United States, Michigan University of Michigan - Infectious Disease Clinic at Taubman Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 United States, Nebraska University of Nebraska Medical Center - Infectious Diseases Not yet recruiting Omaha, Nebraska, United States, 68198-5400 United States, Ohio Cincinnati Children's Hospital Medical Center - Infectious Diseases Not yet recruiting Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania University of Pittsburgh - Medicine - Infectious Diseases Recruiting Pittsburgh, Pennsylvania, United States, 15213-3403 Children's Hospital of Pittsburgh of UPMC - Pediatric Infectious Diseases Recruiting Pittsburgh, Pennsylvania, United States, 15224-1529 United States, Texas University of Texas Southwestern Medical Center - Internal Medicine Subspecialties Clinic Recruiting Dallas, Texas, United States, 75390-8884 United States, Washington Fred Hutchinson Cancer Research Center - Vaccine and Infectious Diseases Recruiting Seattle, Washington, United States, 98109-4433 University of Washington - Medicine Recruiting Seattle, Washington, United States, 98195-7110 收起 << |
NCT02550288 | - | Completed | - | - | |
NCT00385671 | Diabetic Neuropathy, Painful | Phase 4 | Completed | - | United States, California ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torrance, California, United States, 90503 United States, Connecticut For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cromwell, Connecticut, United States, 06416 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Staten Island, New York, United States, 10312 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, North Carolina, United States, 27834 United States, Utah For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Midvale, Utah, United States, 84047 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany, D-44805 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20354 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Siegen, Germany, 57072 收起 << |
NCT01109524 | - | Completed | - | - | |
NCT01430871 | - | Completed | - | United Kingdom ... 展开 >> Academic Unit of Bone Metabolism (Sheffield) Sheffield, South Yorks, United Kingdom, S5 7AU 收起 << | |
NCT01109524 | Lung Neoplasms ... 展开 >> Carcinoma Cancer of the Lung Non-Small-Cell Lung Carcinoma 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Donald W. Hill M.D., P.C. Casa Grande, Arizona, United States, 85122 United States, California Beverly Hills Cancer Center Beverly Hills, California, United States, 90211 Cancer Care Institute Los Angeles, California, United States, 90036 Northern California Hematology & Oncology Oakland, California, United States, 94609 Sharp Clinical Oncology Research San Diego, California, United States, 92123 United States, Florida Broward Oncology Associates, P.A. Ft. Lauderdale, Florida, United States, 33308 Elite Research Institute Miami, Florida, United States, 33125 United States, Illinois Edward H. Kaplan, MD & Associates Skokie, Illinois, United States, 60076 United States, Minnesota Fairview Southdale Medical Oncology Clinic Edina, Minnesota, United States, 55435 United States, North Dakota Mid Dakota Clinic, Pc Bismarck, North Dakota, United States, 58501 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Texas University Medical Center Lubbock, Texas, United States, 79415 United States, Washington Columbia Basin Hematology and Oncology Kennewick, Washington, United States, 99336 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Newfoundland and Labrador Local Institution Grand Falls-Windsor, Newfoundland and Labrador, Canada, A2A 2E2 Canada, Ontario The Credit Valley Hospital Mississauga, Ontario, Canada, L5M 2N1 Sudbury Regional Hospital Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Sciences Centre (Regional Cancer Care) Thunder Bay, Ontario, Canada, P7B 6V4 Toronto East General Hospital Toronto, Ontario, Canada, M4C 3E7 Canada, Quebec Centre de sante et de services sociaux de Rimouski-Neigette Rimouski, Quebec, Canada, G5L 5T1 Puerto Rico Ponce School of Medicine (Caimed Center) Ponce, Puerto Rico, 00716 Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00927 收起 << |
NCT01982734 | Pharmacokinetics of New Curcum... 展开 >>in Formulations Safety of New Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT02197130 | - | Completed | - | - | |
NCT02741245 | - | Completed | - | - | |
NCT03673085 | Thalassemia | Phase 1 | Recruiting | December 2018 | China, Zhejiang ... 展开 >> The first affiliated hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Jianzhong Shentu 13957111817 stjz@zju.edu.cn 收起 << |
NCT00385671 | - | Completed | - | - | |
NCT02197130 | Huntington's Disease | Phase 2 | Completed | - | - |
NCT02958020 | - | Recruiting | October 2028 | China ... 展开 >> Dongzhimen Hospital, Beijing Recruiting Beijing, China Contact: Xinchao Lin The 309th Hospital of Chinese People's Libertation Army Recruiting Beijing, China Contact: Liang Wang Wangjing Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, China Contact: Yanming Xie Affiliated Hospital of Changchun University of Traditional Chinese Medicine Recruiting Changchun, China Contact: Xiangyang Leng Guangdong Provincial Hospital of Traditional Chinese Medicine Recruiting Guangzhou, China Contact: Bolai Chen Guangzhou Kingmed Diagnostics Co., Ltd. Recruiting Guangzhou, China Contact: Jiangtao Xie The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine Recruiting Guangzhou, China Contact: De Liang Gansu Provincial Hospital of Traditional Chinese Medicine Recruiting Lanzhou, China Contact: Xingwen Xie Luoyang Zhenggu Hospital Not yet recruiting Luoyang, China Contact: Yingjie Zhou Longhua Hospital, Shanghai University of TCM Recruiting Shanghai, China Contact: Yongjun Wang 收起 << | |
NCT00315770 | Overweight Me... 展开 >>tabolic Syndrome X Bone Resorption 收起 << | Phase 1 | Active, not recruiting | April 2020 | - |
NCT02589639 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Japan ... 展开 >> Nakayama Clinic Aichi, Japan, 456-0058 Kashiwa City Hospital Chiba, Kashiwa, Japan, 277-0825 Saiseikai Fukuoka General Hospital Fukuoka, Fukuoka, Japan, 810-0001 Seiwakai Medical Corporation Nagata Hospital Fukuoka, Yanagawa, Japan, 832-0059 Kunisaki Makoto Clinic Fukuoka, Japan, 819-0168 Saiseikai Maebashi Hospital Gunma, Maebashi, Japan, 371-0821 Nippon Kokan Fukuyama Hospital Hiroshima, Fukuyama, Japan, 721-0927 Jiyugaoka Yokoyama Naika Clinic Hokkaido, Obihiro, Japan, 080-0016 Jiyugaoka Yamada Clinic Hokkaido, Obihiro, Japan, 080-0848 Souen Diabetes Clinic Hokkaido, Sapporo, Japan, 060-0011 Kotani Diabetes Clinic Hyogo, Kobe, Japan, 657-0028 Nishinomiya Municipal Central Hospital Hyogo, Nishinomiya, Japan, 663-8014 Noritake Clinic Ibaraki, Ushiku, Japan, 300-1207 Yokoi Medical Clinic, Kagawa, I.M. Kagawa, Japan, 761-8075 Izuro Imamura Hospital Kagoshima, Kagoshima, Japan, 892-0824 Wakamatsu Memorial Hospital Kagoshima, Satsumasendai, Japan, 895-0052 Fukumoto clinic Kagoshima, Japan, 891-0401 STOP DM SUZUKI DIABETES CLINIC, Kanagawa, I.M. Kanagawa, Atsugi, Japan, 243-0035 Takai Naika Clinic Kanagawa, Kamakura, Japan, 247-0056 Kokan Clinic Kanagawa, Kawasaki, Japan, 210-0852 Yoshimasa Diabetes & Endocrine Clinic Kyoto, Kyoto, Japan, 604-8151 Medical Corporation KEISEIKAI Kajiyama clinic Kyoto, kyoto, Japan, 615-0035 Saka General Clinic Miyagi, Tagajo, Japan, 985-0835 North Alps Medical Center Azumi Hospital Nagano, Kitaazumi-gun, Japan, 399-8695 Asama Nanroku Komoro Medical center Nagano, Komoro, Japan, 384-8588 Abe Clinic Oita, Oita, Japan, 870-0039 Tsuyama Chuo Hospital Okayama, Tsuyama, Japan, 708-0841 Medical Corporation Kyojinkai Clinic Komatsu Osaka, Neyagawa, Japan, 572-8567 Minamiosaka Hospital Osaka, Osaka, Japan, 559-0012 OCROM Clinic Osaka, Suita, Japan, 565-0853 AMC Nishi-umeda Clinic Osaka, Japan, 530-0001 Shiraiwa Medical Clinic Osaka, Japan, 582-0005 Ageo Central General Hospital Saitama, Ageo, Japan, 362-8588 Medical Corporation Kaishinkai Masunaga Clinic Saitama, Fujimi, Japan, 354-0031 Medical Corporation Fusa Shimizu Clinic Fusa Saitama, Saitama, Japan, 336-0963 Seiwa Clinic Tokyo, Adachi-ku, Japan, 123-0845 Juntendo University Hospital Tokyo, Bunkyo-ku, Japan, 113-8431 Chiyoda Houjin Clinic Tokyo, Chiyoda-ku, Japan, 101-0024 HDC Atlas Clinic Tokyo, Chiyoda-ku, Japan, 102-0082 Fukuwa Clinic Tokyo, Chuo-ku, Japan, 103-0027 Tokyo-Eki Center-building Clinic Tokyo, Chuo-ku, Japan, 103-0027 Tokyo Center Clinic Tokyo, Chuo-ku, Japan, 103-0028 Shin Clinic Tokyo, Ota-ku, Japan, 144-0051 Shinjuku Research Park Clinic Tokyo, Shinjuku-ku, Japan, 169-0073 Sumida Chuou Hospital Tokyo, Sumida-ku, Japan, 131-0046 Sagae City Hospital Yamagata, Sagae, Japan, 991-8508 Clinic Sugiyama Yamagata, Yamagata, Japan, 990-0885 Yamanashi Prefectural Central Hospital Yamanashi, Kofu, Japan, 400-8506 收起 << |
NCT01195662 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT02830789 | Roux-en-Y Gastric Bypass ... 展开 >> Hyperparathyroidism, Secondary 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Department of Enodocrinology and Internal Medicine, Aarhus University Hospital Aarhus, Denmark, 8000 收起 << |
NCT02741245 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT02944097 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT02944084 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT03140397 | Safety After Oral Intake ... 展开 >> Pharmacokinetics After Oral Intake Immune Cells Activity 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 收起 << |
NCT02868489 | Obesity Quali... 展开 >>ty of Life 收起 << | Not Applicable | Recruiting | March 2018 | United States, California ... 展开 >> Faculty of Medical Offices - LLU Recruiting Loma Linda, California, United States, 92354 Contact: Taimmie Wharton 909 558 1000 ext 22126 TWharton@llu.edu Contact: Tammie Wharton, PhD (c), MS, RD 909 677 9593 fkazzi@llu.edu 收起 << |
NCT01195662 | - | Completed | - | - | |
NCT03286777 | Safety of Native vs. Micellar ... 展开 >>6-PN After Oral Intake Pharmacokinetics of Native vs. Micellar 6-PN After Oral Intake PBMC Activity After Native vs. Micellar 6-PN Oral Intake 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 Eberhard Karls University Tuebingen Tübingen, Baden-Württemberg, Germany, 72076 收起 << |
NCT01263691 | Bacillus Anthracis (Anthrax) I... 展开 >>nfection 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Miami Research Associates Miami, Florida, United States, 33143 United States, North Carolina North Carolina Clinical Research Raleigh, North Carolina, United States, 27607 United States, Utah Jean Brown Research Salt Lake City, Utah, United States, 84124 收起 << |
NCT01812629 | Growth and Tolerance Infant St... 展开 >>udy 收起 << | Not Applicable | Completed | - | United States, District of Col... 展开 >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 收起 << |
NCT00745719 | Endstage Renal Disease | Phase 4 | Completed | - | Hong Kong ... 展开 >> Queen Mary Hospital, Tung Wah Hospital Hong Kong, Hong Kong, 0000 收起 << |
NCT03176771 | Tardive Dyskinesia | Phase 2 Phase 3 | Recruiting | July 2019 | - |
NCT02966522 | Cardiac Amyloidosis | Phase 2 | Recruiting | September 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Youngil Koh, MD, PhD go01@snu.ac.kr Contact: Ryul Kim, MD chrono0707@icloud.com 收起 << |
NCT00391950 | Prostate Cancer | Phase 3 | Terminated | - | United Kingdom ... 展开 >> Derby, United Kingdom 收起 << |
NCT00920907 | - | Completed | - | - | |
NCT00453479 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Netherlands ... 展开 >> GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Harderwijk, Netherlands, 3844 DG GSK Investigational Site Utrecht, Netherlands, 3584 CJ GSK Investigational Site Zuidlaren, Netherlands, 9471 GP 收起 << |
NCT01263691 | - | Completed | - | - | |
NCT01650194 | Metastatic Castration-Resistan... 展开 >>t Prostate Cancer 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> Site US2492 MD Anderson Cancer Ctr Houston, Texas, United States, 77030 收起 << |
NCT00920907 | Advanced Melanoma | Phase 1 | Completed | - | United States, California ... 展开 >> The Angeles Clinic & Research Inst. Los Angeles, California, United States, 90025 California Pacific Medical Center San Francisco, California, United States, 94115 United States, Florida H Lee Moffitt Cancer Center Tampa, Florida, United States, 33612-9416 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 11065 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28204 United States, Pennsylvania St Luke'S Hospital And Health Network Bethlehem, Pennsylvania, United States, 18015 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 收起 << |
NCT02202161 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21225 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 收起 << |
NCT02202161 | - | Completed | - | - | |
NCT02918318 | Depression | Phase 2 | Recruiting | January 5, 2020 | - |
NCT03453060 | Thrombosis | Phase 1 | Active, not recruiting | November 2018 | United States, Arizona ... 展开 >> Celerion Tempe, Arizona, United States, 85283 收起 << |
NCT00453479 | - | Completed | - | - | |
NCT01802255 | Poisoning by Inhaled Anaesthet... 展开 >>ic Fluoride Poisoning Recovery From Sedation Renal Function Hepatic Function 收起 << | Phase 3 | Recruiting | June 2020 | Spain ... 展开 >> Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Contact: F Javier Belda, MD, PhD 收起 << |
NCT01925547 | Metabolic Syndrome, Protection... 展开 >> Against 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> Institute of Biological Chemistry and Nutrition, University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
NCT00471237 | Osteoporosis | Phase 2 | Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 << | - | - |
NCT03612856 | End Stage Renal Disease ... 展开 >> Thrombosis 收起 << | Phase 2 | Recruiting | May 2020 | United States, Florida ... 展开 >> Orlando Clinical Research Center Recruiting Orlando, Florida, United States, 32809 Contact: Charles Johnson 407-240-7876 收起 << |
NCT00718861 | Post-menopausal Osteoporosis | Phase 3 | Completed | - | - |
NCT00718861 | - | Completed | - | - | |
NCT00048581 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00696657 | - | Completed | - | - | |
NCT02712320 | Prostatic Neoplasms | Phase 3 | Completed | - | United States, Alabama ... 展开 >> Urology Centers of Alabama Homewood, Alabama, United States, 35209 United States, California Genesis Research, LLC San Diego, California, United States, 92123 United States, Idaho Idaho Urologic Institute - Meridian Meridian, Idaho, United States, 83642 United States, New Jersey AdvanceMed Research Lawrenceville, New Jersey, United States, 08648 United States, North Carolina Carolina Clinical Trials, LLC Concord, North Carolina, United States, 28025 United States, South Carolina Carolina Urologic Research Center Myrtle Beach, South Carolina, United States, 29572 United States, Washington Seattle Urology Research Center Burien, Washington, United States, 98166 收起 << |
NCT02712320 | - | Completed | - | - | |
NCT02000219 | Primary Hyperoxaluria | Phase 2 | Active, not recruiting | February 2020 | Germany ... 展开 >> Universitätsklinikum Bonn, Department of Paediatric Nephrology Bonn, Germany, DE-53113 收起 << |
NCT01047553 | - | Completed | - | - | |
NCT00471237 | - | Terminated(Terminated for futi... 展开 >>lity by sponsor after a pre-planned interim review of data) 收起 << | - | - | |
NCT01047553 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Akita-shi, Akita, Japan Research Site Chitose, Hokkaido, Japan Research Site Obihiro, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site AKO, Hyogo, Japan Research Site Kobe-shi, Hyogo, Japan Research Site Hitachi, Ibaraki, Japan Research Site Tsukuba, Ibaraki, Japan Research Site Kanazawa, Ishikawa, Japan Research Site Sakaide, Kagawa, Japan Research Site Fujisawa, Kanagawa, Japan Research Site Kawasaki-shi, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Koshi, Kumamoto, Japan Research Site Nagaoka, Niigata, Japan Research Site Saiki-shi, Oita, Japan Research Site Moriguchi, Osaka, Japan Research Site Matsue, Shimane, Japan Research Site Bunkyo, Tokyo, Japan Research Site Chuo, Tokyo, Japan Research Site Katsushika-ku, Tokyo, Japan Research Site Kodaira, Tokyo, Japan Research Site Setagaya, Tokyo, Japan Research Site Tosima-ku, Tokyo, Japan Research Site Fukuoka, Japan Research Site Kyoto, Japan 收起 << |
NCT01070784 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Nagoya, Aichi, Japan Research Site Toyota, Aichi, Japan Research Site Yanagawa, Fukuoka, Japan Research Site Asahikawa, Hokkaido, Japan Research Site Sapporo, Hokkaido, Japan Research Site Itami, Hyogo, Japan Research Site Hitachi, Ibaraki, Japan Research Site Tsukuba, Ibaraki, Japan Research Site Sakaide, Kagawa, Japan Research Site Fujisawa, Kanagawa, Japan Research Site Yokohama, Kanagawa, Japan Research Site Koshi, Kumamoto, Japan Research Site Shibata, Miyagi, Japan Research Site Chuo, Tokyo, Japan Research Site Setagaya, Tokyo, Japan Research Site Hiroshima, Japan Research Site Kyoto, Japan 收起 << |
NCT02455154 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 2 | Recruiting | September 2019 | China, Shanghai ... 展开 >> Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weiqi Gao, MD 0086-13641811209 gaoweiqi2733@163.com Contact: Xiaosong Chen, PHD 00862164370045 ext 602268 chenxiaosong0156@hotmail.com Principal Investigator: Kunwei Shen, MD 收起 << |
NCT03435276 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site Harrow, United Kingdom, HA1 3UJ 收起 << |
NCT01070784 | - | Completed | - | - | |
NCT01317797 | - | Completed | - | - | |
NCT03308916 | Liver Diseases, Alcoholic ... 展开 >> Fibrosis 收起 << | Not Applicable | Recruiting | October 30, 2032 | Denmark ... 展开 >> Department of Gastroenterology and Hepatology, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Maja Thiele, MD, PhD 65412752 ext 45 maja.thiele@rsyd.dk Principal Investigator: Maja Thiele, MD PhD Sub-Investigator: Aleksander Krag, MD PhD Professor 收起 << |
NCT01415895 | Back Pain Low... 展开 >>er Back Pain Cervical Pain 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> Annette C. Toledano MD North Miami, Florida, United States, 33181 收起 << |
NCT00048581 | - | Completed | - | - | |
NCT00703755 | Patients With Metabolic Syndro... 展开 >>me 收起 << | Phase 2 | Completed | - | - |
NCT03657030 | Healthy | Phase 1 | Recruiting | May 2019 | United States, Texas ... 展开 >> PPD Development, LP Recruiting Austin, Texas, United States, 78744 Contact: Antonia M Davidson, MD 512-447-2985 Contact: Kristi Wheeler 512-747-4764 Kristi.Wheeler@ppdi.com 收起 << |
NCT02339155 | Infections, Bacterial | Phase 4 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Edgewater, Florida, United States, 32132 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 United States, Tennessee GSK Investigational Site Knoxville, Tennessee, United States, 37920 收起 << |
NCT00869466 | - | Completed | - | United Kingdom ... 展开 >> Wellcome Trust Clinical Research Facility Manchester, England, United Kingdom, M13 9WL Christie Hospital Manchester, England, United Kingdom, M20 4BX Nightingale Centre and Genesis Prevention Centre at Wythenshawe Hospital Manchester, England, United Kingdom, M23 9LT South Manchester University Hospital Manchester, England, United Kingdom, M23 9LT Cancer Care Research Centre at University of Stirling Stirling, England, United Kingdom, FK9 4NF 收起 << | |
NCT01317797 | Rheumatoid Arthritis | Phase 1 | Completed | - | Bulgaria ... 展开 >> Nycomed Investigational Site Sofia, Bulgaria Netherlands Nycomed Investigational Site Leids, Netherlands 收起 << |
NCT02216123 | Malaria, Vivax | Phase 3 | Completed | - | Brazil ... 展开 >> GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 Colombia GSK Investigational Site Cali, Colombia GSK Investigational Site Monteria, Colombia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Mae Sot, Thailand, 63110 GSK Investigational Site Tak, Thailand, 63170 Vietnam GSK Investigational Site Ho Chi Minh, Vietnam 收起 << |
NCT00118937 | Diabetes Mellitus, Type 1 | Phase 4 | Completed | - | - |
NCT01568112 | Healthy | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Research Site St Paul, Minnesota, United States 收起 << |
NCT00403611 | Schistosomiasis Mansoni | Phase 4 | Completed | - | - |
NCT00113308 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT02216123 | - | Completed | - | - | |
NCT03045887 | Asthma | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 << |
NCT02339155 | - | Completed | - | - | |
NCT00562380 | Lymphoma Pros... 展开 >>tate Cancer Sarcoma Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 收起 << |
NCT01568112 | - | Completed | - | - | |
NCT03014674 | Asthma | Phase 3 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Germany GSK Investigational Site Berlin, Germany, 14050 United Kingdom GSK Investigational Site Harrow, Middlesex, United Kingdom, HA1 3UJ 收起 << |
NCT00320359 | Lung Cancer, Small Cell | Phase 3 | Completed | - | - |
NCT00814762 | AIDS | Phase 1 | Completed | - | Germany ... 展开 >> GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Muenchen, Bayern, Germany, 80335 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Berlin, Germany, 12157 GSK Investigational Site Hamburg, Germany, 20099 GSK Investigational Site Hamburg, Germany, 20246 收起 << |
NCT03014674 | - | Completed | - | - | |
NCT01263015 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Completed | - | - |
NCT00975884 | Influenza | Phase 3 | Completed | - | France ... 展开 >> GSK Investigational Site Clermont-Ferrand, France, 63003 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Paris Cedex 18, France, 75877 GSK Investigational Site Paris, France, 75679 GSK Investigational Site Poitiers, France, 86000 收起 << |
NCT01231516 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | June 30, 2019 | - |
NCT01263015 | - | Completed | - | - | |
NCT00410202 | Hepatitis B, Chronic | Phase 3 | Completed | - | - |
NCT00428090 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT00509028 | Asthma | Phase 3 | Completed | - | Japan ... 展开 >> Research Site Takizawa, Iwate, Japan 收起 << |
NCT00509028 | - | Completed | - | - | |
NCT02635386 | Polycystic Ovary Syndrome ... 展开 >> Obesity 收起 << | Phase 3 | Recruiting | August 2019 | United States, Louisiana ... 展开 >> Woman's Hospital Recruiting Baton Rouge, Louisiana, United States, 70815 Contact: Karen Elkind-Hirsch, PhD. 225-231-5278 Contact: Ericka Seidemann, MS 225-231-5275 ericka.seidemann@womans.org Principal Investigator: Karen Elkind-Hirsch, Ph.D. Sub-Investigator: Renee Harris, M.D. 收起 << |
NCT03486873 | Solid Tumors | Phase 3 | Recruiting | May 10, 2028 | - |
NCT01231516 | - | Active, not recruiting | - | - | |
NCT00326339 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00077623 | - | Completed | - | - | |
NCT00410202 | - | Completed | - | - | |
NCT00077623 | Anemia | Phase 3 | Completed | - | - |
NCT03315091 | Solid Tumours | Phase 1 | Completed | - | France ... 展开 >> Research Site Bordeaux Cedex, France, 33075 Research Site Saint Herblain, France, 44805 Netherlands Research Site Amsterdam, Netherlands, 1066 CX Research Site Amsterdam, Netherlands, 1081 HV Research Site Maastricht, Netherlands, 6229 HX United Kingdom Research Site Glasgow, United Kingdom, G12 0YN Research Site Manchester, United Kingdom, M20 4BX 收起 << |
NCT03682848 | HIV Infections | Phase 3 | Not yet recruiting | December 29, 2023 | - |
NCT02348814 | - | Recruiting | March 2018 | United States, California ... 展开 >> UCLA Clinical and Translational Research Center (CTRC) Recruiting Los Angeles, California, United States, 90095 Contact: Stephanie Okimoto, BA, CCRC 310-267-1040 sokimoto@mednet.ucla.edu 收起 << | |
NCT00428090 | - | Completed | - | - | |
NCT00798772 | HIV Infection | Not Applicable | Completed | - | Canada, Ontario ... 展开 >> The Ottawa Hospital, General Campus Ottawa, Ontario, Canada, K1H 8L6 收起 << |
NCT00817063 | Eczema | Phase 3 | Completed | - | - |
NCT01761201 | Latent Tuberculosis Infection ... 展开 >> Infection in Solid Organ Transplant Recipients 收起 << | Phase 3 | Terminated(Recruitment rythm n... 展开 >>ot sufficent to reach the simple size needed.) 收起 << | - | Spain ... 展开 >> Complejo Hospitalario de Albacete Albacete, Spain Hospital Infanta Cristina, Badajoz, Spain Hospital Clinic Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital de Cruces Bilbao, Spain Complejo Hospitalario Universitario Coruña, Spain Hospital Reina Sofía Córdoba, Spain Hospital universitario Virgen de las Nieves Granada, Spain Hospital 12 de Octubre Madrid, Spain Hospital Gregorio Marañón Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario Puerta de Hierro Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Universitario Carlos Haya Málaga, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Marqués de Valdecillas Santander, Spain Hospital Virgen del Rocío Seville, Spain Hospital Universitario La Fe Valencia, Spain 收起 << |
NCT01220843 | Chronic Renal Failure | Phase 3 | Completed | - | France ... 展开 >> CHU Amiens service de nephrologie Amiens, France, 8000 CHU de Bordeaux Service de néphrologie Bordeaux, France, 33076 CHU Caen service de néphrologie Caen, France, 14033 CHU Lyon service de néphrologie Lyon, France, 69437 CHU Marseille Service de néphrologie Marseille, France, 13385 CHU de Montpellier Hôpital Lapeyronie Service de Néphrologie Montpellier, France, 34295 CHU de Nice Service de néphrologie Nice, France, 06002 Hôpital Tenon Service de Nephrologie Paris, France, 75020 Hôpital Européen Georges Pompidou Service de Nephrologie Paris, France, 75098 CHU Reims service de néphrologie Reims, France, 51092 Clinique du Landy Centre de dialyse Saint Ouen, France, 93400 CHU St Etienne Hopital Nord Service de néphrologie St Etienne, France, 42055 Néphrologie - Dialyse Centre de Rein Artificiel TASSIN la Demi Lune, France, 69160 CH Valenciennes hémodialyse Valenciennes, France, 59322 CHU de Nancy service de néphrologie Vandeuvre les Nancy, France, 54511 收起 << |
NCT00817063 | - | Completed | - | - | |
NCT01362296 | - | Completed | - | - | |
NCT02796898 | Prostate Cancer ... 展开 >> Rising Prostate Specific Antigen (PSA) 收起 << | Phase 1 Phase 2 | Recruiting | December 31, 2019 | United States, New Jersey ... 展开 >> AdvanceMed Research Completed Lawrence, New Jersey, United States, 08648 United States, New York Montefiore Medical Center- Montefiore Medical Park Not yet recruiting Bronx, New York, United States, 10461 Contact: Gartrell Benjamin, MD 718-405-8404 bgartrel@montefiore.org Eastchester Center for Cancer Care Recruiting Bronx, New York, United States, 10469 Contact: Carmen Vicuna 718-732-4078 cvicuna@nycancer.com AccuMed Research Associates Recruiting Garden City, New York, United States, 11530-1664 Contact: Tammi Allegra, RN 516-746-2190 tallegra.accumedresearch@gmail.com United States, Pennsylvania MidLantic Urology Recruiting Bala-Cynwyd, Pennsylvania, United States, 19004 Contact: Cheryl A Zinar, RN, BSN 610-667-0458 Principal Investigator: Laurence H Belkoff, DO 收起 << |
NCT02145442 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 Phase 3 | Completed | - | Cuba ... 展开 >> National Institute of Endocrinology Plaza de la Revolución, Havana, Cuba, 10400 收起 << |
NCT01362296 | Lung Cancer, Non-Small Cell | Phase 2 | Completed | - | - |
NCT02331628 | TBI Traumatic Brain Injury | Not Applicable | Active, not recruiting | December 1, 2019 | Israel ... 展开 >> Loewenstein Rehabilitation Center Ra'anana, Israel 收起 << |
NCT02814656 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom 收起 << |
NCT00054418 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | - |
NCT00527735 | Lung Cancer S... 展开 >>mall Cell Lung Cancer Carcinoma, Non-Small-Cell Lung 收起 << | Phase 2 | Completed | - | - |
NCT01587924 | Anaemia | Phase 2 | Completed | - | - |
NCT01587924 | - | Completed | - | - | |
NCT00555321 | Immunosuppression in Solid Org... 展开 >>an Transplant 收起 << | Phase 2 | Terminated | - | - |
NCT00219791 | Neoplasms | Phase 2 | Completed | - | Germany ... 展开 >> Charite - Universitätsmedizin Berlin Berlin, Germany, 12200 收起 << |
NCT02338479 | - | Active, not recruiting | February 2020 | - | |
NCT03330847 | Metastatic Triple Negative Bre... 展开 >>ast Cancer 收起 << | Phase 2 | Recruiting | January 20, 2021 | - |
NCT00527735 | - | Completed | - | - | |
NCT03030196 | Infertility, Male | Phase 2 | Recruiting | January 2021 | Denmark ... 展开 >> Department of Growth and Reproduction, Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Li Juel Mortensen, MD +4535459456 收起 << |
NCT00583076 | Pouchitis | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Cleveland, Ohio, United States, 44195 收起 << |
NCT02795754 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT00534313 | Psoriatic Arthritis | Phase 2 | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - |
NCT02526160 | X-linked Hypophosphatemia | Phase 3 | Completed | - | - |
NCT00534313 | - | Terminated(Lack of efficacy wi... 展开 >>th respect to skin-related lesions in the short-term phase) 收起 << | - | - | |
NCT03183193 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase Obese Overweight 收起 << | Not Applicable | Recruiting | December 2019 | Spain ... 展开 >> Centre for Nutrition Research, University of Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: M. Angeles Zulet, PhD +34948425600 ext 806317 mazulet@unav.es Contact: Itziar Abete, PhD +34948425600 ext 806357 iabetego@unav.es 收起 << |
NCT02204371 | Telangiectasia, Hereditary Hem... 展开 >>orrhagic 收起 << | Phase 2 | Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095 United States, Georgia GSK Investigational Site Augusta, Georgia, United States, 30912-3135 United States, Missouri GSK Investigational Site Saint Louis, Missouri, United States, 63110 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5B 1W8 收起 << |
NCT00555321 | - | Terminated | - | - | |
NCT02713945 | Noonan Syndrome | Phase 3 | Recruiting | October 2021 | France ... 展开 >> CHU Angers Unité d'endocrinologie pédiatrique Recruiting Angers, France Contact: Régis COUTANT, MD CHU Bordeaux Unité de Génétique pédiatrique Recruiting Bordeaux, France Contact: Didier LACOMBE, MD Chu Dijon Recruiting Dijon, France Contact: Sébastien MOUTTON CHRU Lille Unité d'endocrinologie pédiatrique Recruiting Lille, France Contact: Jacques WEILL, MD CHU Lyon Unité d'endocrinologie pédiatrique Recruiting Lyon, France Contact: Marc NICOLINO, MD CHU Marseille La Timone Unité d'Endocrinologie pédiatrique Recruiting Marseille, France Contact: Rachel REYNAUD, MD Chu Montpellier Recruiting Montpellier, France Contact: David GENEVIEVE CHU Nancy Unité de Génétique pédiatrique Recruiting Nancy, France Contact: Bruno LEHEUP, MD Hôpital Robert Debré Unité de Génétique pédiatrique Recruiting Paris, France Contact: Hélène CAVE, MD Hôpital Trousseau Unité d'endocrinologie pédiatrique Recruiting Paris, France Contact: Irène NETCHINE, MD CHU Rennes Unité de Génétique pédiatrique Recruiting Rennes, France Contact: Sylvie ODENT, MD CHU Toulouse Hôpital des Enfants Recruiting Toulouse, France Contact: Thomas EDOUARD, MD edouard.t@chu-toulouse.fr 收起 << |
NCT01396187 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Pfizer Investigational Site Chula Vista, California, United States, 91911 United States, Florida Pfizer Investigational Site Miami, Florida, United States, 33169 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 收起 << |
NCT02204371 | - | Terminated(The study was termi... 展开 >>nated as the asset was sold to another company who decided not to pursue this indication with this drug.) 收起 << | - | - | |
NCT02478151 | End-stage Liver Disease | Phase 1 | Enrolling by invitation | April 2020 | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 收起 << |
NCT03455075 | Healthy Men ... 展开 >> Male Contraception 收起 << | Phase 2 | Recruiting | June 2020 | United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu 收起 << |
NCT01396187 | - | Completed | - | - | |
NCT03633227 | Liver Cirrhosis, Biliary | Phase 4 | Recruiting | June 1, 2020 | United States, California ... 展开 >> Inland Empire Liver Foundation Recruiting Rialto, California, United States, 92377 Contact: Darlene Romo 909-883-2999 dromo@ieliverfoundation.com Contact: Nazly Amaya 909-883-2999 namaya@ieliverfoundation.com Principal Investigator: Zeid Kayali, MD United States, Texas American Research Corporation at Texas Liver Institute Recruiting San Antonio, Texas, United States, 78215 Contact: Nicole Forsyth 210-253-3426 nforsyth@txliver.com Contact: Elisha Moreno 210-253-3426 emoreno@txliver.com Principal Investigator: Eric Lawitz, MD 收起 << |
NCT02640495 | - | Withdrawn(Due to the relative ... 展开 >>low incidence of severe malaria in Southeast Asia.) 收起 << | - | - | |
NCT00644319 | Metastatic Cancer | Phase 2 | Unknown | - | United Kingdom ... 展开 >> Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Contact Person 44-1865-225-205 robert.davies@ndm.ox.ac.uk 收起 << |
NCT00444587 | Breast Cancer | Phase 2 | Completed | - | Bulgaria ... 展开 >> Sofia, Bulgaria, 1527 Estonia Tallinn, Estonia, 13419 Hungary Budapest, Hungary, 1082 Budapest, Hungary, 1115 Budapest, Hungary, 1122 Budapest, Hungary, 1125 Budapest, Hungary, 1135 Budapest, Hungary, 1145 Debrecen, Hungary, 4032 Gyor, Hungary, 9023 Gyula, Hungary, 5700 Nyíregyháza, Hungary, 4400 Szeged, Hungary, 6725 Szekesfehervar, Hungary, 8000 Szombathely, Hungary, 9700 Israel Haifa, Israel, 31096 Holon, Israel, 58100 Petach Tikva, Israel, 49100 Ramat Gan, Israel, 52621 Rehovot, Israel, 76100 Safed, Israel, 13110 Tel Aviv, Israel, 6423906 Zerifin, Israel, 70300 Lithuania Kaunas, Lithuania, 50009 Vilnius, Lithuania, 08660 Macedonia, The Former Yugoslav Republic of Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Slovakia Bratislava, Slovakia, 812 50 Kosice, Slovakia, 041 90 Turkey Adana, Turkey, 01330 Ankara, Turkey, 06590 收起 << |
NCT02416271 | Osteoporosis | Phase 4 | Completed | - | - |
NCT00683904 | Non-small Cell Lung Cancer (NS... 展开 >>CLC) 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> Local Institution Chuo-Ku, Tokyo, Japan, 104-0045 收起 << |
NCT00683904 | - | Completed | - | - | |
NCT02219763 | - | Unknown | February 2015 | United States, Massachusetts ... 展开 >> MGH Weight Center, Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Principal Investigator: Sonja S Goedkoop, MSPH, RD 收起 << | |
NCT02184364 | Menopause | Phase 3 | Completed | - | - |
NCT03136380 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 162-0053 收起 << |
NCT02590887 | Healthy Volunteers | Phase 1 Phase 2 | Unknown | - | Spain ... 展开 >> Hospital Universitario Virgen del Rocío Seville, Spain, 41013 收起 << |
NCT02637921 | Hypoxia Bone ... 展开 >>Resorption 收起 << | Not Applicable | Completed | - | - |
NCT00348140 | - | Completed | - | - | |
NCT00723957 | Advanced/Metastatic Non-Small ... 展开 >>Cell Lung Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00122356 | Breast Cancer | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Sydney South West Area Health Service Sydney, New South Wales, Australia, 2050 Tweed Hospital Tweed Heads, New South Wales, Australia, 2485 Australia, Victoria Box Hill Hospital Box Hill, Victoria, Australia, 3128 Maroondah Breast Clinic East Ringwood, Victoria, Australia, 3135 St Vincent's Health Fitzroy, Victoria, Australia, 3065 Barwon Health Geelong, Victoria, Australia, 3220 St John of God Healthcare Geelong, Victoria, Australia, 3220 South West Healthcare Warrnambool, Victoria, Australia, 3280 收起 << |
NCT00272779 | HIV Infections | Phase 3 | Completed | - | - |
NCT00348140 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT00856947 | Asthma | Phase 2 Phase 3 | Active, not recruiting | April 2019 | Denmark ... 展开 >> Copenhagen University Hospital of Copenhagen Gentofte, Denmark, 2820 Næstved Hospital, Pediatric Department Næstved, Denmark, 4700 收起 << |
NCT00272779 | - | Completed | - | - | |
NCT01170065 | Pulmonary Fibrosis | Phase 2 | Completed | - | - |
NCT00994344 | HIV Infections | Phase 4 | Completed | - | Spain ... 展开 >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital Universitario de Canarias Santa Cruz de Tenerife, Canarias, Spain, 38320 收起 << |
NCT02723955 | Cancer | Phase 1 | Recruiting | May 18, 2020 | United States, California ... 展开 >> GSK Investigational Site Recruiting Duarte, California, United States, 91010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10016 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting New York, New York, United States, 10032 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Pennsylvania GSK Investigational Site Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Tennessee GSK Investigational Site Recruiting Nashville, Tennessee, United States, 37203 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Nashville, Tennessee, United States, 37232-6307 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Victoria GSK Investigational Site Recruiting Heidelberg, Victoria, Australia, 3084 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Melbourne, Victoria, Australia, 3000 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Australia, Western Australia GSK Investigational Site Recruiting Nedlands, Western Australia, Australia, 6009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Canada, Ontario GSK Investigational Site Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com France GSK Investigational Site Not yet recruiting Bordeaux Cedex, France, 33076 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Lyon cedex 08, France, 69373 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Paris, France, 75005 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Villejuif cedex, France, 94805 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Italy GSK Investigational Site Recruiting Siena, Toscana, Italy, 53100 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Barcelona, Spain, 08036 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Madrid, Spain, 28040 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Málaga, Spain, 29010 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Sevilla, Spain, 41009 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03593785 | Hypercholesterolemia | Phase 1 | Recruiting | July 23, 2019 | United States, California ... 展开 >> Research Site Recruiting Glendale, California, United States, 91206 收起 << |
NCT00663208 | Chronic Hepatitis C | Phase 2 | Completed | - | United States, California ... 展开 >> Advanced Clinical Res Inst Anaheim, California, United States, 92801 West Coast Clinical Trials, Llc Cypress, California, United States, 90630 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06510 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 Orlando Clinical Research Center Orlando, Florida, United States, 32809 United States, Maryland Parexel International Corporation Baltimore, Maryland, United States, 21225 United States, Texas Alamo Medical Research San Antonio, Texas, United States, 78215 Puerto Rico Local Institution Santurce, Puerto Rico, 00909 收起 << |
NCT00723957 | - | Completed | - | - | |
NCT03774771 | Primary Hyperparathyroidism | Phase 2 | Completed | - | - |
NCT00663208 | - | Completed | - | - | |
NCT03296098 | Contraception ... 展开 >> Healthy Female 收起 << | Phase 2 | Not yet recruiting | December 2020 | United States, California ... 展开 >> Essential Access Not yet recruiting Los Angeles, California, United States, 90010 Contact: Anita L. Nelson, MD 213-386-5614 ext 4403 nelsona@cfhc.org Contact: Kieumai Vo 213-386-5614 ext 4592 kvo@essentialaccess.org Principal Investigator: Anita L. Nelson, MD Principal Investigator: Ron Freizeres University of California, Davis Not yet recruiting Sacramento, California, United States, 95817 Contact: Mitchell D Creinin, MD 916-734-6886 Contact: Courtney Overstreet 916-734-6227 cboverstreet@ucdavis.edu University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94110 Contact: Abby Sokoloff, MPH 415-206-8715 abby.sokoloff@ucsf.edu Principal Investigator: Phillip Darney, MD United States, Colorado University of Colorado Not yet recruiting Denver, Colorado, United States, 80045 Contact: Ines Crato 303-724-5559 ines.crato@ucdenver.edu Principal Investigator: Stephanie Teal, MD United States, Hawaii University of Hawaii Not yet recruiting Honolulu, Hawaii, United States, 96826 Contact: Bliss Kaneshiro Contact: Tiana Fontanilla, MPH 808-203-6598 United States, Illinois University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Sadia Haider Contact: Kate Lewis 773-834-5437 klewis2@uchicago.edu United States, Maryland Johns Hopkins Bayview Medical Center Not yet recruiting Baltimore, Maryland, United States, 21224 Contact: Anne E. Burke, MD, MPH 410-550-0335 aburke@jhmi.edu Contact: Katrina Thaler, MPH 410-550-8506 kstouff3@jhmi.edu Principal Investigator: Anne E. Burke, MD, MPH United States, Massachusetts Planned Parenthood League of Massachusetts Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Fortin jfortin@pplm.org Principal Investigator: Alisa Goldberg, MD United States, New York New York University, School of Medicine Not yet recruiting New York, New York, United States, 10016 Contact: Treasure Walker Contact: Anna Davis 212-263-6253 anna.davis@nyumc.org Columbia University Not yet recruiting New York, New York, United States, 10032 Contact: Carolyn Westhoff, MD 212-305-4805 clw3@columbia.edu Contact: Claudia Roca 212-342-2986 cr479@mail.cumc.columbia.edu Principal Investigator: Carolyn Westhoff, MD United States, Ohio University of Cincinnati Not yet recruiting Cincinnati, Ohio, United States, 45267 Contact: Michael Thomas, MD 513-584-4130 Contact: Tiffany Rupert 513-584-4130 rupertts@ucmail.uc.edu University Hospitals of Cleveland MacDonald Women's Hospital Not yet recruiting Cleveland, Ohio, United States, 44106 Contact: James H. Liu, MD 440-720-3250 james.liu@uhhs.com Contact: Bridget Ermlich 216-844-8091 bridget.ermlich@uhhospitals.org Principal Investigator: James H. Liu, MD United States, Oregon Oregon Health & Science University Not yet recruiting Portland, Oregon, United States, 97239 Contact: Jeffrey Jensen Contact: Sumi Maristany 503-494-0585 maristan@ohsu.edu United States, Pennsylvania University of Pennsylvania Medical Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Kurt T. Barnhart, MD 215-662-2974 kbarnhart@obgyn.upenn.edu Contact: Andrea Morley 215-615-4202 andrea.morley@uphs.upenn.edu Principal Investigator: Kurt T. Barnhart, MD Univeristy of Pittsburgh School of Medicine Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Beatrice Chen, MD 412-641-5496 chenba@upmc.edu Contact: Jenelle Mock 412-641-4791 mockj@upmc.edu Principal Investigator: Beatrice Chen, MD United States, Rhode Island Women & Infants Hospital of Rhode Island Not yet recruiting Providence, Rhode Island, United States, 02905 Contact: Rebecca Allen Contact: Mindy Marshall mamarshall@wihri.org United States, Utah University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84106 Contact: David Turok, MD 801-213-2774 Contact: Amy Orr 801-213-2774 amy.orr@hsc.utah.edu United States, Virginia Eastern Virginia Medical School (EVMS) Not yet recruiting Norfolk, Virginia, United States, 23507 Contact: David E Archer, MD 757-446-7422 Contact: Erin Maple, MPH 757-446-7971 mapleel@evms.edu 收起 << |
NCT02584283 | Liver Failure ... 展开 >> End Stage Liver Disease Biliary Tract Diseases 收起 << | Phase 3 | Recruiting | October 2019 | Belgium ... 展开 >> Ghent University Hospital Not yet recruiting Gent, De Pintelaan 185, Belgium, 9000 Contact: Roberto I Troisi, MD, PhD +3293325519 roberto.troisi@ugent.be University Hospitals Leuven Recruiting Leuven, Herestraat 49, Belgium, 3000 Contact: Diethard Monbaliu, MD, PhD +3216348727 diethard.monbaliu@uzleuven.be Netherlands Leiden Universtiy Medical Center Not yet recruiting Leiden, Zuid-Holland, Netherlands, 2333 ZA Contact: Bart van Hoek, MD, PhD +31715299756 b.van_hoek@lumc.nl University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Rianne van Rijn, MD +31652724616 r.van.rijn@umcg.nl Contact: Robert J Porte, MD, PhD +31503619027 r.j.porte@umcg.nl Erasmus Medical Center Recruiting Rotterdam, Netherlands, 3015 CE Contact: Jeroen de Jonge, MD, PhD +31633330449 j.dejonge.1@umcg.nl 收起 << |
NCT00816400 | Cancer | Phase 1 | Completed | - | United States, Colorado ... 展开 >> Research Site Denver, Colorado, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Nevada Research Site Las Vegas, Nevada, United States United States, Texas Research Site Dallas, Texas, United States United States, Virginia Research Site Norfolk, Virginia, United States 收起 << |
NCT01116947 | End-Stage Renal Disease | Not Applicable | Completed | - | - |
NCT00442572 | Hepatitis B, Chronic | Phase 2 | Completed | - | Bulgaria ... 展开 >> Mhat St. Ivan Rilski; Clinic of Gastroenterology Sofia, Bulgaria, 1612 收起 << |
NCT03469518 | Hypercholesterolemia ... 展开 >> Osteoporosis Postmenopausal Disorder 收起 << | Not Applicable | Active, not recruiting | December 2018 | - |
NCT00444587 | - | Completed | - | - | |
NCT02854631 | Alcoholic Hepatitis (AH) | Phase 2 | Completed | - | - |
NCT00816400 | - | Completed | - | - | |
NCT02422108 | Testis Infert... 展开 >>ility Sperm 收起 << | Phase 2 | Active, not recruiting | June 2018 | Denmark ... 展开 >> Rigshospitalet Copenhagen, Denmark, 2100 收起 << |
NCT03201302 | Bone Mineral Content ... 展开 >> Bone Density Bone Turnover Markers Athletic Performance 收起 << | Not Applicable | Active, not recruiting | December 2017 | Greece ... 展开 >> Laboratory of Physical Education and Sports, Democritus University of Thrace, School of Physical Education & Sports Sciences Komotini, Greece, 69100 收起 << |
NCT02980666 | Short Bowel Syndrome | Phase 3 | Recruiting | April 12, 2019 | Japan ... 展开 >> Kyushu University Hospital Recruiting Fukuoka-shi, Fukuoka-ken, Japan, 812-8582 Contact: Toshiharu Matsuura +819264111151 matsuura@pedsurg.med.kyushu-u.ac.jp Principal Investigator: Toshiharu Matsuura, MD Tsukuba University Hospital Recruiting Tsukuba, Ibaraki-Ken, Japan, 305-8576 Contact: Kouji Masumoto +181298533900 kmasu@md.tsukuba.ac.jp Principal Investigator: Kouji Masumoto, MD Kagoshima University Recruiting Kagoshima-shi, Kagoshima-Ken, Japan, 890-8520 Contact: Tatsuru Kaji +81992755111 tatu@m2.kufm.kagoshima-u.ac.jp Principal Investigator: Tatsuru Kaji, MD Tohoku University Hospital Recruiting Sendai-shi, Miyagi-Ken, Japan, 980-8574 Contact: Motoshi Wada +81227177000 Principal Investigator: Motoshi Wada, MD Showa University Recruiting Shinagawa-ku, Tokyo-To, Japan, 142-8555 Contact: Masahiro Chiba +81337848000 Principal Investigator: Masahiro Chiba, MD 收起 << |
NCT03113994 | Spinal Cord Injuries ... 展开 >> Osteoporosis Metabolic Syndrome 收起 << | Phase 2 | Recruiting | December 2020 | United States, Florida ... 展开 >> University Of Miami Miller School of Medicine Not yet recruiting Miami, Florida, United States, 33136 Contact: Luisa Betancourt, MD, MS 305-243-6320 lbetancourt@med.miami.edu Principal Investigator: Mark S Nash, Ph.D., FACSM Canada, Ontario University Health Network - Toronto Rehab Lyndhurst Centre Recruiting Toronto, Ontario, Canada, M4G 3V9 Contact: Masae Miyatani, PhD 416-597-3422 ext 6304 masae.miyatani@uhn.ca Contact: Lindsie Blencowe, MSc 416-597-3422 ext 6301 lindsie.blencowe@uhn.ca Principal Investigator: Cathy Craven, BA, MD, MSc, FRCPC, CCD 收起 << |
NCT00442572 | - | Completed | - | - | |
NCT03452111 | Healthy Men ... 展开 >> Male Contraception 收起 << | Phase 2 | Recruiting | September 2021 | United States, California ... 展开 >> Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Recruiting Torrance, California, United States, 90509 Contact: Xiaodan Han 310-222-1865 xhan@labiomed.org Principal Investigator: Christina Wang United States, Kansas University of Kansas Recruiting Kansas City, Kansas, United States, 66160 Contact: Katie Glavin 913-588-8721 kglavin@kumc.edu Principal Investigator: Ajay Nangia, MBBS, FACS United States, Washington University of Washington Medical Center & Health Sciences Recruiting Seattle, Washington, United States, 98195 Contact: Stephanie Page, MD, PhD 206-616-1818 page@uw.edu Chile Chilean Institute of Reproductive Medicine Not yet recruiting Santiago, Chile Contact: Veronica Reyes vreyes@icmer.org Principal Investigator: Gabriela Noe, MS Italy University of Bologna Not yet recruiting Bologna, Italy Contact: Giulia Gava gava.giulia@hotmail.it Principal Investigator: Cristina Meriggiola Kenya Kenyatta National Hospital Not yet recruiting Nairobi, Kenya Contact: Sheila Eshiwani seshiwanin@gmail.com Principal Investigator: John Kinuthia, MBChB, MPH Sweden Karolinska Institutet Not yet recruiting Stockholm, Sweden Contact: Eva Broberg 46(8)517 721 28 eva.k.broberg@karolinska.se Principal Investigator: Kristina Gemzell Danielsson, MD United Kingdom University of Edinburgh Not yet recruiting Edinburgh, United Kingdom Contact: Anne Saunderson 0131 242 2669 A.Saunderson@ed.ac.uk Principal Investigator: Richard Anderson, MD, PhD University of Manchester Not yet recruiting Manchester, United Kingdom Contact: Kate Barugh 0161 27 66201 Kate.Barugh@cmft.nhs.uk Principal Investigator: Cheryl Fitzgerald, MD 收起 << |
NCT02925702 | - | Recruiting | December 2019 | - | |
NCT00855465 | Pulmonary Hypertension | Phase 3 | Completed | - | - |
NCT00985088 | Influenza | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Huntsville, Alabama, United States, 35802 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32216 GSK Investigational Site Miami, Florida, United States, 33143 United States, Idaho GSK Investigational Site Meridian, Idaho, United States, 83642 United States, Kansas GSK Investigational Site Lenexa, Kansas, United States, 66219 United States, Montana GSK Investigational Site Missoula, Montana, United States, 59801 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89104 United States, New Jersey GSK Investigational Site Edison, New Jersey, United States, 08817 United States, New York GSK Investigational Site Rochester, New York, United States, 14609 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44122 Canada, British Columbia GSK Investigational Site Surrey, British Columbia, Canada, V3R 8P8 Canada, Nova Scotia GSK Investigational Site Truro, Nova Scotia, Canada, B2N 1L2 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M9W 4L6 Canada, Quebec GSK Investigational Site Pointe-Claire, Quebec, Canada, H9R 4S3 收起 << |
NCT00855465 | - | Completed | - | - | |
NCT02294734 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Edegem, Belgium, 2650 GSK Investigational Site Erpent, Belgium, 5101 Denmark GSK Investigational Site Aalborg, Denmark, DK-9100 GSK Investigational Site Hellerup, Denmark, 2900 GSK Investigational Site Hvidovre, Denmark, 2650 GSK Investigational Site Kobenhavn, Denmark, DK-2400 GSK Investigational Site Odense, Denmark, 5000 Odense C Netherlands GSK Investigational Site Almelo, Netherlands, 7609 PP GSK Investigational Site Eindhoven, Netherlands, 5623 EJ GSK Investigational Site Zutphen, Netherlands, 7207 AE Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Timisoara, Romania, 300310 Russian Federation GSK Investigational Site Ekaterinburg, Russian Federation, 620109 GSK Investigational Site Kemerovo, Russian Federation, 650002 GSK Investigational Site Moscow, Russian Federation, 105 077 GSK Investigational Site Saint Petersburg, Russian Federation, 194291 GSK Investigational Site Vladimir, Russian Federation, 600023 GSK Investigational Site Yaroslavl, Russian Federation, 150003 收起 << |
NCT01637155 | Obesity Gastr... 展开 >>ic Bypass Gastrectomy 收起 << | Phase 2 | Unknown | - | Spain ... 展开 >> Hospital Clinic i Provincial Barcelona Not yet recruiting Barcelona, Spain, 08036 Contact: Violeta Moize, MD +34 93 227 54 00 vmoize@clinic.ub.es Principal Investigator: Violeta Moize, MD 收起 << |
NCT03274648 | BehçEt Disease | Not Applicable | Not yet recruiting | January 2018 | - |
NCT02903966 | Colitis, Ulcerative | Phase 2 | Recruiting | May 7, 2019 | United States, California ... 展开 >> GSK Investigational Site Recruiting Moreno Valley, California, United States, 92555 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Terminated Oceanside, California, United States, 92056 GSK Investigational Site Recruiting San Diego, California, United States, 92115 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Louisiana GSK Investigational Site Not yet recruiting Marrero, Louisiana, United States, 70072 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Michigan GSK Investigational Site Recruiting Chesterfield, Michigan, United States, 48047 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, New York GSK Investigational Site Recruiting Great Neck, New York, United States, 11021 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Washington GSK Investigational Site Not yet recruiting Seattle, Washington, United States, 98195 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Recruiting Ulm, Baden-Wuerttemberg, Germany, 89081 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Frankfurt, Hessen, Germany, 60431 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Kiel, Schleswig-Holstein, Germany, 24105 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Recruiting Amsterdam, Netherlands, 1105 AZ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Poland GSK Investigational Site Recruiting Katowice, Poland, 40-660 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ksawerow, Poland, 95-054 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Wroclaw, Poland Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Russian Federation GSK Investigational Site Recruiting Rostov-on-Don, Russian Federation, 344091 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting St Pertersburg, Russian Federation, 196247 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Stavropol, Russian Federation, 355018 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Ufa, Russian Federation, 450071 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Sweden GSK Investigational Site Recruiting Stockholm, Sweden, SE-171 76 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Stockholm, Sweden, SE-182 88 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Uppsala, Sweden, SE-752 37 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United Kingdom GSK Investigational Site Recruiting Stockport, Cheshire, United Kingdom, SK2 7JE Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Belfast, United Kingdom, BT16 1RH Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Dudley, United Kingdom, DY1 2HQ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Edgbaston, Birmingham, United Kingdom, B15 2GW Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00747123 | Multiple Myeloma | Phase 2 | Completed | - | Russian Federation ... 展开 >> Investigative Site Moscow, Russian Federation Investigative Site Saint-Petersburg, Russian Federation 收起 << |
NCT01218477 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University Of California Medical Center San Francisco, California, United States, 94143 United States, Maryland Sidney Kimmel Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Texas Ut M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8N 3Z5 Local Institution Toronto, Ontario, Canada, M5G 2M9 Finland Local Institution Helsinki, Finland, 00290 France Local Institution Bordeaux, France, 33076 Local Institution Poitiers Cedex, France, 86021 Germany Local Institution Frankfurt/main, Germany, 60590 Italy Local Institution Bologna, Italy, 40138 Local Institution Orbassano(To), Italy, 10043 United Kingdom Local Institution Glasgow, United Kingdom, G12 0YN 收起 << |
NCT01218477 | - | Completed | - | - | |
NCT01791205 | - | Completed | - | Italy ... 展开 >> Reggio Calabria, Calabria, Italy, 89133 Napoli, Campania, Italy, 80131 Telese Terme, Campania, Italy, 82037 Bologna, Emilia-Romagna, Italy, 40138 Roma, Lazio, Italy, 00133 Roma, Lazio, Italy, 00152 Roma, Lazio, Italy, 00161 Roma, Lazio, Italy, 00189 Legnano, Lombardia, Italy, 20025 Milano, Lombardia, Italy, 20157 Milano, Lombardia, Italy, 20162 Monza, Lombardia, Italy, 20052 Pavia, Lombardia, Italy, 27100 Ancona, Marche, Italy, 60020 Jesi, Marche, Italy, 60035 Torino, Piemonte, Italy, 10126 Torino, Piemonte, Italy, 10128 Bari, Puglia, Italy, 70124 Martina Franca, Puglia, Italy, 74015 Sassari, Sardegna, Italy, 07100 Firenze, Toscana, Italy, 50139 Pisa, Toscana, Italy, 56100 Prato, Toscana, Italy, 59100 Siena, Toscana, Italy, 53100 Perugia, Umbria, Italy, 06122 Cona (Ferrara), Veneto, Italy, 44124 Padova, Veneto, Italy, 35128 Verona, Veneto, Italy, 37126 收起 << | |
NCT00855660 | Pharmacology, Clinical | Phase 1 | Completed | - | Germany ... 展开 >> Köln, Nordrhein-Westfalen, Germany, 51147 收起 << |
NCT02133404 | Secondary Hyperparathyroidism | Phase 2 | Completed | - | Japan ... 展开 >> Chubu, Japan Chugoku, Japan Kanto, Japan Kyushu, Japan Shikoku, Japan Tohoku, Japan 收起 << |
NCT00985088 | - | Completed | - | - | |
NCT01791205 | - | Completed | - | - | |
NCT01687374 | Shoulder Fractures | Phase 4 | Unknown | December 2013 | Denmark ... 展开 >> Hvidovre Hospital Recruiting Hvidovre, Denmark, 2650 Contact: Lars Hyld, DMSc hyld@dadlnet.dk Contact: Ulrich C Bang, M.D. ulrichbangbang@gmail.com Principal Investigator: Ulrich C Bang, M.D. Sub-Investigator: Aage Vestergaard, M.D. 收起 << |
NCT02294734 | - | Completed | - | - | |
NCT00474045 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT00737464 | Anemia | Phase 4 | Completed | - | India ... 展开 >> Indraprastha Apollo Hospitals New Delhi, Delhi, India, 110076 Manipal Institute of Nephrology and Urology; Nephrology Bangalore, India, 560017 Columbia Asia Medical Centre - Hebbal; Nephrology Bangalore, India, 560024 Tanker Foundation Chennai, India, 600 037 MIOT Institute of Nephrology ; Nephrology Chennai, India, 6000089 Madras Medical Mission Hospital Chennai, India, 600037 International Hospital Guwahati, India, 781005 Kamineni Hospitals; Nephrology Hyderabad, India, 500068 Nizam's Institute of Medical Sciences; Nephrology Hyderabad, India, 500082 Regency Hospital Ltd.; Nephrology Kanpur, India, 208005 Wockhardt Hospital and Kidney Institute; Nephrology Kolkata, India, 700029 Meerut Kidney Hospital Meerut, India, 250001 Silver Oaks Hospital; Nephrology Mohali, India, 160 063 Apex Kidney Care Mumbai, India, 400080 Lancelot Dialysis Center Mumbai, India, 400092 Fortis Flt. Lt. Rajan Dhall Hospital; Nephrology New Delhi, India, 110070 Ruby Hall Clinic Pune, India, 411 001 收起 << |
NCT00737464 | - | Completed | - | - | |
NCT01934790 | Prostatic Neoplasms | Phase 1 Phase 2 | Completed | - | United States, Louisiana ... 展开 >> New Orleans, Louisiana, United States, 70112 United States, Nebraska Omaha, Nebraska, United States, 68130 United States, New York Syracuse, New York, United States, 13210 Finland Kuopio, Finland, 70210 Israel Haifa, Israel, 3109601 Jerusalem, Israel, 9112001 Kfar Saba, Israel, 4428164 Petah Tikva, Israel, 4941492 Italy Forlì-Cesena, Emilia-Romagna, Italy, 47014 Milano, Lombardia, Italy, 20133 Norway Bergen, Norway, 5021 Lørenskog, Norway, 1478 Spain Córdoba, Andalucía, Spain, 14004 Barcelona, Spain, 08025 Málaga, Spain, 29010 Sweden Umeå, Sweden, 901 85 收起 << |
NCT01812551 | Osteoporosis ... 展开 >>Cystic Fibrosis 收起 << | Phase 3 | Completed | - | Holy See (Vatican City State) ... 展开 >> CRR Fibrosi Cistica, Divisione Gastroenterologia, Ospedale Bambin Gesù Città del Vaticano, Holy See (Vatican City State) Italy CRR Fibrosi Cistica, Unità Operativa di Pediatria, Ospedale Misericordia Grosseto, Italy CRR Fibrosi Cistica, Clinica Pediatrica, Policlinico Universitario di Messina Messina, Italy Istituto Auxologico Italiano IRCCS Milano, Italy, 20145 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano Milano, Italy CRR Fibrosi Cistica, Dipartimento Pediatria, Università Federico II Napoli, Italy CRR Fibrosi Cistica Adulti, Azienda Ospedaliera Universitaria San Luigi Gonzaga Orbassano, Italy CRR Fibrosi Cistica, Ospedale dei Bambini, ARNAS Civico Palermo, Italy CRR Fibrosi Cistica, Dipartimento di Pediatria, Policlinico Umberto I Roma, Italy CRR Fibrosi Cistica, Divisione di Pediatria, Istituto Burlo Garofolo Trieste, Italy CRR Fibrosi Cistica, Azienda Ospedalierouniversitaria di Verona Verona, Italy 收起 << |
NCT00474045 | - | Completed | - | - | |
NCT00493506 | HIV Infections ... 展开 >> Hepatitis B Dyslipidemia 收起 << | Not Applicable | Completed | - | Cameroon ... 展开 >> Laboratory of Nutrition and Nutritional Biochemistry (LNNB), Department of Biochemistry, University of Yaounde I Yaounde, Cameroon 收起 << |
NCT01934790 | - | Completed | - | - | |
NCT03361735 | Prostate Adenocarcinoma | Phase 2 | Recruiting | December 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Savita Dandapani, MD 626-256-4673 Principal Investigator: Savita Dandapani, MD 收起 << |
NCT02301520 | - | Completed | - | Haiti ... 展开 >> Kay Mackenson Clinic Pierre Payen, Haiti FHADIMAC Port-Au-Prince, Haiti 收起 << | |
NCT01777256 | Systemic Lupus Erythematosus | Phase 2 | Terminated(This study met a pr... 展开 >>otocol defined futility criterion and will be terminated following completion of the Follow Up Visit on the last subject randomised.) 收起 << | - | - |
NCT00475865 | - | Completed | - | - | |
NCT03416062 | Jaundice; Malignant | Phase 3 | Active, not recruiting | September 2019 | Russian Federation ... 展开 >> Irkutsk Regional Clinical Hospital Irkutsk, Russian Federation, 664079 North-West State Medical University named after I.I. Mechnikov Saint Petersburg, Russian Federation, 191015 收起 << |
NCT03317392 | Castration Levels of Testoster... 展开 >>one Castration-Resistant Prostate Carcinoma Metastatic Malignant Neoplasm in the Bone Prostate Adenocarcinoma PSA Progression 收起 << | Phase 1 Phase 2 | Not yet recruiting | April 30, 2020 | - |
NCT00811395 | Multiple Sclerosis | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Austria Sanofi-Aventis Administrative Office Wien, Austria Canada Sanofi-Aventis Administrative Office Laval, Canada Germany Sanofi-Aventis Administrative Office Berlin, Germany Italy Sanofi-Aventis Administrative Office Milano, Italy Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom 收起 << |
NCT01286077 | - | Completed | - | - | |
NCT02718885 | Bone Diseases, Endocrine ... 展开 >> Nutritional and Metabolic Diseases 收起 << | Early Phase 1 | Completed | - | United States, Illinois ... 展开 >> University of Illinois at Urbana-Champaign Urbana, Illinois, United States, 61801 收起 << |
NCT00811395 | - | Completed | - | - | |
NCT01286077 | Multiple Myeloma | Phase 2 | Completed | - | Austria ... 展开 >> Feldkirch N/A, Austria Graz, Austria Wien, Austria Czech Republic Brno, Czech Republic Denmark Vejle, Denmark Germany Hamburg, Germany Kiel, Germany Mÿnchen, Germany Greece Athens, Greece Sweden Huddinge, Sweden Stockholm, Sweden Turkey Adana, Turkey Ankara, Turkey Antalya, Turkey Eskisehir, Turkey Gebse, Turkey Istanbul, Turkey Izmir, Turkey United Kingdom Edinburgh, United Kingdom Sheffield Yorks, United Kingdom Wakefield, United Kingdom 收起 << |
NCT00665626 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT00665925 | - | Completed | - | - | |
NCT00665925 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT01260688 | Hormone Refractory Prostate Ca... 展开 >>ncer Recurrent Prostate Cancer 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc - State Boulevard Fort Wayne, Indiana, United States, 46845 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Canada, British Columbia BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT01006785 | Breast Cancer | Phase 2 | Terminated(The study was termi... 展开 >>nated due to difficulty of find eligible subjects) 收起 << | - | Indonesia ... 展开 >> Dr. Sardjito Hospital, Department of Internal Medicine Yogyakarta, DI Yogyakarta, Indonesia, 55284 Dr. Cipto Mangunkusumo Hospital, Division of Medical Haematology and Oncology Jakarta, DKI Jakarta, Indonesia Dr. Hasan Sadikin Hospital, Department of Internal Medicine Bandung, West Java, Indonesia, 40161 收起 << |
NCT00665626 | - | Completed | - | - | |
NCT03503708 | Alcoholic Liver Disease | Not Applicable | Not yet recruiting | November 30, 2028 | India ... 展开 >> Mazumdar Shaw Medical Centre Not yet recruiting Bangalore, Karnataka, India, 560099 Contact: Alben Sigamani, MD 8884431444 alben.sigamani.dr@narayanahealth.org Contact: Sanjaya Chauhan, PharmD 9611252350 ext Chauhan drsanjayachauhan49@gmail.com 收起 << |
NCT01260688 | - | Completed | - | - | |
NCT01361022 | Healthy | Phase 1 | Completed | - | Taiwan ... 展开 >> 263.511.1 Boehringer Ingelheim Investigational Site Taipei, Taiwan 收起 << |
NCT01285518 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Ft. Meyers, Florida, United States, 33901 Elite Research Institute Miami, Florida, United States, 33169 Comprehensive Phase One (A Division of Comprehensive NeuroScience, Inc.) Miramar, Florida, United States, 33025 United States, Texas Cetero Research San Antonio, Texas, United States, 78229 收起 << |
NCT00635089 | Eosinophilic Esophagitis | Phase 3 | Completed | - | - |
NCT01577745 | - | Completed | - | - | |
NCT01577745 | Solid Tumors | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Los Angeles, California, United States, 90404 United States, Connecticut Research Site New Haven, Connecticut, United States, 06513 United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Ann Arbor, Michigan, United States, 48103 United States, Minnesota Research Site Minneapolis, Minnesota, United States United States, New York Research Site New York, New York, United States, 10002 United States, Ohio Research Site Cincinnati, Ohio, United States, 45201 Research Site Cleveland, Ohio, United States, 44105 United States, Texas Research Site Houston, Texas, United States, 77030 United States, Washington Research Site Seattle, Washington, United States, 98112 Research Site Tacoma, Washington, United States, 98405 收起 << |
NCT03450759 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 << |
NCT00635089 | - | Completed | - | - | |
NCT01285518 | - | Completed | - | - | |
NCT01036022 | Colitis, Ulcerative | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Bonheiden, Belgium, 2820 GSK Investigational Site Brussels, Belgium, 1200 GSK Investigational Site Gent, Belgium, 9000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 2C8 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 5G2 GSK Investigational Site London, Ontario, Canada, N6A 4G5 GSK Investigational Site Vaughan, Ontario, Canada, L4L 4Y7 Canada GSK Investigational Site Quebec, Canada, G1S 4L8 Germany GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Ludwigshafen, Rheinland-Pfalz, Germany, 67067 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Leipzig, Sachsen, Germany, 04129 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Hamburg, Germany, 20148 GSK Investigational Site Hamburg, Germany, 20246 Norway GSK Investigational Site Lørenskog, Norway, 1478 GSK Investigational Site Oslo, Norway, 0514 GSK Investigational Site Oslo, Norway, N-0456 GSK Investigational Site Tønsberg, Norway, 3116 Sweden GSK Investigational Site Göteborg, Sweden, SE-416 85 GSK Investigational Site Lund, Sweden, SE-221 85 GSK Investigational Site Stockholm, Sweden, SE-111 86 GSK Investigational Site Stockholm, Sweden, SE-171 76 收起 << |
NCT03693287 | Infant,Premature ... 展开 >> Parenteral Nutrition Growth 收起 << | Phase 3 | Not yet recruiting | May 30, 2021 | - |
NCT02837380 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 << |
NCT00397891 | Alzheimer Disease | Phase 1 | Completed | - | Japan ... 展开 >> Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Saitama, Japan Pfizer Investigational Site Shizuoka, Japan Pfizer Investigational Site Tokyo, Japan 收起 << |
NCT02578953 | Prostatic Hyperplasia | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-0017 收起 << |
NCT01036022 | - | Completed | - | - | |
NCT00397891 | - | Completed | - | - | |
NCT02287376 | Migraine | Phase 4 | Completed | - | United States, Florida ... 展开 >> Tampa, Florida, United States United States, New York Amherst, New York, United States 收起 << |
NCT02287376 | - | Completed | - | - | |
NCT03250689 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Active, not recruiting | December 3, 2018 | United Kingdom ... 展开 >> GSK Investigational Site Dundee, United Kingdom, DD1 9SY 收起 << |
NCT02698553 | Depressive Disorder, Major | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China, 200030 收起 << |
NCT02951052 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | February 8, 2022 | - |
NCT00420056 | Lymphoma, Mantle-Cell | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Presbyterian Hospital New York, New York, United States, 10021 Weill Medical College of Cornell University - New York Presbyterian Hospital New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 << |
NCT02287350 | - | Completed | - | - | |
NCT02287350 | Pain | Phase 4 | Completed | - | United States, Alabama ... 展开 >> Sheffield, Alabama, United States United States, California Stanford, California, United States United States, Missouri Saint Peters, Missouri, United States United States, Texas Dallas, Texas, United States United States, Wisconsin Milwaukee, Wisconsin, United States 收起 << |
NCT03136991 | Cardiovascular Disease | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 收起 << |
NCT03132649 | - | Recruiting | June 1, 2019 | China, Guangdong ... 展开 >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Chihua Fang, MD (+86)2062782568 s_mountain@126.com Contact: Qingshan Chen, MM (+86)2062782568 s_mountain@126.com 收起 << | |
NCT03132740 | - | Recruiting | June 1, 2019 | China, Guangdong ... 展开 >> Zhujiang Hospital of The Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Chihua Fang, MD (+86)2062782568 s_mountain@126.com Contact: Qingshan Chen, MM (+86)2062782568 s_mountain@126.com 收起 << | |
NCT00420056 | - | Completed | - | - | |
NCT02802501 | Malaria, Vivax | Phase 3 | Recruiting | November 29, 2019 | Indonesia ... 展开 >> GSK Investigational Site Recruiting Jakarta, Indonesia, 10430 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03649165 | Neurofibromatosis Type 1 (NF1)... 展开 >>-Related Plexiform Neurofibromas (PNs) Healthy Participants 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Research Site Baltimore, Maryland, United States, 21225 收起 << |
NCT03645434 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 2 | Recruiting | September 23, 2019 | Germany ... 展开 >> Research Site Not yet recruiting Berlin, Germany, 14050 Research Site Withdrawn Frankfurt, Germany, 60596 Research Site Not yet recruiting Grosshansdof, Germany, 22927 Research Site Not yet recruiting Wiesbaden, Germany, 65187 United Kingdom Research Site Recruiting London, United Kingdom, HA1 3UJ Research Site Not yet recruiting Manchester, United Kingdom, M23 9QZ 收起 << |
NCT00133575 | Smallpox | Phase 1 Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital - Infectious Diseases Boston, Massachusetts, United States, 02115 收起 << |
NCT00133575 | - | Completed | - | - | |
NCT01235741 | - | Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 << | - | - | |
NCT02038764 | Diabetes Mellitus, Type 1 | Phase 1 | Completed | - | United States, California ... 展开 >> VA San Diego Healthcare System (Drug Shipment) San Diego, California, United States, 92161 Veterans Administration San Diego Healthcare System San Diego, California, United States, 92161 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado Barbara Davis Center Aurora, Colorado, United States, 80045 United States, Connecticut Yale School of Medicine New Haven, Connecticut, United States, 06510 Yale New Haven Hospital - Investigational Drug Services New Haven, Connecticut, United States, 06511 Yale University School of Medicine New Haven, Connecticut, United States, 06519 United States, Georgia Atlanta Diabetes Associates Atlanta, Georgia, United States, 30318 United States, Illinois Duchossois Center for Advanced Medicine Chicago, Illinois, United States, 60637 The University of Chicago Medical Center Chicago, Illinois, United States, 60637 University of Chicago Clinical Resource Center Chicago, Illinois, United States, 60637 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Umass Memorial Medical Center Worcester, Massachusetts, United States, 01655 University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota University Of Minnesota Fairview Pharmacy Services Minneapolis, Minnesota, United States, 55454 University Of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, Missouri Barnes- Jewish HOSP Att: Kathryn Vehe Saint Louis, Missouri, United States, 63110 Washington University - Center for Advanced Medicine Saint Louis, Missouri, United States, 63110 Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke Clinical Research Unit Durham, North Carolina, United States, 27710 Duke University Health Systems (DUHS) Investigational Drug Services Durham, North Carolina, United States, 27710 收起 << |
NCT00365859 | Autistic Disorder ... 展开 >> Behavioral Symptoms 收起 << | Phase 3 | Completed | - | - |
NCT02038764 | - | Completed | - | - | |
NCT01235741 | Obesity | Phase 2 | Terminated(Results from previo... 展开 >>us study DFA102 demonstrated neutralizing activity to metreleptin in invitro assay in 2 participants.) 收起 << | - | United States, California ... 展开 >> Research Site Greenbrae, California, United States Research Site La Jolla, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Florida Research Site Winter Park, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Maryland Research Site Hyattsville, Maryland, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Missouri Research Site St. Louis, Missouri, United States United States, Montana Research Site Butte, Montana, United States United States, New York Research Site New York, New York, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Philadelphia, Pennsylvania, United States United States, Texas Research Site Austin, Texas, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Virginia Research Site Arlington, Virginia, United States Research Site Norfolk, Virginia, United States Research Site Richmond, Virginia, United States 收起 << |
NCT02118792 | Dermatitis, Atopic | Phase 3 | Completed | - | United States, Virginia ... 展开 >> Anacor Investigational Site Henrico, Virginia, United States 收起 << |
NCT00549679 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Estonia ... 展开 >> GSK Investigational Site Tallinn, Estonia, 13419 Finland GSK Investigational Site Tampere, Finland, 33520 Germany GSK Investigational Site Gauting, Bayern, Germany, 82131 GSK Investigational Site Berlin, Germany, 10717 GSK Investigational Site Hamburg, Germany, 22291 Netherlands GSK Investigational Site Hoorn, Netherlands, 1624 NP GSK Investigational Site Horn, Netherlands, 6085 NM GSK Investigational Site Veldhoven, Netherlands, 5504 DB Russian Federation GSK Investigational Site Barnaul, Russian Federation, 656 045 GSK Investigational Site Moscow, Russian Federation, 105 077 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site Yaroslavl, Russian Federation, 150003 Slovakia GSK Investigational Site Bratislava, Slovakia, 826 06 GSK Investigational Site Kosice, Slovakia, 041 90 GSK Investigational Site Martin, Slovakia, 036 59 收起 << |
NCT00365859 | - | Completed | - | - | |
NCT01378442 | Cerebral Palsy | Not Applicable | Completed | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 收起 << |
NCT03574142 | Healthy Subjects | Phase 1 | Completed | - | China ... 展开 >> Research Site Beijing, China, 100029 收起 << |
NCT02509117 | Healthy Subjects | Phase 1 | Completed | - | United States, California ... 展开 >> California Clinical Trials Medical Group, Inc Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 收起 << |
NCT02787304 | Non-Alcoholic Steatohepatitis | Phase 2 | Terminated | - | - |
NCT02332798 | Schizophrenia | Phase 1 | Completed | - | United States, California ... 展开 >> Collaborative Neuroscience Network, LLC. Long Beach, California, United States, 90806 收起 << |
NCT02509117 | - | Completed | - | - | |
NCT02118792 | - | Completed | - | - | |
NCT02332798 | - | Completed | - | - | |
NCT02691702 | Healthy Adult Subjects ... 展开 >> Healthy Elderly Subjects 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> QPS-MRA, LLC (Miami Research Associates) South Miami, Florida, United States, 33143 Qps-Mra, Llc South Miami, Florida, United States, 33143 收起 << |
NCT01618019 | Rheumatoid Arthritis | Not Applicable | Completed | - | Korea, Republic of ... 展开 >> Hanyang university hospital Seoul, Korea, Republic of, 133-792 收起 << |
NCT03025880 | Advanced Breast Cancer | Phase 2 | Recruiting | July 2020 | Spain ... 展开 >> Institut Català d'Oncologia. Hospital Universitario Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Hospital Universitario de Canarias Recruiting La Laguna, Canarias, Spain, 38320 Hospital Universitario Virgen de la Arrixaca Recruiting El Palmar, Murcia, Spain, 30120 Clínica Universitaria de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Centro Oncológico de Galicia Recruiting A Coruña, Spain, 15009 Complejo Hospitalario Universitario Reina Sofía Recruiting Cordoba, Spain, 14004 Hospital Universitario Ramón y Cajal Recruiting Madrid, Spain, 28034 Hospital Clínico Universitario San Carlos Recruiting Madrid, Spain, 28040 Hospital Universitario Virgen de la Macarena Recruiting Sevilla, Spain, 41009 Hospital Clínico Universitario de Zaragoza "Lozano Blesa" Recruiting Zaragoza, Spain, 50009 收起 << |
NCT02691702 | - | Completed | - | - | |
NCT00077636 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT01618019 | - | Completed | - | - | |
NCT02793232 | Healthy Subjects | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT01904474 | Obesity | Not Applicable | Completed | - | Portugal ... 展开 >> Instituto Politécnico de Leiria Leiria, Portugal, 2411-901 Hospital de Santa Maria Lisboa, Portugal, 1649-035 收起 << |
NCT01163253 | Psoriasis | Phase 3 | Terminated | - | - |
NCT02750930 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - |
NCT02310750 | Plaque Psoriasis | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 收起 << |
NCT02793232 | - | Completed | - | - | |
NCT00077636 | - | Completed | - | - | |
NCT02750930 | - | Terminated(The termination was... 展开 >> result of GSK business considerations and not due to quality, safety or efficacy concerns with any albiglutide formulations or study conduct) 收起 << | - | - | |
NCT03479892 | Metabolism and Nutrition Disor... 展开 >>der Obesity 收起 << | Phase 1 | Recruiting | May 4, 2019 | United States, Texas ... 展开 >> Novo Nordisk Investigational Site Recruiting San Antonio, Texas, United States, 78209 收起 << |
NCT03715205 | Carcinoma, Non-Small-Cell Lung... 展开 >> Melanoma 收起 << | Phase 4 | Not yet recruiting | November 10, 2025 | - |
NCT02310750 | - | Completed | - | - | |
NCT02760238 | - | Recruiting | October 2025 | Canada, Ontario ... 展开 >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 1Z5 Contact: Vikas Gupta, MD 416-946-2885 vikas.gupta@uhn.ca 收起 << | |
NCT02190721 | Neutropenia | Phase 2 | Completed | - | - |
NCT01163253 | - | Terminated | - | - | |
NCT03448848 | Liver Function Post BCAA Infus... 展开 >>ion 收起 << | Not Applicable | Recruiting | August 2018 | Egypt ... 展开 >> NHTMRI Recruiting Cairo, Egypt Contact: Eman El-Desoki, Ph D 01227409501 eman18350@gmail.com 收起 << |
NCT00439270 | - | Completed | - | - | |
NCT02190721 | - | Completed | - | - | |
NCT00439270 | Metastatic Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Illinois ... 展开 >> University of Chicago Chicago, Illinois, United States, 60637 Springfield Clinic Springfield, Illinois, United States, 62703 United States, New York Hematology-Oncology Associates Of Rockland Nyack, New York, United States, 10960 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030-4009 收起 << |
NCT02478463 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Active, not recruiting | September 10, 2019 | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21287-5554 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 收起 << |
NCT03479086 | Alcohol Dependence | Phase 3 | Recruiting | November 1, 2020 | Australia, New South Wales ... 展开 >> Drug Health Services, Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia, 2050 Contact: Kirsten C Morley, PhD +61295153636 kirsten.morley@sydney.edu.au Contact: Central Intake 95157611 sydneyalcoholtreatmentgroup@gmail.com Principal Investigator: Paul Haber, MBBS 收起 << |
NCT03279965 | - | Recruiting | May 5, 2018 | United Kingdom ... 展开 >> Royal Brompton Hospital Recruiting London, United Kingdom, SW3 6NP Contact: Thomas Semple, FRCR MBBS 02073528121 T.Semple@rbht.nhs.uk Contact: Anand Devaraj 02073528121 A.Devaraj@rbht.nhs.uk Principal Investigator: Anand Devaraj Sub-Investigator: Simon Padley Sub-Investigator: Thomas Semple 收起 << | |
NCT02032875 | Hepatitis C | Phase 3 | Completed | - | United States, Florida ... 展开 >> University Of Miami Schiff Center For Liver Diseases Miami, Florida, United States, 33136 United States, Michigan University Of Michigan Health System Ann Arbor, Michigan, United States, 48109 United States, Texas Baylor St. Luke'S Medical Center Houston, Texas, United States, 77030 American Research Corporation San Antonio, Texas, United States, 78215 United States, Washington Harborview Medical Center Seattle, Washington, United States, 98104 收起 << |
NCT02032875 | - | Completed | - | - | |
NCT02205333 | Advanced Solid Tumors ... 展开 >> Aggressive B-cell Lymphomas 收起 << | Phase 1 Phase 2 | Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 << | - | United States, Arizona ... 展开 >> Research Site Scottsdale, Arizona, United States, 85259 United States, California Research Site Sacramento, California, United States, 95817 Research Site Santa Monica, California, United States, 90404 United States, District of Columbia Research Site Washington, D.C., District of Columbia, United States, 20007 United States, Florida Research Site Tampa, Florida, United States, 33612 United States, Illinois Research Site Chicago, Illinois, United States, 60611 United States, Michigan Research Site Detroit, Michigan, United States, 48202 United States, Nevada Research Site Las Vegas, Nevada, United States, 89169 United States, New Jersey Research Site Hackensack, New Jersey, United States, 7601 United States, North Carolina Research Site Huntersville, North Carolina, United States, 28078 United States, Oregon Research Site Portland, Oregon, United States, 97213 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 United States, Texas Research Site Houston, Texas, United States, 77030 收起 << |
NCT02205333 | - | Terminated(The study was termi... 展开 >>nated early at the sponsor's discretion.) 收起 << | - | - | |
NCT03159442 | Chronic Obstructive Pulmonary ... 展开 >>Disease - COPD 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Research Site London, United Kingdom, HA1 3UJ 收起 << |
NCT01114503 | - | Terminated(Clinical study in G... 展开 >>raves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.) 收起 << | - | - | |
NCT02262754 | Chronic Low Back Pain | Phase 2 | Completed | - | - |
NCT02077491 | Systemic Inflammatory Response... 展开 >> Syndrome 收起 << | Not Applicable | Completed | - | Denmark ... 展开 >> Klinisk Forskningscenter, Amager & Hvidovre Hospitaler Copenhagen, Hvidovre, Denmark, 2650 收起 << |
NCT00256750 | Kidney Transplantation ... 展开 >> Chronic Kidney Failure 收起 << | Phase 3 | Completed | - | - |
NCT01602341 | Dermatitis, Atopic | Phase 2 | Completed | - | United States, California ... 展开 >> Anacor Investigational Site Fremont, California, United States United States, Florida Anacor Investigational Site Miami, Florida, United States United States, Kentucky Anacor Investigational Site Lousiville, Kentucky, United States United States, Michigan Anacor Investigational Site Detroit, Michigan, United States United States, New Mexico Anacor Investigational Site Albuquerque, New Mexico, United States United States, New York Anacor Investigational Site Stony Brook, New York, United States United States, North Carolina Anacor Investigational Site High Point, North Carolina, United States United States, Oregon Anacor Investigational Site Portland, Oregon, United States United States, Tennessee Anacor Investigational Site Knoxville, Tennessee, United States United States, Utah Anacor Investigational Site Salt Lake City, Utah, United States United States, Virginia Anacor Investigational Site Norfolk, Virginia, United States Australia, Australian Capital Territory Anacor Investigational Site Phillip, Australian Capital Territory, Australia, 2606 Australia, New South Wales Anacor Investigational Site Kogarah, New South Wales, Australia, 2217 Australia, Queensland Anacor Investigational Site Wooloongabba, Queensland, Australia Australia, Victoria Anacor Investigational Site Box Hill, Victoria, Australia Anacor Investigational Site Parkville, Victoria, Australia Australia, Western Australia Anacor Investigational Site Fremantle, Western Australia, Australia, 6160 收起 << |
NCT02228395 | - | Completed | - | - | |
NCT02262754 | - | Completed | - | - | |
NCT02228395 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT02739412 | Liver Transplantation | Phase 2 | Recruiting | December 2019 | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Susan M McDermott, MPH RN 617-632-9841 smcderm2@bidmc.harvard.edu Contact: Michael P Curry, md 617-632-9700 mcurry@bidmc.harvard.com Principal Investigator: Michael P Curry, MD Sub-Investigator: Terry Strom, MD Sub-Investigator: Khalid Khwaja, MD Sub-Investigator: Susan M McDermott, MPH RN Sub-Investigator: Maria Koulmanda, PhD 收起 << |
NCT01602341 | - | Completed | - | - | |
NCT00256750 | - | Completed | - | - | |
NCT01114503 | Graves Ophthalmopathy | Phase 2 | Terminated(Clinical study in G... 展开 >>raves' ophthalmopathy terminated until there is a better understanding of an efficacious dose with Otelixizumab from other clinical studies.) 收起 << | - | United Kingdom ... 展开 >> GSK Investigational Site Newcastle upon Tyne, United Kingdom, NE1 3BZ 收起 << |
NCT02378259 | Obesity Diabe... 展开 >>tes Hypertension Steatohepatitis Inflammation 收起 << | Phase 3 | Active, not recruiting | June 2034 | Sweden ... 展开 >> Sahlgrenska University hospital Gothenburg, Sweden, 41345 Skåne University Hospital Malmö, Sweden Karolinska University hospital Stockholm, Sweden 收起 << |
NCT03414151 | - | Recruiting | July 2019 | Canada, Ontario ... 展开 >> Centre For Addiction and Mental Health Recruiting Toronto, Ontario, Canada, M5T1R8 Contact: Nicole MacKenzie, M.Ed 416-535-8501 ext 34719 nicole.mackenzie@camh.ca Principal Investigator: Margaret Hahn, MD, PhD 收起 << | |
NCT01478607 | Painful Diabetic Peripheral Ne... 展开 >>uropathy (PDPN) 收起 << | Phase 3 | Completed | - | - |
NCT02014272 | - | Completed | - | - | |
NCT02014272 | Healthy Volunteers | Phase 1 | Completed | - | Singapore ... 展开 >> Pfizer Investigational Site Singapore, Singapore, 188770 收起 << |
NCT02443740 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01369225 | Alzheimer's Disease | Phase 1 | Completed | - | United States, Florida ... 展开 >> MD Clinical Hallandale Beach, Florida, United States, 33009 Munroe Regional Medical Center Ocala, Florida, United States, 34471 Renstar Medical Research Ocala, Florida, United States, 34471 Trinity Care Solutions Ocala, Florida, United States, 34471 Advanced Imaging of Ocala Ocala, Florida, United States, 34481 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30308 United States, Maryland Foers Medical Arts Pharmacy Bethesda, Maryland, United States, 20814 CBH Health, LLC Rockville, Maryland, United States, 20850 United States, Michigan Borgess Medical Center Kalamazoo, Michigan, United States, 49048 Borgess Research Institute Kalamazoo, Michigan, United States, 49048 KNI Southwest Michigan Imaging Center, LLC Kalamazoo, Michigan, United States, 49048 United States, Missouri Millennium Psychiatric Associates, LLC Creve Coeur, Missouri, United States, 63141 DePaul Health Center-MRI Department St. Louis, Missouri, United States, 63044 United States, New Jersey Memory Enhancement Center of America, Inc. Eatontown, New Jersey, United States, 07724 Central Jersey Radiology Oakhurst, New Jersey, United States, 07755 Korea, Republic of Seoul National University Hospital, Department Neurology Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Inha University Hospital, Department of Neurology Incheon, Korea, Republic of, 400-711 Samsung Medical Center, Department of Neurology Seoul, Korea, Republic of, 1350710 Korea University Anam Hospital IRB Seoul, Korea, Republic of, 136-705 ASAN Medical Center Seoul, Korea, Republic of, 138-736 Konkuk University Medical Center, Department of Neurology Seoul, Korea, Republic of, 143914 收起 << |
NCT02224664 | Parkinson`s Disease | Phase 1 | Completed | - | United States, California ... 展开 >> Orange Coast Memorial Medical Center Fountain Valley, California, United States, 92708 The Parkinson's and Movement Disorder Institute Fountain Valley, California, United States, 92708 Collaborative Neuroscience Network, LLC Long Beach, California, United States, 90806 United States, Colorado Rocky Mountain Movement Disorders Center Englewood, Colorado, United States, 80113 Davita Clinical Research Center Lakewood, Colorado, United States, 80228 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 Compass Research, LLC Orlando, Florida, United States, 32806 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, Massachusetts Massachusetts General Hospital -- FOR DRUG SHIPMENT ONLY Boston, Massachusetts, United States, 02114 Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Quest Research Institute Farmington Hills, Michigan, United States, 48334 United States, New Jersey PRA International Marlton, New Jersey, United States, 08053 United States, North Carolina Carolina Phase I Research, LLC Raleigh, North Carolina, United States, 27612 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Texas Neurology Consultants of Dallas, PA Dallas, Texas, United States, 75231 Walnut Hill Medical Center Dallas, Texas, United States, 75231 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02224664 | - | Completed | - | - | |
NCT00951665 | Metastatic Breast Cancer | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Stanford, California, United States, 94305-5456 United States, Colorado Aurora, Colorado, United States, 80045 United States, Massachusetts Boston, Massachusetts, United States, 02115 United States, Michigan Detroit, Michigan, United States, 48201 United States, New York New York, New York, United States, 10065 收起 << |
NCT02443740 | - | Completed | - | - | |
NCT02947568 | - | Recruiting | December 2019 | Hungary ... 展开 >> 2nd Department of Medicine and Nephrological Center Recruiting Pécs, Baranya, Hungary, 7624 Contact: Gergo A Molnar, MD, PhD +3672536050 gergo.molnar@aok.pte.hu Contact: Eszter Sélley, MD +3672536050 eszter.selley@aok.pte.hu Sub-Investigator: Béla Melegh, MD Sub-Investigator: Lilla Lakner, MD Sub-Investigator: Kulcsár Imre, MD Sub-Investigator: Bene Judit, MD Principal Investigator: István Wittmann, MD 收起 << | |
NCT00726323 | Carcinoma, Renal Cell | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Greenbrae, California, United States, 94904-2007 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Stanford, California, United States, 94305 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Bethesda, Maryland, United States, 20892 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02115 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, New Jersey GSK Investigational Site New Brunswick, New Jersey, United States, 08901 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 收起 << |
NCT00951665 | - | Completed | - | - | |
NCT01806896 | - | Completed | - | - | |
NCT01369225 | - | Completed | - | - | |
NCT01806896 | Huntington's Disease | Phase 2 | Completed | - | France ... 展开 >> Centre d'Investigation Clinique (CIC)/ Institut du Cerveau et de la Möelle Epinière (ICM) Paris Cedex 13, France, 75651 收起 << |
NCT00726323 | - | Completed | - | - | |
NCT00983437 | Traumatic Brain Injury | Phase 3 | Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 << | - | - |
NCT00371683 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00983437 | - | Terminated(Study has been stop... 展开 >>ped by sponsor decision) 收起 << | - | - | |
NCT00371683 | - | Completed | - | - | |
NCT02027376 | - | Completed | - | - | |
NCT02280096 | Multiple Sclerosis | Phase 2 | Unknown | March 2016 | Mexico ... 展开 >> Hospital de Especialidades, CMN Siglo XXI Mexico City, Distrito Federal, Mexico, 06725 收起 << |
NCT02027376 | Advanced Breast Cancer | Phase 1 | Completed | - | Spain ... 展开 >> Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Clínico Universitario San Carlos Madrid, Spain, 28040 Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41071 收起 << |
NCT03211403 | Gout Hyperuri... 展开 >>cemia 收起 << | Phase 1 | Completed | - | Australia, New South Wales ... 展开 >> Atridia Pty Limited Sydney, New South Wales, Australia, 2000 收起 << |
NCT00114777 | Renal Transplantation | Phase 3 | Completed | - | - |
NCT00983801 | Stomach Neoplasms | Phase 2 | Completed | - | Hong Kong ... 展开 >> Local Institution Hong Kong, Hong Kong, B Japan Local Institution Nagoya, Aichi, Japan, 4648681 Local Institution Sunto-Gun, Shizuoka, Japan, 4118777 Korea, Republic of Local Institution Seoul, Korea, Republic of, 135-710 Local Institution Seoul, Korea, Republic of, 136-705 Local Institution Seoul, Korea, Republic of, 138-736 Singapore Local Institution Singapore, Singapore, 169610 Taiwan Local Institution Taipei, Taiwan, 112 Local Institution Taoyuan Hsien, Taiwan, 333 收起 << |
NCT00983801 | - | Completed | - | - | |
NCT02917772 | Carcinoma, Renal Cell ... 展开 >> Clear-cell Metastatic Renal Cell Carcinoma 收起 << | Phase 2 | Recruiting | July 2021 | - |
NCT03493191 | Acute Pain | Phase 1 | Recruiting | September 2018 | Australia ... 展开 >> Linear Clinical Research Limited Recruiting Nedlands, Australia Contact: Sarah Powell +61 (0) 411 062 165 spowell@linear.org.au 收起 << |
NCT00372112 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Camperdown, New South Wales, Australia, 2050 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Bulgaria GSK Investigational Site Ruse, Bulgaria, 7000 GSK Investigational Site Sofia, Bulgaria, 1431 GSK Investigational Site Sofia, Bulgaria, 1606 Germany GSK Investigational Site Weinheim, Baden-Wuerttemberg, Germany, 69469 GSK Investigational Site Hannover, Niedersachsen, Germany, 30159 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 Netherlands GSK Investigational Site Breda, Netherlands, 4819 EV GSK Investigational Site Hoorn, Netherlands, 1624 NP New Zealand GSK Investigational Site Auckland, New Zealand, 1005 GSK Investigational Site Tauranga, New Zealand Romania GSK Investigational Site Bucharest, Romania, 050159 GSK Investigational Site Iasi, Romania, 700506 收起 << |
NCT00374322 | Neoplasms, Breast | Phase 3 | Completed | - | - |
NCT00372112 | - | Completed | - | - | |
NCT00114777 | - | Completed | - | - | |
NCT03273855 | Obesity, Morbid | Not Applicable | Not yet recruiting | February 1, 2020 | - |
NCT00374322 | - | Completed | - | - | |
NCT00395018 | Hepatitis B, Chronic | Phase 3 | Completed | - | - |
NCT00395018 | - | Completed | - | - | |
NCT03418935 | Jaundice, Obstructive | Phase 3 | Active, not recruiting | September 2019 | Russian Federation ... 展开 >> Irkutsk Regional Clinical Hospital Irkutsk, Russian Federation, 664079 North-West State Medical University named after I.I. Mechnikov Saint Petersburg, Russian Federation, 191015 State Budgetary Health Care Institution "City Hospital № 26" Saint Petersburg, Russian Federation, 196247 "BioEk" Ltd. Saint Petersburg, Russian Federation, 197342 Leningrad Regional Clinical Hospital Saint Petersburg, Russian Federation 收起 << |
NCT00077610 | Anemia | Phase 3 | Completed | - | - |
NCT00077610 | - | Completed | - | - | |
NCT00908037 | Purpura, Thrombocytopaenic, Id... 展开 >>iopathic 收起 << | Phase 2 | Completed | - | - |
NCT01880047 | Immune Thrombocytopenia ... 展开 >> Platelet Disorder 收起 << | Phase 2 | Active, not recruiting | March 30, 2019 | United States, New York ... 展开 >> Weill Cornell Medicine New York, New York, United States, 10065 收起 << |
NCT03680105 | Critical Limb Ischemia | Phase 1 | Recruiting | March 2019 | United States, Texas ... 展开 >> ICON Early Phase Services Recruiting San Antonio, Texas, United States, 78209 Contact: Dennis A Ruff, MD 收起 << |
NCT00670501 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | - |
NCT03617263 | Non-alcoholic Fatty Liver Dise... 展开 >>ase in Women With PCOS 收起 << | Phase 2 | Recruiting | January 2020 | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Yanin Tab Srisengfa United States, Indiana Indiana University Health Recruiting Indianapolis, Indiana, United States, 46202 Contact: Regina Weber Mexico Centro de Investigación Medico Biológica y Terapia Avanzada SC (CIMBYTA) Not yet recruiting Guadalajara, Jalisco, Mexico, 44130 Hospital Universitario "Dr. Jose Eleuterio Gonzalez" Not yet recruiting Monterrey, Nuevo León, Mexico, 64460 UBAM Unidad Biomédica Avanzada Monterrey Not yet recruiting Monterrey, Nuevo León, Mexico, 64460 Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada S.C. Not yet recruiting Culiacán, Sinaloa, Mexico, 80230 Medical Care and Research S.A. de C.V. Not yet recruiting Mérida, Yucatán, Mexico, 97070 CEMDEC S.A. de C.V. (Centero Mexicana Desarrollo de Estudios Clinicos) Recruiting Ciudad de mexico, Mexico, 06100 收起 << |
NCT00908037 | - | Completed | - | - | |
NCT00452530 | - | Completed | - | - | |
NCT02016365 | Transthyretin Amyloidosis ... 展开 >> Cardiomyopathy 收起 << | Phase 2 | Completed | - | Sweden ... 展开 >> Dept of Clinical Medicin, Ptieå Hospital Piteå, Sweden, SE-941 28 Dept of clinical medicin, Skellefteå Hospital Skellefteå, Sweden, SE-931 86 Dept of Clinical Medicine, Umeå University Hospital Umeå, Sweden, SE-90185 收起 << |
NCT01781403 | Rectal Cancer | Phase 1 | Active, not recruiting | December 2018 | Korea, Republic of ... 展开 >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 收起 << |
NCT01781403 | - | Active, not recruiting | - | - | |
NCT00452530 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT01922739 | Low Back Pain | Phase 3 | Completed | - | - |
NCT00111800 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01227824 | - | Completed | - | - | |
NCT01227824 | Infection, Human Immunodeficie... 展开 >>ncy Virus I 收起 << | Phase 3 | Completed | - | - |
NCT00555880 | Hypotension, Orthostatic | Phase 4 | Completed | - | United States, Indiana ... 展开 >> Fort Wayne Neurological Center Fort Wayne, Indiana, United States, 46805 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Minnesota VA Medical Center Minneapolis, Minnesota, United States, 55417 United States, Missouri Forest Park Neurophysiology Saint Louis, Missouri, United States, 63139 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Raleigh Neurology Associates Raleigh, North Carolina, United States, 27607 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, South Carolina Absher Neurology, PA Greenville, South Carolina, United States, 29615 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 United States, Texas Diabetes and Glandular Disease research Associates, PA San Antonio, Texas, United States, 78229 收起 << |
NCT00528372 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00423319 | Deep Vein Thrombosis ... 展开 >> Pulmonary Embolism 收起 << | Phase 3 | Completed | - | - |
NCT00555880 | - | Completed | - | - | |
NCT00528372 | - | Completed | - | - | |
NCT00496769 | Atrial Fibrillation | Phase 3 | Completed | - | - |
NCT00423319 | - | Completed | - | - | |
NCT01922739 | - | Completed | - | - | |
NCT00111800 | - | Completed | - | - | |
NCT01417091 | Osteogenesis Imperfecta | Phase 2 | Completed | - | United States, California ... 展开 >> Novartis Investigative Site Anaheim, California, United States, 92801 United States, Florida Novartis Investigative Site Miramar, Florida, United States, 33025 Belgium Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Gent, Belgium, 9000 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3GIA6 Germany Novartis Investigative Site Wuerzburg, Germany, 97074 收起 << |
NCT00551044 | Prostatic Neoplasms | Not Applicable | Completed | - | United Kingdom ... 展开 >> Wirral University Teaching Hospitals NHS Trust Upton, Wirral, Merseyside, United Kingdom, CH48 5PE 收起 << |
NCT00911664 | HIV | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT03368989 | - | Recruiting | January 31, 2021 | United States, Texas ... 展开 >> The University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Isis W Gayed, MD 713-704-1789 isis.w.gayed@uth.tmc.edu 收起 << | |
NCT00737711 | Anemia | Phase 4 | Completed | - | India ... 展开 >> Ahmedabad, India, 380007 Bangalore, India, 560034 Chennai, India, 603103 Coimbatore, India, 641004 Gujarat, India, 387 001 Hyderabad, India, 500001 Kerala, India, 682017 Kolkata, India, 700099 Ludhiana, India Mumbai, India, 400026 Mumbai, India New Delhi, India, 110 060 New Delhi, India, 110017 New Delhi, India, 110026 Vellore, India, 632 004 Vishakpatnam, India, 530002 收起 << |
NCT02167516 | Knee Osteoarthritis | Not Applicable | Completed | - | China, Anhui ... 展开 >> the First Affiliated Hospital of Anhui University of Chinese Medicine HeFei, Anhui, China, 230031 The Taihe County Hospital of Chinese Medicine Taihe, Anhui, China, 236600 The Tianchang City Hospital of Chinese Medicine Tianchang, Anhui, China, 239300 收起 << |
NCT00496769 | - | Completed | - | - | |
NCT00986661 | Cancer Metastatic to the Liver... 展开 >> Hepatocellular Carcinoma 收起 << | Phase 1 | Recruiting | February 2020 | United States, California ... 展开 >> Sharp Memorial Hospital Recruiting San Diego, California, United States, 92123 Contact: Amy King 858-939-5052 Amy.King@sharp.com Principal Investigator: Kristin Rice, M.D. United States, Florida Florida Hospital Tampa Recruiting Tampa, Florida, United States, 33613 Contact: Heather Bingaman, BS 813-615-7068 heather.bingaman@ahss.org Principal Investigator: Alexander Rosemurgy, M.D. United States, Pennsylvania St Luke's University Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Alyse M LaLiberte, MPH 484-503-4151 Alyse.LaLiberte@sluhn.org Contact: Robyn Rex, RN, OCN, CCRP 484-503-4152 robyn.rex@sluhn.org Principal Investigator: Sanjiv Agarwala, MD United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Rhonda Combs, LPN 615-322-2260 rhonda.j.combs@vanderbilt.edu Contact: Melissa Ford, MSN, PhD, RN 615-875-7143 melissa.b.ford@vanderbilt.edu Principal Investigator: Daniel Brown, MD United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Gener Balmes, RN, CCRP 713-794-4153 gcbalmes@mdanderson.org Principal Investigator: Sapna Patel, MD 收起 << |
NCT01160224 | Asthma | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> GSK Investigational Site Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario GSK Investigational Site Hamilton, Ontario, Canada, L8N 4A6 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2X 2P4 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 Canada GSK Investigational Site Quebec, Canada, G1V 4G5 收起 << |
NCT03079518 | Heart Failure, Systolic ... 展开 >> Iron Deficiency 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> Department of Medicine, Division of Cardiology, Pulmonary Diseases and Vascular Medicine at the University Hospital, RWTH Aachen Aachen, NRW, Germany, 52074 收起 << |
NCT02505334 | Diabetes Diab... 展开 >>etes Mellitus, Type 2 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku,, Japan, 104 0061 Novo Nordisk Investigational Site Fukuoka-shi, Fukuoka, Japan Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Hokkaido, Japan, 078-8236 Novo Nordisk Investigational Site Ichikawa-shi, Chiba, Japan Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kobe-shi, Hyogo, Japan Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan, 310-0845 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Neyagawa-shi, Osaka, Japan Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 5590012 Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sappro-shi, Hokkaido, Japan, 060 8648 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 105-8471 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 169-0073 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 收起 << |
NCT00737711 | - | Completed | - | - | |
NCT01023958 | Neoplasms | Phase 2 | Completed | - | United States, California ... 展开 >> 1230.2.5 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States 1230.2.10 Boehringer Ingelheim Investigational Site Los Angeles, California, United States United States, Florida 1230.2.34 Boehringer Ingelheim Investigational Site Miami, Florida, United States 1230.2.29 Boehringer Ingelheim Investigational Site Orlando, Florida, United States United States, Illinois 1230.2.6 Boehringer Ingelheim Investigational Site Chicago, Illinois, United States 1230.2.17 Boehringer Ingelheim Investigational Site Joliet, Illinois, United States United States, Louisiana 1230.2.24 Boehringer Ingelheim Investigational Site Metairie, Louisiana, United States United States, Maryland 1230.2.1 Boehringer Ingelheim Investigational Site Baltimore, Maryland, United States United States, Nevada 1230.2.25 Boehringer Ingelheim Investigational Site Las Vegas, Nevada, United States 1230.2.36 Boehringer Ingelheim Investigational Site Las Vegas, Nevada, United States United States, New Hampshire 1230.2.19 Boehringer Ingelheim Investigational Site Lebanon, New Hampshire, United States United States, New York 1230.2.20 Boehringer Ingelheim Investigational Site New York, New York, United States 1230.2.23 Boehringer Ingelheim Investigational Site New York, New York, United States United States, North Carolina 1230.2.12 Boehringer Ingelheim Investigational Site Charlotte, North Carolina, United States United States, Pennsylvania 1230.2.4 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States United States, Texas 1230.2.38 Boehringer Ingelheim Investigational Site Beaumont, Texas, United States 1230.2.41 Boehringer Ingelheim Investigational Site Tyler, Texas, United States 1230.2.43 Boehringer Ingelheim Investigational Site Webster, Texas, United States United States, Virginia 1230.2.44 Boehringer Ingelheim Investigational Site Fairfax, Virginia, United States Taiwan 1230.2.51 Boehringer Ingelheim Investigational Site Tainan, Taiwan 1230.2.50 Boehringer Ingelheim Investigational Site Taipei, Taiwan 收起 << |
NCT02505334 | - | Completed | - | - | |
NCT03234036 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01087944 | Hepatitis C, Chronic | Phase 1 | Completed | - | United States, California ... 展开 >> Los Angeles, California, United States, 90045 United States, Florida Bradenton, Florida, United States, 34209 Orlando, Florida, United States, 32803 United States, Georgia Marietta, Georgia, United States, 30060 United States, Massachusetts Framingham, Massachusetts, United States, 01702 United States, New Jersey Newark, New Jersey, United States, 07102 Vineland, New Jersey, United States, 08360 United States, New York New York, New York, United States, 10016 Poughkeepsie, New York, United States, 12601 United States, North Carolina Asheville, North Carolina, United States, 28801 United States, South Carolina Columbia, South Carolina, United States, 29204 United States, Texas San Antonio, Texas, United States, 78215 收起 << |
NCT01810770 | Prostatic Neoplasms | Phase 3 | Completed | - | China, Guangdong ... 展开 >> Guangzhou, Guangdong, China, 510060 Guangzhou, Guangdong, China, 510080 China, Jiangsu Nanjing, Jiangsu, China, 210008 Nanjing, Jiangsu, China, 210009 China Beijing, China, 100020 Beijing, China, 100021 Beijing, China, 100029 Beijing, China, 100050 Beijing, China, 100730 Guangzhou, China Shanghai, China, 200032 Shanghai, China, 200040 Shanghai, China, 200072 Shanghai, China, 200127 Shanghai, China, 200433 Korea, Republic of Donggu,, Gwangju Gwang''yeogsi, Korea, Republic of, 61469 Seoul, Korea, Republic of, 03080 Seoul, Korea, Republic of, 05505 Seoul, Korea, Republic of, 06351 Singapore Singapore, Singapore, 119228 Singapore, Singapore, 169610 Singapore, Singapore, 258499 Singapore, Singapore Taiwan Taipei City, Taipei, Taiwan, 112 Kaohsiung, Taiwan, 81362 Taipei, Taiwan, 10002 Taoyuan, Taiwan, 333 收起 << |
NCT01023958 | - | Completed | - | - | |
NCT01087944 | - | Completed | - | - | |
NCT03518268 | Breast Cancer ... 展开 >> Osteoporosis, Osteopenia 收起 << | Phase 1 Phase 2 | Not yet recruiting | June 2020 | - |
NCT01712061 | - | Completed | - | - | |
NCT01342952 | Hypertension, Pulmonary | Phase 2 | Recruiting | October 24, 2024 | - |
NCT01175135 | Schizophrenia | Phase 2 | Completed | - | - |
NCT01712061 | Diabetic Nephropathy | Phase 2 | Completed | - | - |
NCT00442416 | - | Terminated(Strategic decision ... 展开 >>unrelated to safety or efficacy) 收起 << | - | - | |
NCT01192191 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 811-2201 GSK Investigational Site Fukuoka, Japan, 819-8555 GSK Investigational Site Fukushima, Japan, 964-0871 GSK Investigational Site Gunma, Japan, 371-0048 GSK Investigational Site Hiroshima, Japan, 732-0057 GSK Investigational Site Hokkaido, Japan, 001-0901 GSK Investigational Site Hokkaido, Japan, 064-0915 GSK Investigational Site Hokkaido, Japan, 070-8644 GSK Investigational Site Hyogo, Japan, 651-0073 GSK Investigational Site Ibaraki, Japan, 300-0053 GSK Investigational Site Ibaraki, Japan, 310-0015 GSK Investigational Site Ishikawa, Japan, 920-8610 GSK Investigational Site Kagawa, Japan, 760-0073 GSK Investigational Site Kagawa, Japan, 763-8502 GSK Investigational Site Kanagawa, Japan, 239-0821 GSK Investigational Site Kyoto, Japan, 601-1495 GSK Investigational Site Kyoto, Japan, 615-8087 GSK Investigational Site Miyagi, Japan, 981-8563 GSK Investigational Site Miyagi, Japan, 984-8560 GSK Investigational Site Nagano, Japan, 390-0303 GSK Investigational Site Nagano, Japan, 390-0832 GSK Investigational Site Nagano, Japan, 390-8601 GSK Investigational Site Nagano, Japan, 391-0011 GSK Investigational Site Oita, Japan, 870-0921 GSK Investigational Site Oita, Japan, 876-0047 GSK Investigational Site Okayama, Japan, 701-0304 GSK Investigational Site Osaka, Japan, 530-0012 GSK Investigational Site Osaka, Japan, 545-8586 GSK Investigational Site Osaka, Japan, 576-0016 GSK Investigational Site Osaka, Japan, 589-0022 GSK Investigational Site Tokyo, Japan, 185-0014 GSK Investigational Site Tokyo, Japan, 187-0024 GSK Investigational Site Toyama, Japan, 930-0194 GSK Investigational Site Wakayama, Japan, 641-8510 GSK Investigational Site Yamanashi, Japan, 400-0031 收起 << |
NCT01475461 | Type 2 Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00366080 | Narcolepsy | Phase 2 | Terminated(Study was terminate... 展开 >>d based on the interim results of a futility test.) 收起 << | - | Austria ... 展开 >> GSK Investigational Site Innsbruck, Austria, A-6020 GSK Investigational Site Vienna, Austria, A-1190 Finland GSK Investigational Site Espoo, Finland, 02980 Germany GSK Investigational Site Regensburg, Bayern, Germany, 93053 GSK Investigational Site Schwalmstadt, Hessen, Germany, 34613 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Berlin, Germany, 14050 Netherlands GSK Investigational Site Leiden, Netherlands, 2333 CL Spain GSK Investigational Site Barcelona, Spain, 08035 GSK Investigational Site Barcelona, Spain, 08036 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB3 8RE GSK Investigational Site Edinburgh, United Kingdom, EH3 6HP GSK Investigational Site London, United Kingdom, W1G 6BF 收起 << |
NCT02257359 | Embryo Transfer | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01175135 | - | Completed | - | - | |
NCT01517373 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01192191 | - | Completed | - | - | |
NCT00163293 | Asthma | Phase 3 | Completed | - | Canada ... 展开 >> Altana Pharma/Nycomed Calgary, Canada, T2T5C7 Altana Pharma/Nycomed Fleurimont, Canada, J1H 5M4 Altana Pharma/Nycomed London,ON, Canada, N6A1V2 Altana Pharma/Nycomed London, Canada, N6C 4Y7 Altana Pharma/Nycomed Winnipeg, Canada, R3A1R9 Hungary Altana Pharma/Nycomed Budapest, Hungary South Africa Altana Pharma/Nycomed Kapstadt, South Africa 收起 << |
NCT00632424 | Advanced Solid Tumors | Phase 1 | Terminated(Business Objectives... 展开 >> Changed) 收起 << | - | United States, California ... 展开 >> Stanford University Stanford, California, United States, 94305 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 收起 << |
NCT01517373 | - | Completed | - | - | |
NCT00163293 | - | Completed | - | - | |
NCT01759979 | Choledocholithiasis | Not Applicable | Completed | - | United States, California ... 展开 >> Los Angeles County Hospital Los Angeles, California, United States, 90033 收起 << |
NCT00442416 | Anemia | Phase 3 | Terminated(Strategic decision ... 展开 >>unrelated to safety or efficacy) 收起 << | - | - |
NCT01475461 | - | Completed | - | - | |
NCT00632424 | - | Terminated(Business Objectives... 展开 >> Changed) 收起 << | - | - | |
NCT02542813 | Postpartum Hemorrhage | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 2GG 收起 << |
NCT03034967 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | - |
NCT00691652 | - | Terminated | - | - | |
NCT01342211 | - | Completed | - | - | |
NCT01342211 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 2 | Completed | - | - |
NCT01642407 | Pulmonary Arterial Hypertensio... 展开 >>n Hypertension, Pulmonary 收起 << | Phase 4 | Completed | - | Japan ... 展开 >> Kitasato University Hospital Sagamihara, Kanagawa, Japan, 252-0375 Osaka University Hospital Suita, Osaka, Japan, 565-0871 Toho University Omori Medical Center Ota-ku, Tokyo, Japan, 143-8541 National Center for Child Health and Development Setagaya-ku, Tokyo, Japan, 157-8535 Shizuoka Children's Hospital Shizuoka, Japan, 420-8660 收起 << |
NCT02683746 | - | Completed | - | - | |
NCT01642407 | - | Completed | - | - | |
NCT01370018 | HIV Disease | Not Applicable | Completed | - | United States, New York ... 展开 >> Cabrini Medical Center New York, New York, United States, 10003 收起 << |
NCT00691652 | Lymphoma | Phase 1 Phase 2 | Terminated | - | United States, Oregon ... 展开 >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 收起 << |
NCT01399515 | Retinitis Pigmentosa ... 展开 >> Retinal Diseases Eye Diseases Eye Disease, Hereditary Retinal Degeneration 收起 << | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Department of Ophthalmology, Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT02683746 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00321932 | Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Osteoporosis Ovarian Cancer 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 收起 << |
NCT00321932 | - | Completed | - | - | |
NCT02378506 | Arthritis, Rheumatoid | Phase 3 | Completed | - | Bulgaria ... 展开 >> MHAT Plovdiv Plovdiv, Bulgaria, 4000 DCC "Aleksandrovska" EOOD Sofia, Bulgaria, 1431 UMHAT "Sv. Ivan Rilski" EAD, Sofia Sofia, Bulgaria, 1612 Medical Center - "New rehabilitation center" EOOD Stara Zagora, Bulgaria, 6000 Croatia Chc Rijeka Rijeka, Croatia, 51000 Medicinski Centar Kuna Peric Zagreb, Croatia, 10000 Germany Centrum für innovative Diagnostik und Therapie Frankfurt/Main, Hessen, Germany, 60528 Rheumaforschung - Studienambulanz Dr. Wassenberg Ratingen, Nordrhein-westfalen, Germany, 40882 Schlosspark-Klinik, Innere Medizin II, Rheumatologie Berlin, Germany, 14059 Medizinische Hochschule Hannover Hannover, Germany, 30625 Immunologisches Zentrum Vogelsang-Gommern GmbH Vogelsang-Gommern, Germany, 39245 Greece Rheumatology Department Rion Patras, Achaia, Greece, 26500 University Hospital of Heraklion Heraklion, Crete, Greece, 71110 Rheumatology Unit Thessaloniki, Greece, 56429 Hungary Qualiclinic Kft. Budapest, Hungary, 1036 Pest Megyei Flor Ferenc Korhaz Kistarcsa, Hungary, 2143 Szabolcs-Szatmar-Bereg megyei Nyiregyhaza, Hungary, 4400 Poland Krakowskie Centrum Medyczne sp. Z.O.O Krakow, Poland, 31-501 NZOZ Lecznica MAK-MED s.c. Nadarzyn, Poland, 05-830 Prywatna Praktyka Lekarska Prof. UM dr hab.med. Pawel Hrycaj Poznan, Poland, 61-397 Reumatika-Centrum Reumatologii Warszawa, Poland, 02-691 Serbia Institute of Rheumatology Belgrade, Beograd, Serbia, 11000 Slovakia Reumatologicka ambulancia Bratislava, Slovakia, 841 04 AAGS, s.r.o. Dunajska Streda, Slovakia, 929 01 Reumatologicka ambulancia, MUDr. Zuzana Cizmarikova, s.r.o. Poprad, Slovakia, 058 01 REUMEX s.r.o. Rimavska Sobota, Slovakia, 979 01 REUMA-GLOBAL s.r.o. Trnava, Slovakia, 917 01 Reumatologicka ambulancia Zilina, Slovakia, 010 01 South Africa Panorama Medical Centre Panorama, Cape Town, South Africa, 7500 Wits Clinical Research CMJAH Clinical Trial Site Parktown, Johannesburg, South Africa, 2193 St. Augustines Hospital Durban/Berea, Kwazulu-natal, South Africa, 4001 收起 << |
NCT02378506 | - | Completed | - | - | |
NCT02938520 | HIV Infections | Phase 2 Phase 3 | Active, not recruiting | July 7, 2022 | - |
NCT01396148 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Czechia Fakultni nemocnice Brno Brno, Czechia, 613 00 FN Brno Brno, Czechia, 625 00 Masarykuv onkologicky ustav Brno, Czechia, 656 33 France CHU de La Timone, Hopital enfants Marseille cedex 5, France, 13385 Hopital d'Enfants de la Timone Marseille cedex 5, France, 13385 Hopital de la Timone Marseille cedex 5, France, 13385 收起 << |
NCT03083184 | Tunnelled Hemodialysis Cathete... 展开 >>r Infection 收起 << | Phase 3 | Not yet recruiting | March 2021 | France ... 展开 >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN 0473751081 placarin@chu-clermontferrand.fr Principal Investigator: Julien ANIORT 收起 << |
NCT01684215 | Neoplasms Bre... 展开 >>ast Neoplasms 收起 << | Phase 2 | Completed | - | Japan ... 展开 >> Aichi Cancer Center Hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 National Hospital Organization Hokkaido Cancer Center Sapporo, Hokkaido, Japan, 003-0804 Kumamoto Shinto General Hospital Kumamoto-city, Kumamoto, Japan, 862-8655 Saitama Cancer Center Kita-adachi-gun, Saitama, Japan, 362-0806 National Cancer Center Hospital Chuo-Ku, Tokyo, Japan, 104-0045 Chiba Cancer Center Chiba, Japan, 260-8717 National Hospital Organization Shikoku Cancer Center Ehime, Japan, 791-0280 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Hiroshima City Hiroshima Citizens Hospital Hiroshima, Japan, 730-8518 Iwate Medical University Hospital Iwate, Japan, 020-8505 Hakuaikai Medical Corporation Sagara Hospital Kagoshima, Japan, 892-0833 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Kumamoto City Hospital Kumamoto, Japan, 862-8505 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization Osaka National Hospital Osaka, Japan, 540-0006 收起 << |
NCT01684215 | - | Completed | - | - | |
NCT02287779 | - | Completed | - | - | |
NCT01512160 | Post-surgical Dental Pain | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | United States, Texas ... 展开 >> Pfizer Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT01342926 | Atrophy, Geographic | Phase 2 | Completed | - | - |
NCT01512160 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01396148 | - | Completed | - | - | |
NCT00985673 | Influenza | Phase 2 | Completed | - | United States, Georgia ... 展开 >> GSK Investigational Site Stockbridge, Georgia, United States, 30281 United States, North Carolina GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Fort Worth, Texas, United States, 76135 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 4J6 收起 << |
NCT02287779 | Non-Alcoholic Steatohepatitis | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> New Orleans Center for Clinical Research Knoxsville, Tennessee, United States, 37920 收起 << |
NCT02319148 | Healthy Volunteers | Phase 1 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT02319148 | - | Completed | - | - | |
NCT00903617 | - | Completed | - | - | |
NCT01529346 | Postoperative Dental Pain | Phase 2 | Completed | - | United States, Texas ... 展开 >> Central Texas Oral Surgery Associates Austin, Texas, United States, 78705 Premier Research Group Limited Austin, Texas, United States, 78705 PPD Development, LP Austin, Texas, United States, 78744 收起 << |
NCT01342926 | - | Completed | - | - | |
NCT02683122 | - | Completed | - | France ... 展开 >> Centre Chirurgical Marie Lannelongue Le Plessis Robinson, France, 92350 收起 << | |
NCT00903617 | Dyslipidaemias | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Pembroke Pines, Florida, United States, 33026 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46260 United States, Kentucky GSK Investigational Site Louisville, Kentucky, United States, 40213 United States, Maine GSK Investigational Site Auburn, Maine, United States, 04210 United States, Minnesota GSK Investigational Site Brooklyn Center, Minnesota, United States, 55430 United States, North Carolina GSK Investigational Site Statesville, North Carolina, United States, 28677 United States, Ohio GSK Investigational Site Cincinnati, Ohio, United States, 45246 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78205 United States, Virginia GSK Investigational Site Richmond, Virginia, United States, 23294 United States, Washington GSK Investigational Site Olympia, Washington, United States, 98502 GSK Investigational Site Seattle, Washington, United States, 98104 收起 << |
NCT00920140 | Cancer | Phase 2 | Completed | - | - |
NCT01514864 | - | Terminated(Lack of efficacy an... 展开 >>d slow accrual) 收起 << | - | - | |
NCT01529346 | - | Completed | - | - | |
NCT00596947 | Transplants and Implants | Phase 4 | Terminated(due to low study en... 展开 >>rollment) 收起 << | - | United States, Pennsylvania ... 展开 >> Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT02193815 | Psoriasis Vulgaris | Phase 1 | Completed | - | Germany ... 展开 >> Bioskin GmbH Hamburg, Germany, 20095 收起 << |
NCT00596947 | - | Terminated(due to low study en... 展开 >>rollment) 收起 << | - | - | |
NCT00985673 | - | Completed | - | - | |
NCT02373202 | Rheumatoid Arthritis | Phase 3 | Completed | - | Japan ... 展开 >> Investigational Site Number 392010 Asahi-Shi, Japan Investigational Site Number 392001 Asahikawa-Shi, Japan Investigational Site Number 392070 Beppu-Shi, Japan Investigational Site Number 392036 Chiba-Shi, Japan Investigational Site Number 392083 Chuo-Ku, Japan Investigational Site Number 392004 Fukui-Shi, Japan Investigational Site Number 392039 Fukuoka-Shi, Japan Investigational Site Number 392030 Ichinomiya-Shi, Japan Investigational Site Number 392002 Iizuka-Shi, Japan Investigational Site Number 392019 Kagoshima-Shi, Japan Investigational Site Number 392066 Kamakura-Shi, Japan Investigational Site Number 392050 Kato-Shi, Japan Investigational Site Number 392037 Kawachi-Nagano-Shi, Japan Investigational Site Number 392099 Kawasaki-Shi, Japan Investigational Site Number 392013 Kitakyushu-Shi, Japan Investigational Site Number 392097 Kochi-Shi, Japan Investigational Site Number 392065 Kushiro-Shi, Japan Investigational Site Number 392026 Matsuyama-Shi, Japan Investigational Site Number 392034 Miyagi-Gun, Japan Investigational Site Number 392076 Nagoya-Shi, Japan Investigational Site Number 392080 Nagoya-Shi, Japan Investigational Site Number 392046 Narashino-Shi, Japan Investigational Site Number 392059 Oita-Shi, Japan Investigational Site Number 392062 Okayama-Shi, Japan Investigational Site Number 392027 Osaki-Shi, Japan Investigational Site Number 392049 Sagamihara-Shi, Japan Investigational Site Number 392014 Sapporo-Shi, Japan Investigational Site Number 392041 Sapporo-Shi, Japan Investigational Site Number 392073 Sapporo-Shi, Japan Investigational Site Number 392006 Sasebo-Shi, Japan Investigational Site Number 392021 Sendai-Shi, Japan Investigational Site Number 392022 Sendai-Shi, Japan Investigational Site Number 392033 Sendai-Shi, Japan Investigational Site Number 392071 Sendai-Shi, Japan Investigational Site Number 392029 Shizuoka-Shi, Japan Investigational Site Number 392023 Takaoka-Shi, Japan Investigational Site Number 392003 Tomakomai-Shi, Japan Investigational Site Number 392074 Urasoe-Shi, Japan Investigational Site Number 392079 Urayasu-Shi, Japan Investigational Site Number 392048 Yokohama-Shi, Japan 收起 << |
NCT00920140 | - | Completed | - | - | |
NCT01514864 | Carcinoma, Non-small Cell Lung | Phase 2 | Terminated(Lack of efficacy an... 展开 >>d slow accrual) 收起 << | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Brazil Local Institution Barretos, Sao Paulo, Brazil, 14784 Local Institution S?o Paulo, Sao Paulo, Brazil, 05403 Canada, Ontario The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Germany Local Institution Frankfurt, Germany, 60488 Local Institution Heidelberg, Germany, 69120 Local Institution Heidelberg, Germany, 69126 Local Institution Koeln, Germany, 50924 Local Institution Koeln, Germany, 50931 Poland Local Institution Gdansk, Poland, 80-219 Local Institution Lodz, Poland, 93-509 Local Institution Warsaw, Poland, 02-781 Taiwan Local Institution Taipei, Taiwan, 112 United Kingdom Local Institution Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ Local Institution London, Greater London, United Kingdom, SW3 6JJ Local Institution Manchester, Greater Manchester, United Kingdom, M20 4BX Local Institution Edinburgh, Midlothian, United Kingdom, EH4 2XU Local Institution Sutton, Surrey, United Kingdom, SM2 5PT Local Institution Gwent, United Kingdom, NP20 2UB 收起 << |
NCT02373202 | - | Completed | - | - | |
NCT00159783 | Bipolar Disorder | Phase 3 | Completed | - | - |
NCT02193815 | - | Completed | - | - | |
NCT02341482 | Healthy | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT01336621 | Epilepsy | Phase 3 | Completed | - | - |
NCT02341482 | - | Completed | - | - | |
NCT01577381 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01577381 | Age-Related Maculopathy | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00159783 | - | Completed | - | - | |
NCT01819922 | Healthy | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT01819922 | - | Completed | - | - | |
NCT00313144 | Alpha1-antitrypsin Deficiency | Phase 4 | Terminated(Study terminated ea... 展开 >>rly due to Aralast being phased out of the market.) 收起 << | - | United States, California ... 展开 >> Adupa Rao, MD San Marino, California, United States, 91108 收起 << |
NCT00195260 | Neoplasms | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Pfizer Investigational Site Birmington, Alabama, United States, 35233 United States, Arizona Pfizer Investigational Site Scottsdale, Arizona, United States, 85258 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90033 United States, Florida Pfizer Investigational Site Tampa, Florida, United States, 33612 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30341 United States, Indiana Pfizer Investigational Site Indianpolis, Indiana, United States, 46202 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21287 United States, Michigan Pfizer Investigational Site Detroit, Michigan, United States, 48202 Pfizer Investigational Site Lansing, Michigan, United States, 48910 United States, New York Pfizer Investigational Site New York, New York, United States, 10016 Pfizer Investigational Site New York, New York, United States, 10032 United States, North Carolina Pfizer Investigational Site Charlotte, North Carolina, United States, 28203 Pfizer Investigational Site Charlotte, North Carolina, United States, 28211 Pfizer Investigational Site UNC Chapel Hill, North Carolina, United States, 27514 Pfizer Investigational Site UNC Chapel Hill, North Carolina, United States, 27759 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44106-1736 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78258 Pfizer Investigational Site Tyler, Texas, United States, 75702 United States, Washington Pfizer Investigational Site Seattle, Washington, United States, 98104 收起 << |
NCT00195260 | - | Completed | - | - | |
NCT00404768 | Obstetric Labour, Premature | Phase 2 | Completed | - | - |
NCT00633464 | - | Completed | - | - | |
NCT03041961 | Healthy Young Men | Not Applicable | Completed | - | United Kingdom ... 展开 >> Department of Life Sciences and Medecine London, Central London, United Kingdom, SE1 9NH 收起 << |
NCT02503761 | Late Onset Neonatal Sepsis | Phase 3 | Completed | - | - |
NCT01336621 | - | Completed | - | - | |
NCT00313144 | - | Terminated(Study terminated ea... 展开 >>rly due to Aralast being phased out of the market.) 收起 << | - | - | |
NCT02880943 | Clear-cell Metastatic Renal Ce... 展开 >>ll Carcinoma Bone Metastases 收起 << | Phase 1 Phase 2 | Active, not recruiting | February 2021 | France ... 展开 >> CHU Bordeaux (St. André) Bordeaux, France, 33000 Centre François Baclesse Caen, France, 14000 Hôpital Cochin Paris, France, 75014 Hopital Europeen Georges Pompidou Paris, France, 75015 Institut Gustave Roussy Villejuif, France, 94805 cedex 收起 << |
NCT01925274 | Metastatic Colorectal Cancer | Phase 2 | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | United States, California ... 展开 >> CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Drug Management Only: UCLA West Medical Pharmacy, Att: Steven L Wong, Pharm D Los Angeles, California, United States, 90095-7349 Drug Management Only: UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 UCLA West Medical Pharmacy Los Angeles, California, United States, 90095-7349 Regulatory Management Only: TRIO-US Central Administration Los Angeles, California, United States, 90095 TRIO-US Central Administration (Regulatory Management only) Los Angeles, California, United States, 90095 TRIO_US Los Angeles, California, United States, 90095 West Valley Hematology/Oncology Med Group Northridge, California, United States, 91328 United States, Missouri Siteman Cancer Center - West County Creve Coeur, Missouri, United States, 63141 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Drug Shipping Address: Washington University Infusion Center Pharmacy Saint Louis, Missouri, United States, 63110 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center - South County Saint Louis, Missouri, United States, 63129 Siteman Cancer Center - St Peters Saint Peters, Missouri, United States, 63376 United States, Nevada Regulatory Office: Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89014 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89052 Comprehensive Cancer Centers of Nevada Henderson, Nevada, United States, 89074 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89128 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89148 Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89169 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Kadlec Clinic Hematology and Oncology Kennewick, Washington, United States, 99336 Kadlec Medical Center Richland, Washington, United States, 99352 Outpatient Imaging Center Richland, Washington, United States, 99352 Spokane Valley Cancer Center Spokane Valley, Washington, United States, 99216 Medical Oncology Associates, PS Spokane, Washington, United States, 99208 Japan Aichi cancer center central hospital Nagoya, Aichi, Japan, 464-8681 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Korea, Republic of National Cancer Center Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Spain Hospital General Universitario Gregorio Marañón Madrid, Spain, 28009 收起 << |
NCT00404768 | - | Completed | - | - | |
NCT02716194 | - | Completed | - | - | |
NCT01925274 | - | Terminated(Enrollment to the s... 展开 >>tudy was terminated on 11Nvo2014 due to slow recruitment. There were no safety or efficacy issues that contributed to this decision.) 收起 << | - | - | |
NCT00633464 | Triple Negative Locally Advanc... 展开 >>ed Non-resectable Breast Cancer Metastatic Breast Cancer 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> Local Institution Graz, Austria, 8036 Local Institution Wien, Austria, 1090 Czech Republic Local Institution Brno, Czech Republic, 656 53 Local Institution Prague 5, Czech Republic, 150 06 Local Institution Praha 2, Czech Republic, 128 08 France Local Institution Bayonne, France, 64100 Local Institution Dijon Cedex, France, 21079 Local Institution Lyon, France, 69008 Local Institution Paris Cedex 13, France, 75651 Local Institution Saint Brieuc, France, 22015 Local Institution Saint Herblain Cedex, France, 44805 Local Institution Toulouse Cedex, France, 31052 Greece Local Institution Thessaloniki, Greece, 54642 Italy Local Institution Napoli, Italy, 80131 Poland Local Institution Gdansk, Poland, 80952 Local Institution Olsztyn, Poland, 10-513 Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08208 Local Institution Barcelona, Spain, 08221 收起 << |
NCT02969044 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02969044 | - | Completed | - | - | |
NCT02716194 | Hemophilia A | Phase 1 | Completed | - | Bulgaria ... 展开 >> UMHAT "Sv. Georgi", EAD Plovdiv, Bulgaria, 4000 Germany Werlhof-Institut Hannover, Niedersachsen, Germany, 30159 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Vivantes Klinikum im Friedrichshain - Landsberger Allee Berlin, Germany, 10249 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Universitaetsklinikum Gießen Marburg, Germany, 35043 Hungary Semmelweis Egyetem AOK I.sz. Belgyogyaszati Klinika Budapest, Hungary, 1083 Italy Presidio Ospedaliero di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy, 31033 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 Policlinico Umberto I di Roma-Università di Roma La Sapienza Roma, Italy, 00144 Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6525 GA Erasmus Medisch Centrum Rotterdam, Netherlands, 3015 AA Poland Instytut Hematologii i Transfuzjologii Warszawa, Poland, 02-776 Russian Federation FSBI "Kirov SR Institute of Hematology and Blood Transfusion FMBA" Kirov, Russian Federation, 610027 FSBI "Hematological Research Center" MoH of RF Moscow, Russian Federation, 125167 SBEI HPE "Samara State Medical University" of the MoH of the RF Samara, Russian Federation, 443099 Spain Complejo Hospitalario Universitario A Coruña A Coruña, La Coruña, Spain, 15006 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Regional Universitario de Malaga Malaga, Spain, 29010 Hospital Universitario Son Espases Palma de Mallorca, Spain, 07120 United Kingdom Royal Cornwall Hospital Truro, Cornwall, United Kingdom, TR1 3LJ Royal London Hospital London, Greater London, United Kingdom, E1 1BB Royal Free Hospital London, Greater London, United Kingdom, NW3 2QG St Thomas' Hospital Centre for Haemostasis & Thrombosis London, Greater London, United Kingdom, SE1 7EH Manchester Royal Infirmary Manchester, Greater Manchester, United Kingdom, M13 9WL University Hospital of Wales Cardiff, West Glamorgan, United Kingdom, CF14 4XW 收起 << |
NCT00244751 | Cirrhosis, Liver | Phase 2 | Completed | - | - |
NCT00244751 | - | Completed | - | - | |
NCT03314493 | Coronary Artery Calcification ... 展开 >> Vascular Calcification 收起 << | Phase 3 | Completed | - | Brazil ... 展开 >> Instituto de Medicina Integral Prof. Fernando Figueira Recife, Pernambuco, Brazil, 50070-550 收起 << |
NCT01970865 | ALK-positive Non Small Cell Lu... 展开 >>ng Cancer (NSCLC) and ROS1-positive NSCLC 收起 << | Phase 2 | Active, not recruiting | February 19, 2019 | - |
NCT01718054 | Sickle Cell Disease | Phase 2 Phase 3 | Unknown | September 2017 | Tanzania ... 展开 >> Muhimbili University of Heath and Allied Sciences (MUHAS) Dar es Salaam, Tanzania 收起 << |
NCT03077048 | Renal Insufficiency, Chronic | Phase 1 Phase 2 | Completed | - | Czechia ... 展开 >> Thomayer Hospital Clinical - Pharmacology Unit (CPU) Prague, Czechia, 140 59 收起 << |
NCT02452047 | Bacterial Infections | Phase 3 | Completed | - | - |
NCT02629185 | - | Completed | - | United Kingdom ... 展开 >> University of Sheffield Sheffield, United Kingdom, S10 2TN 收起 << | |
NCT01792635 | Diabetes Mellitus, Type 2 | Phase 2 | Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 << | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 收起 << |
NCT01929863 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Miami, Florida, United States, 33169 收起 << |
NCT01792635 | - | Terminated(The study was termi... 展开 >>nated prematurely on 16 May 2014 due to a safety concern.) 收起 << | - | - | |
NCT01929863 | - | Completed | - | - | |
NCT00441116 | Alopecia | Phase 3 | Completed | - | - |
NCT01970865 | - | Active, not recruiting | - | - | |
NCT02452047 | - | Completed | - | - | |
NCT02231021 | Type 2 Diabetes Mellitus | Phase 4 | Recruiting | November 2018 | Korea, Republic of ... 展开 >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Principal Investigator: Kun-Ho Yoon, MD, PhD Sub-Investigator: Yoon-Hee Choi, MD, PhD Sub-Investigator: Hye-Kyung Yang, MD 收起 << |
NCT00441116 | - | Completed | - | - | |
NCT02003924 | Nonmetastatic Castration-Resis... 展开 >>tant Prostate Cancer Prostate Cancer Cancer of the Prostate 收起 << | Phase 3 | Active, not recruiting | May 31, 2020 | - |
NCT00663702 | Arthritis, Rheumatoid | Phase 3 | Completed | - | - |
NCT01050998 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02003924 | - | Active, not recruiting | - | - | |
NCT00239356 | Schizophrenia | Phase 3 | Completed | - | Canada, Ontario ... 展开 >> Local Institution Ottawa, Ontario, Canada Canada, Quebec Local Institution Sherbrooke, Quebec, Canada Croatia Local Institution Rijeka, Croatia Local Institution Zagreb, Croatia Czech Republic Local Institution Hradec Kralove, Czech Republic Local Institution Prague 6, Czech Republic France Local Institution Nantes Orvault, France Local Institution Rennes Cedex, France Local Institution Uzes, France Hungary Local Institution Budapest, Hungary Local Institution Gyor, Hungary Netherlands Local Institution Vught, Netherlands Poland Local Institution Krakow, Poland Local Institution Poznan, Poland Romania Local Institution Bucharest, Romania Russian Federation Local Institution St. Petersburg, Russian Federation South Africa Local Institution Westdene, Free State, South Africa Local Institution Johannesburg, Gauteng, South Africa Local Institution Cape Town, Western Cape, South Africa United Kingdom Local Institution Antrim, United Kingdom 收起 << |
NCT00239356 | - | Completed | - | - | |
NCT03122340 | Acute Coronary Syndrome | Phase 3 | Completed | - | Russian Federation ... 展开 >> Cardiology Research Institute Tomsk, Russian Federation, 634012 收起 << |
NCT03067961 | Salmonella Typhi Infection | Not Applicable | Active, not recruiting | August 15, 2019 | United Kingdom ... 展开 >> Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine Oxford, Oxfordshire, United Kingdom, OX3 7LE 收起 << |
NCT02565628 | - | Completed | - | - | |
NCT01050998 | - | Completed | - | - | |
NCT00663702 | - | Completed | - | - | |
NCT01863043 | Infant, Premature ... 展开 >> Nutrition, Enteral 收起 << | Not Applicable | Active, not recruiting | February 2019 | United States, Florida ... 展开 >> Neonatal intensive care unit at Shands children's hospital at the Univeristy of Florida Gainesville, Florida, United States, 32504 收起 << |
NCT01327547 | - | Completed | - | - | |
NCT02565628 | Idiopathic Parkinson's Disease | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 United States, Florida MD Clinical Hallandale Beach, Florida, United States, 33009 QPS-MRA, LLC (Broward Research Group) Hollywood, Florida, United States, 33024 Qps-Mra Llc South Miami, Florida, United States, 33143 QPS-MRA, LLC (Miami research Associates) South Miami, Florida, United States, 33143 QPS-MRA, LLC (MRA Clinical Research) South Miami, Florida, United States, 33143 United States, Georgia Atlanta Center for Medical Research Atlanta, Georgia, United States, 30331 United States, New Jersey CRI Worldwide, LLC Marlton, New Jersey, United States, 08053 United States, Ohio CTI Clinical Research Center Cincinnati, Ohio, United States, 45255 收起 << |
NCT02496221 | - | Completed | - | - | |
NCT01172847 | Healthy Volunteer | Phase 1 | Completed | - | United States, Arkansas ... 展开 >> Little Rock, Arkansas, United States, 72204 收起 << |
NCT01327547 | HIV Coinfection | Phase 4 | Completed | - | - |
NCT01172847 | - | Completed | - | - | |
NCT01734993 | Rheumatoid Arthritis | Phase 3 | Completed | - | France ... 展开 >> Bordeaux, France, 33076 Montpellier, France, 34295 Nantes, France, 44035 Paris, France, 75679 Strasbourg, France, 67098 Toulouse, France, 31059 收起 << |
NCT02496221 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT03431077 | Catecholamine-resistant Hypote... 展开 >>nsion (CRH) Distributive Shock High Output Shock Sepsis 收起 << | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Investigational Site Charlotte, North Carolina, United States, 28203 United States, Ohio Investigational Site Cincinnati, Ohio, United States, 45229 United States, Texas Investigational Site San Antonio, Texas, United States, 78207 收起 << |
NCT03622112 | Asthma | Phase 2 | Not yet recruiting | September 6, 2019 | - |
NCT01734993 | - | Completed | - | - | |
NCT00833989 | Ischaemic Attack, Transient | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90095-6984 GSK Investigational Site Orange, California, United States, 92868-4280 United States, Colorado GSK Investigational Site Fort Collins, Colorado, United States, 80524 United States, Michigan GSK Investigational Site Detroit, Michigan, United States, 48201 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4N 3M5 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Wiesbaden, Hessen, Germany, 65199 GSK Investigational Site Celle, Niedersachsen, Germany, 29223 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT03169959 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Research Site Baltimore, Maryland, United States, 21225 收起 << |
NCT00537654 | Prostatic Hyperplasia | Phase 1 | Completed | - | United States, Indiana ... 展开 >> GSK Investigational Site Evansville, Indiana, United States, 47714 United States, Texas GSK Investigational Site Austin, Texas, United States, 78752 收起 << |
NCT02114203 | Phase 1 Sickle Cell | Phase 1 | Completed | - | United States, Illinois ... 展开 >> University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612-5836 University of Illinois at Chicago Clinical Research Center Chicago, Illinois, United States, 60612 University of Illinois Hospital and Health Sciences System Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center E7E Boston, Massachusetts, United States, 02118 Boston Medical Center Boston, Massachusetts, United States, 02118 Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Interfaith Medical Center Brooklyn, New York, United States, 11213 Interfaith Medical Center Brooklyn, New York, United States, 11238 United States, North Carolina UNC Hospitals' Investigational Drug Service Pharmacy Chapel Hill, North Carolina, United States, 27514 UNC School of Medicine Clinical and Translational Research Center Chapel Hill, North Carolina, United States, 27599 United States, Virginia Investigational Drug Services Richmond, Virginia, United States, 23298 Virginia Commonwealth University Richmond, Virginia, United States, 23298 Belgium Pfizer Clinical Research Unit Brussels, Belgium, B-1070 Italy Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano, Italy, 20122 A.O.O.R Villa Sofia - V. Cervello Palermo, Italy, 90146 Netherlands Centre for Human Drug Research Leiden, Netherlands, 2333 CL United Kingdom Royal Liverpool and Broadgreen University Hospital Trust Liverpool, Merseyside, United Kingdom, L7 8XP Guy's and St Thomas' NHS Foundation Trust London, United Kingdom, SE1 9RT King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Imperial College Healthcare NHS Trust London, United Kingdom, W12 0HS Central Manchester University Hospitals NHS Foundation Trust Manchester, United Kingdom, M13 9WL Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Oxford University Hospitals NHS Trust Oxford, United Kingdom, OX3 7LE 收起 << |
NCT00451321 | - | Terminated | - | - | |
NCT03483090 | Osteoarthritis, Knee | Phase 2 | Recruiting | July 30, 2020 | Australia, Queensland ... 展开 >> University of the Sunshine Coast Clinical Trials Centre, Morayfield Health Hub Recruiting Morayfield, Queensland, Australia, 4506 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray University of the Sunshine Coast Clinical Trials Centre, USC Health Clinics Recruiting Sippy Downs, Queensland, Australia, 4556 Contact: Jessica Baird +61 7 5456 3797 trials@usc.edu.au Contact: Georgina Street +61 7 5456 3798 gstreet@usc.edu.au Principal Investigator: Susan Thackwray Australia, South Australia CSIRO Nutrition and Health Research Clinic Recruiting Adelaide, South Australia, Australia, 5000 Contact: Bianca Benassi-Evans Australia, Victoria Emeritus Research Recruiting Camberwell, Victoria, Australia, 3124 Contact: Edwin Young +61 3 950 96166 edwinyoung@emeritusresearch.com Contact: Teresa Ringeri +61 3 950 96166 teresaringeri@emeritusresearch.com Principal Investigator: Andrew Ostor 收起 << |
NCT02563899 | - | Completed | - | - | |
NCT02114203 | - | Completed | - | - | |
NCT00802854 | - | Completed | - | Korea, Republic of ... 展开 >> Chonbuk National University Hospital Deokjin-gu, Jeollabuk-do, Korea, Republic of, 561-712 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Dong-A University Medical Center (Dong-A University Hospital) Busen, Korea, Republic of, 602-715 Keimyung University Dongsan Medical Center (KUDMC) Daegu, Korea, Republic of, 700-712 Daegu fatima hospital Daegu, Korea, Republic of, 701-724 Daegu Catholic University Medical Center (DCUMC) Daegu, Korea, Republic of, 705-718 Ajou University Hospital Gyeonggi-do, Korea, Republic of, 443-721 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Seoul Medical Center Seoul, Korea, Republic of, 131-795 Asan Medical Center Seoul, Korea, Republic of, 138-736 收起 << | |
NCT02780882 | Ectopic ACTH Syndrome | Phase 2 | Withdrawn(Due to stringent inc... 展开 >>lusion/exclusion criteria, study investigator deemed it not feasible.) 收起 << | June 2019 | United States, California ... 展开 >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 收起 << |
NCT00802854 | - | Completed | - | - | |
NCT00451321 | Diabetes Mellitus, Type 1 | Phase 2 | Terminated | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35294 United States, California GSK Investigational Site Walnut Creek, California, United States, 94598 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, District of Columbia GSK Investigational Site Washington, D.C., District of Columbia, United States, 20037 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32207 GSK Investigational Site Pinellas Park, Florida, United States, 33781 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Maryland GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 1655 United States, Michigan GSK Investigational Site Kalamazoo, Michigan, United States, 49048 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55455 United States, Mississippi GSK Investigational Site Gulfport, Mississippi, United States, 39501 United States, Nebraska GSK Investigational Site Omaha, Nebraska, United States, 68131 United States, Ohio GSK Investigational Site Mentor, Ohio, United States, 44060 United States, South Dakota GSK Investigational Site Rapid City, South Dakota, United States, 57701 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229-4801 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M4G 3E8 收起 << |
NCT00833989 | - | Completed | - | - | |
NCT02832362 | Common Cold | Phase 1 | Completed | - | Canada, Quebec ... 展开 >> GSK Investigational Site Quebec City, Quebec, Canada, G1P 0A2 收起 << |
NCT02871570 | Moderate Hepatic Impairment ... 展开 >> Normal Hepatic Function 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> Orlando Clincial Research Center Orlando, Florida, United States, 32809 收起 << |
NCT02871570 | - | Completed | - | - | |
NCT02849613 | Stroke | Phase 2 Phase 3 | Withdrawn(Not authorized by Re... 展开 >>gulatory agencies - new protocol phase 1a in progress) 收起 << | - | France ... 展开 >> University Grenoble Hospital / EFS Grenoble, France, 38043 收起 << |
NCT03329573 | Anxiety Disorders | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China, 201508 收起 << |
NCT01571284 | - | Completed | - | - | |
NCT02563899 | Hyperhidrosis | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> GSK Investigational Site Raleigh, North Carolina, United States, 27612 United States, Texas GSK Investigational Site Austin, Texas, United States, 78759 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H2K 4L5 收起 << |
NCT02893488 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT00529789 | Major Depressive Disorder | Phase 2 | Completed | - | - |
NCT01571284 | Colorectal Cancer Metastatic | Phase 3 | Completed | - | - |
NCT01028911 | - | Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 << | - | - | |
NCT00529789 | - | Completed | - | - | |
NCT03149848 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom 收起 << |
NCT01028911 | Alzheimer's Disease | Phase 1 | Terminated(This study terminat... 展开 >>ed 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.) 收起 << | - | United States, Kansas ... 展开 >> Pfizer Investigational Site Wichita, Kansas, United States, 67207 Pfizer Investigational Site Wichita, Kansas, United States, 67211 收起 << |
NCT01652885 | - | Completed | - | - | |
NCT01652885 | Dermatitis, Atopic | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Anacor Investigational Site Fremont, California, United States, 94538 Anacor Investigational Site San Diego, California, United States, 92123 United States, Indiana Anacor Investigational Site Indianapolis, Indiana, United States, 46256 United States, North Carolina Anacor Investigational Site High Point, North Carolina, United States, 27262 Anacor Investigational Site Winston-Salem, North Carolina, United States, 27104 United States, Texas Anacor Investigational Site Houston, Texas, United States, 77030 收起 << |
NCT03570450 | Stroke | Phase 1 | Recruiting | September 2020 | France ... 展开 >> CHU Recruiting Grenoble, France, 38043 Contact: Olivier Detante, MD PhD 04 76 76 57 89 ext +33 odetante@chu-grenoble-alpes.fr Contact: Laetitia Wioland, PhD 04 76 76 57 89 ext +33 lwioland@chu-grenoble.fr 收起 << |
NCT01875081 | Alcoholic Liver Cirrhosis | Phase 2 | Completed | - | Korea, Republic of ... 展开 >> Pharmicell Co., Ltd. Seoul, Korea, Republic of 收起 << |
NCT01316939 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT01696279 | Chronic Kidney Disease ... 展开 >> Hyperphosphatemia 收起 << | Phase 2 | Active, not recruiting | February 27, 2019 | Argentina ... 展开 >> Centro Infantil Del Rinon S.R.L San Miguel de Tucuman, Tucuman, Argentina, 4000 Chile Hospital Luis Calvo Mackenna Santiago, Chile, 7500539 Hospital Dr. Sotero del Rio Santiago, Chile, 8207257 Czechia Fakultni nemocnice Ostrava Ostrava, Czechia, 70852 University Hospital Motol Prague 5, Czechia, 15006 Germany Kinder-und Jugendklinik Erlangen Erlangen, Germany, 91054 Medizinische Hochschule Hannover Hannover, Germany, 30625 Hungary Semmelweis Egyetem Altalanos Orvostudomanyi Kar Budapest, Bokay Janos, Hungary, 1083 Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum Debrecen, Hungary, 4032 Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar Szeged, Hungary, 6720 Poland Uniwersytecki Dzieciecy Szpital Kliniczny Bialystok, Poland, 15-274 Uniwersytecki Szpital Dzieciecy w Krakowie, Klinika Nefrologii Dzieciecej ze Stacja Dializ Krakow, Poland, 30663 NZOZ tri-Medica Lodz, Poland, 93-338 Uniwersytecki Szpital Kliniczny Wroclaw, Poland, 50556 Romania Spitalul Clinic de Urgenta pentru Copii Sf. Maria Iasi, Romania Spitalul Clinic de Urgenta pentru Copii - Louis Turcanu Timisoara, Romania, 300350 Russian Federation Children City Clinical Hospital of Saint Vladimir Moscow, Russian Federation, 107014 Saint-Petersburg State Budgetary Healthcare Institution "Children City Hospital #1" Saint-Petersburg, Russian Federation, 198205 State Budgetary Healthcare Instit. of Sverdiov Region "Regional Children Clinical Hosp #1" Yekaterinburg, Russian Federation, 620143 Turkey Cukurova University Faculty of Medicine Paediatric Nephrology Adana, Turkey, 01330 Izmir Tepecik Training and Research Hospital Izmir, Turkey, 4500 Manisa Celal Bayar University Hafsa Sultan Hospital Manisa, Turkey, 45030 收起 << |
NCT00396994 | Osteopenia | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Hebrew SeniorLife, Institute for Aging Research Boston, Massachusetts, United States, 02131 收起 << |
NCT01316939 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT00708552 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT02241876 | Head and Neck Neoplasms | Phase 4 | Unknown | - | Brazil ... 展开 >> State University of Campinas - UNICAMP, Hospital das Clinicas Not yet recruiting Campinas, São Paulo, Brazil, 13083-888 Contact: Patricial Moriel 55 (19) 35218884 morielpa@fcm.unicamp.br Contact: Marília B Visacri 55 (19) 35218884 mariberlofa@gmail.com Principal Investigator: Marilia B Visacri 收起 << |
NCT01920568 | Fractures, Bone | Phase 3 | Completed | - | China, Guangdong ... 展开 >> GSK Investigational Site Guangzhou, Guangdong, China, 510060 GSK Investigational Site Guangzhou, Guangdong, China, 510120 GSK Investigational Site Guangzhou, Guangdong, China, 510515 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210002 GSK Investigational Site Nanjing, Jiangsu, China, 210009 China, Jilin GSK Investigational Site Changchun, Jilin, China, 130012 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 China GSK Investigational Site Beijing, China, 100021 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100036 GSK Investigational Site Beijing, China, 100071 GSK Investigational Site Fuzhou, China, 350001 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Harbin, China GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200032 GSK Investigational Site Shanghai, China, 200070 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shanghai, China, 200233 GSK Investigational Site Tianjin, China, 300060 Singapore GSK Investigational Site Singapore, Singapore, 119074 Taiwan GSK Investigational Site Taichung, Taiwan, 404 GSK Investigational Site Taoyuan, Taiwan, 333 收起 << |
NCT03568942 | Infections, Bacterial | Phase 2 | Recruiting | December 14, 2018 | United States, California ... 展开 >> GSK Investigational Site Recruiting La Mesa, California, United States, 91942 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00708552 | - | Completed | - | - | |
NCT01920568 | - | Completed | - | - | |
NCT00724867 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT03728868 | Healthy Individuals | Not Applicable | Recruiting | October 1, 2019 | Sweden ... 展开 >> Geriatric Medicine, Sahlgrenska University Hospital, Mölndal Recruiting Gothenburg, Västra Götaland, Sweden, 43180 Contact: Maria Falkdal, Nurse +4631 34 310 67 maria.falkdal@gu.se Contact: Linda Jonsson, Nurse 收起 << |
NCT03517254 | Anterior Cruciate Ligament Rec... 展开 >>onstruction 收起 << | Not Applicable | Recruiting | April 2019 | Mexico ... 展开 >> Instituto Nacional de Rehabilitación Recruiting Mexico City, Mexico, 14389 Contact: Sandra Hernández Valencia, MSc +5255 5999-1000 ext 15212 sandrahv710@gmail.com Contact: Saúl León Ballesteros, MD, MSc +5255 5999-1000 ext 15212 saulno1@yahoo.com Principal Investigator: Sandra Hernández Valencia, MSc,PhD (c) Principal Investigator: Saúl León, MD,MSc Sub-Investigator: Laura Moreno Altamirano, MD,MSc,PhD Sub-Investigator: Patricia Clark Peralta, MD,MSc,PhD Sub-Investigator: Guadalupe Gomez Pineda, MD Sub-Investigator: Juan Manuel Mejía Aranguré, MD,MSc,PhD Sub-Investigator: Rebeca Salas Romero, MSc Sub-Investigator: Andrea Pegueros Pérez, MSc 收起 << |
NCT00724867 | - | Completed | - | - | |
NCT02349139 | Cancer of the Prostate ... 展开 >> Neoplasms, Prostate Prostate Cancer Prostatic Cancer Neoplasms, Prostatic Prostate Neoplasms, Castration-resistant 收起 << | Phase 1 | Terminated(Business Decision) | - | United States, California ... 展开 >> UCLA Medical Center, Clark Urology Center Los Angeles, California, United States, 90095 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center, Hospital of the Univ. of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 收起 << |
NCT01012167 | Schizophrenia | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Baltimore VA Medical Center Baltimore, Maryland, United States, 21201 Community Mental Health Centers Baltimore, Maryland, United States, 21201 Keypoint Community Mental Health Centers Baltimore, Maryland, United States, 21222 Maryland Psychiatric Research Center Baltimore, Maryland, United States, 21228 Maryland Psychiatric Research Center Catonsville, Maryland, United States, 21228 Keypoint Mental health Center Dundalk, Maryland, United States, 21222 收起 << |
NCT03372083 | Iron Over Load | Phase 4 | Recruiting | November 14, 2019 | Italy ... 展开 >> Novartis Investigative Site Recruiting Cona, FE, Italy, 44100 Novartis Investigative Site Recruiting Cagliari, ITA, Italy, 09121 Novartis Investigative Site Recruiting Napoli, Italy, 80138 Lebanon Novartis Investigative Site Recruiting Hazmiyeh, Beirut, Lebanon, PO BOX 213 Oman Novartis Investigative Site Recruiting Muscat, Oman, 123 Russian Federation Novartis Investigative Site Recruiting Moscow, Russian Federation, 117198 Thailand Novartis Investigative Site Recruiting Bangkok noi, Bangkok, Thailand, 10700 Novartis Investigative Site Completed Muang, Chiangmai, Thailand, 50200 United Arab Emirates Novartis Investigative Site Recruiting Dubai, United Arab Emirates, 9115 收起 << |
NCT01012167 | - | Completed | - | - | |
NCT02722044 | Rheumatoid Arthritis | Phase 3 | Completed | - | United States, Michigan ... 展开 >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Medication Management, LLC Greensboro, North Carolina, United States, 27408 United States, Oklahoma Lynn Health Science Institute Oklahoma City, Oklahoma, United States, 73112 United States, Pennsylvania Altoona Center for Clinical Research, PC Duncansville, Pennsylvania, United States, 16635 United States, Texas Austin Regional Clinic, PA Austin, Texas, United States, 78731 Accurate Clinical Management Houston, Texas, United States, 77004 Accurate Clinical Research, Inc. Houston, Texas, United States, 77034 收起 << |
NCT02574325 | Nonalcoholic Steatohepatitis | Phase 2 | Unknown | December 2016 | United States, Missouri ... 展开 >> Gastroenterology & Hepatology CRU, St Louis University St Louis, Missouri, United States, 63104 收起 << |
NCT01119846 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85013 United States, California GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43212 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78209 United States, Washington GSK Investigational Site Tacoma, Washington, United States, 98418 收起 << |
NCT02518698 | - | Completed | - | United States, Kentucky ... 展开 >> Louisville, Kentucky, United States 收起 << | |
NCT01439373 | Hepatitis C, Chronic | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Anaheim, California, United States, 92801 GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site Coronado, California, United States, 92118 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Oceanside, California, United States, 92056 United States, Florida GSK Investigational Site Miramar, Florida, United States, 33025 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89109 United States, Oklahoma GSK Investigational Site Tulsa, Oklahoma, United States, 74104 United States, Texas GSK Investigational Site Houston, Texas, United States, 77004 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 收起 << |
NCT02293902 | Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT02722044 | - | Completed | - | - | |
NCT00819234 | Obesity | Phase 2 | Completed | - | - |
NCT01439373 | - | Completed | - | - | |
NCT00927082 | - | Completed | - | - | |
NCT00819234 | - | Completed | - | - | |
NCT02069886 | Thalassemia (Transfusion Delen... 展开 >>dent) 收起 << | Phase 4 | Withdrawn | December 2018 | - |
NCT01286779 | - | Completed | - | - | |
NCT00431236 | Nausea and Vomiting, Chemother... 展开 >>apy-Induced 收起 << | Phase 3 | Completed | - | - |
NCT00383149 | Metastatic Pancreatic Cancer | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Georgetn Univ Lombardi Can Ctr Washington, District of Columbia, United States, 20007 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 University Of Miami Miami, Florida, United States, 33136 United States, Michigan University Of Michigan Ann Arbor, Michigan, United States, 48109 Wayne State University Detroit, Michigan, United States, 48201 United States, Missouri Ellis Fischel Cancer Center Columbia, Missouri, United States, 65203 United States, South Carolina Cancer Centers Of The Carolinas Greenville, South Carolina, United States, 29615 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 收起 << |
NCT02293902 | - | Completed | - | - | |
NCT00927082 | Hepatitis B, Chronic | Phase 4 | Completed | - | - |
NCT00371150 | Hepatitis B Infection | Phase 4 | Completed | - | - |
NCT00371150 | - | Completed | - | - | |
NCT01286779 | Hemophilia B | Phase 3 | Completed | - | - |
NCT01945775 | - | Active, not recruiting | - | - | |
NCT02398201 | Mitochondrial Diseases | Phase 2 | Completed | - | United Kingdom ... 展开 >> Clinical Research Facility, Royal Victoria Infirmary Newcastle upon Tyne, Tyne and Wear, United Kingdom, NE1 4LP 收起 << |
NCT03665207 | Critical Illness ... 展开 >> Hyperglycemia 收起 << | Phase 3 | Recruiting | September 2025 | Belgium ... 展开 >> Department of Intensive Care Medicine, University Hospital Antwerp Not yet recruiting Antwerp, Belgium, 2650 Contact: Philippe Jorens, MD, PhD +32 3 8213635 Philippe.Jorens@uza.be Principal Investigator: Philippe Jorens, MD, PhD Department of Intensive Care Medicine, University Hospital Ghent Not yet recruiting Ghent, Belgium, 9000 Contact: Dominique Benoit, MD, PhD +32 9 3322775 Dominique.Benoit@UGent.be Principal Investigator: Dominique Benoit, MD, PhD Sub-Investigator: Eric Hoste, MD, PhD Sub-Investigator: Harlinde Peperstraete, MD Sub-Investigator: Joris Vermassen, MD Department of Intensive Care Medicine, Jessa Hospital Hasselt Not yet recruiting Hasselt, Belgium, 3500 Contact: Jasperina Dubois, MD + 32 11 308971 jasperina.dubois@jessazh.be Principal Investigator: Jasperina Dubois, MD Department of Intensive Care Medicine, University Hospitals Leuven Recruiting Leuven, Belgium, 3000 Contact: Greet Van den Berghe, MD, PhD +32 16 344021 greet.vandenberghe@kuleuven.be Contact: Jan Gunst, MD, PhD +32 16 344021 jan.gunst@kuleuven.be Principal Investigator: Greet Van den Berghe, MD, PhD Principal Investigator: Jan Gunst, MD, PhD Medical Intensive Care Unit, University Hospitals Leuven Not yet recruiting Leuven, Belgium, 3000 Contact: Greet Hermans, MD, PhD +32 16 344275 greet.hermans@uzleuven.be Principal Investigator: Greet Hermans, MD, PhD Sub-Investigator: Alexander Wilmer, MD, PhD 收起 << |
NCT00383149 | - | Completed | - | - | |
NCT03257215 | Atopic Dermatitis | Phase 4 | Recruiting | March 30, 2019 | Australia, Victoria ... 展开 >> Royal Children's Hospital Melbourne Recruiting Melbourne, Victoria, Australia, 3052 Contact: Kirsten P Perrett, MBBS 收起 << |
NCT01945775 | Breast Neoplasms ... 展开 >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation 收起 << | Phase 3 | Active, not recruiting | September 22, 2019 | - |
NCT01299610 | Dermatitis, Atopic | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Berlin, Germany, 10117 收起 << |
NCT01990859 | - | Completed | - | - | |
NCT01299610 | - | Completed | - | - | |
NCT01990859 | Melanoma | Phase 2 | Completed | - | Japan ... 展开 >> Local Institution Fukuoka-shi, Fukuoka, Japan, 8128582 Local Institution Kumamoto-shi, Kumamoto, Japan, 8608556 Local Institution Matsumoto-shi, Nagano, Japan, 3908621 Local Institution Sunto-gun, Shizuoka, Japan, 4118777 Local Institution Chuo-ku, Tokyo, Japan, 1040045 Local Institution Chuo-shi, Yamanashi, Japan, 4093898 收起 << |
NCT00976560 | Depressive Disorder, Major | Phase 2 | Completed | - | United States, Illinois ... 展开 >> GSK Investigational Site Hoffman Estates, Illinois, United States, 60169 GSK Investigational Site Park Ridge, Illinois, United States, 60068 United States, New York GSK Investigational Site New York, New York, United States, 10128 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43210 Bulgaria GSK Investigational Site Pazardzhik, Bulgaria, 4400 GSK Investigational Site Plovdiv, Bulgaria, 4000 GSK Investigational Site Ruse, Bulgaria GSK Investigational Site Sofia, Bulgaria, 1113 Estonia GSK Investigational Site Tartu, Estonia, 50417 Germany GSK Investigational Site Huettenberg, Hessen, Germany, 35625 GSK Investigational Site Schwerin, Mecklenburg-Vorpommern, Germany, 19053 GSK Investigational Site Achim, Niedersachsen, Germany, 28832 GSK Investigational Site Westerstede, Niedersachsen, Germany, 26655 GSK Investigational Site Bielefeld, Nordrhein-Westfalen, Germany, 33647 GSK Investigational Site Dresden, Sachsen, Germany, 01097 GSK Investigational Site Berlin, Germany, 10629 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Samara, Russian Federation, 443016 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation 收起 << |
NCT00284141 | - | Completed | - | - | |
NCT03539601 | Atopic Dermatitis | Phase 4 | Recruiting | May 25, 2020 | United States, Arkansas ... 展开 >> Dermatology Trial Associates Recruiting Bryant, Arkansas, United States, 72022 United States, California California Dermatology & Clinical Research Institute Recruiting Encinitas, California, United States, 92024 United States, Florida Park Avenue Dermatology Recruiting Orange Park, Florida, United States, 32073 Forward Clinical Trials, Inc. Recruiting Tampa, Florida, United States, 33624 United States, Kentucky DS Research Recruiting Louisville, Kentucky, United States, 40241 United States, North Carolina M3-Wake Research, Inc. Recruiting Raleigh, North Carolina, United States, 27612 United States, Texas Arlington Research Center Inc Recruiting Arlington, Texas, United States, 76011 United States, Virginia Virginia Clinical Research, Inc Recruiting Norfolk, Virginia, United States, 23502 收起 << |
NCT00976560 | - | Completed | - | - | |
NCT03356977 | Atopic Dermatitis | Phase 4 | Recruiting | February 23, 2019 | - |
NCT03695029 | Hepatitis B Virus Infection | Phase 4 | Recruiting | December 31, 2021 | Taiwan ... 展开 >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ivy Chiou +886-2-23123456 ext 71737 ivyntuh@gmail.com 收起 << |
NCT00284141 | Pulmonary Diseases ... 展开 >> Neoplasms, Lung 收起 << | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Canada Sanofi-Aventis Administrative Office Laval, Canada France Sanofi-Aventis Administrative Office Paris, France 收起 << |
NCT00095173 | - | Completed | - | - | |
NCT03460652 | ADHD | Phase 3 | Recruiting | March 2019 | United States, Arkansas ... 展开 >> Woodland International Research Recruiting Little Rock, Arkansas, United States, 72211 Contact: Lacey Earls 501-221-8681 lacey@woodlandintlresearchgrp.com Principal Investigator: Jim Aukstuolis, MD United States, Colorado MCB Clinical Research Centers Recruiting Colorado Springs, Colorado, United States, 80910 Contact: Nichole Gonzalez 719-634-6576 ngonzalez@mcbcrc.com Principal Investigator: Andrew Sedillo, MD United States, Florida Meridien Research Recruiting Bradenton, Florida, United States, 34201 Contact: Margaret Bell 941-756-8680 mbell@meridienresearch.net Principal Investigator: Andrew Cutler, MD Clinical Neuroscience Solutions, Inc. Recruiting Jacksonville, Florida, United States, 32256 Contact: Sandeep Jandir 904-281-5757 sjandir@cnshealthcare.com Principal Investigator: Nandita Jones, MD Innovative Clinical Research, Inc. Recruiting Lauderhill, Florida, United States, 33319 Contact: Kadian Watson 954-990-6326 kwatson@segaltrials.com Principal Investigator: Rishi Kakar, MD Meridien Research Recruiting Maitland, Florida, United States, 32751 Contact: Sondra Chapman 407-644-1165 schapman@meridienresearch.net Principal Investigator: Andrea Marraffino, MD Clinical Neuroscience Solutions, Inc. Recruiting Orlando, Florida, United States, 32801 Contact: Rebecca Klipper 407-425-5100 rklipper@cnshealthcare.com Principal Investigator: Robert Molpus, MD United States, Illinois Capstone Clinical Research Recruiting Libertyville, Illinois, United States, 60048 Contact: Kelly Burns 847-549-7214 kburns@capstoneclinical.com Principal Investigator: Michael Greenbaum, MD United States, Kansas Psychiatric Associates Recruiting Overland Park, Kansas, United States, 66211 Contact: Glynis Murphy, PhD 913-438-8221 research@murphyclinic.com Principal Investigator: William Murphy, MD United States, Nevada Center for Psychiatry and Behavioral Medicine, Inc. Recruiting Las Vegas, Nevada, United States, 89128 Contact: Jordan Karbins 702-838-0742 jordankabins@gmail.com Principal Investigator: Ann Childress, MD United States, New Jersey Hassman Research Institute Recruiting Berlin, New Jersey, United States, 08009 Contact: Vania Dasilva 856-753-7335 vdasilva@hritrials.com Principal Investigator: Howard Hassman, MD United States, Ohio Neuro-Behavioral Clinical Research Recruiting Canton, Ohio, United States, 44718 Contact: Natalie Kuemerle 330-493-1118 nkuemerle@nb-cr.com Principal Investigator: Shishuka Malhotra, MD Midwest Clinical Research Center, LLC Recruiting Dayton, Ohio, United States, 45417 Contact: Rebecca Vernon 937-424-1050 rvernon@midwestclinical.com Principal Investigator: Otto Dueno, MD United States, Oregon Oregon Center for Clinical Investigations, Inc. Recruiting Portland, Oregon, United States, 97214 Contact: Christina Friesen 503-276-6224 christina.friesen@occi.org Principal Investigator: Beal Essink, MD Oregon Center for Clinical Investigations, Inc. Recruiting Salem, Oregon, United States, 97301 Contact: Emily Valdez 503-540-0100 emily.valdez@occi.org Principal Investigator: Drissana Tran, MD United States, Tennessee Clinical Neuroscience Solutions, Inc. Recruiting Memphis, Tennessee, United States, 38119 Contact: Kelly Iskiwitz, BS 901-843-1045 kiskiwitz@cnshealthcare.com Principal Investigator: Valerie Arnold, MD United States, Texas FutureSearch Trials Recruiting Austin, Texas, United States, 78731 Contact: Erin Ashmore 214-369-2600 ext 109 erina@fstrials.com Principal Investigator: Michael Downing, MD Bayou City Research, Ltd. Recruiting Houston, Texas, United States, 77007 Contact: Kathy Harpst 832-251-7000 ext 302 Principal Investigator: Matthew Brams, MD Houston Clinical Trials Recruiting Houston, Texas, United States, 77098 Contact: Janice Roggenkamp 713-527-8448 jroggenkamp@houstonclintrials.com Principal Investigator: Alain Katic, MD 收起 << |
NCT00095173 | Juvenile Rheumatoid Arthritis | Phase 3 | Completed | - | - |
NCT00422097 | Cancer | Phase 1 | Completed | - | United States, District of Col... 展开 >>umbia Georgetown University Medical Center Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Michigan Wayne State University (Hwcrc) Detroit, Michigan, United States, 48201 收起 << |
NCT01762761 | - | Active, not recruiting | - | - | |
NCT00422097 | - | Completed | - | - | |
NCT01762761 | Purpura, Thrombocytopenic, Idi... 展开 >>opathic and Hepatitis C 收起 << | Phase 3 | Active, not recruiting | November 15, 2018 | China, Fujian ... 展开 >> Novartis Investigative Site Fuzhou, Fujian, China, 350001 China, Guangdong Novartis Investigative Site Guangzhou, Guangdong, China, 510080 Novartis Investigative Site Guangzhou, Guangdong, China, 510515 Novartis Investigative Site Zhongshan, Guangdong, China, 528403 China, Hunan Novartis Investigative Site Changsha, Hunan, China, 410013 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210029 China, Jiangxi Novartis Investigative Site Nanchang, Jiangxi, China, 330006 China, Shandong Novartis Investigative Site Jianan, Shandong, China, 250012 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100034 Novartis Investigative Site Beijing, China, 100044 Novartis Investigative Site Beijing, China, 100083 Novartis Investigative Site Beijing, China, 100730 Novartis Investigative Site Chengdu, China, 610041 Novartis Investigative Site Jiang Su Province, China, 215006 Novartis Investigative Site Shanghai, China, 200025 Novartis Investigative Site Shanghai, China Novartis Investigative Site Tianjin, China, 300020 收起 << |
NCT01163851 | Hypercholesterolemia ... 展开 >> Dyslipidemia 收起 << | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Premier Research Group, Limited Peoria, Arizona, United States, 85381 Dedicated Phase 1, Inc. Phoenix, Arizona, United States, 85013 Premier Research Group Limited Phoenix, Arizona, United States, 85027 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66211 Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 收起 << |
NCT00256867 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00256867 | - | Completed | - | - | |
NCT00087568 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT01163851 | - | Completed | - | - | |
NCT02210091 | - | Completed | - | - | |
NCT00087568 | - | Completed | - | - | |
NCT02210091 | Hemophilia A | Phase 3 | Completed | - | - |
NCT01842607 | Asthma | Phase 3 | Completed | - | - |
NCT01021553 | - | Completed | - | - | |
NCT01842607 | - | Completed | - | - | |
NCT01021553 | Premature Ejaculation | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site San Diego, California, United States, 92120 GSK Investigational Site San Jose, California, United States, 95128 United States, Indiana GSK Investigational Site Fort Wayne, Indiana, United States, 46825 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Pennsylvania GSK Investigational Site Bala-Cynwyd, Pennsylvania, United States, 19004 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1081 HV GSK Investigational Site Utrecht, Netherlands, 3584 CJ 收起 << |
NCT01376167 | - | Completed | - | - | |
NCT00557856 | Advanced Solid Tumors | Phase 1 | Completed | - | United States, Pennsylvania ... 展开 >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212-3505 Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Italy S.C Diagnostica Radiologica 2 Milano, Italy, 20133 S.C. Chirurgia Generale Indirizzo Oncologico 1 (epato-gastro-pancreatica) Milano, Italy, 20133 S.C. Medicina Oncologica I, Fondazione IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 Dipartimento di Medicina Milano, Italy, 20141 UO di Oncologia ed Ematologia, Istituto Clinico Humanitas-Humanitas Cancer Center Rozzano (MI), Italy, 20089 Korea, Republic of Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 收起 << |
NCT01376167 | Malaria, Vivax | Phase 2 | Completed | - | Bangladesh ... 展开 >> GSK Investigational Site Bandarban, Bangladesh Brazil GSK Investigational Site Manaus, Amazonas, Brazil, 69040-000 GSK Investigational Site Porto Velho, Rondônia, Brazil, 76812-329 Cambodia GSK Investigational Site Oddar Meancheay Province, Cambodia Ethiopia GSK Investigational Site Gondar, Ethiopia GSK Investigational Site Jimma, Ethiopia India GSK Investigational Site Bikaner, India GSK Investigational Site Chennai, India, 600016 GSK Investigational Site Lucknow, India, 226003 GSK Investigational Site Secunderabad, India, 500 003 Peru GSK Investigational Site Iquitos, Loreto, Peru, Iqui 01 Philippines GSK Investigational Site Rio Tuba, Bataraza, Philippines, 5306 Thailand GSK Investigational Site Bangkok, Thailand, 10400 GSK Investigational Site Tak, Thailand, 63110 收起 << |
NCT00207090 | Advanced Solid Tumors ... 展开 >> Neoplasms 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 收起 << |
NCT00557856 | - | Completed | - | - | |
NCT01091116 | Osteoarthritis, Knee | Phase 2 | Completed | - | France ... 展开 >> Centre Hospitalier Régional - Hôpital Porte Madeleine Orléans, France, 45000 Hôtel Dieu - GHU Ouest Paris, France, 75181 Department of Rheumatology, Purpan University Hospital Toulouse, France, 31300 Germany Rheumatologie/Immunologie - Rheumazentrum, Krankenhaus Doberan Bad Doberan, Germany, 18209 Klinik für Rheumatologie und Klinische Immunologie, Charité - Campus Charité Mitte Berlin, Germany, 10117 Orthopädische Praxis Dr. Wagenitz Berlin, Germany, 12247 ClinPharm International, Prüfzentrum Bochum Bochum, Germany, 44787 ClinPharm International, Prüfzentrum Dresden Dresden, Germany, 01067 Medizinische Klinik 3, Universität Erlangen-Nürnberg Erlangen, Germany, 91054 ClinPharm Prüfzentrum Frankfurt / aM Frankfurt, Germany, 60596 ClinPharm Prüfzentrum Görlitz Görlitz, Germany, 02826 Clinical Research Hamburg Hamburg, Germany, 22143 Orthopädie Zentrum Altona Hamburg, Germany, 22767 ClinPharm International, Prüfzentrum Leipzig Leipzig, Germany, 04103 ClinPharm Prüfzentrum Magdeburg Magdeburg, Germany, 39104 Italy Servizio di Reumatologia, Ospedale Privato Accreditato Nigrisoli Bologna, Italy, 40138 Dipartimento di Biomedicina - SOD Reumatologia - Azienda Ospedaliera Universitaria Careggi Firenze, Italy, 50139 Dipartimento di Medicina Interna Azienda Ospedaliero Universitaria Pisana-Stabilimento di Santa Chiara Pisa Pisa, Italy, 56126 Istituto di Reumatologia, "Policlinico Le Scotte" Università degli Studi di Siena Siena, Italy, 53100 Spain Servicio de Reumatologia, Hospital de Basurto Bilbao, Spain, 48013 Servicio de Reumatologia, Hospital Universitario La Paz Madrid, Spain, 28046 Servicio de Reumatologia, Corporacio Sanitaria Parc Tauli, Hospital de Sabadell Sabadell, Spain, 08208 Servicio de Reumatologia, Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 收起 << |
NCT03665506 | - | Recruiting | June 2021 | Germany ... 展开 >> Onkologische Schwerpunktpraxis Kurfürstendamm Recruiting Berlin, Germany, 10707 Contact: Ingo Schwaner, MD +49 30 887742570 ingo.schwaner@onkologie-kurfuerstendamm.de 收起 << | |
NCT00207090 | - | Completed | - | - | |
NCT03165812 | Diabetes Mellitus, Type 2 ... 展开 >> Overweight 收起 << | Not Applicable | Recruiting | April 2019 | Malaysia ... 展开 >> Hospital Serdang Recruiting Kajang, Selangor, Malaysia, 43400 Contact: Tikfu Gee, MBBS, MS +60 18-984 2300 groupesantesoin@gmail.com Principal Investigator: Tikfu Gee, MBBS, MS Sub-Investigator: Ng Ooi Chuan, MBBS, MRCP Sub-Investigator: Ching Siew Mooi, MFamMed Sub-Investigator: Subashini a/p Chellappah Thambiah, MBBS, Mpath Sub-Investigator: Intan Nureslyna Samsudin, Mpath Sub-Investigator: Zubaidah Hanipah, MD, MS Sub-Investigator: Lim Shu Yu, MS Hospital Kuala Lumpur Recruiting Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur, Malaysia, 50586 Contact: Tikfu Gee, MBBS, MS +6018 984 2300 groupesantesoin@gmail.com Principal Investigator: Tikfu Gee, MBBS, MS Sub-Investigator: Ng Ooi Chuan, MBBS, MRCP Sub-Investigator: Ching Siew Mooi, MFamMed Sub-Investigator: Subashini a/p Chellappah Thambiah, MBBS, Mpath Sub-Investigator: Intan Nureslyna Samsudin, Mpath Sub-Investigator: Zubaidah Hanipah, MD, MS Sub-Investigator: Lim Shu Yu, MS Sub-Investigator: Raflis Ruzairee Awang, MBChB, MS 收起 << |
NCT01091116 | - | Completed | - | - | |
NCT01134055 | Macular Degeneration | Phase 2 | Completed | - | - |
NCT00867087 | Lymphoma, B-Cell | Phase 2 | Completed | - | - |
NCT01134055 | - | Completed | - | - | |
NCT00710684 | Alzheimer's Disease | Phase 2 | Completed | - | - |
NCT01268566 | Glioblastoma Multiforme | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Research Site Tucson, Arizona, United States United States, California Research Site Los Angeles, California, United States Research Site Stanford, California, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Massachusetts Research Site Boston, Massachusetts, United States United States, Michigan Research Site Detroit, Michigan, United States United States, New York Research Site New York, New York, United States United States, Ohio Research Site Canton, Ohio, United States United States, Pennsylvania Research Site Pittsburgh, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site San Antonio, Texas, United States United States, Washington Research Site Seattle, Washington, United States 收起 << |
NCT03054194 | Healthy Participants | Phase 1 | Completed | - | United States, Texas ... 展开 >> Eisai Trial Site San Antonio, Texas, United States, 78217 收起 << |
NCT02634073 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 4 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01718587 | Liver Cirrhosis | Phase 1 Phase 2 | Unknown | July 2014 | China ... 展开 >> Yihua An Beijing, China 收起 << |
NCT00867087 | - | Completed | - | - | |
NCT01268566 | - | Completed | - | - | |
NCT00171704 | Hormone Sensitive Resected Pri... 展开 >>mary Breast Cancer in Postmenopausal Women 收起 << | Phase 3 | Completed | - | Denmark ... 展开 >> Novartis Investigative Site Aalborg, Denmark Novartis Investigative Site Arhus, Denmark Novartis Investigative Site Copenhagen, Denmark Novartis Investigative Site Esbjerg, Denmark Novartis Investigative Site Herlev, Denmark Novartis Investigative Site Herning, Denmark Novartis Investigative Site Hillerod, Denmark Novartis Investigative Site Kløvervænget, Denmark Novartis Investigative Site Roskilde, Denmark Novartis Investigative Site Sonderborg, Denmark Novartis Investigative Site Vejle, Denmark Novartis Investigative Site Viborg, Denmark United Kingdom Novartis Investigative Site Sheffield, United Kingdom 收起 << |
NCT02634073 | - | Completed | - | - | |
NCT01196936 | Breast Cancer | Phase 2 | Active, not recruiting | December 2018 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109-5718 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas MD Anderson Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario University Health Network, Toronto Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT01174446 | - | Completed | - | - | |
NCT00171704 | - | Completed | - | - | |
NCT00710684 | - | Completed | - | - | |
NCT02271984 | - | Completed | - | - | |
NCT01174446 | Hemophilia B | Phase 3 | Completed | - | - |
NCT02271984 | Healthy | Phase 1 | Completed | - | Germany ... 展开 >> Please contact the Merck KGaA Communication Center Darmstadt, Germany 收起 << |
NCT02034916 | Breast Neoplasms ... 展开 >> BRCA 1 Gene Mutation BRCA 2 Gene Mutation 收起 << | Phase 2 | Completed | - | - |
NCT03351751 | Healthy Volunteers | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 收起 << |
NCT02737306 | Graft Vs Host Disease | Phase 2 | Recruiting | December 2019 | United States, Florida ... 展开 >> University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 United States, Illinois Loyola University Medical Center Cardinal Bernardin Cancer Center Recruiting Maywood, Illinois, United States, 60153 United States, Michigan Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55409 United States, North Carolina Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Transplant Institute Methodist Hospital Recruiting San Antonio, Texas, United States, 78229 United States, West Virginia West Virginia University Medicine Recruiting Morgantown, West Virginia, United States, 26506 收起 << |
NCT01491932 | Dyskinesias P... 展开 >>arkinson Disease Movement Disorders Parkinsonian Disorders Anti-Dyskinesia Agents 收起 << | Phase 2 | Completed | - | - |
NCT01114620 | Influenza | Phase 4 | Completed | - | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 813-8588 收起 << |
NCT01424514 | - | Completed | - | - | |
NCT02034916 | - | Completed | - | - | |
NCT01114620 | - | Completed | - | - | |
NCT00495469 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT01154140 | Non Squamous Lung Cancer | Phase 3 | Completed | - | - |
NCT01362348 | Macular Degeneration | Phase 2 | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | United States, Arizona ... 展开 >> GSK Investigational Site Phoenix, Arizona, United States, 85014 United States, Florida GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Georgia GSK Investigational Site Decatur, Georgia, United States, 30030 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 United States, Michigan GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Texas GSK Investigational Site Austin, Texas, United States, 78705 GSK Investigational Site Houston, Texas, United States, 77030 France GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Paris cedex 12, France, 75571 Germany GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53127 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 收起 << |
NCT01090492 | Raynaud's Disease ... 展开 >> Peripheral Vascular Disease 收起 << | Phase 2 | Completed | - | - |
NCT01424514 | Rhinitis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> GSK Investigational Site Mississauga, Ontario, Canada, L4W 1N2 收起 << |
NCT00495469 | - | Completed | - | - | |
NCT01154140 | - | Completed | - | - | |
NCT00793871 | Gastrointestinal Neoplasms, Ga... 展开 >>strointestinal Stromal Tumors 收起 << | Phase 4 | Completed | - | China, Jiangsu ... 展开 >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 收起 << |
NCT01090492 | - | Completed | - | - | |
NCT01001169 | Influenza | Phase 2 | Completed | - | Japan ... 展开 >> GSK Investigational Site Tokyo, Japan, 157-8535 收起 << |
NCT01362348 | - | Terminated(Lack of efficacy id... 展开 >>entified during a preliminary analysis) 收起 << | - | - | |
NCT00793871 | - | Completed | - | - | |
NCT00420199 | Active Rheumatoid Arthritis | Phase 3 | Completed | - | Belgium ... 展开 >> Local Institution Bruxelles, Belgium, 1200 Local Institution Yvoir, Belgium, 5530 Germany Local Institution Berlin, Germany, 14059 Local Institution Berlin, Germany, BE-10117 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Spain Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08907 Sweden Local Institution Stockholm, Sweden, 171 76 United Kingdom Local Institution London, Greater London, United Kingdom, SE19RT Local Institution Leeds, North Yorkshire, United Kingdom, LS7 4SA 收起 << |
NCT01240915 | - | Completed | - | - | |
NCT01240915 | Colitis, Ulcerative | Phase 2 | Completed | - | - |
NCT03397641 | Atrial Fibrillation | Phase 1 | Completed | - | United Kingdom ... 展开 >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS 收起 << |
NCT01001169 | - | Completed | - | - | |
NCT00371345 | Breast Cancer ... 展开 >> Metastasis 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Ucsf-Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Florida Mayo Clinic Florida Jacksonville, Florida, United States, 32224 United States, Massachusetts Dana-Farber Cancer Inst Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, North Carolina University Of North Carolina At Chapel Hill Chapel Hill, North Carolina, United States, 275997305 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas University Of Texas Md Anderson Cancer Ctr Houston, Texas, United States, 77030 Argentina Local Institution Haedo, Buenos Aires, Argentina, 1684 Local Institution Buenos Aires, Argentina, 1019 Local Institution Buenos Aires, Argentina, 1185 Belgium Local Institution Bruxelles, Belgium, 1000 Local Institution Bruxelles, Belgium, 1200 France Local Institution Dijon Cedex, France, 21079 Local Institution Paris, France, 75231 Local Institution Saint Herblain Cedex, France, 44805 Local Institution Toulouse Cedex 3, France, 31052 Italy Local Institution Modena, Italy, 41100 Peru Local Institution Arequipa, Peru Local Institution Lima, Peru, 34 Local Institution Lima, Peru, LIMA 11 Spain Local Institution Barcelona, Spain, 08035 Local Institution Lleida, Spain, 25198 Local Institution Madrid, Spain, 28041 收起 << |
NCT00420199 | - | Completed | - | - | |
NCT02229227 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00371345 | - | Completed | - | - | |
NCT00555906 | Multiple Myeloma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern Medical Faculty Foundation Chicago, Illinois, United States, 60611 Northwestern Memorial Hospital/Main Labs Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110-1093 Barnes-Jewish Hospital St. Louis, Missouri, United States, 63110 Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York Presbyterian, Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 Czech Republic Vseobecna fakultni nemocnice v Praze Praha 2, Czech Republic, 12808 Germany Universitaetsklinikum Heidelberg Heidelberg, Germany, 69120 Klinikum Johannes-Gutenberg -Universitaet, III. Medizinische Klinik und Poliklinik Mainz, Germany, 55131 收起 << |
NCT01920594 | Surgical Procedures | Phase 2 | Completed | - | United States, Alabama ... 展开 >> GSK Investigational Site Birmingham, Alabama, United States, 35233 United States, California GSK Investigational Site Los Angeles, California, United States, 90048 United States, Colorado GSK Investigational Site Aurora, Colorado, United States, 80045 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30322 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109-5864 United States, Minnesota GSK Investigational Site Rochester, Minnesota, United States, 55905 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio GSK Investigational Site Cleveland, Ohio, United States, 44195 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 308902 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 United States, Virginia GSK Investigational Site Charlottesville, Virginia, United States, 22908 GSK Investigational Site Richmond, Virginia, United States, 23298 Canada, Alberta GSK Investigational Site Calgary, Alberta, Canada, T2N 2T9 Canada, Quebec GSK Investigational Site Quebec City, Quebec, Canada, G1V 4G5 收起 << |
NCT02179918 | Advanced Solid Tumors | Phase 1 | Completed | - | United States, California ... 展开 >> Research Administration Office Los Angeles, California, United States, 90095 Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States, 90095 UCLA Hematology-Oncology Clinic Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 United States, Connecticut Smilow Cancer Center at Yale-New Haven Hospital New Haven, Connecticut, United States, 06510 Smilow Cancer Hospital at Yale-New Haven New Haven, Connecticut, United States, 06510 United States, Texas South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States, 78229 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 << |
NCT01920594 | - | Completed | - | - | |
NCT00555906 | - | Completed | - | - | |
NCT00979602 | Influenza | Phase 3 | Completed | - | - |
NCT02216097 | Post-Traumatic Stress Disorder | Phase 2 | Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 << | - | United States, New York ... 展开 >> Clinical and Translational Science Institute (CTSI) New York, New York, United States, 10016 NYU CTSI Research Pharmacy (Drug Shipment Address) New York, New York, United States, 10016 NYU School of Medicine New York, New York, United States, 10016 收起 << |
NCT02179918 | - | Completed | - | - | |
NCT02229227 | - | Completed | - | - | |
NCT00979602 | - | Completed | - | - | |
NCT02216097 | - | Terminated(The study stopped b... 展开 >>ased on Pfizer portfolio prioritization and not due to safety and/or efficacy concern or change in benefitrisk assessment of PF-04457845.) 收起 << | - | - | |
NCT01347866 | Advanced Cancer | Phase 1 | Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 << | - | United States, California ... 展开 >> Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095-6984 Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Medical Center Los Angeles, California, United States, 90095 UCLA Oncology Center Los Angeles, California, United States, 90095 Santa Monica - UCLA Medical Center and Orthopaedic Hospital Santa Monica, California, United States, 90404 UCLA Santa Monica Hematology Oncology Santa Monica, California, United States, 90404 United States, Colorado Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver (CTRC) Aurora, Colorado, United States, 80045 University of Colorado Hospital Anschutz Inpatient Pavilion Aurora, Colorado, United States, 80045 University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, South Carolina Medical University of South Carolina, Hollings Cancer Center Charleston, South Carolina, United States, 29425 Medical University of South Carolina Charleston, South Carolina, United States, 29425 MUSC, Investigational Drug Services Charleston, South Carolina, United States, 29425 MUSC Health East Cooper Mount Pleasant, South Carolina, United States, 29464 MUSC Specialty Care-North North Charleston, South Carolina, United States, 29406 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Italy Ospedale San Raffaele Milano, Italy, 20132 Spain Hospital General Vall d'Hebron Barcelona, Spain, 08035 收起 << |
NCT01622283 | Rhinitis, Allergic, Perennial ... 展开 >>and Seasonal 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> GSK Investigational Site Kagoshima, Japan, 890-0081 收起 << |
NCT02593539 | Activated PI3K-delta Syndrome | Phase 2 | Recruiting | December 11, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Recruiting Cambridge, United Kingdom, CB2 0GG Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00612456 | Macular Degeneration | Phase 2 | Completed | - | - |
NCT01347866 | - | Terminated(Refer to Detailed D... 展开 >>escription for documentaion of Termination Statement.) 收起 << | - | - | |
NCT00643201 | Venous Thrombosis | Phase 3 | Completed | - | - |
NCT01051063 | Leukaemia, Myelocytic, Acute | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21201 United States, Massachusetts GSK Investigational Site Worcester, Massachusetts, United States, 01655 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 France GSK Investigational Site Angers cedex 09, France, 49933 GSK Investigational Site Grenoble cedex 9, France, 38043 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille cedex 9, France, 13273 GSK Investigational Site Nantes cedex 1, France, 44093 GSK Investigational Site Paris cedex 10, France, 75475 GSK Investigational Site Pessac cedex, France, 33604 GSK Investigational Site Pierre-Bénite cedex, France, 69495 Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Heidelberg, Baden-Wuerttemberg, Germany, 69120 GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Erlangen, Bayern, Germany, 91054 GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Rostock, Mecklenburg-Vorpommern, Germany, 18057 GSK Investigational Site Oldenburg, Niedersachsen, Germany, 26133 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48149 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Dresden, Sachsen, Germany, 01307 GSK Investigational Site Berlin, Germany, 12200 收起 << |
NCT03447314 | Neoplasms | Phase 1 | Recruiting | February 14, 2020 | United States, Missouri ... 展开 >> GSK Investigational Site Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Recruiting Dallas, Texas, United States, 75230 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Washington GSK Investigational Site Recruiting Tacoma, Washington, United States, 98405 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Netherlands GSK Investigational Site Not yet recruiting Amsterdam, Netherlands, 1066 CX Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Spain GSK Investigational Site Not yet recruiting Barcelona, Spain, 08035 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00678392 | Kidney Neoplasms | Phase 3 | Completed | - | - |
NCT00612456 | - | Completed | - | - | |
NCT01525550 | Well-differentiated Pancreatic... 展开 >> Neuroendocrine Tumor 收起 << | Phase 4 | Completed | - | - |
NCT00643201 | - | Completed | - | - | |
NCT01051063 | - | Completed | - | - | |
NCT00077649 | Hepatitis C, Chronic | Phase 4 | Completed | - | - |
NCT03069989 | Idiopathic Pulmonary Fibrosis | Phase 1 | Active, not recruiting | May 23, 2019 | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, SW3 6HP GSK Investigational Site London, United Kingdom, WC1E 6JF GSK Investigational Site London, United Kingdom 收起 << |
NCT00678392 | - | Completed | - | - | |
NCT03709706 | Neoplasms | Phase 2 | Not yet recruiting | April 22, 2021 | - |
NCT03590613 | Autoimmune Diseases | Phase 1 | Active, not recruiting | September 21, 2018 | Japan ... 展开 >> GSK Investigational Site Fukuoka, Japan, 812-0025 收起 << |
NCT01229436 | Dupuytren's Contracture | Phase 3 | Completed | - | Denmark ... 展开 >> Pfizer Investigational Site Copenhagen, Denmark, 1402 K Pfizer Investigational Site Silkeborg, Denmark, 8600 France Pfizer Investigational Site Montpellier cedex 5, France, 34295 Pfizer Investigational Site Nice, France, 06000 Pfizer Investigational Site Paris, France, 75016 Pfizer Investigational Site Paris, France, Cedex 15 75908 Germany Pfizer Investigational Site Bad Neustadt, Germany, 97616 Pfizer Investigational Site Berlin, Germany, 10627 Pfizer Investigational Site Bonn, Germany, 53123 Pfizer Investigational Site Muenster, Germany, 48149 Pfizer Investigational Site Nurnberg, Germany, 90471 Pfizer Investigational Site Tubingen, Germany, 72076 Hungary Pfizer Investigational Site Miskolc, Hungary, 3526 Italy Pfizer Investigational Site Sesto San Giovanni, Milano, Italy, 20099 Pfizer Investigational Site Modena, Italy, 41124 Pfizer Investigational Site Savona, Italy, 17100 Spain Pfizer Investigational Site Elche, Alicante, Spain, 03203 Pfizer Investigational Site Hospitalet De Llobregat, Barcelona/ Spain, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08022 Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Málaga, Spain, 29010 Sweden Pfizer Investigational Site Malmö, Sweden, SE-205 02 Pfizer Investigational Site Stockholm, Sweden, SE 118 83 Pfizer Investigational Site Uppsala, Sweden, 751 85 United Kingdom Pfizer Investigational Site Derby, United Kingdom, DE22 3NE Pfizer Investigational Site Glasgow, United Kingdom, G4 0SF Pfizer Investigational Site Norwich, United Kingdom, NR4 7UY Pfizer Investigational Site Southampton, United Kingdom, SO16 6YD 收起 << |
NCT00077649 | - | Completed | - | - | |
NCT01229436 | - | Completed | - | - | |
NCT03359473 | Cachexia | Phase 2 | Recruiting | November 3, 2019 | United States, California ... 展开 >> GSK Investigational Site Not yet recruiting Torrance, California, United States, 90502 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Florida GSK Investigational Site Recruiting Jacksonville, Florida, United States, 32216 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, North Carolina GSK Investigational Site Recruiting High Point, North Carolina, United States, 27262 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, South Carolina GSK Investigational Site Recruiting Spartanburg, South Carolina, United States, 29303 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Germany GSK Investigational Site Recruiting Frankfurt, Hessen, Germany, 60596 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Grosshansdorf, Schleswig-Holstein, Germany, 22927 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01727791 | Healthy Lactating Women | Phase 4 | Completed | - | Belgium ... 展开 >> Pfizer Clinical Research Unit Brussels, Belgium, B-1070 收起 << |
NCT03457727 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01525550 | - | Completed | - | - | |
NCT01727791 | - | Completed | - | - | |
NCT01205165 | - | Completed | - | - | |
NCT00111787 | Neoplasms, Breast | Phase 2 | Completed | - | - |
NCT02105987 | - | Completed | - | - | |
NCT03044353 | Amyloidosis | Phase 2 | Suspended(Pending data review.... 展开 >>) 收起 << | September 23, 2021 | United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02115 United Kingdom GSK Investigational Site Cambridge, United Kingdom, CB2 0GG GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT01205165 | Hepatitis B, Chronic | Phase 4 | Completed | - | - |
NCT01009060 | Schizophrenia | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Garden Grove, California, United States, 92845 GSK Investigational Site Los Angeles, California, United States, 90073 GSK Investigational Site National City, California, United States, 91950 GSK Investigational Site Sacramento, California, United States, 95817 GSK Investigational Site San Diego, California, United States, 92102 GSK Investigational Site Torrance, California, United States, 90502 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46222 United States, Maryland GSK Investigational Site Catonsville, Maryland, United States, 21228 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02114 GSK Investigational Site Jamaica Plain, Massachusetts, United States, 02130 United States, New Jersey GSK Investigational Site Mount Laurel, New Jersey, United States, 08054 United States, New York GSK Investigational Site New York, New York, United States, 10016 GSK Investigational Site New York, New York, United States, 10032 United States, North Carolina GSK Investigational Site Butner, North Carolina, United States, 27509 收起 << |
NCT01607372 | Asthma and Rhinitis | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> GSK Investigational Site Toronto, Ontario, Canada, M5V 2T3 收起 << |
NCT01009060 | - | Completed | - | - | |
NCT00968526 | Influenza | Phase 3 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Wilrijk, Belgium, 2610 收起 << |
NCT02105987 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Completed | - | - |
NCT00853112 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT00968526 | - | Completed | - | - | |
NCT00424294 | - | Terminated(See Detailed Descri... 展开 >>ption field) 收起 << | - | - | |
NCT00853112 | Hypertension, Pulmonary | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01059617 | Influenza | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> GSK Investigational Site Milford, Massachusetts, United States, 01757 United States, North Carolina GSK Investigational Site Salisbury, North Carolina, United States, 28144 GSK Investigational Site Winston-Salem, North Carolina, United States, 27103 收起 << |
NCT02424539 | Rhinitis, Allergic, Perennial ... 展开 >>and Seasonal 收起 << | Phase 4 | Completed | - | China, Fujian ... 展开 >> GSK Investigational Site Xiamen, Fujian, China, 361003 China, Guangdong GSK Investigational Site Shenzhen, Guangdong, China, 518038 China, Hunan GSK Investigational Site Changsha, Hunan, China, 410005 GSK Investigational Site Changsha, Hunan, China, 410011 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 China, Shanxi GSK Investigational Site Taiyuan, Shanxi, China, 030016 China, Zhejiang GSK Investigational Site Wenzhou, Zhejiang, China, 323027 China GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China GSK Investigational Site Changsha, China GSK Investigational Site Chongqing, China, 400014 GSK Investigational Site Fuzhou, China, 350025 GSK Investigational Site Hangzhou, China, 310052 GSK Investigational Site Shanghai, China, 200040 GSK Investigational Site Shanghai, China, 200092 GSK Investigational Site Shanghai, China, 200127 收起 << |
NCT01332331 | Hypertension, Pulmonary | Phase 2 | Suspended(Ongoing juvenile rat... 展开 >> toxicology studies.) 收起 << | February 1, 2019 | - |
NCT00759564 | Pneumonia | Phase 1 | Completed | - | United States, Indiana ... 展开 >> Centurion Clinical Research Indianapolis, Indiana, United States, 46260 Belgium Pfizer Clinical Research Unit Bruxelles, Belgium, 1070 收起 << |
NCT00424294 | Arthritis, Rheumatoid | Phase 2 | Terminated(See Detailed Descri... 展开 >>ption field) 收起 << | - | - |
NCT01962415 | Primary Immunodeficiency (PID)... 展开 >> Congenital Bone Marrow Failure Syndromes Inherited Metabolic Disorders (IMD) Hereditary Anemias Inflammatory Conditions 收起 << | Phase 2 | Recruiting | November 2020 | United States, Pennsylvania ... 展开 >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jason Rowan, RN 412-692-6195 jason.rowan@chp.edu Sub-Investigator: Maria Escolar, MD Sub-Investigator: Randy Windreich, MD Sub-Investigator: Jessie Barnum, MD Sub-Investigator: Craig Byersdorfer, MD Sub-Investigator: Beth Carella, DO 收起 << |
NCT01303627 | Urinary Tract Problem | Phase 4 | Completed | - | Turkey ... 展开 >> Ministry of Health Diskapi Yildirim Beyazit Research and Training Hospital departement of 1. Anesthesiology Ankara, Turkey, 06110 收起 << |
NCT01119846 | - | Completed | - | - | |
NCT01303627 | - | Completed | - | - | |
NCT01059617 | - | Completed | - | - | |
NCT02564042 | Psoriasis | Phase 2 | Completed | - | - |
NCT01495000 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | India ... 展开 >> GSK Investigational Site Ahmedabad, India, 380015 GSK Investigational Site Bangalore, India, 560043 GSK Investigational Site Bangalore, India, 560052 GSK Investigational Site Bangalore, India, 560054 GSK Investigational Site Delhi, India, 110060 GSK Investigational Site Mangalore, India, 575002 GSK Investigational Site Nagpur, India, 440010 GSK Investigational Site Nagpur, India, 440012 GSK Investigational Site Pune, India, 411030 GSK Investigational Site Trivandrum, India, 695011 GSK Investigational Site Vadodra, India, 390007 收起 << |
NCT00759564 | - | Completed | - | - | |
NCT01495000 | - | Completed | - | - | |
NCT01149291 | - | Completed | - | Turkey ... 展开 >> Site Reference ID/Investigator# 37822 Antalya, Turkey, 07059 Site Reference ID/Investigator# 68286 Antalya, Turkey, 7130 Site Reference ID/Investigator# 40677 Antalya, Turkey Site Reference ID/Investigator# 85153 Istanbul, Turkey, 34180 Site Reference ID/Investigator# 40672 Istanbul, Turkey Site Reference ID/Investigator# 40674 Istanbul, Turkey Site Reference ID/Investigator# 40678 Istanbul, Turkey Site Reference ID/Investigator# 40686 Istanbul, Turkey Site Reference ID/Investigator# 61585 Istanbul, Turkey Site Reference ID/Investigator# 63764 Istanbul, Turkey Site Reference ID/Investigator# 63765 Istanbul, Turkey Site Reference ID/Investigator# 63766 Istanbul, Turkey Site Reference ID/Investigator# 69973 İstanbul, Turkey Site Reference ID/Investigator# 63763 Izmir, Turkey, 7070 Site Reference ID/Investigator# 48127 Izmir, Turkey Site Reference ID/Investigator# 64444 Karaman, Turkey Site Reference ID/Investigator# 40684 Kayseri, Turkey Site Reference ID/Investigator# 48132 Konya, Turkey Site Reference ID/Investigator# 68283 Kutahya, Turkey, 43260 Site Reference ID/Investigator# 68281 Mersin, Turkey, 33000 Site Reference ID/Investigator# 68282 Mersin, Turkey, 33000 Site Reference ID/Investigator# 69974 Mersin, Turkey 收起 << | |
NCT02308111 | Liver Cirrhosis, Biliary | Phase 4 | Recruiting | April 2025 | - |
NCT00640328 | - | Completed | - | - | |
NCT02796833 | Home Parenteral Nutrition | Phase 4 | Recruiting | December 2018 | Canada, Ontario ... 展开 >> Toronto General Hospital, University Health Network Recruiting Toronto, Ontario, Canada 收起 << |
NCT00310375 | - | Completed | - | - | |
NCT03462121 | Mild to Moderate Dementia Due ... 展开 >>to Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease 收起 << | Phase 2 | Recruiting | April 30, 2019 | Canada, Ontario ... 展开 >> Kawartha Centre - Redefining Healthy Aging Recruiting Peterborough, Ontario, Canada, K9H 2P4 Contact: Jennifer K Ingram, MD FRCPC 705-749-3906 Contact: Krista Gillis 05-930-2667 (24 Hr.) Principal Investigator: Jennifer K Ingram, MD Toronto Memory Program Recruiting Toronto, Ontario, Canada, M3B 2S7 Principal Investigator: Sharon Cohen, MD Gerontion Research Inc., The Center for Memory & Aging Recruiting Toronto, Ontario, Canada, M4G 3E8 Principal Investigator: Giovanni Marotta, MD Canada, Quebec Recherches Neuro-Hippocampe Inc. d/b/a Clinique de la Memoire de l'Outaouais Recruiting Gatineau, Quebec, Canada, J8T 8J1 Principal Investigator: Richard Bergeron, MD Diex Recherche Sherbrooke Inc. Recruiting Sherbrooke, Quebec, Canada, J1L 0H8 Principal Investigator: Marcel Germain, MD 收起 << |
NCT00310375 | Epilepsy | Phase 3 | Completed | - | - |
NCT01773876 | Invasive Candidiasis | Phase 3 | Completed | - | France ... 展开 >> Hospital Aix en Provence Aix en Provence, France, 13616 Hospital University of Besançon Besançon, France, 67091 University Hospital of Avicennes Bobigny, France, 93009 Hospital University of Bordeaux Bordeaux, France, 33000 Hospital University of Clermont Ferrand Clermont Ferrand, France, 63003 University Hospital of Beaujon Clichy, France, 92110 University Hospital of Dijon Dijon, France, 21000 Hospital of Draguignan Draguignan, France, 83300 Hospital University of Grenoble Grenoble, France, 38043 Hospital of Versailles Le Chesnay, France, 78150 University Hospital Edouard Herriot Lyon, France, 96433 Hospital University of Montpellier Montpellier, France, 34295 Interegional Hospital André Grégoire Montreuil, France, 93105 University Hospital Saint Louis Paris, France, 75010 University Hospital of La Pitié Salpetrière Paris, France, 75013 Hospital St Joseph Paris, France, 75014 Hospital University of Bichat Paris, France, 75877 Hospital of Pontoise Pontoise, France, 95303 Hospital University of Reims Reims, France, 51092 Departemental Hospital of Roche sur Yon Roche Sur Yon, France, 85925 University Hospital of Saint Etienne Saint Etienne, France, 42055 University Hospital of Strasbourg Strasbourg, France, 67091 收起 << |
NCT02564042 | - | Completed | - | - | |
NCT00920426 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Fort Lauderdale, Florida, United States, 33308 GSK Investigational Site Orlando, Florida, United States, 32803 GSK Investigational Site Vero Beach, Florida, United States, 32960 United States, North Carolina GSK Investigational Site Charlotte, North Carolina, United States, 28209 收起 << |
NCT00945282 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | Argentina ... 展开 >> GSK Investigational Site Buenos Aires, Argentina, B1602DBG 收起 << |
NCT00920426 | - | Completed | - | - | |
NCT03236792 | AL Amyloidosis | Phase 1 Phase 2 | Recruiting | June 2020 | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Keren Osman, MD Contact: Sonia Rai, MHA,MD 212-241-6021 sonia.rai@mssm.edu Principal Investigator: Keren Osman, MD Columbia University Medical Center Not yet recruiting New York, New York, United States, 10032 Contact: Suzanne Lentzsch, MD,PhD Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Heather Landau, MD Contact: Beth Hoover HooverE@mskcc.org Principal Investigator: Heather Landau, MD 收起 << |
NCT00640328 | Multiple Sclerosis | Phase 2 | Completed | - | - |
NCT02344225 | Retinopathy of Prematurity | Phase 2 | Completed | - | United States, New York ... 展开 >> SUNY Downstate Medical Center/University Hospital of Brooklyn Brooklyn, New York, United States, 11203 收起 << |
NCT01419028 | - | Completed | - | United States, California ... 展开 >> Cedars-Sinai Medical Center LA, California, United States United States, Indiana Indiana University school of medicine Indianapolis, Indiana, United States, 46202 United States, Missouri Shriners Hospital for Children St. Louis, Missouri, United States United States, Oregon Oregon Health & Science University Portland, Oregon, United States United States, Texas Cook Children's Health Care System Fort Worth, Texas, United States Australia Royal Children's Hospital Parkville Victoria, Australia Canada University of Manitoba Health Sciences Centre Winnipeg, Canada, MB R3A 1R9 Germany Universitatsmedizin Mainz, Villa Mainz, Germany, 55131 Universitätsklinikum Würzburg Kinderklinik, Pädiatrische Infektiologie und Immunologie Würzburg, Germany, 97080 Spain Hospital Infantil Universitario Nino Jesus Universidad autonoma de Madrid Madrid, Spain Taiwan National Taiwan University Hospital Taipei, Taiwan, 10041 United Kingdom Birmingham Childrens Hospital Birmingham, United Kingdom 收起 << | |
NCT03511105 | Healthy Volunteers | Phase 1 | Recruiting | February 3, 2019 | Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00945282 | - | Completed | - | - | |
NCT02480010 | - | Terminated(The study was termi... 展开 >>nated at the time of interim analysis since none of the participants showed a PSA response.) 收起 << | - | - | |
NCT02666287 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site London, United Kingdom, NW10 7EW 收起 << |
NCT02924454 | Drug Overdose ... 展开 >> Overdose of Beta-adrenergic Blocking Drug Blood Pressure 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Bispebjerg University Hospital Copenhagen Copenhagen NW, Capital Region of Denmark, Denmark, 2400 收起 << |
NCT03677596 | Leukemia Prec... 展开 >>ursor b-Cell Lymphoblastic Leukemia-Lymphoma ACUTE LYMPHOBLASTIC LEUKEMIA 收起 << | Phase 4 | Not yet recruiting | May 16, 2025 | - |
NCT02910466 | Chronic Hypoparathyroidism ... 展开 >> Hypoparathyroidism 收起 << | Phase 4 | Active, not recruiting | July 30, 2021 | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT02899026 | Polymyalgia Rheumatica | Phase 3 | Withdrawn(GSK decision to retu... 展开 >>rn rights to sirukumab to Janssen and discontinue sirukumab development in polymyalgia rheumatica.) 收起 << | August 26, 2021 | - |
NCT02480010 | Prostate Cancer | Phase 2 | Terminated(The study was termi... 展开 >>nated at the time of interim analysis since none of the participants showed a PSA response.) 收起 << | - | France ... 展开 >> Lyon, France, 69008 Montpellier, France, 34298 Germany Berlin, Germany, 12203 Italy Parma, Italy, 43100 Roma, Italy, 00152 Netherlands Rotterdam, Netherlands, 3075 EA Spain Barcelona, Spain, 08035 Valencia, Spain, 46009 United Kingdom Cardiff, United Kingdom, CF14 2TL Sutton, United Kingdom, SM2 5PT Weston Super Mare, United Kingdom, BS23 4TQ 收起 << |
NCT03562195 | Asthma | Phase 3 | Recruiting | April 2, 2021 | China, Guangdong ... 展开 >> GSK Investigational Site Not yet recruiting Guangzhou, Guangdong, China, 510120 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Jilin GSK Investigational Site Not yet recruiting Changchun, Jilin, China, 130041 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Xinjiang GSK Investigational Site Not yet recruiting Urumqi, Xinjiang, China, 830054 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China, Zhejiang GSK Investigational Site Recruiting Wenzhou, Zhejiang, China, 323027 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com China GSK Investigational Site Not yet recruiting Guangzhou, China, 511400 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Recruiting Shanghai, China Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03329547 | Infections, Bacterial | Phase 1 | Withdrawn(Change in commercial... 展开 >> strategy) 收起 << | February 2, 2018 | - |
NCT02924688 | Asthma | Phase 3 | Active, not recruiting | February 21, 2019 | - |
NCT01820494 | Growth and Tolerance Infant St... 展开 >>udy 收起 << | Not Applicable | Completed | - | United States, Maryland ... 展开 >> Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Michigan Children's Hospital of Detroit Detroit, Michigan, United States, 48201 United States, Nebraska Children's Hospital Omaha, Nebraska, United States, 68114 收起 << |
NCT02751294 | Malaria, Vivax | Phase 1 | Completed | - | United States, Maryland ... 展开 >> GSK Investigational Site Baltimore, Maryland, United States, 21225 收起 << |
NCT01472614 | Type-2 Diabetes Mellitus | Phase 3 | Completed | - | Indonesia ... 展开 >> Private Clinic at Jl. Prof. Dr. Moestopo 164 Surabaya, East Java, Indonesia Surabaya Diabetes and Nutrition Centre, Dr. Soetomo Hospital Surabaya, East Java, Indonesia 收起 << |
NCT03258762 | Toxoplasmosis | Phase 1 | Completed | - | Australia, Victoria ... 展开 >> GSK Investigational Site Melbourne, Victoria, Australia, 3004 收起 << |
NCT03417830 | Amyloidosis | Phase 1 | Terminated(Change in benefit/r... 展开 >>isk profile.) 收起 << | - | Sweden ... 展开 >> GSK Investigational Site Uppsala, Sweden, SE-751 85 GSK Investigational Site Uppsala, Sweden, SE-751 收起 << |
NCT03055195 | Dermatitis, Atopic | Phase 2 | Terminated(Study reached pre-d... 展开 >>etermined futility criteria following interim analysis. No safety concerns were noted.) 收起 << | - | - |
NCT02404662 | Dual Diagnosis | Not Applicable | Active, not recruiting | September 2018 | Ireland ... 展开 >> St. Patrick's University Hospital Dublin, Ireland, Dublin 8 收起 << |
NCT03575962 | HIV Infections | Phase 1 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Nottingham, United Kingdom, NG11 6JS 收起 << |
NCT03000686 | Healthy Volunteers | Phase 1 | Recruiting | June 14, 2019 | Germany ... 展开 >> GSK Investigational Site Recruiting Hannover, Niedersachsen, Germany, 30625 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03697824 | Neoplasms | Phase 2 | Not yet recruiting | July 17, 2022 | - |
NCT01644396 | - | Completed | - | - | |
NCT02802514 | Diabetes Mellitus | Phase 4 | Terminated | - | United States, Massachusetts ... 展开 >> GSK Investigational Site Boston, Massachusetts, United States, 02114 收起 << |
NCT03604042 | Weight Gain | Not Applicable | Recruiting | December 9, 2018 | France ... 展开 >> Hopital de la Croix Rousse Recruiting Lyon, France, 69004 Contact: Jean-Charles Picaud, Prof +33 4 72 00 41 22 jean-charles.picaud@chu-lyon.fr 收起 << |
NCT03393975 | Congenital Thrombotic Thromboc... 展开 >>ytopenic Purpura 收起 << | Phase 3 | Active, not recruiting | January 21, 2021 | United Kingdom ... 展开 >> University College London Hospitals London, Greater London, United Kingdom, NW1 2PG 收起 << |
NCT03345407 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Active, not recruiting | January 10, 2019 | - |
NCT02502812 | Cardiovascular Disease | Phase 1 | Completed | - | India ... 展开 >> GSK Investigational Site Telangana, India, 500 013 收起 << |
NCT02964507 | Neoplasms | Phase 2 | Recruiting | June 1, 2020 | - |
NCT03651765 | Obesity Associated With Defect... 展开 >>s in Leptin-melanocortin Pathway 收起 << | Phase 2 Phase 3 | Recruiting | March 2023 | United States, Wisconsin ... 展开 >> Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Robert Haws 715-389-3044 Germany Charité - Universitätsmedizin Berlin Recruiting Berlin, Germany, 13353 Contact: Peter Kühnen 49 30 450 666839 收起 << |
NCT02738931 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01644396 | Moderate to Severe Plaque Psor... 展开 >>iasis 收起 << | Phase 4 | Completed | - | Russian Federation ... 展开 >> Site Reference ID/Investigator# 67547 Ekaterinburg, Russian Federation, 620076 Site Reference ID/Investigator# 78433 Kazan, Russian Federation, 420012 Site Reference ID/Investigator# 67542 Moscow, Russian Federation, 107076 Site Reference ID/Investigator# 67546 Saratov, Russian Federation, 410028 Site Reference ID/Investigator# 78417 Smolensk, Russian Federation, 214018 Site Reference ID/Investigator# 78413 St. Petersburg, Russian Federation, 190013 Site Reference ID/Investigator# 67545 St. Petersburg, Russian Federation, 194044 收起 << |
NCT01457989 | - | Completed | - | - | |
NCT03286842 | HER2-ve Metastatic Breast Canc... 展开 >>er Germline BRCA1/2 Mutations Somatic BRCA1/2 Mutations 收起 << | Phase 3 | Recruiting | November 30, 2020 | - |
NCT03741088 | Carcinoma, Hepatocellular ... 展开 >> Liver Metastases 收起 << | Not Applicable | Recruiting | February 21, 2019 | Spain ... 展开 >> Clinica Diagonal Recruiting Esplugues De Llobregat, Barcelona, Spain, 08950 Contact: Joan Vidal-Jove 0034 932 05 32 13 jvidal@khuab.com Principal Investigator: Joan Vidal-Jove Hospital universitario Mutua Terrassa Recruiting Terrassa, Barcelona, Spain, 08221 Contact: Joan Vidal-Jove 0034 937 36 50 50 jvidal@mutuaterrassa.es Principal Investigator: Joan Vidal-Jove Hospital Universitario Vall d´Hebrón Recruiting Barcelona, Spain, 08035 Contact: Xavier Serres 0034 93 489 30 00 xavierserresc@gmail.com Principal Investigator: Xavier Serres 收起 << |
NCT01531933 | Prediabetic | Phase 3 | Completed | - | Indonesia ... 展开 >> Department of Internal Medicine, dr. M. Djamil Padang Hospital Padang, West Sumatera, Indonesia 收起 << |
NCT03741283 | Aging Malnutr... 展开 >>ition Drug Prescribing 收起 << | Not Applicable | Recruiting | December 15, 2020 | Denmark ... 展开 >> Amager & Hvidovre Hospital Recruiting Hvidovre, Region Hovedstaden, Denmark, 2650 Contact: Aino L Andersen, Msc 0045 24616108 Aino.leegaard.andersen@regionh.dk Contact: Morten B Houlind, Msc 0045 28 83 85 63 morten.baltzer.houlind@regionh.dk 收起 << |
NCT02262169 | Non-Bleeding Peptic Ulcers | Phase 3 | Recruiting | March 2019 | Indonesia ... 展开 >> Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Udayana Sanglah General Hospital Recruiting Denpasar, Bali, Indonesia, 80114 Contact: IDN Wibawa Prof. DR. Dr., SpPD-KGEH agusbobwibawa@yahoo.com Principal Investigator: IDN Wibawa Prof. DR. Dr., SpPD-KGEH Sub-Investigator: Nyoman Purwadi dr., Sp.PD-KGEH Sub-Investigator: I Gusti Agung Suryadarma dr., Sp.PD-KGEH Sub-Investigator: I Ketut Mariadi dr., Sp.PD Sub-Investigator: Gde Somayana dr., Sp.PD Sub-Investigator: Putu Prathiwi Primadharsini dr., M. Biomed, Sp.PD Sub-Investigator: Anak Agung Ayu Ngurah Susraini dr., Sp.PA (K) Sub-Investigator: Herman Saputra dr., Sp.PA (K) 收起 << |
NCT03367195 | Gastroesophageal Reflux Diseas... 展开 >>e (GERD) 收起 << | Phase 3 | Active, not recruiting | December 2018 | Indonesia ... 展开 >> Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Padjajaran Dr. Hasan Sadikin Hospital Bandung, Indonesia Division of Gastroenterology Department of Internal Medicine Faculty of Medicine, University of Indonesia Dr. Cipto Mangunkusumo National General Hospital Jakarta, Indonesia, 10430 Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Diponegoro Dr. Kariadi Hospital Semarang, Indonesia Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Airlangga Dr. Soetomo Hospital Surabaya, Indonesia Division of Gastroenterohepatology Department of Internal Medicine Faculty of Medicine, University of Gadjah Mada Dr. Sardjito Hospital Yogyakarta, Indonesia 收起 << |
NCT03324880 | Hypoparathyroidism | Phase 4 | Recruiting | December 26, 2020 | - |
NCT03372603 | Cough | Phase 2 | Active, not recruiting | April 22, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7BL GSK Investigational Site Cottingham, United Kingdom, HU16 5JQ GSK Investigational Site North Shields, United Kingdom, NE29 8NH 收起 << |
NCT03398421 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT01999686 | Polycystic Ovary Syndrome (PCO... 展开 >>S) Insulin Resistance 收起 << | Phase 3 | Recruiting | October 2018 | Indonesia ... 展开 >> Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Lambung Mangkurat, Ulin Banjarmasin Hospital Recruiting Banjarmasin, Indonesia Contact: Iwan D Putra, dr., SpOG-K +62811503472 i_darmaputra@yahoo.com Principal Investigator: Iwan D Putra, dr., SpOG-K Sub-Investigator: Hardyan Sauqi, dr., SpOG Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Udayana, Sanglah Hospital Recruiting Denpasar, Indonesia Contact: Putu Doster Mahayasa, dr., SpOG-K +628123812259 dmahayasa@gmail.com Principal Investigator: Putu Doster Mahayasa, dr., SpOG-K Sub-Investigator: Anom Suardika, dr., SpOG Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Hasanuddin, Dr. Wahidin Sudirohusodo Hospital Recruiting Makasar, Indonesia Contact: Nusratuddin Abdullah, Dr., dr., SpOG-K, MARS +6281342752561 nusraya@yahoo.com Principal Investigator: Nusratuddin Abdullah, Dr., dr., SpOG-K, MARS Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Brawijaya, Dr. Saiful Anwar Hospital Recruiting Malang, Indonesia Contact: Arsana Wiyasa IW, Dr., dr., SpOG-K +62811343876 abiyasa9@yahoo.com Principal Investigator: Arsana Wiyasa IW, Dr., dr., SpOG-K Sub-Investigator: Sutrisno Sutrisno, dr., SpOG-K Sub-Investigator: Widjajanto Ngartjono, dr., SpOG-K Sub-Investigator: Pande M Dwijayasa, dr., SpOG-K Sub-Investigator: Hermawan Wibisono, dr., SpOG Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Sam Ratulangi, Prof. Dr. Kandou Hospital Recruiting Manado, Indonesia Contact: Eddy Suparman, Prof., Dr., dr., SpOG-K +62811431600 obsgyn_manado@yahoo.com.sg Principal Investigator: Eddy Suparman, Prof., Dr., dr., SpOG-K Sub-Investigator: Freddy W Wagey, Dr., dr., SpOG-K Sub-Investigator: Maria F Loho, dr., SpOG-K Sub-Investigator: Juneke J Kaeng, dr., SpOG-K Sub-Investigator: Maya E Mewengkang, dr., SpOG Sub-Investigator: Linda M Mamengko, dr., SpOG-K Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Diponegoro University, Dr. Kariadi Hospital Recruiting Semarang, Indonesia Contact: Syarief Taufik, dr., SpOG-K +628112715580 tofik_obg@yahoo.com Principal Investigator: Syarief Taufik, dr., SpOG-K Sub-Investigator: Inu Mulyantoro, dr., SpOG-K Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Airlangga, Dr. Soetomo Hospital. Recruiting Surabaya, Indonesia Contact: Soehartono Ds, Prof., dr., SpOG-K +62811347720 batabsby@yahoo.com Principal Investigator: Soehartono Ds, Prof., dr., SpOG-K Sub-Investigator: Budi Santoso, Prof., Dr., dr., SpOG-K Sub-Investigator: Relly Y Primariawan, SpOG-K 收起 << |
NCT03557281 | Tuberculosis | Phase 2 | Not yet recruiting | September 13, 2020 | - |
NCT02925546 | Heart Failure, Congestive | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT03541005 | Overweight and Obesity | Phase 3 | Recruiting | December 1, 2019 | Cuba ... 展开 >> National Institute of Endocrinology Recruiting Havana, La Habana, Cuba, 10400 Contact: Eduardo Cabrera Rode, Dr. diabetes@infomed.sld.cu Sub-Investigator: Ileana Cubas Dueñas, Dr. Sub-Investigator: Ana I. Conesa González, Dr. Sub-Investigator: José Hernández, Dr. Principal Investigator: Judith Parlá Sardiñas, Dr. Sub-Investigator: Silvia Marín Julia, Dr. Sub-Investigator: Yuri Arnold Domínguez, Dr. Sub-Investigator: Antonio D. Reyes Rodríguez, PD Sub-Investigator: Aimee Álvarez Álvarez, MD Sub-Investigator: Ragmila Echevarría Valdés, BSc Sub-Investigator: Janet Rodríguez Acosta, BSc Sub-Investigator: Liudmila Jorge Espinosa, CPhT Sub-Investigator: Kenia Enrique Lugo, BNurs Sub-Investigator: Masiel Peña Roque, BNurs Sub-Investigator: Rocío Montes de Oca Somoano, Dr. 收起 << |
NCT01928082 | - | Terminated(The fellow conducti... 展开 >>ng the recruitment and screening left the institution) 收起 << | - | - | |
NCT01433562 | Breast Cancer | Phase 2 Phase 3 | Completed | - | Indonesia ... 展开 >> Surgery-Oncology Division, Department of Surgery, Faculty of Medicine, University of Airlangga / Dr. Soetomo Hospital Surabaya, East Java, Indonesia, 60286 收起 << |
NCT01928082 | Hypercalciuria ... 展开 >> Hypercalciuria, Familial Idiopathic Osteopenia Osteoporosis 收起 << | Phase 2 | Terminated(The fellow conducti... 展开 >>ng the recruitment and screening left the institution) 收起 << | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT00323882 | Prostate Cancer ... 展开 >> Neoplasm Metastasis 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> The Angeles Clinic and Research Institute Los Angeles, California, United States, 11818 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Michigan Josephine Ford Cancer Center-Downriver Brownstown, Michigan, United States, 48183 Henry Ford Medical Center-Fairlane Dearborn, Michigan, United States, 48126 Henry Ford Hospital Detroit, Michigan, United States, 48202-2689 Henry Ford Medical Center-West Bloomfield West Bloomfield, Michigan, United States, 48322 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Carolina BioOncology Institute Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195 收起 << |
NCT00254293 | - | Completed | - | - | |
NCT03315741 | Bronchiolitis Obliterans ... 展开 >> Graft Vs Host Disease 收起 << | Phase 1 | Recruiting | March 31, 2020 | United States, California ... 展开 >> Stanford University School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Joe L Hsu, MD, MPH 650-725-9536 joehsu@stanford.edu Contact: Efthymia I Matthaiou, PhD 650-497-6766 ematth@stanford.edu Principal Investigator: Joe L Hsu, MD, MPH 收起 << |
NCT00323882 | - | Completed | - | - | |
NCT00254293 | Rheumatoid Arthritis | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> Orlando Clinical Research Center Orlando, Florida, United States, 32806 United States, Georgia Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana New Orleans Center For Clinical Research New Orleans, Louisiana, United States, 70119 United States, Minnesota Davita Clinical Research Minneapolis, Minnesota, United States, 55404 United States, North Carolina The Arthritis Clinic & Carolina Bone & Joint Charlotte, North Carolina, United States, 28210 收起 << |
NCT00048165 | Heart Transplantation | Phase 4 | Completed | - | - |
NCT01733459 | Polycystic Ovary Syndrome (PCO... 展开 >>S) 收起 << | Phase 3 | Completed | - | Indonesia ... 展开 >> Department of Obstetrics and Gynecology, Faculty of Medicine, University of Padjadjaran, Hasan Sadikin Hospital Bandung, West Java, Indonesia, 40161 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, dr. Cipto Mangunkusumo Hospital Jakarta, Indonesia, 10430 收起 << |
NCT02668146 | Essential Tremor | Phase 2 | Unknown | June 2017 | United States, California ... 展开 >> VA Greater Los Angeles Los Angeles, California, United States, 90073 收起 << |
NCT03555019 | Immature Infant ... 展开 >> Essential Fatty Acid Deficiency 收起 << | Not Applicable | Recruiting | June 30, 2028 | Norway ... 展开 >> Oslo University Hospital Recruiting Oslo, Norway Contact: Sissel J Moltu, MD, PhD +4722118780 uxsilt@ous-hf.no Contact: Tom A Stiris, Professor +4722118780 uxomst@ous-hf.no 收起 << |
NCT01173016 | Hurler Syndrome | Phase 1 | Unknown | March 2016 | United States, Minnesota ... 展开 >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01865474 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | Indonesia ... 展开 >> Department of Internal Medicine, Faculty of Medicine, University of Andalas/ dr. M. Djamil Padang Hospital Padang, Sumatera Barat, Indonesia 收起 << |
NCT01942122 | Endometrioma ... 展开 >>Visual Analogue Pain Scale: Moderate or Severe Pain 收起 << | Phase 2 Phase 3 | Recruiting | February 2019 | Indonesia ... 展开 >> Yasmin Clinic, Dr. Cipto Mangunkusumo Hospital (Kencana) Recruiting Jakarta Pusat, Jakarta, Indonesia, 10430 Contact: Kanadi Sumapraja, SpOG(K), MD +6221 3928720 kanadisuma@yahoo.com Contact: Budi Wiweko, SpOG(K), MD +6221 39831098 wiwekobudi@yahoo.co.id Sub-Investigator: R. Muharam, SpOG(K), MD Sub-Investigator: Andon Hestiantoro, SpOG(K), MD Sub-Investigator: Budi Wiweko, SpOG(K), MD Sub-Investigator: Herbert Situmorang, SpOG(K), MD Sub-Investigator: Gita Pratama, SpOG(K), MD Sub-Investigator: Achmad K Harzif, SpOG, MD Sub-Investigator: Mila Maidarti, SpOG, MD Sub-Investigator: Vita Silvana, SpOG, MD Department of Obstetrics and Gynecology, RSUP Persahabatan Recruiting Jakarta Pusat, Jakarta, Indonesia Contact: Botefilia, SpOG (K), MD +62214891708 botefilia@yahoo.com Principal Investigator: Botefilia, SpOG (K), MD Sub-Investigator: Zakia, SpOG, MD Sub-Investigator: Devi Marischa, SpOG, MD Department of Obstetrics and Gynecology RSUP Fatmawati Recruiting Jakarta, Indonesia Contact: Agus S As'adi, SpOG (K), MD +62217501524 agus_surur_asadi@yahoo.com Principal Investigator: Agus S As'adi, SpOG (K), MD Sub-Investigator: Luky S Syahbana, SpOG (K), MD Sub-Investigator: Malvin, SpOG (K), MD 收起 << |
NCT03714685 | Healthy Males | Phase 1 | Not yet recruiting | April 2019 | - |
NCT01469884 | Renal Allograft ... 展开 >> Hepatitis C 收起 << | Phase 4 | Completed | - | Brazil ... 展开 >> Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande Do Sul, Brazil, 90020090 收起 << |
NCT00950859 | - | Completed | - | - | |
NCT00950859 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 2 | Completed | - | - |
NCT00048165 | - | Completed | - | - | |
NCT01754012 | Aging | Not Applicable | Completed | - | France ... 展开 >> Auvergne Research Center on Human Nutrition Clermont-Ferrand, France, 63009 Italy University of Bologna-Department of Speciality, Diagnostic and Experimental Medicine Bologna, Italy, 40126 Netherlands University of Wageningen-Division of Human Nutrition Wageningen, Netherlands, 6703 HD Poland Warsaw University of Life Science SGGW-WULS-Department of Human Nutrition Warsaw, Poland, 02-776 United Kingdom Department of Nurition-University of East Anglia Norwich, United Kingdom, NR4 7TJ 收起 << |
NCT03355664 | Malaria, Falciparum | Phase 3 | Recruiting | March 31, 2020 | Cambodia ... 展开 >> Siem Pang Health Center Recruiting Siem Pang, Stung Treng, Cambodia, 1803 Contact: Rupam Tripura, M.D. (66) 2 203 6333 Rupam@tropmedres.ac, Contact: James Callery (66) 2 203 6333 James.C@tropmedres.ac Pailin Referral Hospital Not yet recruiting Pailin, Cambodia, 2401 Contact: Rupam. , Tripura, M.D. (66) 2 203 6333 Rupam@tropmedres.ac Contact: Thomas J Peto, PhD. (66) 2 203 6333 Tom@tropmedres.ac Vietnam Hospital for Tropical Diseases of Khanh Hoa, Not yet recruiting Van Ninh, Khanh Hoa, Vietnam Phuoc Long Hospital Not yet recruiting Phuoc Long, Phuoc, Vietnam Contact: Rob van der Pluijm, M.D. (66) 2 203 6333 Rob@tropmedres.ac 收起 << |
NCT03324932 | Breast Cancer | Phase 3 | Recruiting | December 2023 | Japan ... 展开 >> Hisako Ono Recruiting Kyoto, Japan, 6028566 Contact: Hisako Ono, MD 0752515534 hisako-o@koto.kpu-m.ac.jp Contact: Tetsuya taguchi, PhD 0752515534 ttaguchi@koto.kpu-m.ac.jp Sub-Investigator: Hisako Ono, MD 收起 << |
NCT00392925 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> Research Site Deland, Florida, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Kansas Research Site Overland Park, Kansas, United States United States, Louisiana Research Site Baton Rouge, Louisiana, United States United States, Michigan Research Site Detroit, Michigan, United States United States, Minnesota Research Site Edina, Minnesota, United States United States, Montana Research Site Butte, Montana, United States United States, Ohio Research Site Cincinnati, Ohio, United States United States, Oregon Research Site Portland, Oregon, United States United States, Utah Research Site Salt Lake City, Utah, United States United States, Washington Research Site Olympia, Washington, United States 收起 << |
NCT00392925 | - | Completed | - | - | |
NCT03137329 | Obesity | Not Applicable | Active, not recruiting | June 30, 2019 | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT03709680 | Solid Tumors ... 展开 >>Ewing Sarcoma Rhabdoid Tumor Rhabdomyosarcoma Neuroblastoma Medulloblastoma 收起 << | Phase 1 | Not yet recruiting | September 27, 2023 | - |
NCT02976701 | ST Elevation Myocardial Infarc... 展开 >>tion 收起 << | Phase 2 Phase 3 | Recruiting | December 2019 | Indonesia ... 展开 >> Binawaluya Cardiac Hospital Recruiting Jakarta, Indonesia, 13570 Contact: Muhammad Munawar, SpJP(K), MD +62-21-87781605 muna@cbn.net.id Contact: Jimmy Agung Pambudi, MD jimmyagung27@gmail.com Sub-Investigator: Beny Hartono, SpJP, MD Sub-Investigator: Jimmy A Pambudi, MD Sub-Investigator: Emile TH Parapat, SpJP, MD 收起 << |
NCT00719849 | Leukemia Lymp... 展开 >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases 收起 << | Phase 2 | Terminated(A new protocol was ... 展开 >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) 收起 << | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 收起 << |
NCT03374033 | Infant, Very Low Birth Weight | Not Applicable | Recruiting | July 30, 2022 | Italy ... 展开 >> Ospedale G. Salesi Recruiting Ancona, Italy, 60123 Contact: Virgilio P. Carnielli, MD, PhD 00390715962045 v.carnielli@univpm.it Contact: Chiara Biagetti, MD 00390715962014 chiara.biagetti@ospedaliriuniti.marche.it 收起 << |
NCT03216876 | Primary Sclerosing Cholangitis | Phase 1 | Withdrawn(Lack of feasibility) | July 2019 | United States, California ... 展开 >> Univeristy of California Davis Medical Center Sacramento, California, United States, 95817 收起 << |
NCT03058458 | Healthy Volunteers ... 展开 >> Asthma 收起 << | Phase 1 | Completed | - | United Kingdom ... 展开 >> Investigator Site Harrow, United Kingdom 收起 << |
NCT00089973 | Neoplasms, Breast | Phase 2 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Jacksonville, Florida, United States, 32224 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, North Carolina GSK Investigational Site Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 Belgium GSK Investigational Site Bruxelles, Belgium, 1000 Malaysia GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia, 56000 GSK Investigational Site Bandar Tun Razak, Cheras, Malaysia, 59100 Singapore GSK Investigational Site Singapore, Singapore, 119074 GSK Investigational Site Singapore, Singapore, 169610 United Kingdom GSK Investigational Site Southampton, Hampshire, United Kingdom, SO16 6YD GSK Investigational Site Manchester, Lancashire, United Kingdom, M20 4BX GSK Investigational Site Newcastle Upon Tyne, Northumberland, United Kingdom, NE4 6BE GSK Investigational Site London, United Kingdom, W12 0NN 收起 << |
NCT03324685 | Drug Interactions | Phase 1 | Completed | - | United States, Florida ... 展开 >> Research Site Daytona Beach, Florida, United States, 32117 收起 << |
NCT00719849 | - | Terminated(A new protocol was ... 展开 >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) 收起 << | - | - | |
NCT00089973 | - | Completed | - | - | |
NCT03027557 | Primary Hyperparathyroidism ... 展开 >> Parathyroid Adenoma Parathyroid Hyperplasia 收起 << | Phase 3 | Enrolling by invitation | March 30, 2019 | Denmark ... 展开 >> Aalborg University Hospital Aalborg, Denmark, 9000 收起 << |
NCT03478319 | Healthy Volunteers | Phase 1 | Recruiting | May 2019 | Canada ... 展开 >> Syneos Health Recruiting Québec, Canada, G1P0A2 Contact: Richard Larouche, MD Richard.larouche@syneoshealth.com 收起 << |
NCT03452475 | Plasmodium Falciparum | Phase 3 | Not yet recruiting | December 1, 2020 | - |
NCT00569803 | Transplantation | Phase 1 | Completed | - | United States, Texas ... 展开 >> Ppd Development Austin, Texas, United States, 78744 收起 << |
NCT03649412 | Autoimmune Diseases | Phase 1 | Recruiting | April 24, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Recruiting Nottingham, United Kingdom, NG11 6JS Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT00423891 | Hepatitis B, Chronic | Phase 1 Phase 2 | Completed | - | - |
NCT01972477 | Diabetic Patients ... 展开 >> Low HDL-cholesterol (< 35 mg/dL) Lifestyle Intervention for at Least 1 Month 收起 << | Phase 2 Phase 3 | Withdrawn | January 2018 | Indonesia ... 展开 >> Surabaya Diabetes and Nutrition Center, Dr. Soetomo Hospital; Pusat Diagnostik Terpadu Building 7th Floor Surabaya, East Java, Indonesia 收起 << |
NCT00569803 | - | Completed | - | - | |
NCT00423891 | - | Completed | - | - | |
NCT03654053 | Cirrhosis | Phase 3 | Not yet recruiting | March 2023 | - |
NCT02475655 | HIV Infections | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 UCSD Antiviral Research Center CRS San Diego, California, United States, 92103 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Missouri Washington University Therapeutics (WT) CRS Saint Louis, Missouri, United States, 63110-1010 United States, New York Weill Cornell Chelsea CRS New York, New York, United States, 10010 Weill Cornell Uptown CRS New York, New York, United States, 10065 University of Rochester Adult HIV Therapeutic Strategies Network CRS Rochester, New York, United States, 14642 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 Case Clinical Research Site Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island The Miriam Hospital Clinical Research Site (TMH CRS) CRS Providence, Rhode Island, United States, 02906 United States, Tennessee Vanderbilt Therapeutics (VT) CRS Nashville, Tennessee, United States, 37204 收起 << |
NCT00424255 | - | Completed | - | - | |
NCT02145988 | Diabetes Peri... 展开 >>pheral Arterial Disease 收起 << | Phase 2 Phase 3 | Terminated(Recruitment rate is... 展开 >> unexpectedly too low (insufficient number of eligible patients).) 收起 << | - | Indonesia ... 展开 >> Department of Internal Medicine, Faculty of Medicine, University of Udayana/Sanglah Hospital Denpasar, Bali, Indonesia Department of Internal Medicine, RSUD Wangaya Denpasar, Bali, Indonesia 收起 << |
NCT00424255 | Neoplasms, Head and Neck | Phase 3 | Completed | - | - |
NCT01662999 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Nebraska ... 展开 >> Icon Clinical Pharmacology Omaha, Nebraska, United States, 68154 收起 << |
NCT01668784 | Advanced or Metastatic (Medica... 展开 >>lly or Surgically Unresectable) Clear-cell Renal Cell Carcinoma 收起 << | Phase 3 | Active, not recruiting | September 28, 2018 | - |
NCT03429426 | - | Enrolling by invitation | December 31, 2026 | Denmark ... 展开 >> Department of Rheumatology, Aarhus University Hospital Aarhus, Denmark, 8000 收起 << | |
NCT03737370 | Metastatic Castrate Resistant ... 展开 >>Prostate Cancer 收起 << | Phase 1 | Recruiting | October 31, 2021 | United States, Massachusetts ... 展开 >> Lahey Hospital & Medical Center Not yet recruiting Boston, Massachusetts, United States, 01805 Contact: Amanda Pietras 781-744-2766 amanda.pietras@lahey.org Principal Investigator: Brendan J Connell, MD Tufts Medical Center Recruiting Boston, Massachusetts, United States, 02111 Contact: Amanda Campbell 617-636-2883 acampbell3@tuftsmedicalcenter.org Contact: Erica Holt 617-636-2675 eholt@tuftsmedicalcenter.org Principal Investigator: Paul Mathew, MD 收起 << |
NCT01668784 | - | Active, not recruiting | - | - | |
NCT01584648 | Melanoma | Phase 3 | Active, not recruiting | October 15, 2018 | - |
NCT01774721 | Non-small Cell Lung Cancer Wit... 展开 >>h EGFR-Activating Mutations 收起 << | Phase 3 | Active, not recruiting | March 29, 2019 | - |
NCT01662999 | - | Completed | - | - | |
NCT01153763 | Melanoma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90025 GSK Investigational Site Los Angeles, California, United States, 90095 GSK Investigational Site San Francisco, California, United States, 94115 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030-4009 Australia, New South Wales GSK Investigational Site Newcastle, New South Wales, Australia, 2300 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 France GSK Investigational Site Bordeaux, France, 33075 GSK Investigational Site Boulogne-Billancourt, France, 92100 GSK Investigational Site Lille, France, 59037 GSK Investigational Site Marseille Cedex 5, France, 13385 GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Paris Cedex 10, France, 75475 GSK Investigational Site Villejuif, France, 94805 Germany GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 GSK Investigational Site Kiel, Schleswig-Holstein, Germany, 24105 GSK Investigational Site Luebeck, Schleswig-Holstein, Germany, 23538 GSK Investigational Site Berlin, Germany, 10117 Italy GSK Investigational Site Napoli, Campania, Italy, 80131 GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Padova, Veneto, Italy, 35128 收起 << |
NCT00673387 | Overweight Ob... 展开 >>esity 收起 << | Phase 2 | Completed | - | - |
NCT01774721 | - | Active, not recruiting | - | - | |
NCT00673387 | - | Completed | - | - | |
NCT01153763 | - | Completed | - | - | |
NCT00394251 | Breast Cancer | Phase 2 | Completed | - | - |
NCT03437525 | Type 2 Diabetes Treated With I... 展开 >>nsulin 收起 << | Not Applicable | Active, not recruiting | April 30, 2018 | China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 << |
NCT00394251 | - | Completed | - | - | |
NCT02641054 | Idiopathic Parkinson Disease | Phase 2 | Completed | - | France ... 展开 >> Clevexel Pharma Maisons-Alfort, France, 94700 收起 << |
NCT03438617 | Type 2 Diabetes Mellitus | Not Applicable | Active, not recruiting | July 31, 2018 | China, Shanghai ... 展开 >> Shanghai Sixth People's Hospital Shanghai, Shanghai, China, 200235 An Ting Community Health Center Shanghai, Shanghai, China Cao He Jing Community Health Center Shanghai, Shanghai, China Cao Yang Community Health Center Shanghai, Shanghai, China Hong Mei Community Health Center Shanghai, Shanghai, China Kang Jian Community Health Center Shanghai, Shanghai, China Long Hua Community Health Center Shanghai, Shanghai, China Nan Jing Xi Road Community Health Center Shanghai, Shanghai, China Tao Pu Community Health Center Shanghai, Shanghai, China Tian Lin Community Health Center Shanghai, Shanghai, China Zhen Ru Community Health Center Shanghai, Shanghai, China 收起 << |
NCT03665519 | Primary Biliary Cirrhosis | Not Applicable | Recruiting | December 2020 | Kazakhstan ... 展开 >> National Research Medical Center Recruiting Astana, Kazakhstan, 010000 Contact: Galiya Shaimardanova, PhD +77017299148 galiya_masugut@mail.ru Contact: Gulmira Dossatayeva, MD, MBA +77015127500 g_dossatayeva@inbox.ru Principal Investigator: Abay Baigenzhin, MD, PhD Sub-Investigator: Gulmira Dossatayeva, MD, MBA Sub-Investigator: Maiya Zhumabayeva, MD Sub-Investigator: Galiya Shaimardanova, PhD 收起 << |
NCT01525238 | - | Completed | - | - | |
NCT00680901 | Neoplasms, Gastrointestinal Tr... 展开 >>act 收起 << | Phase 3 | Active, not recruiting | December 31, 2020 | - |
NCT01225822 | Venous Thromboembolism | Phase 2 | Completed | - | - |
NCT01610492 | Glomerulonephritis, Membranous | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Exeter, Devon, United Kingdom, EX2 5DW GSK Investigational Site Stevenage, Hertfordshire, United Kingdom, SG1 4AB GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, United Kingdom, G11 6NT GSK Investigational Site Manchester, United Kingdom, M13 9WL GSK Investigational Site Reading, United Kingdom, RG1 5AN GSK Investigational Site Salford, United Kingdom, M6 8HD GSK Investigational Site Whitechapel, London, United Kingdom, E1 1BB 收起 << |
NCT01610492 | - | Completed | - | - | |
NCT01947998 | - | Recruiting | December 31, 2019 | United Kingdom ... 展开 >> Recruiting Multiple Locations, United Kingdom 收起 << | |
NCT01584648 | - | Active, not recruiting | - | - | |
NCT02566655 | Osteoporosis ... 展开 >>Spinal Fractures 收起 << | Phase 1 | Recruiting | December 2018 | Spain ... 展开 >> Hospital Clínico Virgen de la Arrixaca Recruiting El Palmar, Murcia, Spain, 30120 Contact: Natalia García Iniesta +34968381221 nagarini@yahoo.es Principal Investigator: Luis F Linares Ferrando, MD Sub-Investigator: Carlos Marras Fernández-Cid, MD Sub-Investigator: José M Moraleda Jiménez, MD Sub-Investigator: Miguel Blanquer Blanquer, MD Sub-Investigator: Ana M García Hernández, MD Sub-Investigator: Joaquín A Gómez Espuch, MD Sub-Investigator: Valentín Cabañas Perianes, MD Sub-Investigator: María Dolores López Lucas, Graduate Sub-Investigator: Darío Sánchez Salinas, Graduate Sub-Investigator: Francisca Iniesta Martínez, Graduate Sub-Investigator: Carmen Algueró Martín, Graduate Sub-Investigator: Ernesto Doménech Abellán, MD Sub-Investigator: Mª Dolores Morales Cano, MD Sub-Investigator: Nuria Lozano Rivas, MD Sub-Investigator: Monica Rodriguez Valiente, MD Sub-Investigator: Mariano Espinosa de Rueda Ruiz, MD Sub-Investigator: Jose Becerra Ratia, MD Sub-Investigator: Bartolomé García García, MD Sub-Investigator: Robert Sackstein, MD Sub-Investigator: Jose Luis Peris, MD Sub-Investigator: Pilar María Arrabal García, MD 收起 << |
NCT00680901 | - | Active, not recruiting | - | - | |
NCT01525238 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United States, Alabama ... 展开 >> The Children Hospital Of Alabama Birmingham, Alabama, United States, 35233 United States, California Axis Clinical Trials Los Angeles, California, United States, 90036 United States, Florida Nemours Childrens Hospital Orlando, Florida, United States, 32827 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kentucky Kosair Charities Pediatric Clinical Research Unit Louisville, Kentucky, United States, 40202 United States, Louisiana Lsuhsc-Shreveport Shreveport, Louisiana, United States, 71103 United States, Missouri Childrens Mercy Hospital Kansas City, Missouri, United States, 64108 United States, New York Women And Children'S Hopsital Of Buffalo Buffalo, New York, United States, 14222 United States, Ohio Promedica Toledo Children'S Hospital Toledo, Ohio, United States, 43606 Mercy Children'S Hospital Toledo, Ohio, United States, 43608 United States, Pennsylvania Children'S Hospital Of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children'S Hospital Of Pittsburgh Of Upmc Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Methodist Le Bonheur Hlthcare Memphis, Tennessee, United States, 38103 United States, Texas Christus Santa Rosa Childrens Hospital San Antonio, Texas, United States, 78207 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44150 Local Institution Monterrey, Nuevo Leon, Mexico, 64460 Local Institution Veracruz, Mexico, 91910 收起 << |
NCT01419028 | - | Completed | - | - | |
NCT01225822 | - | Completed | - | - | |
NCT01030094 | - | Completed | - | - | |
NCT02104219 | - | Completed | - | - | |
NCT03275558 | Recurrent Glioblastoma ... 展开 >> Gliosarcoma Anaplastic Gliomas 收起 << | Phase 1 | Withdrawn(Study halted prior t... 展开 >>o enrollment of first participant. (It has been determined on 2018 May 15 that the NCT03275558 study will be stopped by sponsor decision)) 收起 << | - | Hong Kong ... 展开 >> The Hong Kong Cancer Institute Hong Kong, Hong Kong, 518031 Singapore National University Cancer Institute, Singapore, Singapore, 119074 收起 << |
NCT00996840 | Lung Injury, Acute | Phase 2 | Completed | - | United States, Kentucky ... 展开 >> GSK Investigational Site Lexington, Kentucky, United States, 40536-0293 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37232-7110 收起 << |
NCT02104219 | - | Completed | - | United States, Georgia ... 展开 >> Atlanta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, Missouri Springfield, Missouri, United States St. Louis, Missouri, United States United States, North Carolina Durham, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, Texas Houston, Texas, United States United States, Washington Seattle, Washington, United States Australia Sydney, Australia Canada, Manitoba Winnipeg, Manitoba, Canada France Le Kremlin-Bicêtre, France Paris, France Toulouse, France Netherlands Rotterdam, Netherlands Russian Federation Moscow, Russian Federation Turkey Istanbul, Turkey United Kingdom Manchester, United Kingdom Sheffield, United Kingdom 收起 << | |
NCT02803437 | - | Active, not recruiting | May 31, 2021 | Japan ... 展开 >> Multiple Locations, Japan 收起 << | |
NCT01065779 | - | Completed | - | - | |
NCT02803554 | Aging | Not Applicable | Completed | - | - |
NCT00996840 | - | Completed | - | - | |
NCT01765010 | Osteoporosis | Phase 4 | Unknown | March 2013 | Korea, Republic of ... 展开 >> Seoul National University Medical School Recruiting Seoul, Korea, Republic of, 110-744 Contact: Chan Soo Shin, MD, PhD 82220723734 csshin@snu.ac.kr Contact: Jung Hee Kim, MD 8220724839 jhkxingfu@gmail.com Principal Investigator: Chan Soo Shin, MD, PhD 收起 << |
NCT02235493 | - | Completed | - | United States, Missouri ... 展开 >> St. Louis, Missouri, United States 收起 << | |
NCT03195517 | Osteopenia Bo... 展开 >>ne Turnover Markers Quality of Life 收起 << | Not Applicable | Completed | - | - |
NCT01065779 | - | Completed | - | - | |
NCT02057692 | Alagille Syndrome | Phase 2 | Completed | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 University of California at San Francisco San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine/Texas Children's Hospital Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84113 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT00416130 | Breast Cancer | Phase 1 Phase 2 | Unknown | January 2015 | Singapore ... 展开 >> National University Hospital Singapore, Singapore, 149547 National Cancer Centre Singapore, Singapore, 169610 收起 << |
NCT02602704 | Arthritis, Rheumatoid | Phase 4 | Active, not recruiting | November 7, 2018 | Korea, Republic of ... 展开 >> Hanyang University Seoul, Korea, Republic of, 04763 收起 << |
NCT02235493 | - | Completed | - | - | |
NCT02057692 | - | Completed | - | - | |
NCT02164552 | - | Unknown | December 2014 | Saudi Arabia ... 展开 >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Recruiting Jeddah, Makkah, Saudi Arabia, 21589 Contact: Veronica B Orbacedo, BSc 0096612640000 ext 25574 vorbacedo@yahoo.com Contact: Ramia Al-sobhi, BSc 0096612640000 ext 25528 ceor@kau.edu.sa Sub-Investigator: Ahmed Y Ali, MD Sub-Investigator: Ghazi Y Refai, MD Sub-Investigator: Mohammed H Qari, FRCPA Sub-Investigator: Heba S Kary, MD 收起 << | |
NCT02419105 | Hypogonadism ... 展开 >>Pre-frail Seniors 收起 << | Phase 3 | Recruiting | March 2022 | Switzerland ... 展开 >> Dept. of Geriatrics and Aging Research, University of Zurich / Geriatric Clinic University Hospital Zurich Recruiting Zürich, ZH, Switzerland, 8037 Contact: Heike A Bischoff-Ferrari, MD, DrPH (+41)44 2552699 Heike.Bischoff@usz.ch Principal Investigator: Heike A Bischoff-Ferrari, MD, DrPH Sub-Investigator: Andreas Egli Linder, MD 收起 << |
NCT03597841 | - | Recruiting | July 2019 | Turkey ... 展开 >> Ankara University Recruiting Ankara, Turkey Contact: Güle Çınar, MD gbinjune@gmail.com Contact: Alpay Azap, MD Alpay.Azap@medicine.ankara.edu.tr Başkent University Recruiting Ankara, Turkey Contact: Hamiyet Demirkaya, MD demirkayamelikehamiyet@gmail.com Contact: Özlem Azap, MD ozlem.azap@gmail.com Hacettepe University Recruiting Ankara, Turkey Contact: Murat Akova, MD akova.murat@gmail.com Contact: Abdullah Tarık Aslan, MD abdullah.aslan@hacettepe.edu.tr Ministry of Health, Ankara Training and Research Hospital Recruiting Ankara, Turkey Contact: Necla Tülek, MD ntulek@superonline.com Uluduağ University Recruiting Bursa, Turkey Contact: Halis Akalın, MD halis@uludag.edu.tr Dicle University Recruiting Diyarbakır, Turkey Contact: Mustafa K. Çelen, MD mkcelen@hotmail.com American Hospital Recruiting Istanbul, Turkey Contact: Şiran Keske, MD sirank@amerikanhastanesi.org Cerrahpaşa University Recruiting Istanbul, Turkey Contact: Neşe Saltoğlu, MD saltoglu.nese@gmail.com Contact: İlker İ. Balkan, MD ilkerinancbalkan@hotmail.com Istanbul Bilim University Not yet recruiting Istanbul, Turkey Contact: Nuriye Taşdelen Fışgın, MD fnuriye@yahoo.com Istanbul Training and Research Hospital Recruiting Istanbul, Turkey Contact: Burcu Isler, MD +905053566790 burcubayrak85@gmail.com Koç University Recruiting Istanbul, Turkey Contact: Önder Ergönül, MD oergonul@ku.edu.tr Marmara University Recruiting Istanbul, Turkey Contact: Elif Tükenmez Tigen, MD fetukenmez@yahoo.com Ministry of Health Okmeydanı Training and Research Hospital Recruiting Istanbul, Turkey Contact: Funda Şimşek, MD fundasimsek67@gmail.com Ministry Of Health, Kartal Koşuyolu High Speciality Educational and Research Hospital Recruiting Istanbul, Turkey Contact: Şirin Menekşe, MD meneksesirin@hotmail.com Dokuz Eylül University Recruiting İzmir, Turkey Contact: Sema Alp Çavuş, MD sema_alp@yahoo.com 收起 << | |
NCT01435382 | Hypercholesterolemia ... 展开 >> Dyslipidemias Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 United States, Florida Elite Research Institute Miami, Florida, United States, 33169 United States, Kansas Vince and Associates Clinical Research Overland Park, Kansas, United States, 66212 United States, Maryland PAREXEL International - Baltimore Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 United States, Michigan Jasper Clinic, Inc. Kalamazoo, Michigan, United States, 49007 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45212 收起 << |
NCT01707849 | Hepatitis C Recurrence After L... 展开 >>iver Transplant 收起 << | Phase 3 | Completed | - | Spain ... 展开 >> Department of HPB Surgery and Transplant, Hospital Vall d´Hebron Barcelona, Spain, 08035 收起 << |
NCT01473407 | Chronic Kidney Disease ... 展开 >> Chronic Renal Failure 收起 << | Phase 3 | Completed | - | - |
NCT01389596 | - | Completed | - | - | |
NCT01712074 | - | Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 << | - | - | |
NCT01389596 | Epilepsy, Partial Seizures | Phase 3 | Completed | - | - |
NCT01712074 | Alzheimer's Disease | Phase 2 | Terminated(The study was termi... 展开 >>nated October 23, 2015 as pre-specified, interim analysis futility criteria were met. The termination was not due to safety concerns.) 收起 << | - | - |
NCT01435382 | - | Completed | - | - | |
NCT01473420 | Chronic Renal Failure ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | - |
NCT03573089 | Kidney Failure, Chronic ... 展开 >> Hyperphosphatemia 收起 << | Not Applicable | Not yet recruiting | December 31, 2025 | - |
NCT01473407 | - | Completed | - | - | |
NCT03384719 | Growth Acceleration ... 展开 >> Growth; Stunting, Nutritional 收起 << | Not Applicable | Not yet recruiting | April 2019 | - |
NCT01473420 | - | Completed | - | - | |
NCT02130557 | Leukemia, Myelogenous, Chronic... 展开 >>, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive 收起 << | Phase 3 | Active, not recruiting | April 4, 2020 | - |
NCT00570063 | Schizophrenia | Phase 2 | Terminated | - | United States, California ... 展开 >> California Clinical Trials Medical Group, Inc. Glendale, California, United States, 91206 Glendale Adventist Medical Center Glendale, California, United States, 91206 Telecare-Cresta Loma Lemon Grove, California, United States, 91945 California Clinical Trials Medical Group Paramount, California, United States, 90723 LaPaz Geropsychiatric Center Paramount, California, United States, 90723 California Clinical Trials Medical Group San Diego, California, United States, 92123 United States, Connecticut Connecticut Mental Health Center-Yale University, Clinical Neuroscience Research Unit New Haven, Connecticut, United States, 06519 United States, New Jersey CRI Worldwide, LLC Willingboro, New Jersey, United States, 08046 United States, Oklahoma St. Anthony Hospital Oklahoma City, Oklahoma, United States, 73101 IPS Research Company Oklahoma City, Oklahoma, United States, 73103 收起 << |
NCT02210806 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> Amphastar Site 0001 San Jose, California, United States, 95117 United States, Oregon Amphastar Site 0025 Medford, Oregon, United States, 97504 United States, Texas Amphastar Site 0030 New Braunfels, Texas, United States, 78130 Amphastar Site 0032 San Antonio, Texas, United States, 78229 收起 << |
NCT00886821 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Florida ... 展开 >> Cetero Research Miami Gardens, Florida, United States, 33169 United States, Texas Cetero Research - San Antonio San Antonio, Texas, United States, 78229 收起 << |
NCT02130557 | - | Active, not recruiting | - | - | |
NCT02072824 | Partial Onset Seizures | Phase 3 | Completed | - | - |
NCT00886821 | - | Completed | - | - | |
NCT02072824 | - | Completed | - | - | |
NCT02007512 | Breast Cancer | Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT00531752 | - | Completed | - | - | |
NCT00570063 | - | Terminated | - | - | |
NCT01994291 | Macular Edema, Diabetic | Phase 2 | Terminated | - | - |
NCT01994291 | - | Terminated | - | - | |
NCT00531752 | Attention Deficit Hyperactivit... 展开 >>y Disorder 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Bay Area Research Institute Lafayette, California, United States, 94549 Pharmacology Research Institute Los Alamitos, California, United States, 90720 Pharmacology Research Institute Newport Beach, California, United States, 92660 United States, Illinois The University of Illinois at Chicago, Institute for Juvenile Research Chicago, Illinois, United States, 60608 United States, Massachusetts Massachusetts General Hospital, ADHD Program Cambridge, Massachusetts, United States, 02138 United States, New York New York University School of Medicine New York, New York, United States, 10010 United States, Virginia NeuroScience, Inc Herndon, Virginia, United States, 20170 收起 << |
NCT02650193 | Non-metastatic Breast Cancer | Phase 2 | Completed | - | Hungary ... 展开 >> CRU Hungary Kft.,CRU Early Phase Unit, Miskolci Semmelweis Kórház és Egyetemi Oktató Kórház Miskolc, BAZ Megye, Hungary, 3529 Debreceni Egyetem Klinikai Központ, ÁOK, Onkológiai Klinika Debrecen, Hajdú-bihar Megye, Hungary, 4032 Országos Onkológiai Intézet Budapest, Hungary, 1122 Spain Hospital Universitario Arnau de Vilanova Lleida, Cataluna, Spain, 25198 Hospital Universitario de Fuenlabrada, Servicio de oncologia Fuenlanbrada, Madrid, Spain, 28942 START Madrid - CIOCC, Unidad de fases 1 planta 3, Hospital Universitario HM Sanchinarro Madrid, Spain, 28050 Hospital Arnau de Vilanova. planta 6, unidad de Oncología Valencia, Spain, 46015 收起 << |
NCT01860196 | Adult Cerebral Palsy | Phase 4 | Completed | - | - |
NCT03355079 | Cancer-related Malnutrition | Phase 4 | Recruiting | July 2020 | France ... 展开 >> Hôpital Cochin Recruiting Paris, France, 75014 收起 << |
NCT02650193 | - | Completed | - | - | |
NCT02606097 | Gastrointestinal Stromal Tumou... 展开 >>r (GIST) 收起 << | Phase 2 | Unknown | - | Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Taoyuan, Taiwan, 333 Contact: Chun-Nan Yeh, MD 886-3-3281200 ext 3219 yehchunnan@gmail.com 收起 << |
NCT03042195 | Head and Neck Neoplasm | Not Applicable | Completed | - | Denmark ... 展开 >> Clinic for Ear, Nose and Throat Surgery, Rigshospital Copenhagen, Denmark, 2100 Cph OE 收起 << |
NCT02007512 | - | Active, not recruiting | - | - | |
NCT03021291 | Overweight and Obesity | Not Applicable | Completed | - | United States, California ... 展开 >> Arternis Institute for Clinical Research San Diego, California, United States, 92103 Clinical Trial Investigators Tustin, California, United States, 92780 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida Westside Center for Clinical Research Jacksonville, Florida, United States, 32205 United States, Louisiana Pennington Biomedical Research Baton Rouge, Louisiana, United States, 70808 United States, Massachusetts Boston University Medical Center Boston, Massachusetts, United States, 02118 United States, New York Cornell Weill Medical College New York, New York, United States, 10065 United States, Ohio Radiant Research Cincinnati, Ohio, United States, 45249 Aventiv Research Columbus, Ohio, United States, 43213 United States, Pennsylvania Geisinger Health System Danville, Pennsylvania, United States, 17822 United States, Texas Texas Diabetes and Endocrinology Round Rock, Texas, United States, 78681 Czechia Health & Care SRO Prague, Czechia, 182 00 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy IRCCS Policlinico San Donato Milan, Italy, 20097 University of Rome Rome, Italy, 00186 Spain University of Navarra Pamplona, Spain, 31008 收起 << |
NCT00797108 | Pneumonia, Bacterial | Phase 2 | Completed | - | United States, California ... 展开 >> eStudySite, Inc. Chula Vista, California, United States, 91911 Sharp Chula Vista Medical Center Chula Vista, California, United States, 91911 eStudySite, Inc. Oceanside, California, United States, 92056 Tri-City Medical Center Oceanside, California, United States, 92056 United States, Illinois Medical Arts Associates, Ltd Moline, Illinois, United States, 61265 Trinity Medical Center Rock Island, Illinois, United States, 61201 United States, Minnesota Infectious Disease Minneapolis Limited Minneapolis, Minnesota, United States, 55422 United States, Ohio Summa Health System Akron, Ohio, United States, 44304 Summa Health System Akron, Ohio, United States, 44309 Summa Health System Akron, Ohio, United States, 44310 United States, Utah Utah Valley Pulmonary Clinic Provo, Utah, United States, 84604 Utah Valley Regional Medical Center Provo, Utah, United States, 84604 Australia, Queensland Infection Management Services, Building 17, Level 1 Brisbane, Queensland, Australia, 4102 Canada, Ontario Hamilton Health Sciences - General Site Hamilton, Ontario, Canada, L8L 2X2 Hamilton Health Sciences- McMaster Site Hamilton, Ontario, Canada, L8N 3Z5 Hamilton Health Sciences - Henderson Site Hamilton, Ontario, Canada, L8V 1C3 Korea, Republic of Asan Medical Center, Division of Infectious Diseases Seoul, Korea, Republic of, 138-736 Poland Oddzial Chorob Wewnetrznych i Gastroenterologii Bialystok, Poland, 15-003 Oddzial Chorob Pluc Brzesko, Poland, 32-800 Kliniczny Oddzial Gruzlicy i Chorob Pluc Krakow, Poland, 30-901 Oddzial Kliniczny Pulmonologii i Alergologii Lodz, Poland, 90-153 Oddzial Pulmonologiczny III Poznan, Poland, 60-569 Oddzial Pulmonologiczny Proszowice, Poland, 32-100 II Oddzial Chorob Wewnetrznych Warszawa, Poland, 03-401 收起 << |
NCT03543644 | Healthy Overw... 展开 >>eight and Obesity Metabolic Syndrome PreDiabetes Diabetes Overweight Obesity Dysglycemia Cardiovascular Diseases Cardiovascular Risk Factor Hypertension 收起 << | Not Applicable | Recruiting | November 2020 | Canada, Ontario ... 展开 >> St Michael's Hospital Recruiting Toronto, Ontario, Canada, M5C2T2 Contact: Maxine Seider, MSc, RD 4168677460 ext 8216 seiderm@smh.ca Principal Investigator: John Sievenpiper, MD, PhD, FRCPC 收起 << |
NCT00797108 | - | Completed | - | - | |
NCT01889238 | Advanced, Androgen Receptor Po... 展开 >>sitive Triple Negative Breast Cancer 收起 << | Phase 2 | Active, not recruiting | June 30, 2019 | - |
NCT01628107 | Chronic Renal Failure Requirin... 展开 >>g Hemodialysis 收起 << | Phase 3 | Completed | - | - |
NCT01889238 | - | Active, not recruiting | - | - | |
NCT03008954 | Overweight Ob... 展开 >>esity 收起 << | Not Applicable | Completed | - | Czechia ... 展开 >> Hradec Králové Hradec, Czechia, 500 00 Charles University Prague, Czechia, 121 08 Denmark University of Cophenhagen Copenhagen, Denmark, DK-1958 Italy Federico University Hospital Naples, Italy, 80131 Policlinico Umberto I Rome, Italy, 00161 收起 << |
NCT01628120 | Chronic Renal Failure Requirin... 展开 >>g Hemodialysis 收起 << | Phase 3 | Completed | - | - |
NCT01628107 | - | Completed | - | - | |
NCT02976246 | Vitamin K Supplementation ... 展开 >> Endstage Renal Disease Cardiovascular Disease Bone Disease 收起 << | Phase 2 Phase 3 | Recruiting | August 2020 | Denmark ... 展开 >> Holbaek Hospital Not yet recruiting Holbaek, Denmark, 4300 Contact: Marianne Berthelsen, MDS mbte@regionsjaelland.dk Zealand University Hospital Recruiting Roskilde, Denmark, 4000 Contact: Karin Levy-Schousboe, phd student +45 23351803 kshb@regionsjaelland.dk Contact: Peter Marckmann, MDS +45 23351228 pmar@regionsjaelland.dk 收起 << |
NCT02418650 | Healthy | Phase 1 | Completed | - | United Kingdom ... 展开 >> Quotient Clinical Nottingham, United Kingdom, NG11 6JS 收起 << |
NCT01628120 | - | Completed | - | - | |
NCT00942968 | Cancer | Phase 4 | Completed | - | - |
NCT01006122 | - | Completed | - | - | |
NCT01006122 | Excessive Daytime Sleepiness ... 展开 >> Narcolepsy 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Pfizer Investigational Site Phoenix, Arizona, United States, 85006 Pfizer Investigational Site Phoenix, Arizona, United States, 85051 Pfizer Investigational Site Tucson, Arizona, United States, 85712 United States, California Pfizer Investigational Site Los Angeles, California, United States, 90048 Pfizer Investigational Site Orange, California, United States, 92868 United States, Florida Pfizer Investigational Site Brandon, Florida, United States, 33511 Pfizer Investigational Site St. Petersburg, Florida, United States, 33707 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30342 Pfizer Investigational Site Macon, Georgia, United States, 31201 United States, Illinois Pfizer Investigational Site Vernon Hills, Illinois, United States, 60061 United States, Kentucky Pfizer Investigational Site Crestview Hills, Kentucky, United States, 41017 Pfizer Investigational Site Louisville, Kentucky, United States, 40217 United States, Mississippi Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39401 Pfizer Investigational Site Hattiesburg, Mississippi, United States, 39402 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Dublin, Ohio, United States, 43017 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19114 Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19139 United States, South Carolina Pfizer Investigational Site Columbia, South Carolina, United States, 29201 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78731 Pfizer Investigational Site Houston, Texas, United States, 77063 收起 << |
NCT02366637 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 << | - | United Kingdom ... 展开 >> Medicines Evaluation Unit Ltd Wythenshawe, Manchester, United Kingdom, M23 9QZ Nottingham University Hospital NHS Trust Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom, B15 2WB Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Respiratory Medicine, Bradford Institute of Health Research Bradford, United Kingdom, BD9 6RJ 收起 << |
NCT03299244 | Secondary Hyperparathyroidism ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Recruiting | November 26, 2019 | - |
NCT00565812 | Osteoarthritis | Phase 2 | Completed | - | - |
NCT02471820 | Multiple Myeloma | Phase 2 | Completed | - | Greece ... 展开 >> General Hospital of Athens "G. Gennimatas" Athens, Attica, Greece, 11527 General Hospital of Athens "Alexandra" Athens, Attica, Greece, 11528 University General Hospital of Patras Patra, Greece, 26504 Theageneio Anticancer Hospital of Thessaloniki Thessaloniki, Greece, 54007 收起 << |
NCT00425061 | Asthma | Phase 2 | Completed | - | - |
NCT02366637 | - | Terminated(Study terminated on... 展开 >> 7 April 2015 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study) 收起 << | - | - | |
NCT00942968 | - | Completed | - | - | |
NCT00744497 | Prostatic Neoplasms | Phase 3 | Completed | - | - |
NCT00425061 | - | Completed | - | - | |
NCT00528879 | - | Completed | - | - | |
NCT00528879 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00107718 | Melanoma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90089 GSK Investigational Site San Francisco, California, United States, 94115 GSK Investigational Site Santa Monica, California, United States, 90404-2104 United States, Connecticut GSK Investigational Site New Haven, Connecticut, United States, 06520 United States, Florida GSK Investigational Site Jacksonville, Florida, United States, 32209 GSK Investigational Site Miami Beach, Florida, United States, 33140 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60637 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland GSK Investigational Site Lutherville-Timonium, Maryland, United States, 21093 United States, New York GSK Investigational Site New York, New York, United States, 10016 United States, Ohio GSK Investigational Site Toledo, Ohio, United States, 43614-5809 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213-2584 Australia, New South Wales GSK Investigational Site Waratah, New South Wales, Australia, 2298 GSK Investigational Site Westmead, New South Wales, Australia, 2145 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site South Brisbane, Queensland, Australia, 4101 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 收起 << |
NCT00565812 | - | Completed | - | - | |
NCT03693300 | Non-small Cell Lung Cancer (NS... 展开 >>CLC) 收起 << | Phase 2 | Not yet recruiting | December 30, 2022 | United States, Tennessee ... 展开 >> Research Site Not yet recruiting Knoxville, Tennessee, United States, 37920 France Research Site Not yet recruiting Saint Priest en Jarez, France, 42270 United Kingdom Research Site Not yet recruiting Leeds, United Kingdom, LS9 7TF 收起 << |
NCT00744497 | - | Completed | - | - | |
NCT00281684 | Toothache | Phase 2 | Completed | - | Italy ... 展开 >> GSK Investigational Site Verona, Veneto, Italy, 37134 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 110-768 United Kingdom GSK Investigational Site Croydon, Surrey, United Kingdom, CR7 7YE GSK Investigational Site Leeds, United Kingdom, LS2 9NG GSK Investigational Site Manchester, United Kingdom, M13 9WL 收起 << |
NCT00974311 | - | Completed | - | - | |
NCT01208012 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Germany ... 展开 >> IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 收起 << |
NCT00974311 | Castration-Resistant Prostate ... 展开 >>Cancer 收起 << | Phase 3 | Completed | - | - |
NCT00569062 | Depressive Disorder, Major | Phase 2 | Terminated(Negative data from ... 展开 >>a GSK PoC study in RA combined with evidence of greater sensitivity of toll-like receptor pathways to p38 inhibition.) 收起 << | - | Estonia ... 展开 >> GSK Investigational Site Tartu, Estonia, 50417 India GSK Investigational Site Bangalore, India, 560029 GSK Investigational Site Bangalore, India, 560034 GSK Investigational Site Ludhiana, India, 141001 GSK Investigational Site Manipal,, India, 576 104 GSK Investigational Site Mumbai, India, 400010 GSK Investigational Site Pune, India, 411004 Russian Federation GSK Investigational Site Moscow, Russian Federation, 107076 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Moscow, Russian Federation, 119992 GSK Investigational Site Moscow, Russian Federation, 123367 GSK Investigational Site Nizhny Novgorod, Russian Federation, 603115 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation GSK Investigational Site St.Petersburg, Russian Federation, 193167 收起 << |
NCT01254019 | Muscular Dystrophies | Phase 3 | Completed | - | - |
NCT03610334 | Healthy Volunteers | Phase 1 | Recruiting | July 2019 | France ... 展开 >> Centre d'Investigation Clinique - Centre de Pharmacologie Clinique et d'Evaluations Thérapeutiques (CIC-CPCET) Recruiting Marseille, France, 13385 Contact: Christine Audebert, MD 491384641 ext +33 christine.audebert@ap-hm.fr Contact: Laurence Attolini, PhD 491388003 ext +33 laurence.attolini@ap-hm.fr Principal Investigator: Christine Audebert, MD Sub-Investigator: Marie-Noelle Lefebvre, MD Sub-Investigator: Frank Rouby, MD 收起 << |
NCT00549744 | Asthma | Phase 2 | Completed | - | New Zealand ... 展开 >> GSK Investigational Site Wellington, New Zealand, 6035 South Africa GSK Investigational Site George, Eastern Cape, South Africa, 6529 GSK Investigational Site Bloemfontein, South Africa, 9301 收起 << |
NCT02545907 | Amyloidosis | Phase 1 Phase 2 | Unknown | April 2018 | United Kingdom ... 展开 >> Derriford Hospital Not yet recruiting Plymouth, Devon, United Kingdom, PL6 8DH Contact: Hannah Hunter, Dr 01752517505 HannahHunter@nhs.net Contact: Claire Brown clairebrown10@nhs.net Principal Investigator: Hannah Hunter, Dr Sub-Investigator: Tim Nokes, Dr Royal Bournemouth General Hospital Not yet recruiting Bournemouth, Dorset, United Kingdom, BH7 7DW Contact: Rachel Hall, Dr 01202726246 rachel.hall@rbch.nhs.uk Contact: Nicola Naraine 01202726127 nicola.naraine@rbch.nhs.uk Principal Investigator: Rachel Hall, Dr Principal Investigator: Helen McCarthy, Dr Guy's Hospital Not yet recruiting London, Greater London, United Kingdom, SE1 7EH Contact: Matthew Streetly, Dr 02071882900 Matthew.Streetly@gstt.nhs.uk Contact: Abhijit Jadhav 02071882022 Abhijit.Jadhav@gstt.nhs.uk Principal Investigator: Matthew Streetly, Dr Manchester Royal Infirmary Not yet recruiting Manchester, Greater Manchester, United Kingdom, M13 9WL Contact: Eleni Tholouli, Dr 01612768676 eleni.tholouli@cmft.nhs.uk Contact: Ian Venables 01619014575 Ian.Venables@cmft.nhs.uk Principal Investigator: Eleni Tholouli, Dr Sub-Investigator: Alberto Rocco, Dr Sub-Investigator: Rajesh Krishna, Dr Southampton General Hospital Not yet recruiting Southampton, Hampshire, United Kingdom, SO16 6YD Contact: Matthew Jenner, Dr 02381205764 Matthew.Jenner@uhs.nhs.uk Contact: Julie Gwilt 02381204202 J.gwilt@southampton.ac.uk Principal Investigator: Matthew Jenner, Dr Sub-Investigator: Srinivasan Narayanan, Dr Leicester Royal Infirmary Not yet recruiting Leicester, Leicestershire, United Kingdom, LE1 5WW Contact: Mamta Garg, Dr 01162586037 mamta.garg@uhl-tr.nhs.uk Contact: Amy King 01162585998 amy.king@uhl-tr.nhs.uk Principal Investigator: Mamta Garg, Dr Sub-Investigator: Ashish Masurekar, Dr Sub-Investigator: Linda Barton, Dr Norfolk and Norwich University Hospital Not yet recruiting Norwich, Norfolk, United Kingdom, NR4 7UY Contact: Martin Auger, Dr 01603268895 martin.auger@nnuh.nhs.uk Contact: Helen Darby 01603288897 helen.darby@nnuh.nhs.uk Principal Investigator: Martin Auger, Dr Sub-Investigator: Kris Bowles, Dr Sub-Investigator: Matthew Lawes, Dr Royal Hallamshire Hospital Not yet recruiting Sheffield, South Yorkshire, United Kingdom, S10 2JF Contact: John Snowden, Dr 01142713357 John.Snowden@sth.nhs.uk Contact: Rachael Selby 01142261023 r.selby@sheffield.ac.uk Principal Investigator: John Snowden, Dr Sub-Investigator: Yousef Ezaydi, Dr Sub-Investigator: Andrew Chantry, Dr Freeman Hospital Not yet recruiting Newcastle-upon-Tyne, Tyne and Wear, United Kingdom, NE7 7DN Contact: Jonathan Wallis, Dr 01912138479 jonathan.wallis@nuth.nhs.uk Contact: Tobias Menne, Dr 01912138480 tobias.meene@nuth.nhs.uk Principal Investigator: Jonathan Wallis, Dr Sub-Investigator: Tobias Menne, Dr Sub-Investigator: Graham Jackson, Professor Birmingham Queen Elizabeth Hospital Not yet recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Mark Cook, Dr 01214721311 ext 8597 Mark.Cook@uhb.nhs.uk Contact: Peter Hazlewood 01213714396 p.a.hazlewood@bham.ac.uk Principal Investigator: Mark Cook, Dr Sub-Investigator: Timothy Wong, Dr Birmingham Heartlands Hospital Not yet recruiting Birmingham, West Midlands, United Kingdom, B9 5SS Contact: Guy Pratt, Dr 01214243698 Guy.Pratt@HeartofEngland.nhs.uk Contact: James Whitehouse 01214244075 James.Whitehouse@HeartofEngland.nhs.uk Principal Investigator: Guy Pratt, Dr Sub-Investigator: Shankara Paneesha St James' University Hospital Leeds, West Yorkshire, United Kingdom, LS9 7TF Bristol Haematology and Oncology Centre Not yet recruiting Bristol, United Kingdom, BS2 8ED Contact: Jenny Bird, Dr 01173424394 Jenny.Bird@uhbristol.nhs.uk Contact: Anja Schmidtmann 01173426743 Anja.Schmidtmann@uhbristol.nhs.uk Principal Investigator: Jenny Bird, Dr Sub-Investigator: James Griffin, Dr The Beatson West of Scotland Cancer Centre Not yet recruiting Glasgow, United Kingdom, G12 0YN Contact: Grant McQuaker, Dr 01413017140 Grant.McQuaker@ggc.scot.nhs.uk Contact: Donna Kelly 01413017090 Donna.Kelly@ggc.scot.nhs.uk Principal Investigator: Grant McQuaker, Dr Sub-Investigator: Richard Soutar, Dr Sub-Investigator: Jennifer Travers, Dr 收起 << |
NCT02566031 | COPD | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Novartis Investigative Site Chuncheon, Gangwon-do, Korea, Republic of, 24253 Novartis Investigative Site Wonju, Gangwon-Do, Korea, Republic of, 26426 Novartis Investigative Site Anyang-si, Gyeonggi-do, Korea, Republic of, 14068 Novartis Investigative Site Guri-si, Gyeonggi-do, Korea, Republic of, 471-701 Novartis Investigative Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-712 Novartis Investigative Site Suwon-si, Gyeonggi-do, Korea, Republic of, 16499 Novartis Investigative Site Jeonju-si, Jeollabuk-do, Korea, Republic of, 561-712 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 02559 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 06351 Novartis Investigative Site Seoul, Korea, Korea, Republic of, 08308 Novartis Investigative Site Koyang, Kyunggi, Korea, Republic of, 410-719 Novartis Investigative Site Gwangju, Korea, Republic of, 61469 Novartis Investigative Site Incheon, Korea, Republic of, 403-720 Novartis Investigative Site Incheon, Korea, Republic of, 405 760 Novartis Investigative Site Jeju, Korea, Republic of, 63241 Novartis Investigative Site Seoul, Korea, Republic of, 03722 Novartis Investigative Site Seoul, Korea, Republic of, 04763 Novartis Investigative Site Seoul, Korea, Republic of, 05030 Novartis Investigative Site Seoul, Korea, Republic of, 06273 Novartis Investigative Site Seoul, Korea, Republic of, 06591 Novartis Investigative Site Seoul, Korea, Republic of, 110-746 Novartis Investigative Site Seoul, Korea, Republic of, 150-713 Novartis Investigative Site Seoul, Korea, Republic of, 156-707 Novartis Investigative Site Ulsan, Korea, Republic of, 44033 收起 << |
NCT03188497 | Acute Toxic Effects ... 展开 >> Tumor Responses 收起 << | Phase 1 | Completed | - | China, Guangdong ... 展开 >> the Fifth Hospital Affiliated to Sun Yat-Sen University Zhuhai, Guangdong, China, 519000 收起 << |
NCT01641393 | Exocrine Pancreatic Insufficie... 展开 >>ncy: Cystic Fibrosis 收起 << | Phase 3 | Completed | - | - |
NCT03558503 | Bladder Cancer ... 展开 >> Urothelial Carcinoma Urothelial Carcinoma Bladder 收起 << | Phase 2 | Recruiting | September 2020 | United States, Arizona ... 展开 >> Mayo Clinic Not yet recruiting Phoenix, Arizona, United States, 85054 Contact: Mark Tyson, MD Tyson.Mark@mayo.edu Contact: Christina Mihok Mihok.Christina@mayo.edu United States, Arkansas Arkansas Urology Recruiting Little Rock, Arkansas, United States, 72211 Contact: Richard Emanuel D'Anna, MD 501-219-8900 alturodoc@hotmail.com Contact: Katie O'Brien 501.219.8900 ext 2002 katie@arkansasurology.com United States, California Tower Urology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Arnold Cinman, MD 310-854-9898 cinman5676@towerurology.com Contact: Shiblee Nomanee 310854-9898 ext 168 nomanees@towerurology.com UCLA - University of California, Los Angeles Not yet recruiting Los Angeles, California, United States, 90095 Contact: Chamie Karim, MD 310-206-8183 kchamie@mednet.ucla.edu Contact (310)794-5929 Providence Medical Institute Recruiting Santa Monica, California, United States, 90404 Contact: Jennifer Linehan, MD 520-440-5142 Jennifer.Linehan@providence.org Contact: Kelly Garver 310-582-7456 Garverk@JWCI.ORG United States, Iowa University of Iowa Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Michael O'Donnell, MD 319-356-2421 michael-odonnell@uiowa.edu Contact (319)384-5458 United States, Maryland John Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21218 Contact: Max Kates, MD 410-550-3506 Mkates@jhmi.edu Contact 410-955-6850 United States, Michigan University of Michigan Comprehensive Cancer Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Alon Weizer, MD 734-647-8903 aweizer@med.umich.edu United States, Nebraska Adult & Pediatric Urology, PC Recruiting Omaha, Nebraska, United States, 68114 Contact: Trainer Andrew, MD 402-399-7894 atrainer@adultpediatricuro.com Contact: Kim Ganzel 402-397-7894 research@adultpediatricuro.com United States, New York Manhattan Medical Research Recruiting New York, New York, United States, 10016 Contact: Huang William, MD Contact: Carmela Graci-Pipitone 917-409-3919 cgpipitone@manhattanmedicalresearch.com Weill Cornell Medical College Not yet recruiting New York, New York, United States, 10065 Contact: Douglas Scherr, MD 212-746-5788 dss2001@med.cornell.edu Contact: Thomas Flynn 212.746.4739 thf3001@med.cornell.edu Montefiore Medical Center (Albert Einstein) Not yet recruiting New York, New York, United States, 10461 Contact: Alexander Sankin, MD 718-920-4531 asankin@montefiore.org Contact 347-842-1715 Western New York Urology Associates Recruiting New York, New York, United States, 14225 Contact: Kent Chevli, MD kchevli@wnyurology.com Contact: Stephanie Malczewski 716-844-5553 smalczewski@wnyurology.com United States, North Carolina The University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27572 Contact: Angela Smith, MD 919-966-8217 angela_smith@med.unc.edu Contact 919-537-3505 United States, Oregon Oregon Urology Not yet recruiting Springfield, Oregon, United States, 97477 Contact: Bryan Mehlhaff, MD 541-284-5509 investigator@oregonurology.com Contact: Stephanie Kerns 541-284-5508 stephanie@oregonurology.com United States, Pennsylvania Penn State Hershey State College Not yet recruiting Hershey, Pennsylvania, United States, 17033 Contact: Jay Raman, MD 717-531-8887 jraman@hmc.psu.edu Contact: Kathleen Lehman (717) 531-5930 klehman3@hmc.psu.edu United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 Contact: Neil Shore, MD 843-839-1679 Nshore@gsuro.com Contact: Lindsey Rabon 843-839-1679 LRabon@atlanticurologyclinics.com United States, Texas Urology San Antonio Not yet recruiting Fredericksburg, Texas, United States, 78233 Contact: Daniel Saltzstein, MD 210-617-4116 saltzstein@urologysa.com Contact: Kethsaly Salinas 210-617-4116 kethsaly.Salinas@urologysa.com Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Seth Lerner, MD 713-798-4001 slerner@bcm.edu; godoy@bcm.edu Contact 713-798-8514 Israel Carmel Medical Center Not yet recruiting Haifa, Israel, 3436212 Contact: Boris Fridman, MD 972-537176389 BORISFR@clalit.org.il Contact: Hilla Cohen 972-544753731 HillaCo@clalit.org.il Rabin Medical Center Not yet recruiting Petah tikva, Israel, 49372 Contact: Yaron Erlich, CM yarone@clalit.org.il Contact: Natali Oginets 972-542003783 nataliog@clalit.org.il Sheba Medical Center Not yet recruiting Ramat Gan, Israel, 52621 Contact: Menahem Laufer, MD Contact: Efrat Ezra 972-545446438 Efrat.Ezra@sheba.health.gov.il 收起 << |
NCT01476501 | Sub-optimal Vitamin D Status ... 展开 >> Bone Disease Diabetic Nephropathy 收起 << | Phase 2 | Unknown | December 2015 | Canada, Alberta ... 展开 >> Clinical Research Unit, University of Alberta Edmonton, Alberta, Canada, T6G 0K2 收起 << |
NCT02461992 | - | Completed | - | - | |
NCT02178592 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | December 31, 2019 | - |
NCT00134693 | Arthritis, Rheumatoid | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Darlinghurst, New South Wales, Australia, 2010 Australia, Queensland GSK Investigational Site Douglas, Queensland, Australia, 4814 GSK Investigational Site Woolloongabba, Queensland, Australia, 4102 Australia, South Australia GSK Investigational Site Daw Park, South Australia, Australia, 5041 GSK Investigational Site Woodville, South Australia, Australia, 5011 Australia, Tasmania GSK Investigational Site Hobart, Tasmania, Australia, 7000 Australia, Western Australia GSK Investigational Site Shenton Park, Western Australia, Australia, 6008 France GSK Investigational Site Amiens, Picardie, France, 80054 GSK Investigational Site Montpellier Cedex 5, France, 34295 Germany GSK Investigational Site Villingen-Schwenningen, Baden-Wuerttemberg, Germany, 78054 GSK Investigational Site Hildesheim, Niedersachsen, Germany, 31134 GSK Investigational Site Chemnitz, Sachsen, Germany, 09111 GSK Investigational Site Leipzig, Sachsen, Germany, 04107 GSK Investigational Site Leipzig, Sachsen, Germany, 04229 GSK Investigational Site Berlin, Germany, 12163 GSK Investigational Site Berlin, Germany, 13125 GSK Investigational Site Berlin, Germany, 14059 GSK Investigational Site Berlin, Germany, 14109 Russian Federation GSK Investigational Site Ekaterinburg, Russian Federation, 620102 GSK Investigational Site Moscow, Russian Federation, 115522 GSK Investigational Site Ryazan, Russian Federation, 390026 GSK Investigational Site Yaroslavl, Russian Federation, 150003 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Wigan, Lancashire, United Kingdom, WN6 9EP GSK Investigational Site Liverpool, Merseyside, United Kingdom, L9 7AL GSK Investigational Site Newcastle, Northumberland, United Kingdom, NE1 4LP GSK Investigational Site Oxford, United Kingdom, OX3 7LP GSK Investigational Site Sheffield, United Kingdom, S10 2RX 收起 << |
NCT02461992 | Hemophilia A | Phase 1 | Completed | - | China ... 展开 >> Phase I Unit, Clinical Pharmacology Research Center, Peking Union Medical College Hospital Beijing, China, 100032 Hematology Department,Beijing Children's Hospital, Capital Medical University Beijing, China, 100045 收起 << |
NCT00381394 | Leishmaniasis, Visceral | Phase 2 | Completed | - | India ... 展开 >> GSK Investigational Site Muzaffarpur, India, 842001 GSK Investigational Site Muzaffarpur, India GSK Investigational Site Patna, India, 800007 收起 << |
NCT02639975 | Glaucoma | Phase 1 | Completed | - | - |
NCT03528681 | Hyperkalemia | Phase 3 | Not yet recruiting | October 7, 2019 | - |
NCT00390845 | Pain, Neuropathic | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Broadmeadow, New South Wales, Australia, 2292 GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Wuerzburg, Bayern, Germany, 97080 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44789 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 Russian Federation GSK Investigational Site Moscow, Russian Federation, 117292 United Kingdom GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ GSK Investigational Site Glasgow, Lanarkshire, United Kingdom, G12 0YN GSK Investigational Site Solihull, West Midlands, United Kingdom, B91 2JL GSK Investigational Site Liverpool, United Kingdom, L9 7LJ GSK Investigational Site London, United Kingdom, W12 0NN GSK Investigational Site London, United Kingdom, WC1X 8LD 收起 << |
NCT02125409 | Colorectal Cancer | Phase 3 | Unknown | - | Spain ... 展开 >> Hospital Clínico Universitario Lozano Blesa Not yet recruiting Zaragoza, Spain, 50009 Contact: Angel Lanas Arbeloa, Physician +34 976 765786 alanas@unizar.es Principal Investigator: Angel Lanas Arbeloa, Physician 收起 << |
NCT01817166 | Multiple Sclerosis | Phase 3 | Recruiting | January 2022 | France ... 展开 >> CHU d'Amiens - Hôpital Nord Not yet recruiting Amiens Cedex 1, France, 80054 Sub-Investigator: Olivier Godefroy, MD, PhD Sub-Investigator: Abdullatif Al Khedr, MD CHU de Lyon - Hôpital Pierre Wertheimer Recruiting Bron, France, 69677 Sub-Investigator: Christian Confavreux, MD, PHD Sub-Investigator: Sandra Vukusic, MD, PhD CHU de Caen - Hôpital Côte de Nacre Recruiting Caen Cedex 9, France, 14033 Sub-Investigator: Gilles Defer, MD, PhD Sub-Investigator: Nathalie Derache Belpalme, MD CHU de Clermont Ferrand - Hôpital Gabriel-Montpied Recruiting Clermont Ferrand, France, 63003 Sub-Investigator: Pierre Clavelou, MD, PhD Sub-Investigator: Frédéric Thaite, MD CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91100 Sub-Investigator: Ivania Patry, MD Clinique des Cèdres - Capio Not yet recruiting Cornebarrieu, France, 31700 Sub-Investigator: Claude Mekies, MD CHU de Dijon Recruiting Dijon, France, 21079 Sub-Investigator: Thibault Moreau, MD, PhD CHU de Martinique - Hôpital Pierre Zobda-Quitman Not yet recruiting Fort-de-France, France, 97261 Sub-Investigator: Philippe Cabre, MD CHU de Grenoble - Hôpital A Michallon Recruiting Grenoble, France, 38043 Sub-Investigator: Olivier Casez, MD CHRU de Lille - Hôpital Roger Salengro Recruiting Lille, France, 59037 Sub-Investigator: Patrick Vermersch, MD, PhD Sub-Investigator: Hélène Zephyr, MD Sub-Investigator: Olivier Outteryck, MD CHU de Limoges - Hôpital Dupuytren Recruiting Limoges, France, 87042 Sub-Investigator: Laurent Magy, MD, PhD Sub-Investigator: Alexis Montcuquet, MD Groupe Hospitalier de l'Institut Catholique de Lille Recruiting Lomme Cedex, France, 59462 Sub-Investigator: Patrick Hautecoeur, MD Sub-Investigator: Cécile Donzé-Parret, MD CHU de Montpellier - Hôpital Gui de Chauliac Recruiting Montpellier, France, 34295 Sub-Investigator: William Camu, MD, PhD Sub-Investigator: Bertrand Carlander, MD Sub-Investigator: Mahmoud Charif, MD Sub-Investigator: Pierre Labauge, MD, PhD CHU de Nancy - Hôpital Central Recruiting Nancy, France, 54035 Sub-Investigator: Marc Debouverie, MD, PhD Sub-Investigator: Sophie Pittion-Vouyovitch, MD CHU de Nantes - Hôtel-Dieu Recruiting Nantes, France, 44093 Sub-Investigator: Sandrine Wiertlewski, MD Sub-Investigator: David Laplaud, MD CHU de Nice - Hôpital Pasteur Recruiting Nice, France, 06002 Sub-Investigator: Christine Lebrun-Fresnay, MD CHU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Eric Thouvenot, MD, PhD Sub-Investigator: Giovanni Castelnovo, MD APHP - Hôpital Saint-Antoine Not yet recruiting Paris Cedex 12, France, 75571 Sub-Investigator: Bruno Stankoff, MD, PhD Sub-Investigator: Claire Giannesini, MD MAILLART Elisabeth - La Pitié Salpétrière Not yet recruiting Paris, France, 75013 Contact: MAILLART Elisabeth, PH Fondation Ophtalmologique Adolphe Rothschild Recruiting Paris, France, 75019 Sub-Investigator: Olivier Gout, MD CH de Pau Not yet recruiting Pau, France, 64000 Sub-Investigator: Mickaël Bonnan, MD CH de Perpignan - Hôpital Saint Jean Recruiting Perpignan, France, 66046 Sub-Investigator: Nicolas Gaillard, MD Sub-Investigator: Anais Dutray, MD CH de Cornouaille - Site Quimper - Hôpital Laennec Recruiting Quimper, France, 29107 Sub-Investigator: Marc Coustans, MD CHU de Reims - Hôpital Maison Blanche Recruiting Reims, France, 51092 Sub-Investigator: Ayman Tourbah, MD CHU de Rennes - Hôpital PontChaillou Recruiting Rennes, France, 35033 Sub-Investigator: Gilles Edan, MD, PhD Sub-Investigator: Emmanuelle Le Page, MD Sub-Investigator: Véronique Deburghgraeve, MD CHU de Rouen - Hôpital Charles Nicolle Recruiting Rouen, France, 76031 Sub-Investigator: Didier Hannequin, MD, PhD Sub-Investigator: Bertrand Bourre, MD CH de Poissy - Saint-Germain-en-Laye Recruiting Saint-Germain-en-Laye, France, 78100 Sub-Investigator: Olivier Heinzlef, MD CH de Saumur Recruiting Saumur Cedex, France, 49403 Sub-Investigator: Richard Devy, MD CHRU de Strasbourg - Hôpital Civil Recruiting Strasbourg Cedex, France, 67091 Sub-Investigator: Jérôme De Sèze, MD, PhD CHRU de Toulouse - Hôpital Purpan Recruiting Toulouse Cedex 9, France, 31059 Sub-Investigator: David Brassat, MD, PhD CHRU de Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Sub-Investigator: Philippe Corcia, MD, PhD Sub-Investigator: Anne-Marie Guennoc, MD CH de Versailles - Hôpital Mignot Recruiting Versailles, France, 78000 Sub-Investigator: Fernando Pico, MD, PhD Sub-Investigator: Chantal Nifle, MD CH de Vichy - Jacques Larin Not yet recruiting Vichy, France, 03207 Sub-Investigator: Renato Colamarino, MD 收起 << |
NCT01302938 | Overactive Bladder | Phase 4 | Terminated(Stop date for rando... 展开 >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) 收起 << | - | United States, California ... 展开 >> Mytrus, Inc. San Francisco, California, United States, 94104 University of California San Francisco San Francisco, California, United States, 94121 收起 << |
NCT02503644 | Scleroderma, Diffuse ... 展开 >> Diffuse Cutaneous Systemic Sclerosis 收起 << | Phase 2 | Active, not recruiting | November 2018 | - |
NCT02799264 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 1 | Completed | - | United States, Kansas ... 展开 >> GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT02027987 | Traumatic Brain Injury | Phase 1 | Unknown | December 2016 | China, Shaanxi ... 展开 >> Institute of Neurosurgery, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an City, Shaanxi, China, 710032 Contact: Hu S Jie, M.D., Ph.D. 086 029 84773307 hushijie@fmmu.edu.cn Contact: Fei Zhou, M.D., Ph.D. 086 029 13992888996 feizhou@fmmu.edu.cn Principal Investigator: Hu S Jie, M.D., Ph.D. 收起 << |
NCT02310269 | - | Recruiting | September 27, 2023 | - | |
NCT00562965 | Lymphoma, Follicular | Phase 3 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT01491165 | Other Surgical Procedures | Phase 2 Phase 3 | Unknown | June 2014 | China ... 展开 >> Yihua An Recruiting Beijing, China Contact: Yihua An, doctor 0086-10-88276848 doctoran2010@hotmail.com 收起 << |
NCT01233869 | Polycystic Kidney, Autosomal D... 展开 >>ominant 收起 << | Phase 2 | Completed | - | - |
NCT01817699 | Kidney Transplantation ... 展开 >> Anemia Vitamin D Deficiency Renal Insufficiency, Chronic 收起 << | Phase 4 | Enrolling by invitation | March 2020 | Japan ... 展开 >> CANDLE Trial Study Group Suita, Osaka, Japan, 565-0871 收起 << |
NCT01302938 | - | Terminated(Stop date for rando... 展开 >>mization 31/5/2012. Recruitment terminated due to lack of recruitment. No new safety issues were identified.) 收起 << | - | - | |
NCT01703624 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> Medicines Evaluation Unit Manchester, United Kingdom, M23 9QZ 收起 << |
NCT00121667 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT01233869 | - | Completed | - | - | |
NCT00562965 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT02811887 | Liver Cirrhosis, Alcoholic | Not Applicable | Recruiting | December 2018 | Denmark ... 展开 >> Bispebjerg Hospital, Department of Physical and Occupational Therapy Recruiting Copenhagen, Denmark, 2400 Contact: Marius Henriksen, PT, PhD +4535312251 marius.henriksen@regionh.dk 收起 << |
NCT03085277 | Enteral Feeding Intolerance ... 展开 >> Necrotizing Enterocolitis Late-Onset Neonatal Sepsis 收起 << | Not Applicable | Recruiting | December 31, 2019 | China, Guangdong ... 展开 >> Foshan Maternal and Child Health Hospital Not yet recruiting Foshan, Guangdong, China Contact: Yiheng Dai daiyiheng@163.com Contact: Xiaoyan Gao gxy270000@sina.com Principal Investigator: Yiheng Dai Sub-Investigator: Xiaoyan Gao The First Affiliated Hospital of Jinan Medical University Not yet recruiting Guangzhou, Guangdong, China Contact: Guosheng Liu tlgs@jnu.edu.cn Contact: Wenchao Chen follen@163.com Principal Investigator: Guosheng Liu Sub-Investigator: Wenchao Chen Sub-Investigator: Xia Wu The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Hu Hao freehaotiger@126.com Contact: Fei Ma maf.0@163.com Principal Investigator: Hu Hao Sub-Investigator: Mengxian Liu Longgang District Central Hospital of Shenzhen Not yet recruiting Shenzhen, Guangdong, China Contact: Huixian Qiu szlgqhx@126.com Contact: Xunbin Huang hxb_2710@163.com Principal Investigator: Huixian Qiu Sub-Investigator: Xunbin Huang Sub-Investigator: Shujuan Zeng Shenzhen Guangming People's Hospital Not yet recruiting Shenzhen, Guangdong, China Contact: Zhenzhi Ye zhenzhiye2@163.com Contact: Xiaoli Chen fmcxl213@126.com Principal Investigator: Zhenzhi Ye Sub-Investigator: Xiaoli Chen Shenzhen Luohu Maternal and Child Health Hospital Recruiting Shenzhen, Guangdong, China Contact: Yuefeng Li liyuefeng111@sina.com Contact: Xuelei Gong gongxuelei1987@163.com Principal Investigator: Yuefeng Li Sub-Investigator: Xuelei Gong Shenzhen Nanshan Maternal and Child Health Hospital Recruiting Shenzhen, Guangdong, China Contact: Luanying Tian 1782701141@qq.com Contact: Xiujuan Wu wuxiujuan1978@126.com Principal Investigator: Luanying Tian Sub-Investigator: Xiujuan Wu Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China Contact: Benqing Wu +86 139 0243 6593 wubenqing783@126.com Contact: Lu Ding +86 13922851709 459208691@qq.com Principal Investigator: Benqing Wu Sub-Investigator: Ding Lu Sub-Investigator: Jinzhen Su Taiwan China Medical University Children Hospital Not yet recruiting Taichung, Taiwan Contact: Hung-Chih Lin d0373.cmuh@gmail.com Contact: Hsiang-Yu Lin hylin.neo@gmail.com Principal Investigator: Hung-Chih Lin Sub-Investigator: Hsiang-Yu Lin 收起 << |
NCT00121667 | - | Completed | - | - | |
NCT03388528 | Mitochondrial Diseases | Not Applicable | Recruiting | September 7, 2018 | United Kingdom ... 展开 >> Grainne Gorman Recruiting Newcastle upon Tyne, Tyne And Wear, United Kingdom, NE2 4HH Contact: David Houghton, PhD 07729221941 david.houghton@ncl.ac.uk Contact: Paula Hynd, BSc 0191 208 3084 paula.hynd@ncl.ac.uk 收起 << |
NCT00269087 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Kodaira, Japan, 187-0002 GSK Investigational Site Kyoto, Japan, 612-0026 GSK Investigational Site Osaka, Japan, 596-8501 GSK Investigational Site Tokyo, Japan, 164-0012 收起 << |
NCT03141983 | End-Stage Renal Disease | Phase 2 | Recruiting | May 2021 | United States, District of Col... 展开 >>umbia The George Washington University Recruiting Washington, District of Columbia, United States, 20037 Contact: Dominic Raj, MD 202-741-2283 draj@mfa.gwu.edu Contact: Sarah Andrews, BS (202) 741-2571 scandrews@mfa.gwu.edu United States, Massachusetts Brigham & Women's Hospital Recruiting Boston, Massachusetts, United States, 02120 Contact: David Charytan, MD 617-525-7718 dcharytan@partners.org Contact: Angeles Cinelli, BA (617) 525-9436 mcinelli@partners.org United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Alp Ikizler, MD 615-343-6104 alp.ikizler@vanderbilt.edu Contact: Adrienne R Clagett, NP (615) 875-5494 adrienne.r.clagett@vanderbilt.edu United States, Washington University of Washington Kidney Research Institute Recruiting Seattle, Washington, United States, 98104 Contact: Jonathan Himmelfarb, MD 206-616-4717 jhimmelfarb@nephrology.washington.edu Contact: Lori Linke (206) 720-3835 llinke@nephrology.washington.edu 收起 << |
NCT02856113 | Diabetes Mellitus, Type 2 | Phase 3 | Recruiting | June 11, 2021 | - |
NCT02384668 | Graves' Disease | Not Applicable | Active, not recruiting | January 2021 | Denmark ... 展开 >> Department of Endocrinology and Internal Medicine, Aarhus University Hospital Aarhus C, Denmark, 8000 Gentofte Hospital Gentofte, Denmark, 2900 Department of Internal Medicine, Regionshospitalet Herning Herning, Denmark, 7400 Department of Internal Medicine, Regionshospitalet Holstebro Holstebro, Denmark, 7500 Department of Internal Medicine, Regionshospitalet Horsens Horsens, Denmark, 8700 Department of Internal Medicine, Regionhospitalet Randers Randers, Denmark, 8930 Department of Internal Medicine, Diagnostisk Center, Regionshospitalet Silkeborg Silkeborg, Denmark, 8600 Department of Internal Medicine, Regionshospitalet Viborg Viborg, Denmark, 8800 收起 << |
NCT03201965 | Amyloidosis | Phase 3 | Recruiting | October 30, 2025 | - |
NCT03603639 | Photosensitive Epilepsy | Phase 2 | Recruiting | February 11, 2019 | United States, Arkansas ... 展开 >> Clinical Trials, Inc. and Arkansas Epilepsy Program Recruiting Little Rock, Arkansas, United States, 72205 United States, Idaho Consultants in Epilepsy & Neurology, PLLC Recruiting Boise, Idaho, United States, 83702 United States, Maryland Johns Hopkins University- School of Medicine Not yet recruiting Baltimore, Maryland, United States, 21287 United States, Missouri Washington University Hospital Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, Pennsylvania Unniversity of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01306942 | Metastatic Breast Cancer | Phase 1 Phase 2 | Active, not recruiting | June 2018 | Spain ... 展开 >> Instituto Catalán de Oncología de Barcelona (Hospital Duran i Reynalds) Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Alvaro Cunqueiro Vigo, Pontevedra, Spain, 36204 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 收起 << |
NCT00121641 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00121641 | - | Completed | - | - | |
NCT02572960 | Osteoporosis ... 展开 >>Vitamin D Deficiency Cardiovascular Disease 收起 << | Phase 4 | Completed | - | Denmark ... 展开 >> Department of Endocrinology and Internal Medicine Aarhus, Denmark, 8000 收起 << |
NCT03387579 | Cholestasis of Parenteral Nutr... 展开 >>ition 收起 << | Phase 3 | Not yet recruiting | April 2019 | - |
NCT03049267 | Hidradenitis Suppurativa | Phase 2 | Completed | - | Netherlands ... 展开 >> Erasmus University Medical Center Rotterdam, Netherlands 收起 << |
NCT03582137 | Parkinson Disease | Phase 2 | Not yet recruiting | June 2019 | - |
NCT02146664 | Acute Non-ST Elevation Myocard... 展开 >>ial Infarction 收起 << | Phase 2 Phase 3 | Withdrawn(The investigational ... 展开 >>cases were no longer relevant considering the recent implementation of our current national healthcare system.) 收起 << | March 2018 | Indonesia ... 展开 >> Central Army Hospital RSPAD Gatot Soebroto Central Jakarta, Jakarta, Indonesia Binawaluya Cardiac Hospital Jakarta, Indonesia, 13570 收起 << |
NCT02729051 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT02398526 | - | Active, not recruiting | September 30, 2023 | Germany ... 展开 >> Multiple Locations, Germany 收起 << | |
NCT03395704 | Hereditary Hemochromatosis | Phase 2 | Recruiting | December 2018 | United States, Arkansas ... 展开 >> Investigative Site Recruiting North Little Rock, Arkansas, United States, 72117 United States, California Investigative Site Recruiting Palo Alto, California, United States, 94305 Investigative Site Recruiting Rialto, California, United States, 92377 Investigational Site Recruiting San Diego, California, United States, 91942 United States, Michigan Investigative Site Recruiting Wyoming, Michigan, United States, 49519 United States, Mississippi Investigative Site Recruiting Jackson, Mississippi, United States, 39216 United States, New York Investigative Site Recruiting East Setauket, New York, United States, 11733 Investigative Site Recruiting Manhasset, New York, United States, 11030 Investigative Site Recruiting New York, New York, United States, 10029 United States, Texas Investigative Site Recruiting Dallas, Texas, United States, 75246 Investigative Site Recruiting Fort Worth, Texas, United States, 76104 Investigative Site Recruiting Houston, Texas, United States, 77058 Investigative Site Recruiting San Antonio, Texas, United States, 78215 United States, Washington Investigative Site Recruiting Seattle, Washington, United States, 98104 Australia, New South Wales Investigative Site Recruiting Westmead, New South Wales, Australia, 2145 Australia, Queensland Investigative Site Recruiting Brisbane, Queensland, Australia, 4120 Investigative Site Recruiting Herston, Queensland, Australia, 4029 Australia, Victoria Investigative Site Recruiting Melbourne, Victoria, Australia, 3004 France Investigative Site Recruiting Bondy, France, 93140 Investigative Site Recruiting Orléans, France, 45000 Investigative Site Recruiting Pessac, France, 33604 Investigative Site Recruiting Rennes Cedex 9, France, 35033 United Kingdom Investigative Site Recruiting Bradford, England, United Kingdom, BD9 6RJ Investigative Site Recruiting Newcastle Upon Tyne, England, United Kingdom, NE7 7DN Investigative Site Recruiting Portsmouth, England, United Kingdom, PO6 3LY 收起 << |
NCT02660736 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT02322450 | Essential Hypertension | Phase 2 | Completed | - | France ... 展开 >> Hôpital Arthur Gardiner Dinard, France, 35800 Hôpital Cardiologique, CHRU de Lille Lille, France, 59037 Hospices Civils de Lyon - Hôpital de la Croix Rousse Lyon, France, 69317 Hôpital Européen Georges Pompidou Paris, France, 75015 收起 << |
NCT02041299 | Iron Overload ... 展开 >> Sickle Cell Disease Other Anemias 收起 << | Phase 4 | Recruiting | September 2019 | - |
NCT01597635 | Lung Injury, Acute | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Sacramento, California, United States, 95817 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60611 United States, Massachusetts GSK Investigational Site Springfield, Massachusetts, United States, 01199 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, New York GSK Investigational Site New York, New York, United States, 10003 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 GSK Investigational Site Greensboro, North Carolina, United States, 27403 GSK Investigational Site Winston-Salem, North Carolina, United States, 27517 United States, Ohio GSK Investigational Site Columbus, Ohio, United States, 43215 United States, Oregon GSK Investigational Site Portland, Oregon, United States, 97239 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19104 GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina GSK Investigational Site Charleston, South Carolina, United States, 29425 Canada, British Columbia GSK Investigational Site Vancouver, British Columbia, Canada, V5Z 1M9 GSK Investigational Site Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Nova Scotia GSK Investigational Site Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario GSK Investigational Site Kingston, Ontario, Canada, K7L 2V7 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Sainte-Foy, Quebec, Canada, G1V 4G5 收起 << |
NCT03009292 | Solid Tumor | Phase 1 | Recruiting | December 2019 | China, Beijing ... 展开 >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Lin Shen 86100881211226561 China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China Contact: Yuxian Bai 8645186298694 收起 << |
NCT02422082 | Osteopenia | Not Applicable | Completed | - | Sweden ... 展开 >> Geriatric Medicine, Mölndal Hospital Mölndal, Västra Götaland, Sweden, 43180 收起 << |
NCT00560404 | - | Completed | - | - | |
NCT02984475 | Beta Thalassemia Major Anemia | Phase 4 | Recruiting | April 2019 | Egypt ... 展开 >> Abo El Reesh Hospital Recruiting Cairo., Egypt Contact: Mona Gaber, Bachelor. 0223648368 mona.sobhy@pharma.cu.edu.eg El Demerdash (Ain Shams Teaching Hospital). Completed Cairo., Egypt 收起 << |
NCT03472742 | - | Recruiting | July 31, 2021 | Japan ... 展开 >> Niigata University Medical & Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Division of Gastroenterology and Hepatology 收起 << | |
NCT00560404 | Anemia | Phase 3 | Completed | - | Brazil ... 展开 >> Belo Horizonte, Brazil, 30150-320 Brasilia, Brazil, 70390-108 Campinas, Brazil, 13086-970 Campo Grande, Brazil, 79002-073 Cariacica, Brazil, 29152-230 Curitiba, Brazil, 80050-350 Curitiba, Brazil, 80440-020 Fortaleza, Brazil, 60430160 Jaboatão Dos Guararapes, Brazil, 54400-170 Joinville, Brazil, 89227-680 Juiz de Fora, Brazil, 36036900 Londrina, Brazil, 86015-000 Natal, Brazil, 59020-110 Porto Alegre, Brazil, 90035-903 Porto Alegre, Brazil, 90610000 Ribeirão Preto, Brazil, 14025-170 Rio de Janeiro, Brazil Salvador, Brazil, 40110-060 Sao Jose Do Rio Preto, Brazil, 15090-000 Sao Luis, Brazil, 65020-305 Sao Paulo, Brazil, 01246-903 Sao Paulo, Brazil, 01323-900 Sao Paulo, Brazil, 01532-001 Sao Paulo, Brazil, 03065-000 Sao Paulo, Brazil, O4023 Sorocaba, Brazil, 18030-210 收起 << |
NCT00707239 | Pneumonia, Bacterial | Phase 2 | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - |
NCT00459121 | Lung Cancer | Phase 2 | Terminated | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << |
NCT01597635 | - | Completed | - | - | |
NCT02981797 | - | Active, not recruiting | December 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << | |
NCT00707239 | - | Terminated(See termination rea... 展开 >>son in detailed description.) 收起 << | - | - | |
NCT01226563 | Acute Myocardial Infarction ... 展开 >> Congestive Heart Failure ST-Elevation Myocardial Infarction 收起 << | Not Applicable | Completed | - | - |
NCT02245932 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Not Applicable | Completed | - | Netherlands ... 展开 >> Maastricht University Medical Center Maastricht, Limburg, Netherlands 收起 << |
NCT00359177 | Vomiting | Phase 1 | Completed | - | United States, Florida ... 展开 >> GSK Investigational Site Gainesville, Florida, United States, 32608 GSK Investigational Site Orlando, Florida, United States, 32809 收起 << |
NCT02402530 | Complex Regional Pain Syndrome... 展开 >>, Type I 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT02148471 | - | Completed | - | Canada, Ontario ... 展开 >> Toronto General Hospital Toronto, Ontario, Canada, M5G 1Z5 收起 << | |
NCT03198728 | Hypogonadism, Male | Phase 3 | Recruiting | April 30, 2019 | - |
NCT02197702 | Asthma | Phase 2 Phase 3 | Completed | - | Canada, Quebec ... 展开 >> CHU Sainte Justine Montreal, Quebec, Canada, H3T1C5 收起 << |
NCT03655704 | Pulmonary Arterial Hypertensio... 展开 >>n 收起 << | Early Phase 1 | Not yet recruiting | August 2020 | Canada, Alberta ... 展开 >> Peter Lougheed Centre 3500 26 Ave NE Not yet recruiting Calgary, Alberta, Canada, T1Y 6J4 Contact: Jason Weatherald 403-943-4779 jcweathe@ucalgary.ca Canada Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec Not yet recruiting Québec, Canada, G1V 4G5 Contact: Steeve Provencher, MD, MSc 418-656-4747 steve.provencher@criucpq.ulaval.ca Contact: Sébastien Bonnet, PhD, FAHA 418 656 8711 sebastien.bonnet@criucpq.ulaval.ca Principal Investigator: Steeve Provencher, MD, MSc Principal Investigator: Sébastien Bonnet, PhD, FAHA Sub-Investigator: Sarah Bernard, MSc 收起 << |
NCT03399227 | - | Not yet recruiting | March 31, 2023 | - | |
NCT03036800 | Obesity Weigh... 展开 >>t Loss Diabetes Mellitus 收起 << | Phase 4 | Recruiting | January 2021 | Ireland ... 展开 >> St Vincent's University Hospital Recruiting Dublin, Ireland Contact: Carel Le Roux, Prof 0171 66 831 carel.leroux@ucd.ie Principal Investigator: Carel LeRoux, Prof Sub-Investigator: Donel O'Shea, Prof United Kingdom NHS Greater Glasgow and Clyde West Glasgow Ambulatory Care Hospital Not yet recruiting Glasgow, United Kingdom Contact: Mike Lean, Prof 0141 201 8604 mike.lean@glasgow.ac.uk University Hospitals of Leicester NHS Trust, Leicester General Hospital Recruiting Leicester, United Kingdom Contact: Melanie Davies, Prof 0116 258 6481 melanie.davies@uhl-tr.nhs.uk Sub-Investigator: David Webb, Dr University Hospital Aintree Recruiting Liverpool, United Kingdom Contact: John Wilding, Prof 0151 529 5899 J.P.H.Wilding@liverpool.ac.uk Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Contact: Barbara McGowan, Dr 020 7188 1912 barbara.mcGowan@gstt.nhs.uk 收起 << |
NCT03732495 | Thyroid Cancer Metastatic | Phase 2 | Not yet recruiting | June 15, 2022 | - |
NCT01659671 | Obstructive Sleep Apnea Syndro... 展开 >>me 收起 << | Not Applicable | Completed | - | Sweden ... 展开 >> ORL dep, Karolinska University Hospital Stockholm, Sweden, 141 86 收起 << |
NCT02207504 | Castration-resistant Prostate ... 展开 >>Cancer 收起 << | Phase 1 | Active, not recruiting | December 2018 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00459121 | - | Terminated | - | - | |
NCT00549198 | - | Completed | - | - | |
NCT03152617 | - | Recruiting | December 2027 | Sweden ... 展开 >> Department of Gastrosurgical R & E, the Sahlgrenska Academy,University of Gothenburg Recruiting Göteborg, Sweden, SE41345 Contact: Lars Fandriks, M.D., PhD. +46313424123 lars.fandriks@gastro.gu.se 收起 << | |
NCT03657186 | Overweight We... 展开 >>ight Loss 收起 << | Not Applicable | Recruiting | August 2019 | Germany ... 展开 >> Analyze & Realize Recruiting Berlin, Germany, 10369 Contact: Udo Bongartz, Dr. med. Barbara Grube Recruiting Berlin, Germany, 10709 Contact: Barbara Grube Jörg Förstermann Recruiting Berlin, Germany, 14059 Contact: Jörg Förstermann 收起 << |
NCT00582010 | Reperfusion Injury ... 展开 >> Liver Injury 收起 << | Phase 2 Phase 3 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Washington University of Washington Seattle, Washington, United States, 98195-6540 收起 << |
NCT00549198 | Infection, Human Immunodeficie... 展开 >>ncy Virus I HIV Infection 收起 << | Phase 4 | Completed | - | - |
NCT02750618 | - | Active, not recruiting | - | - | |
NCT00582010 | - | Completed | - | - | |
NCT02750618 | X-Linked Hypophosphatemia | Phase 2 | Active, not recruiting | August 16, 2019 | United States, Connecticut ... 展开 >> Yale School of Medicine New Haven, Connecticut, United States, 06510 United States, Indiana Indiana University School of Medicine Indianapolis, Indiana, United States, 46202 United States, Missouri Shriners Hospital for Children Saint Louis, Missouri, United States, 63110 收起 << |
NCT01220050 | Renal Transplant ... 展开 >> Secondary Hyperparathyroidism 收起 << | Phase 2 | Completed | - | Italy ... 展开 >> Mario Negri Institute - Clinical Research Center for Rare Diseases Ranica, Bergamo, Italy, 24020 收起 << |
NCT03458559 | Prostate Cancer Metastatic to ... 展开 >>Bone 收起 << | Phase 3 | Recruiting | May 16, 2024 | Netherlands ... 展开 >> VU University Medical Center Recruiting Amsterdam, Netherlands, 1081 HV Contact: Jessica CL Notohardjo, MD 收起 << |
NCT03758352 | Liver Transplant; Complication... 展开 >>s Ischemia Reperfusion Injury 收起 << | Not Applicable | Not yet recruiting | November 2020 | - |
NCT00646776 | Antivirals/HIV | Phase 1 | Completed | - | United States, New Jersey ... 展开 >> Bristol-Myers Squibb Clinical Pharmacology Unit Hamilton, New Jersey, United States, 08690 收起 << |
NCT00646776 | - | Completed | - | - | |
NCT00091832 | Breast Cancer ... 展开 >> Metastases Bone Metastases in Subjects With Advanced Breast Cancer 收起 << | Phase 2 | Completed | - | - |
NCT00477971 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00477971 | - | Completed | - | - | |
NCT02358044 | Hepatitis C | Phase 3 | Completed | - | - |
NCT02264431 | - | Recruiting | January 2024 | France ... 展开 >> Grenoble University Hospital Recruiting Grenoble, Rhône-Alpes, France, 38043 Contact: Tiphaine Montagnon +33 4 76 76 68 14 tmontagnon@chu-grenoble.fr Contact: Matthieu Lesgoirres mlesgoirres@chu-grenoble.fr Principal Investigator: Anne-Laure Borel, Pr MD PhD Sub-Investigator: Jean-Louis Pépin, Pr MD PhD Sub-Investigator: Catherine Arvieux, Pr MD PhD Sub-Investigator: Nelly Wion, MD PhD Sub-Investigator: Sandrine Coumes, MD PhD Sub-Investigator: Jean-Pierre Zarski, Pr MD PhD Sub-Investigator: Marie-Noëlle Hilleret, MD PhD Sub-Investigator: Jean-Christian Borel, MD PhD Sub-Investigator: Renaud Tamisier, Pr MD PhD Sub-Investigator: Olivier Ormezzano, MD PhD 收起 << | |
NCT00582556 | Prostate Cancer | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> University of Wisconsin Madison, Wisconsin, United States, 53792 收起 << |
NCT02358044 | - | Completed | - | - | |
NCT00091832 | - | Completed | - | - | |
NCT00331032 | Herpes Simplex II | Phase 1 | Completed | - | United States, California ... 展开 >> University of California San Francisco San Francisco, California, United States, 94143 Kenya Kenya Medical Research Institute Kisumu, Kenya, 40100 收起 << |
NCT02386553 | Spinal Muscular Atrophy | Phase 2 | Active, not recruiting | January 25, 2022 | United States, Colorado ... 展开 >> Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Florida Nemours Children's Clinic Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60611 United States, Maryland The Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York Columbia University Medical Center, The SMA Clinical Research Center New York, New York, United States, 10032 United States, Utah Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 Australia, Victoria Royal Children's Hospital- Melbourne Parkville, Victoria, Australia, 3052 Germany Dept. of Neuropediatrics and Muscle Disorders Universitätsklinikum Freiburg Freiburg, Baden-Württemberg, Germany, 79106 Italy Bambino Gesu' Children's Research Hospital Roma, Lazio, Italy, 165 Fondazione Serena Onlus - Centro Clinico Nemo Milano, Italy, 20162 Qatar Hamad General Hospital Doha, Qatar, 3050 Taiwan Kaohsiung Medical University Hospital Kaohsiung City, Taiwan, 806 National Taiwan University Hospital Taipei, Taiwan, 100 Turkey Hacettepe University Medical Faculty Ankara, Sihhiye, Turkey, 6100 收起 << |
NCT00582556 | - | Completed | - | - | |
NCT01293045 | Osteoporosis | Phase 1 | Completed | - | France ... 展开 >> CRNH - Centre de Recherche sur Volontaires - Hôpital AVICENNE Bobigny, Seine-saint-denis, France, 93009 收起 << |
NCT01235689 | Crohn's Disease | Phase 3 | Completed | - | - |
NCT01235689 | - | Completed | - | - | |
NCT03175471 | - | Recruiting | January 2021 | United States, Ohio ... 展开 >> Cincinnati Childrens Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Alexander Miethke, MD 513-636-5581 alexander.miethke@cchmc.org Principal Investigator: Alexander Miethke, MD 收起 << | |
NCT00692913 | Osteoporosis | Phase 3 | Completed | - | - |
NCT03155269 | Growth and Development | Not Applicable | Completed | - | India ... 展开 >> GSK Investigational Site Pune, India, 411001 收起 << |
NCT01018017 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Neuss, Nordrhein-Westfalen, Germany, 41460 收起 << |
NCT00692913 | - | Completed | - | - | |
NCT00526669 | Neoplasms, Gastrointestinal Tr... 展开 >>act 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Loma Linda, California, United States, 92354 GSK Investigational Site Los Angeles, California, United States, 90033 United States, District of Columbia GSK Investigational Site Washington, District of Columbia, United States, 20007 United States, Louisiana GSK Investigational Site Shreveport, Louisiana, United States, 71103 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 GSK Investigational Site Southgate, Michigan, United States, 48195 United States, Missouri GSK Investigational Site Jefferson City, Missouri, United States, 65109 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75137 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 Korea, Republic of GSK Investigational Site Hwasun, Korea, Republic of, 519-809 GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Mexico GSK Investigational Site Mexico City, Mexico, CP 14080 Russian Federation GSK Investigational Site Astrakhan, Russian Federation, 414044 GSK Investigational Site Chelyabinsk, Russian Federation, 454087 GSK Investigational Site St. Petersburg, Russian Federation, 197022 GSK Investigational Site Ufa,, Russian Federation, 450054 Taiwan GSK Investigational Site Changhua, Taiwan, 500 GSK Investigational Site Taipei, Taiwan, 100 GSK Investigational Site Taipei, Taiwan, 104 GSK Investigational Site Taipei, Taiwan, 112 收起 << |
NCT03354988 | Osteopenia Prematurity | Not Applicable | Active, not recruiting | August 2018 | Egypt ... 展开 >> Ain shams university hospital Cairo, Egypt 收起 << |
NCT00526669 | - | Completed | - | - | |
NCT01083186 | - | Completed | - | Greece ... 展开 >> Site Reference ID/Investigator# 47002 Arta, Greece, 47100 Site Reference ID/Investigator# 43772 Athens, Greece, 115 21 Site Reference ID/Investigator# 27492 Athens, Greece, 115 27 Site Reference ID/Investigator# 43769 Athens, Greece, 115 27 Site Reference ID/Investigator# 38257 Athens, Greece, 11526 Site Reference ID/Investigator# 47003 Athens, Greece, 11526 Site Reference ID/Investigator# 27497 Athens, Greece, 11527 Site Reference ID/Investigator# 47004 Athens, Greece, 11527 Site Reference ID/Investigator# 27489 Athens, Greece, 11528 Site Reference ID/Investigator# 27495 Athens, Greece, 16673 Site Reference ID/Investigator# 43773 Athens, Greece, 17237 Site Reference ID/Investigator# 27498 Haidari, Athens, Greece, 12462 Site Reference ID/Investigator# 38259 Ioannina, Greece, 45500 Site Reference ID/Investigator# 22121 Larissa, Greece, 411 10 Site Reference ID/Investigator# 43771 Larissa, Greece, 41223 Site Reference ID/Investigator# 43767 Maroussi Athens, Greece, 15123 Site Reference ID/Investigator# 27496 Nikaia, Greece, 18454 Site Reference ID/Investigator# 43768 North Ionia, Athens, Greece, 142 33 Site Reference ID/Investigator# 27491 Piraeus, Greece, 18536 Site Reference ID/Investigator# 27494 Thessaloniki, Greece, 546 36 Site Reference ID/Investigator# 27493 Thessaloniki, Greece, 54636 Site Reference ID/Investigator# 38255 Thessaloniki, Greece, 56403 Site Reference ID/Investigator# 43770 Thessaloniki, Greece, 570 01 Site Reference ID/Investigator# 39839 Thessaloniki, Greece 收起 << | |
NCT01083186 | - | Completed | - | - | |
NCT01572792 | Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << | Phase 3 | Completed | - | - |
NCT00447382 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | Former Serbia and Montenegro ... 展开 >> Belgrade, Former Serbia and Montenegro, 11000 Germany Frankfurt, Germany, 60590 Macedonia, The Former Yugoslav Republic of Skopje, Macedonia, The Former Yugoslav Republic of, 1000 Russian Federation Moscow, Russian Federation, 119034 South Africa Cape Town, Western Cape, South Africa, 7925 收起 << |
NCT02261376 | Healthy | Phase 1 | Completed | - | United Kingdom ... 展开 >> Hammersmith Medicines Research Ltd London, United Kingdom, NW10 7EW 收起 << |
NCT03639311 | HIV Infections | Phase 2 | Not yet recruiting | November 30, 2020 | United States, Florida ... 展开 >> GSK Investigational Site Not yet recruiting Fort Lauderdale, Florida, United States, 33316 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Texas GSK Investigational Site Not yet recruiting Dallas, Texas, United States, 75246 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT03317483 | - | Completed | - | - | |
NCT02292771 | Obstetric Labour, Premature | Phase 3 | Terminated(The study was stopp... 展开 >>ed due to the feasibility of recruiting the study in a timely manner) 收起 << | - | - |
NCT01572792 | - | Completed | - | - | |
NCT00447382 | - | Completed | - | - | |
NCT00812929 | Asthma | Phase 2 | Completed | - | United States, Colorado ... 展开 >> GSK Investigational Site Denver, Colorado, United States, 80230 United States, Massachusetts GSK Investigational Site North Dartmouth, Massachusetts, United States, 02747 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73120 United States, Pennsylvania GSK Investigational Site Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina GSK Investigational Site Orangeburg, South Carolina, United States, 29118 United States, Texas GSK Investigational Site El Paso, Texas, United States, 79925 收起 << |
NCT03770052 | Type 2 Diabetes Mellitus ... 展开 >> Inadequate Glucose Control 收起 << | Phase 4 | Not yet recruiting | December 31, 2020 | Korea, Republic of ... 展开 >> Pusan National University Hospital Busan, Korea, Republic of 收起 << |
NCT01086410 | Asthma | Phase 3 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Oklahoma GSK Investigational Site Oklahoma City, Oklahoma, United States, 73103 United States, Texas GSK Investigational Site San Antonio, Texas, United States, 78229 Germany GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39112 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 10117 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Hamburg, Germany, 20253 Poland GSK Investigational Site Bialystok, Poland, 15-010 GSK Investigational Site Gdansk, Poland, 80-405 GSK Investigational Site Gidle, Poland, 97-540 GSK Investigational Site Krakow, Poland, 31-023 GSK Investigational Site Lodz, Poland, 93-513 GSK Investigational Site Olsztyn, Poland, 10-357 GSK Investigational Site Warszawa, Poland, 01-138 收起 << |
NCT01791842 | Fibrous Dysplasia of Bone | Phase 2 | Unknown | May 2015 | France ... 展开 >> Hopital Edouard Herriot - service de rhumatologie Recruiting Lyon, France, 69003 Contact: Roland Chapurlat, Professor +33472117481 Principal Investigator: Roland CHAPURLAT, Professor Sub-Investigator: Deborah GENSBURGER, Dr Hôpital Lariboisière - service de rhumatologie Not yet recruiting Paris, France, 75010 Contact: Philippe ORCEL, Professor Principal Investigator: Philippe ORCEL, Professor 收起 << |
NCT02377466 | Obstetric Labour, Premature | Phase 3 | Terminated(Asset terminated by... 展开 >> PIB) 收起 << | - | - |
NCT02705807 | Cardiovascular Disease | Phase 4 | Completed | - | Japan ... 展开 >> GSK Investigational Site Okayama, Japan, 701-1192 收起 << |
NCT00812929 | - | Completed | - | - | |
NCT02377466 | - | Terminated(Asset terminated by... 展开 >> PIB) 收起 << | - | - | |
NCT03096561 | Accidental Hypothermia ... 展开 >> Hyperkalemia Cardiac Arrest 收起 << | Not Applicable | Recruiting | July 2019 | Switzerland ... 展开 >> University Hospital Vaudois Recruiting Lausanne, Valais, Switzerland, 1011 Contact: Mathieu Pasquier, MD +41 (0)21 314 55 90 Mathieu.Pasquier@chuv.ch Hospital of Valais Recruiting Sion, Valais, Switzerland, 1951 Contact: Matthieu de Riedmatten, MD 0041(0)793773628 matderied@yahoo.fr 收起 << |
NCT02045797 | Infections, Bacterial | Phase 2 | Completed | - | - |
NCT02705807 | - | Completed | - | - | |
NCT02292771 | - | Terminated(The study was stopp... 展开 >>ed due to the feasibility of recruiting the study in a timely manner) 收起 << | - | - | |
NCT03325127 | - | Withdrawn(Project plan changed... 展开 >>, study conduct was no longer needed.) 收起 << | September 28, 2018 | - | |
NCT02045797 | - | Completed | - | - | |
NCT01086410 | - | Completed | - | - | |
NCT01568892 | HIV Infections | Phase 3 | Completed | - | - |
NCT00603382 | Asthma | Phase 2 | Completed | - | - |
NCT00603746 | Asthma | Phase 2 | Completed | - | - |
NCT01316887 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 3 | Completed | - | - |
NCT00603278 | Asthma | Phase 2 | Completed | - | - |
NCT01568892 | - | Completed | - | - | |
NCT02833103 | Sphincter of Oddi Dysfunction | Phase 4 | Unknown | February 2018 | China, Shanghai ... 展开 >> Zhang Yong Recruiting Shanghai, Shanghai, China, 200092 Contact: Yong Zhang, MD,PhD +86 21 25078999-7905 Principal Investigator: Yong Zhang, MD,PhD Principal Investigator: Houbao Liu, MD,PhD Sub-Investigator: Tao Suo, MD,PhD Principal Investigator: Jian Wang, MD,PhD Sub-Investigator: Wei Chen, MD,PhD Principal Investigator: Yajin Chen, MD,PhD Sub-Investigator: Yunyao Xu, MD,PhD Principal Investigator: Xiujun Cai, MD,PhD Sub-Investigator: Xiao Liang, MD,PhD Sub-Investigator: Lin Ji, MD,PhD Principal Investigator: Jianying Lou, MD,PhD Sub-Investigator: Ji Wang, MD,PhD Principal Investigator: Xitai Sun, MD,PhD Sub-Investigator: Xiaodong Shan, MD,PhD Principal Investigator: Yu He, MD,PhD Sub-Investigator: Dajiang Li, MD,PhD 收起 << |
NCT00603746 | - | Completed | - | - | |
NCT00603278 | - | Completed | - | - | |
NCT01316887 | - | Completed | - | - | |
NCT01205451 | Spasticity, Post-Stroke | Phase 3 | Completed | - | China, Guangdong ... 展开 >> GSK Investigational Site Guangzhou, Guangdong, China China, Heilongjiang GSK Investigational Site Haerbin, Heilongjiang, China, 150001 China, Hubei GSK Investigational Site Wuhan, Hubei, China, 430060 China, Jiangsu GSK Investigational Site Nanjing, Jiangsu, China, 210029 GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Shenyang, Liaoning, China, 110001 China, Sichuan GSK Investigational Site Chengdu, Sichuan, China, 610041 China GSK Investigational Site Beijing, China, 100050 GSK Investigational Site Beijing, China, 100068 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Hangzhou, China, 310016 GSK Investigational Site Shanghai, China, 200025 GSK Investigational Site Shanghai, China, 200040 收起 << |
NCT01667679 | Migraine Head... 展开 >>aches 收起 << | Phase 3 | Completed | - | United States, California ... 展开 >> San Francisco Clinical Research Center San Francisco, California, United States, 94109 California Medical Clinic for Headache Santa Monica, California, United States, 90404 United States, Connecticut Associated Neurologists of Southern CT, P.C. Fairfied, Connecticut, United States, 06824 United States, Florida Premiere Research Institute West Palm Beach, Florida, United States, 33407 United States, Massachusetts MedVadis Watertown, Massachusetts, United States, 02472 United States, Michigan Michigan Head and Pain Institute Ann Arbor, Michigan, United States, 48104-5199 United States, Missouri ClinVest Springfield, Missouri, United States, 65807 Mercy Health Research St. Louis, Missouri, United States, 63141 United States, New York DENT Neurologic Institute Amherst, New York, United States, 14226 United States, North Carolina Headache Welness Center Greensboro, North Carolina, United States, 27405 PMG Research of Winston Salem, LLC Winston Salem, North Carolina, United States, 27103 United States, Pennsylvania Jefferson Headache Center Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina Coastal Carolina Research Center Mt. Pleasant, South Carolina, United States, 29464 收起 << |
NCT01270958 | Rhinitis, Allergic, Perennial | Phase 4 | Completed | - | Vietnam ... 展开 >> GSK Investigational Site Ha Noi, Vietnam, 084 收起 << |
NCT01205451 | - | Completed | - | - | |
NCT01667679 | - | Completed | - | - | |
NCT02429791 | HIV Infections | Phase 3 | Active, not recruiting | August 13, 2021 | - |
NCT00603382 | - | Completed | - | - | |
NCT01270958 | - | Completed | - | - | |
NCT02429791 | - | Active, not recruiting | - | - | |
NCT02497937 | Heart Failure | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> GSK Investigational Site Minneapolis, Minnesota, United States, 55415 GSK Investigational Site Rochester, Minnesota, United States, 55905 收起 << |
NCT03446573 | HIV Infections | Phase 2 Phase 3 | Recruiting | July 22, 2022 | - |
NCT02973295 | Non-Alcoholic Fatty Liver Dise... 展开 >>ase 收起 << | Phase 4 | Not yet recruiting | June 30, 2019 | Croatia ... 展开 >> Clinical Hospital Centre Rijeka, Kresimirova 42, Croatia, 51000 收起 << |
NCT02927431 | Virus Diseases | Phase 2 | Terminated(The study was stopp... 展开 >>ed early due to lack of enrollment.) 收起 << | - | - |
NCT00424619 | Hip Fracture | Phase 4 | Completed | - | - |
NCT00424619 | - | Completed | - | - | |
NCT03385369 | Safety Health... 展开 >>y Subjects 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Anaheim, California, United States, 92801 收起 << |
NCT02497937 | - | Completed | - | - | |
NCT01602549 | Gastroparesis | Phase 2 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Germany GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Bochum, Nordrhein-Westfalen, Germany, 44791 GSK Investigational Site Bonn, Nordrhein-Westfalen, Germany, 53105 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50937 GSK Investigational Site Jena, Thueringen, Germany, 07747 GSK Investigational Site Berlin, Germany, 13088 Sweden GSK Investigational Site Uppsala, Sweden, SE-751 85 United Kingdom GSK Investigational Site Cambridge, United Kingdom, C2B 2PY GSK Investigational Site Newcastle Upon Tyne, United Kingdom, NE4 5PL GSK Investigational Site Norwich, United Kingdom, NR4 7UY 收起 << |
NCT02422797 | HIV Infections | Phase 3 | Active, not recruiting | August 12, 2021 | - |
NCT02594462 | Sickle Cell Disease | Phase 4 | Active, not recruiting | June 2019 | Brazil ... 展开 >> Bahiana School of Medicne and Public Health Salvador, Bahia, Brazil University of Sao Paulo Ribeirao Preto, Sao Paulo, Brazil, 14049-900 收起 << |
NCT02880852 | - | Completed | - | - | |
NCT03400488 | Coronary Artery Disease | Phase 1 | Completed | - | United States, California ... 展开 >> Research Site Glendale, California, United States, 91206 收起 << |
NCT02422797 | - | Active, not recruiting | - | - | |
NCT02880852 | Systemic Lupus Erythematosus | Phase 1 | Completed | - | China ... 展开 >> GSK Investigational Site Shanghai, China GSK Investigational Site Suzhou, China, 215004 收起 << |
NCT01808261 | Cerebrovascular Accident | Phase 2 | Terminated(This study was term... 展开 >>inated for futility.) 收起 << | - | - |
NCT02927431 | - | Terminated(The study was stopp... 展开 >>ed early due to lack of enrollment.) 收起 << | - | - | |
NCT01328054 | - | Completed | - | - | |
NCT03628079 | Cancer of the Gastrointestinal... 展开 >> Tract Cancer of Unknown Origin 收起 << | Phase 1 Phase 2 | Recruiting | June 2020 | Sweden ... 展开 >> Dept of oncology, University Hospital Recruiting Uppsala, Sweden, 75185 收起 << |
NCT01328054 | Cancer | Phase 4 | Completed | - | United States, Michigan ... 展开 >> GSK Investigational Site Detroit, Michigan, United States, 48202 United States, New Hampshire GSK Investigational Site Lebanon, New Hampshire, United States, 03756 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84112 收起 << |
NCT01201720 | Liver Cirrhosis ... 展开 >> Liver Failure 收起 << | Phase 4 | Completed | - | Spain ... 展开 >> Hospital Clínic of Barcelona Barcelona, Spain, 08028 收起 << |
NCT01602549 | - | Completed | - | - | |
NCT03261999 | Prostatic Neoplasms | Phase 3 | Active, not recruiting | November 2018 | United States, Alabama ... 展开 >> Urology Centers of Alabama Homewood, Alabama, United States, 35209 United States, Arizona Arizona Institute of Urology Tucson, Arizona, United States, 85704 United States, Colorado The Urology Center of Colorado Denver, Colorado, United States, 80211 United States, North Carolina Carolina Clinical Trials, LLC Concord, North Carolina, United States, 28025 United States, Texas Urology San Antonio, P.A San Antonio, Texas, United States, 78229 United States, Virginia Urology of Virginia, PLLC Virginia Beach, Virginia, United States, 23462 Czechia Fakultní nemocnice Hradec Králové, Urologická klinika Hradec Králové, Czechia, 500 05 Uromedical Center Olomouc Olomouc, Czechia, 779 00 Thomayerova nemocnice, Urologické oddělení Praha, Czechia, 140 59 Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of, 49241 Keimyung University Dongsan Medical Center Daegu, Korea, Republic of, 41931 National Cancer Center Gyeonggi-do, Korea, Republic of, 10408 Seoul National University Bundang Hosptal Gyeonggi-do, Korea, Republic of, 13620 Hallym University Sacred Heart Hospital Gyeonggi-do, Korea, Republic of, 14068 Korea University Anam Hospital Seoul, Korea, Republic of, 02841 Lithuania Hospital of Lithuanian University of Health Sciences Kauno klinikos Kaunas, Lithuania, 50009 Klaipėda University Hospital Klaipėda, Lithuania, 92288 National Cancer Institute Vilnius, Lithuania, 08660 Vilnius University Hospital, Santaros klinikos Vilnius, Lithuania, 08661 Slovakia UROCENTRUM MILAB, s.r.o. Prešov, Slovakia, 080 01 Fakultná nemocnica s poliklinikou Žilina Urológia Žilina, Slovakia, 012 07 收起 << |
NCT01899768 | Cough | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Manchester, Lancashire, United Kingdom, M23 9LT GSK Investigational Site Belfast, United Kingdom, BT9 7AB 收起 << |
NCT01402648 | Adenocarcinoma of Colon Recurr... 展开 >>ent 收起 << | Phase 1 Phase 2 | Completed | - | Italy ... 展开 >> Ospedale Policlinico Consorziale - Gastroenterology Unit Bari, Italy, 70124 收起 << |
NCT01808261 | - | Terminated(This study was term... 展开 >>inated for futility.) 收起 << | - | - | |
NCT01325584 | Cancer Hepati... 展开 >>c Injury 收起 << | Phase 2 | Terminated(Alternative product... 展开 >> is now approved and available for use.) 收起 << | - | United States, Illinois ... 展开 >> Cancer Treatment Centers of America at Midwestern Regional Medical Center Zion, Illinois, United States, 60099 收起 << |
NCT03744663 | Opioid Use | Phase 2 | Not yet recruiting | November 2019 | United States, North Carolina ... 展开 >> Wake Forest Baptist Medical Center Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Ernesto Aranda-Aguirre, MD earandaa@wakehealth.edu 收起 << |
NCT01899768 | - | Completed | - | - | |
NCT01325584 | - | Terminated(Alternative product... 展开 >> is now approved and available for use.) 收起 << | - | - | |
NCT01725126 | Obesity | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Chula Vista, California, United States, 91910 United States, Florida GSK Investigational Site Miami, Florida, United States, 33169 United States, Kansas GSK Investigational Site Overland Park, Kansas, United States, 66211 收起 << |
NCT02429804 | Hormone-Resistant Prostate Can... 展开 >>cer Metastatic Malignant Neoplasm in the Bone Metastatic Prostate Carcinoma 收起 << | Phase 1 | Terminated(Accrual factor) | - | United States, California ... 展开 >> Stanford University, School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00679367 | Multiple Myeloma | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Boston University Cancer Research Center Boston, Massachusetts, United States, 02118 收起 << |
NCT01362244 | Nasal Polyps | Phase 2 | Completed | - | Belgium ... 展开 >> GSK Investigational Site Gent, Belgium, 9000 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ United Kingdom GSK Investigational Site Cambridge, United Kingdom GSK Investigational Site London, United Kingdom, EC1M 6BQ GSK Investigational Site London, United Kingdom, SE1 1YR GSK Investigational Site London, United Kingdom, SW3 6NP GSK Investigational Site London, United Kingdom, WC1X 8DA 收起 << |
NCT01725126 | - | Completed | - | - | |
NCT01821781 | Immune Deficiency Disorders ... 展开 >> Severe Combined Immunodeficiency Chronic Granulomatous Disease X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Hyper-IgM DiGeorge Syndrome Chediak-Higashi Syndrome Common Variable Immune Deficiency Immune Dysregulatory Disorders Hemophagocytic Lymphohistiocytosis IPEX Autoimmune Lymphoproliferative Syndrome X-linked Lymphoproliferative Syndrome 收起 << | Phase 2 | Recruiting | March 2021 | United States, Missouri ... 展开 >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jeffrey Bednarski, MD 314-454-6018 Bednarski_J@kids.wustl.edu Contact: Lisa Murray, CCRP 314-454-4240 Murray_L@kids.wustl.edu Principal Investigator: Jeffrey Bednarski, MD United States, Texas Methodist Heathcare Recruiting San Antonio, Texas, United States, 78229 Contact: Troy Quigg, DO, MS Troy.Quigg@mhshealth.com 收起 << |
NCT02848937 | - | Unknown | December 2016 | Italy ... 展开 >> Carlo Maria Guastoni Recruiting Legnano, Milano, Italy, 20025 Contact: Carlo Maria Guastoni, DR + 39 348 2807180 carlo.guastoni@asst-ovestmi.it Contact: Ugo Teatini, DR + 39 347 8851870 UTeatini@aogarbagnate.lombardia.it Sub-Investigator: Ugo Teatini, DR 收起 << | |
NCT03486015 | Pain | Not Applicable | Completed | - | - |
NCT00679367 | - | Completed | - | - | |
NCT01293292 | Osteoporosis | Phase 4 | Completed | - | United Kingdom ... 展开 >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom, S5 7AU 收起 << |
NCT02311790 | Insulin Sensitivity | Not Applicable | Completed | - | United States, Massachusetts ... 展开 >> Jean Mayer Human Nutrition Research Center on Aging Boston, Massachusetts, United States, 02111 收起 << |
NCT03114215 | ALS Amyotroph... 展开 >>ic Lateral Sclerosis Motor Neuron Disease 收起 << | Phase 2 | Active, not recruiting | December 2017 | France ... 展开 >> Hopital Gui De Chauliac Montpellier, France, 34000 收起 << |
NCT01362244 | - | Completed | - | - | |
NCT01575717 | Vitamin D Deficiency ... 展开 >> Hepatocellular Carcinoma 收起 << | Not Applicable | Unknown | January 2013 | United States, New York ... 展开 >> The Mount Sinai Hospital Recruiting New York, New York, United States, 10029 Principal Investigator: Andrea D Branch, PhD 收起 << |
NCT02064283 | Prostate Cancer | Not Applicable | Completed | - | United States, Michigan ... 展开 >> The University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 收起 << |
NCT01466062 | - | Completed | - | - | |
NCT01466062 | Respiratory Syncytial Virus In... 展开 >>fection 收起 << | Phase 3 | Completed | - | Japan ... 展开 >> Site Reference ID/Investigator# 56847 Hyogo, Japan Site Reference ID/Investigator# 56845 Shimotsuke, Japan Site Reference ID/Investigator# 56842 Tokyo, Japan Site Reference ID/Investigator# 56844 Tokyo, Japan Site Reference ID/Investigator# 56846 Tokyo, Japan Site Reference ID/Investigator# 56843 Yokohama, Japan 收起 << |
NCT03574805 | Asthma | Phase 1 | Recruiting | October 20, 2019 | Australia, South Australia ... 展开 >> CMAX Recruiting Adelaide, South Australia, Australia, 500 Contact: Kate Richardson 61 8 7088 7900 Kathryn.Richardson@cmax.com.au Principal Investigator: Thomas Polasek, MD Australia, Victoria Nucleus Network Limited Recruiting Melbourne, Victoria, Australia, 3004 Contact: Jessica Faggian 61 3 9076 8900 j.faggian@nucleusnetwork.com.au Principal Investigator: Oscar Walsh, MD Australia Linear Recruiting Perth, Australia Contact: Nicola Norton, RN 61 0 414 416 034 nnorton@linear.org.au Contact: Simon Scott, BSc, MPharmMed 61 0 432 149 680 sscott@linear.org.au Principal Investigator: Lara Hatchuel, MD 收起 << |
NCT02825251 | Diabetes Diab... 展开 >>etes Mellitus, Type 1 收起 << | Phase 3 | Completed | - | - |
NCT01488097 | Cholesterol Ester Storage Dise... 展开 >>ase (CESD) Lysosomal Acid Lipase Deficiency LAL-Deficiency 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Eureka, California, United States, 95501-320 Sacramento, California, United States, 95817 San Francisco, California, United States, 94143 United States, Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York New York, New York, United States, 10029 Canada, Ontario Sudbury, Ontario, Canada Czechia Prague, Czechia France Paris, France United Kingdom Leeds, United Kingdom Salford, United Kingdom 收起 << |
NCT03384290 | Healthy Subjects | Phase 1 | Active, not recruiting | November 2018 | Australia, Victoria ... 展开 >> Nucleus Network Limited Melbourne, Victoria, Australia, 3004 收起 << |
NCT01488097 | - | Completed | - | - | |
NCT02825251 | - | Completed | - | - | |
NCT00587158 | - | Completed | - | - | |
NCT02469298 | Virus Diseases | Phase 2 | Completed | - | - |
NCT02931929 | Gastrointestinal Stromal Tumor... 展开 >>s 收起 << | Phase 1 Phase 2 | Unknown | October 2017 | - |
NCT03513523 | Fatty Liver | Not Applicable | Recruiting | May 2019 | United States, Florida ... 展开 >> Indago Research and Health Center Recruiting Hialeah, Florida, United States, 33012 Altus Research, Inc. Recruiting Lake Worth, Florida, United States, 33461 Lone Star Research Center Recruiting Miami, Florida, United States, 33145 Med-Care Research Corp Recruiting Miami, Florida, United States, 33165 Legacy Clinical Solutions: Sensible Healthcare, LLC Recruiting Ocoee, Florida, United States, 34761 Contact: Jennifer Millan 407-654-2724 jmillan@sensiblehealthcare.net Principal Investigator: William Bowman, MD IMIC, Inc Recruiting Palmetto Bay, Florida, United States, 33157 Lenus Research & Medical Group Recruiting Sweetwater, Florida, United States, 33172 United States, Nebraska Barrett Clinic, P.C. Recruiting La Vista, Nebraska, United States, 68128 Contact: Amy Workman 402-991-9500 aworkman@barrettclinic.com Principal Investigator: Kevin Ahlers, MD United States, North Carolina Trial Management Associates, LLC Recruiting Wilmington, North Carolina, United States, 28403 Contact: Gail Threatt 910-338-1555 gthreatt@trialmgt.com Principal Investigator: Barton Williams, MD 收起 << |
NCT01081392 | Inflammation | Not Applicable | Unknown | May 2010 | Belgium ... 展开 >> CHU Brugmann Brussels, Belgium, 1020 收起 << |
NCT00587158 | Transplant; Failure, Kidney ... 展开 >> Renal Disease, End Stage Hyperparathyroidism, Secondary 收起 << | Not Applicable | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00433160 | Osteoporosis | Phase 3 | Completed | - | Japan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 454-0933 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-2101 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 070-0034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 655-0853 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iwate, Japan, 020-8505 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kagoshima, Japan, 890-0014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 231-0023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagano, Japan, 386-0493 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 854-0083 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oita, Japan, 879-7125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 555-0032 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 358-0007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shimane, Japan, 693-0021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokushima, Japan, 770-8503 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 163-0202 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tottori, Japan, 683-0853 收起 << |
NCT01600222 | Psoriasis Vulgaris | Phase 2 | Completed | - | Canada, British Columbia ... 展开 >> Guildford Dermatology Specialists Surrey, British Columbia, Canada, V3R 6A7 PerCuro Clinical Research Victoria, British Columbia, Canada, V8V 3P9 Canada, Manitoba Winnipeg Clinic Dermatology Research Winnipeg, Manitoba, Canada, R3C 0N2 Canada, New Brunswick Maritime Medical Research Center Bathurst, New Brunswick, Canada, E2A 4Z9 Canada, Ontario Ultranova Skincare Barrie, Ontario, Canada, L4M 6L2 Co-Medica Courtice, Ontario, Canada, L1E 3C3 Mediprobe Research London, Ontario, Canada, N5X 2P1 The Centre for Dermatology Richmond Hill, Ontario, Canada, L4B 1A5 K. Papp Clinical Research Waterloo, Ontario, Canada, N2J 1C4 Canada, Quebec Centre de Dermatologie Maizerets Quebec City, Quebec, Canada, G1J 1X7 收起 << |
NCT01600222 | - | Completed | - | - | |
NCT01639703 | Hepatocellular Carcinoma | Phase 4 | Completed | - | Austria ... 展开 >> AKH Vienna, Austria Germany Universitätsklinikum Erlangen Erlangen, Germany Korea, Republic of SMC Seoul, Korea, Republic of SNUH Seoul, Korea, Republic of Switzerland Zurich University Hospital Zurich, Switzerland 收起 << |
NCT01639703 | - | Completed | - | - | |
NCT03545672 | - | Recruiting | December 1, 2018 | China, Shanghai ... 展开 >> Renji Hospital Recruiting Shanghai, Shanghai, China, 200127 Contact: Zehao Fung, postgraduate fengzehao2016@126.com Contact: Pan Jiang, postgraduate jiangpanmed@163.com 收起 << | |
NCT02469298 | - | Completed | - | - | |
NCT00433160 | - | Completed | - | - | |
NCT01602562 | - | Completed | - | - | |
NCT01453049 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 << | - | China, Hubei ... 展开 >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 收起 << |
NCT01453049 | - | Terminated(US FDA/EMA/SFDA dec... 展开 >>isions to rosiglitazone-containing medicines, ethic) 收起 << | - | - | |
NCT00896363 | - | Completed | - | - | |
NCT01602562 | Herpes Simplex | Phase 3 | Completed | - | Japan ... 展开 >> GSK Investigational Site Aichi, Japan, 446-8602 GSK Investigational Site Aichi, Japan, 453-8511 GSK Investigational Site Aichi, Japan, 466-8560 GSK Investigational Site Hiroshima, Japan, 734-8551 GSK Investigational Site Hyogo, Japan, 650-0047 GSK Investigational Site Hyogo, Japan, 654-0081 GSK Investigational Site Kagoshima, Japan, 890-8520 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Osaka, Japan, 594-1101 GSK Investigational Site Saitama, Japan, 339-8551 GSK Investigational Site Tokyo, Japan, 162-8655 收起 << |
NCT00896363 | Depressive Disorder | Phase 2 | Completed | - | Russian Federation ... 展开 >> GSK Investigational Site Ekaterinburg, Russian Federation, 620030 GSK Investigational Site Kemerovo, Russian Federation, 650036 GSK Investigational Site Lipetsk Region, Russian Federation, 399083 GSK Investigational Site Moscow, Russian Federation, 119992 GSK Investigational Site Nizhny Novgorod, Russian Federation, 603107 GSK Investigational Site Saint Petersburg, Russian Federation, 190005 GSK Investigational Site Saint Petersburg, Russian Federation, 191180 GSK Investigational Site Saint-Petersburg, Russian Federation GSK Investigational Site Saratov, Russian Federation, 410060 GSK Investigational Site Smolensk, Russian Federation, 214 019 GSK Investigational Site St-Petersburg, Russian Federation, 197341 GSK Investigational Site St. Petersburg, Russian Federation, 190121 GSK Investigational Site St. Petersburg, Russian Federation, 194044 GSK Investigational Site St.Petersburg, Russian Federation, 193167 GSK Investigational Site Tomsk, Russian Federation, 634014 收起 << |
NCT00761267 | - | Completed | - | - | |
NCT03249792 | Solid Tumor L... 展开 >>ymphoma 收起 << | Phase 1 | Recruiting | October 25, 2021 | United States, California ... 展开 >> University of California San Diego Moores Cancer Center ( Site 0004) Recruiting La Jolla, California, United States, 92093 Contact: Study Coordinator 858-822-7742 United States, Illinois University of Chicago ( Site 0002) Recruiting Chicago, Illinois, United States, 60637 Contact: Study Coordinator 773-702-1835 United States, New York New York Presbyterian Hospital/Columbia University ( Site 0001) Recruiting New York, New York, United States, 10032 Contact: Study Coordinator 646-317-5381 United States, Texas Mary Crowley Cancer Research Center. ( Site 0005) Recruiting Dallas, Texas, United States, 75230 Contact: Study Coordinator 214-658-1945 MD Anderson Cancer Centr. ( Site 0006) Active, not recruiting Houston, Texas, United States, 77030 Israel Sheba Medical Center ( Site 0301) Recruiting Ramat-Gan, Israel, 5265601 Contact: Study Coordinator +97235302542 收起 << |
NCT00761267 | Candidemia | Phase 3 | Completed | - | - |
NCT02332135 | Secondary Hyperparathyroidism ... 展开 >> Maintenance Hemodialysis 收起 << | Not Applicable | Unknown | March 2018 | China, Beijing ... 展开 >> Beijing Friedship Hospital Recruiting Beijing, Beijing, China, 100050 Contact: Wenhu Liu, Doctor +86-01-63139144 liuwh0211@126.com Sub-Investigator: Zongli Diao, Master 收起 << |
NCT00542984 | Osteoporosis, Postmenopausal | Phase 3 | Completed | - | Korea, Republic of ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of 收起 << |
NCT01121354 | Infection | Phase 1 | Completed | - | United States, Maryland ... 展开 >> PAREXEL Early Phase Clinical Unit Baltimore, Maryland, United States, 21225 收起 << |
NCT00712933 | Systemic Lupus Erythematosus | Phase 3 | Completed | - | - |
NCT00712933 | - | Completed | - | - | |
NCT00543218 | Osteoporosis, Post-Menopausal | Phase 3 | Completed | - | Taiwan ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Changhua, Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Niao Sung Hsiang, Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Taipei, Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559) Mon-Fri from 9 am - 5 pm Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tao-Yuan, Taiwan 收起 << |
NCT00166725 | Prostate Cancer | Phase 2 | Completed | - | Italy ... 展开 >> Orbassano Orbassano, Italy 收起 << |
NCT01444807 | Metastatic Renal Cell Carcinom... 展开 >>a 收起 << | Phase 2 | Recruiting | September 2019 | Italy ... 展开 >> Istituto Tumori Milano Recruiting Milan, Mi, Italy, 20156 Contact: Giuseppe Procopio, MD +390223902557 Giuseppe.Procopio@istitutotumori.mi.it Contact: Elena Verzoni, MD +390223902557 elena.verzoni@istitutotumori.mi.it Principal Investigator: Giuseppe Procopio, MD Cinzia Ortega Recruiting Alba, Italy Alessandra Bearz Recruiting Aviano, Italy Alfredo Berruti Recruiting Brescia, Italy Saverio Cinieri Recruiting Brindisi, Italy Francesco Atzori Recruiting Cagliari, Italy Rodolfo Passalaqua Recruiting Cremona, Italy Francesco Di Costanzo Recruiting Firenze, Italy Vincenzo Emanuele Chiuri Recruiting Lecce, Italy Alessandra Mosca Recruiting Novara, Italy Vittorio Gebbia Recruiting Palermo, Italy Enrico Cortesi Recruiting Roma, Italy Francesco Cognetti Recruiting Roma, Italy Contact: Michele Milella Franco Morelli Recruiting San Giovanni Rotondo, Italy 收起 << |
NCT00694824 | - | Completed | - | Italy ... 展开 >> Nhephrology Dialysis Transplantation Unit St.Orsola University Hospital Bologna, Italy, 40100 收起 << | |
NCT01910402 | Infection, Human Immunodeficie... 展开 >>ncy Virus 收起 << | Phase 3 | Active, not recruiting | December 31, 2020 | - |
NCT03228940 | Fabry Disease | Phase 1 Phase 2 | Not yet recruiting | February 15, 2020 | Canada, Nova Scotia ... 展开 >> Queen Elizabeth II Health Sciences Centre, Victoria General Site Not yet recruiting Halifax, Nova Scotia, Canada, B3H2Y9 Contact: Michael West, MD (902) 473-4023 mwets@dal.ca 收起 << |
NCT01910402 | - | Active, not recruiting | - | - | |
NCT02038569 | Psoriasis Vulgaris | Phase 2 | Completed | - | - |
NCT00543023 | Osteoporosis, Post-Menopausal | Phase 3 | Completed | - | China ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shatin, China 收起 << |
NCT00519376 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Berlin, Germany, 14057 收起 << |
NCT00529100 | Non-Small Cell Lung Cancer | Phase 1 Phase 2 | Completed | - | Canada, Alberta ... 展开 >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8V 5C2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottawa, Ontario, Canada, K1H 8L6 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00519376 | - | Completed | - | - | |
NCT02038569 | - | Completed | - | - | |
NCT00196755 | Peritoneal Dialysis ... 展开 >> Chronic Kidney Disease 收起 << | Phase 3 | Completed | - | Belgium ... 展开 >> UZ Gasthuisberg Leuven, Belgium, B-3000 Denmark Fredericia Sygehus Fredericia, Denmark, DN-7000 Copenhagen University Hospital Herlev, Denmark, DN-2730 Aarhus University Hospital Århus N, Denmark, DN-8200 France CHRU Clémenceau Caen, France, FR-14033 Italy Ospedale civico e benfratelli Palermo, Italy, IT-90127 Ospedale San Bortolo Vicenza, Italy, IT-36100 Netherlands AMC Amsterdam, Netherlands, NL-1105 AZ Spain Fundacion Jimenez Diaz Madrid, Spain, ES-28040 Hospital Universitario La Paz Madrid, Spain, ES-28046 United Kingdom University Hospital ,Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH High Wycombe Hospital Buckinghamshire, United Kingdom, HP11 2TT University of Wales College of Medicine Cardiff, United Kingdom, CF 14 4XN Glasgow Western Infirmary Glasgow, United Kingdom, G11 6NT Royal Hospital The Royal London London, United Kingdom, E1 1BB Milton Keynes General Hospital Milton Keynes, United Kingdom, MK6 5LD The Churchill Hospital, Oxford Radcliffe Hospitals NHS Trust Oxford, United Kingdom, OX3 7LJ 收起 << |
NCT00529100 | - | Completed | - | - | |
NCT00016432 | Breast Cancer | Phase 3 | Completed | - | - |
NCT03687125 | Multiple Myeloma in Relapse ... 展开 >> Multiple Myeloma Progression Multiple Myeloma With Failed Remission 收起 << | Phase 1 Phase 2 | Recruiting | March 7, 2023 | United States, Alabama ... 展开 >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Luciano Costa, MD United States, Kansas University of Kansas Medical Center Kansas City Not yet recruiting Kansas City, Kansas, United States, 66160 Contact: Leyla Shune, MD United States, New York Memorial Sloan Kettering Cancer Centre Not yet recruiting New York, New York, United States, 10065 Contact: Sergio Giralt, MD United States, North Carolina Carolinas Healthcare System Not yet recruiting Charlotte, North Carolina, United States, 28204 Contact: Shebli Atrash United States, Tennessee Vanderbilt-Ingram Cancer Center Not yet recruiting Nashville, Tennessee, United States, 37203 Contact: Michael Byrne, MD United States, Texas University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Qaiser Bashir, MD United States, Wisconsin Froedtert & Medical College of Wisconsin, Cancer Center - Froedtert Hospital Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Anita D'Souza Norway Oslo Myeloma Center, Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Fredrik Hellem Schjesvold Switzerland Universitatsspital Basel Not yet recruiting Basel, Switzerland Contact: Dominik Heim Universitatsspital Bern Not yet recruiting Bern, Switzerland Contact: Thomas Pabst Department of Clinical Research Oncology/Hematology, Kantonsspital St. Gallen Not yet recruiting Saint Gallen, Switzerland Contact: Dagmar Hess-Mildenberger University Hospital Zurich Not yet recruiting Zürich, Switzerland Contact: Rouven Muller 收起 << |
NCT01318993 | - | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - | |
NCT01318993 | Crohn's Disease | Phase 3 | Terminated(This study was term... 展开 >>inated due to the lack of efficacy of GSK1605786A in Crohn's disease based on the results of Study CCX114151.) 收起 << | - | - |
NCT03441984 | HIV Infections | Phase 1 | Completed | - | United States, Texas ... 展开 >> GSK Investigational Site Austin, Texas, United States, 78744 收起 << |
NCT00937326 | Diabetes Mellitus, Type 2 | Phase 2 | Completed | - | - |
NCT00621023 | Myelodysplastic Syndrome | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT00130403 | Osteoporosis, Postmenopausal | Phase 4 | Completed | - | United States, New Jersey ... 展开 >> sanofi-aventis, US Bridgewater, New Jersey, United States, 08807 Australia, New South Wales sanofi-aventis, Australia Cove, New South Wales, Australia Belgium sanofi-aventis, Belgium Diegem, Belgium Canada, Quebec sanofi-aventis, Canada Laval, Quebec, Canada France sanofi-aventis, France Paris, France Netherlands sanofi-aventis, Netherlands Gouda, Netherlands United Kingdom sanofi-aventi, UK Guildford, Surrey, United Kingdom 收起 << |
NCT00527085 | Renal Osteodystrophy | Phase 2 | Completed | - | - |
NCT02523209 | - | Completed | - | France ... 展开 >> Chu Saint-Etienne Saint-Etienne, France, 42055 收起 << | |
NCT00219219 | Prostate Cancer | Phase 4 | Completed | - | Italy ... 展开 >> Bologna Bologna, Italy 收起 << |
NCT00621023 | - | Completed | - | - | |
NCT03446612 | Anaemia | Phase 2 | Not yet recruiting | December 2, 2019 | United Kingdom ... 展开 >> GSK Investigational Site Not yet recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com GSK Investigational Site Not yet recruiting Edinburgh, United Kingdom, EH16 4TJ Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01668654 | Epilepsy | Phase 3 | Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90027 United States, Florida GSK Investigational Site Gulf Breeze, Florida, United States, 32561 GSK Investigational Site Port Charlotte, Florida, United States, 33952 GSK Investigational Site Wellington, Florida, United States, 33414 United States, Minnesota GSK Investigational Site Saint Paul, Minnesota, United States, 55102-2534 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27710 United States, Tennessee GSK Investigational Site Memphis, Tennessee, United States, 38105 United States, Texas GSK Investigational Site Austin, Texas, United States, 78723 GSK Investigational Site Dallas, Texas, United States, 75230-2507 收起 << |
NCT00937326 | - | Completed | - | - | |
NCT01668654 | - | Terminated(FDA placed a clinic... 展开 >>al hold on the Pediatric Program requiring retigabine discontinuation in subjects; early termination allows for timely reporting of results.) 收起 << | - | - | |
NCT01018186 | Asthma | Phase 3 | Completed | - | - |
NCT03010176 | Solid Tumors ... 展开 >>Lymphoma 收起 << | Phase 1 | Recruiting | October 22, 2021 | United States, California ... 展开 >> UCLA Medical Center ( Site 0005) Recruiting Santa Monica, California, United States, 90404 Contact: Study Coordinator 310-582-4048 United States, New York Mount Sinai Hospital ( Site 0002) Recruiting New York, New York, United States, 10029 Contact: Study Coordinator 646-543-2859 Columbia University ( Site 0003) Recruiting New York, New York, United States, 10032 Contact: Study Coordinator 646-317-3141 United States, Texas Mary Crowley Cancer Research Center. ( Site 0001) Recruiting Dallas, Texas, United States, 75230 Contact: Study Coordinator 214-658-1945 France Institut Gustave Roussy ( Site 0049) Recruiting Villejuif, France, 94805 Contact: Study Coordinator +33142114211 Israel Sheba Medical Center ( Site 0040) Recruiting Ramat Gan, Israel, 5265601 Contact: Study Coordinator +97235302542 United Kingdom The Royal Marsden Foundation Trust ( Site 0031) Recruiting London, United Kingdom, SW3 6JJ Contact: Study Coordinator +442078118311 收起 << |
NCT03177980 | - | Recruiting | December 31, 2019 | Sweden ... 展开 >> Skåne Uniersity Hospital Recruiting Lund, Sweden, 221 85 Contact: Elisabeth Norman, MD, PhD +46 705594340 elisabeth.norman@med.lu.se Principal Investigator: Elisabeth Norman, MD, PhD Karolinska University Hospital Not yet recruiting Stockholm, Sweden, 171 76 Contact: Boubou Hallberg, MD, PhD + 46 70 002 10 10 boubou.hallberg@ki.se Principal Investigator: Boubou Hallberg, MD, PhD 收起 << | |
NCT00112437 | Osteoporosis | Phase 2 | Completed | - | - |
NCT01018186 | - | Completed | - | - | |
NCT00604825 | Menopausal and Female Climacte... 展开 >>ric States 收起 << | Phase 2 | Completed | - | - |
NCT00369850 | Breast Cancer ... 展开 >> Osteoporosis 收起 << | Phase 3 | Completed | - | Australia, New South Wales ... 展开 >> Institute of Oncology at Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Australia, Queensland Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia, 4029 France Institut Bergonie Bordeaux, France, 33076 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 European Institute of Oncology Milano, Italy, 20141 New Zealand Dunedin Hospital Dunedin, New Zealand Peru Instituto Nacional de Enfermedades Neoplasicas Lima, Peru, 34 South Africa Groote Schuur Hospital Cape Town, South Africa, 7925 Spain Hospital Ruber Internacional Madrid, Spain, 28034 Switzerland Kantonspital Aarau Aarau, Switzerland, CH-5001 Inselspital Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Ospedale Beata Vergine Mendrisio, Switzerland, CH-6850 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 收起 << |
NCT01313312 | Nervous System Disorders | Phase 3 | Completed | - | - |
NCT03029247 | Anaemia | Phase 2 | Recruiting | June 5, 2019 | United States, California ... 展开 >> GSK Investigational Site Recruiting La Mesa, California, United States, 91942 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Colorado GSK Investigational Site Not yet recruiting Lakewood, Colorado, United States, 80228 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Florida GSK Investigational Site Terminated Miami, Florida, United States, 33176 GSK Investigational Site Not yet recruiting Orlando, Florida, United States, 32809 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Illinois GSK Investigational Site Recruiting Chicago, Illinois, United States, 60643 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com United States, Minnesota GSK Investigational Site Completed Minneapolis, Minnesota, United States, 55404 United States, Texas GSK Investigational Site Not yet recruiting San Antonio, Texas, United States, 78215 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01536379 | Transplantation, Organ | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Cambridge, United Kingdom, CB2 0QQ GSK Investigational Site London, United Kingdom, SE1 9RT 收起 << |
NCT02061540 | - | Completed | - | - | |
NCT00604825 | - | Completed | - | - | |
NCT02061540 | Primary Sclerosing Cholangitis... 展开 >> (PSC) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> Scripps Clinic : La Jolla, California, United States, 92037 University of California at Davis Sacramento, California, United States, 95817 United States, Colorado University of Colorado Aurora, Colorado, United States, 80045 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 Canada, Alberta University of Calgary Liver Unit Calgary, Alberta, Canada, T2N 4Z6 Canada, Ontario University Health Network, Toronto Western Hospital Toronto, Ontario, Canada, M5T 2S8 United Kingdom University of Birmingham Birmingham, England, United Kingdom, B15 2TT Royal Free Hospital London, United Kingdom, NW3 2QG 收起 << |
NCT01276288 | - | Completed | - | - | |
NCT01536379 | - | Completed | - | - | |
NCT01364623 | Female Sexual Dysfunction | Phase 1 | Completed | - | United States, Texas ... 展开 >> Premier Research International LLC Austin, Texas, United States, 78705 收起 << |
NCT01584765 | - | Completed | - | - | |
NCT01313312 | - | Completed | - | - | |
NCT01276288 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... 展开 >> 1245.42.1 Boehringer Ingelheim Investigational Site Neuss, Germany 收起 << |
NCT00112437 | - | Completed | - | - | |
NCT00302484 | Osteoporosis ... 展开 >>Liver Transplantation 收起 << | Not Applicable | Unknown | - | Austria ... 展开 >> Medical University of Vienna, Department of Surgery, Division of Transplantation Vienna, Austria, A-1090 收起 << |
NCT01251367 | Post-stroke Spasticity ... 展开 >> Spasticity Post-Traumatic Brain Injury 收起 << | Phase 3 | Completed | - | - |
NCT01641692 | Asthma | Phase 2 | Completed | - | - |
NCT01251367 | - | Completed | - | - | |
NCT01453296 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 << |
NCT01641692 | - | Completed | - | - | |
NCT00514215 | Kidney Cancer ... 展开 >> Lung Cancer Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 2 | Completed | - | United States, Michigan ... 展开 >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 收起 << |
NCT00514215 | - | Completed | - | - | |
NCT01453296 | - | Completed | - | - | |
NCT00397475 | RENAL INSUFFICIENCY, CHRONIC ... 展开 >> Hyperparathyroidism, Secondary 收起 << | Not Applicable | Completed | - | Germany ... 展开 >> University Hospital of Saarland, Dpt. of Internal Medicine IV, Div. of Nephrology and Hypertension Homburg, Saarland, Germany, 66421 收起 << |
NCT01271803 | Malignant Melanoma | Phase 1 | Completed | - | United States, California ... 展开 >> UCLA Department of Medicine Los Angeles, California, United States, 90024 University of California at San Francisco San Francisco, California, United States, 94115 The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States, 90025 United States, Colorado University of Colorado; Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Indiana Indiana University - Department of Medicine, Division of Gastroenterology/Hepatology Indianapolis, Indiana, United States, 46202 United States, Michigan Karmanos Cancer Inst. ; Hudson Webber; Cancer Research Building Detroit, Michigan, United States, 48201 United States, New York New York University Medical Center New York, New York, United States, 10036 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Australia, Victoria Peter Maccallum Cancer Institute; Medical Oncology Melbourne, Victoria, Australia, 3000 收起 << |
NCT02693964 | - | Completed | - | United States, Colorado ... 展开 >> Barbara Davis Center for Diabetes Aurora, Colorado, United States, 80045 收起 << | |
NCT00055471 | Prostatic Neoplasms ... 展开 >> Metastases, Neoplasm 收起 << | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Research Site Cleveland, Ohio, United States, 44195 United States, Wisconsin Research Site Madison, Wisconsin, United States 收起 << |
NCT00515502 | - | Completed | - | - | |
NCT00515502 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 14050 GSK Investigational Site Hamburg, Germany, 22291 收起 << |
NCT01562275 | Neoplasms | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States, 02215 United States, Michigan Detroit, Michigan, United States, 48201 United States, Tennessee Nashville, Tennessee, United States, 37203 Spain Barcelona, Spain, 08035 Valencia, Spain, 46010 收起 << |
NCT01271803 | - | Completed | - | - | |
NCT00733304 | - | Completed | - | - | |
NCT00055471 | - | Completed | - | - | |
NCT01370811 | Sialorrhoea | Phase 2 | Completed | - | United States, Michigan ... 展开 >> QUEST Research Institute Bingham Farms, Michigan, United States, 48025 收起 << |
NCT01739855 | Evaluation of Expected Bone Lo... 展开 >>ss After Bariatric Surgery Possible Prevention of Bone Loss After Surgery by Calcium and Vitamin D Supplementation 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> Medical University Vienna Vienna, Austria, 1060 收起 << |
NCT01562275 | - | Completed | - | - | |
NCT00733304 | Macular Degeneration | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Beverly Hills, California, United States, 90211 GSK Investigational Site Sacramento, California, United States, 95841 United States, Florida GSK Investigational Site Winter Haven, Florida, United States, 33880 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46280 United States, Massachusetts GSK Investigational Site Boston, Massachusetts, United States, 02111 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48105 GSK Investigational Site Grand Rapids, Michigan, United States, 49525 United States, Utah GSK Investigational Site Salt Lake City, Utah, United States, 84132 Australia, New South Wales GSK Investigational Site Sydney, New South Wales, Australia, 2145 GSK Investigational Site Sydney, New South Wales, Australia, 2150 Australia, Victoria GSK Investigational Site Melbourne, Victoria, Australia Australia, Western Australia GSK Investigational Site Perth, Western Australia, Australia, 6009 Italy GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Milano, Lombardia, Italy, 20157 GSK Investigational Site Torino, Piemonte, Italy, 10122 GSK Investigational Site Firenze, Toscana, Italy, 50134 GSK Investigational Site Padova, Veneto, Italy, 35128 收起 << |
NCT01332292 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Cypress, California, United States, 90630 GSK Investigational Site Huntington Beach, California, United States, 92647 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80206 United States, Illinois GSK Investigational Site Normal, Illinois, United States, 61761 United States, Oregon GSK Investigational Site Medford, Oregon, United States, 97504 收起 << |
NCT01332292 | - | Completed | - | - | |
NCT01453023 | Asthma | Phase 2 | Completed | - | United States, California ... 展开 >> GSK Investigational Site Huntington Beach, California, United States, 92647 收起 << |
NCT03500003 | Nutrition | Not Applicable | Recruiting | April 2019 | France ... 展开 >> Centre de Recherche en Nutrition Humaine d'Auvergne Recruiting Clermont-Ferrand, France, 63000 Contact: Ruddy Richard, Prof +33473608250 ruddy.richard@udamail.fr Contact: Adeline Blot +33473608253 ablot@chu-clermontferrand.fr Principal Investigator: Ruddy Richard, Prof Sub-Investigator: Prulière Amandine Sub-Investigator: Laporte Françoise 收起 << |
NCT02348372 | Anaemia | Phase 1 | Completed | - | Australia, New South Wales ... 展开 >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 收起 << |
NCT01640184 | Hyperparathyroidism ... 展开 >> Disorders of Parathyroid Gland 收起 << | Not Applicable | Completed | - | China, Beijing ... 展开 >> Beijing Chao-Yang Hospital Beijing, Beijing, China, 100020 Beijing Friendship Hospital Beijing, Beijing, China, 100050 收起 << |
NCT01453023 | - | Completed | - | - | |
NCT01691794 | - | Completed | - | - | |
NCT03297944 | Psychomotor Impairment | Phase 4 | Recruiting | August 31, 2019 | United States, Kentucky ... 展开 >> Center on Drug and Alcohol Research Recruiting Lexington, Kentucky, United States, 40508 Contact: Marion Coe 859-257-6488 收起 << |
NCT01691794 | HIV, Pediatric | Phase 4 | Completed | - | United States, Arizona ... 展开 >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Georgia Grady Health System Ponce Family And Youth Clinic Atlanta, Georgia, United States, 30322 United States, Texas Children'S Medical Center Of Dallas Dallas, Texas, United States, 75235 Argentina Local Institution Buenos Aires, Bs As, Buenos Aires, Argentina, 1141 Local Institution Buenos Aires, Argentina, 1181 Local Institution Buenos Aires, Argentina, 1425 Brazil Local Institution Salvador, Bahia, Brazil, 40110-160 Local Institution Salvador, Bahia, Brazil, 40110 Local Institution Porto Alegre, RIO Grande DO SUL, Brazil, 90035-903 Local Institution Porto Alegre, Rio Grande Do Sul, Brazil, 90035 Local Institution Sao Paulo, SP, Brazil, 01416-901 Local Institution Sao Paulo, Brazil, 01246 Chile Local Institution Santiago, Metropolitana, Chile, 8207257 Local Institution Santiago, Metropolitana, Chile, 8380418 Mexico Local Institution Guadalajara, Jalisco, Mexico, 44280 Local Institution Monterrey, Nuevo LEON, Mexico, 64000 Local Institution Merida, Yucatan, Mexico, 97000 Local Institution Puebla, Mexico, 72000 Peru Local Institution Lima, Peru, 1 Local Institution Lima, Peru, LIMA 10 Russian Federation Local Institution Moscow, Russian Federation, 129110 Local Institution St. Petersburg, Russian Federation, 190103 South Africa Local Institution Port Elizabeth, Eastern CAPE, South Africa, 6001 Local Institution Bloemfontein, FREE State, South Africa, 9301 Local Institution Soweto, Gauteng, South Africa, 2013 Local Institution Cape Town, Western CAPE, South Africa, 7505 Local Institution Cape Town, Western CAPE, South Africa, 7530 收起 << |
NCT01640184 | - | Completed | - | - | |
NCT01689896 | Low Testosterone ... 展开 >> Hypogonadism Pain 收起 << | Phase 4 | Withdrawn(Difficult to obtain ... 展开 >>placebo) 收起 << | - | United States, Maryland ... 展开 >> Johns Hopkins Medical Institutions Baltimore, Maryland, United States, 21205 收起 << |
NCT00732472 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | United Kingdom ... 展开 >> GSK Investigational Site Reading, Berkshire, United Kingdom, RG2 0TG GSK Investigational Site Buckshaw Village, Chorley, Lancashire, United Kingdom, PR7 7NA GSK Investigational Site Waterloo, Liverpool, Merseyside, United Kingdom, L22 0LG GSK Investigational Site Clydebank, Glasgow, United Kingdom, G81 2DR GSK Investigational Site Edgbaston, Birmingham, United Kingdom, B15 2SQ GSK Investigational Site Llanishen, United Kingdom, CF14 5GJ GSK Investigational Site Manchester, United Kingdom, M15 6SX 收起 << |
NCT02025179 | Spinal Cord Injury ... 展开 >> Bone Loss Osteoporosis 收起 << | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 收起 << |
NCT02582749 | Prostate Cancer ... 展开 >> Bone Metastases Prostate Neoplasms 收起 << | Phase 2 | Active, not recruiting | January 2020 | United States, Arizona ... 展开 >> University of Arizona Cancer Center at Dignity Health St. Joseph's Phoenix, Arizona, United States, 85004 United States, Illinois Illinois CancerCare, P. C. Peoria, Illinois, United States, 61615 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 United States, Iowa University of Iowa Hopital and Clinics Iowa City, Iowa, United States, 52242 United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Henry Ford Hospital Detroit, Michigan, United States, 48202 Metro Health Cancer Center Wyoming, Michigan, United States, 49519 United States, Nebraska GU Research Network, LLC Omaha, Nebraska, United States, 68130 United States, New York Integrated Medical Professionals, PLLC Lake Success, New York, United States, 11042 United States, Texas University of Texas Medical Branch at Galveston Galveston, Texas, United States, 77555 United States, Wisconsin Clement J. Zablocki VA Medical Center Milwaukee, Wisconsin, United States, 53295 收起 << |
NCT01138475 | Gastric Bypass ... 展开 >> Parathyroid Hormone 收起 << | Phase 3 | Completed | - | United States, Michigan ... 展开 >> William Beaumont Health Center Royal Oak, Michigan, United States, 48073 收起 << |
NCT01138475 | - | Completed | - | - | |
NCT00732472 | - | Completed | - | - | |
NCT01381549 | Infections, Urinary Tract | Phase 2 | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | United States, California ... 展开 >> GSK Investigational Site Los Angeles, California, United States, 90033 United States, Iowa GSK Investigational Site Council Bluffs, Iowa, United States, 51503 United States, Kansas GSK Investigational Site Topeka, Kansas, United States, 66604 United States, Texas GSK Investigational Site Corsicana, Texas, United States, 75110 Canada, Quebec GSK Investigational Site Chicoutimi, Quebec, Canada, G7H 5H6 GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 France GSK Investigational Site Suresnes, France, 92151 GSK Investigational Site Toulouse cedex 9, France, 31059 Greece GSK Investigational Site Athens, Greece, 11527 GSK Investigational Site Chaidari, Greece, 12462 GSK Investigational Site Goudi, Athens, Greece, 11527 GSK Investigational Site Thessaloniki, Greece, 56429 Russian Federation GSK Investigational Site Irkutsk, Russian Federation, 664079 GSK Investigational Site Moscow, Russian Federation, 125367 GSK Investigational Site Rostov-on-Don, Russian Federation, 344022 GSK Investigational Site Smolensk, Russian Federation, 214018 GSK Investigational Site St'Petersburg, Russian Federation, 194354 Spain GSK Investigational Site Alicante, Spain, 03010 GSK Investigational Site Elche (Alicante), Spain, 03203 GSK Investigational Site Getafe/Madrid, Spain, 28905 GSK Investigational Site Granada, Spain, 18003 GSK Investigational Site Madrid, Spain, 28040 GSK Investigational Site Murcia, Spain GSK Investigational Site Pama de Mallorca, Spain, 07010 收起 << |
NCT02416947 | Osteoporosis, Postmenopausal | Not Applicable | Completed | - | - |
NCT00617188 | Ovarian Cancer | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 收起 << |
NCT01357317 | Chronic Kidney Disease | Phase 3 | Unknown | March 2014 | United States, Virginia ... 展开 >> VA Medical Center Recruiting Salem, Virginia, United States, 24153 Principal Investigator: Csaba P. Kovesdy, M.D. 收起 << |
NCT01043523 | - | Completed | - | United States, California ... 展开 >> Palo Alto, California, United States, 94304 United States, New York New York, New York, United States, 10032 United States, North Carolina Durham, North Carolina, United States, 27710 United States, Ohio Cinncinati, Ohio, United States, 45229 United States, Pennsylvania Hershey, Pennsylvania, United States, 17033 Italy Many Locations, Italy Japan Many Locations, Japan Singapore Many Locations, Singapore Taiwan Many Locations, Taiwan 收起 << | |
NCT01381549 | - | Terminated(Microbiological fin... 展开 >>dings of resistance on therapy in patients with complicated urinary tract infection) 收起 << | - | - | |
NCT00617188 | - | Completed | - | - | |
NCT02025179 | - | Completed | - | - | |
NCT00043186 | Low Bone Mineral Density | Phase 2 | Completed | - | - |
NCT01043523 | - | Completed | - | - | |
NCT02966834 | Cholestasis | Phase 2 | Recruiting | April 1, 2020 | - |
NCT03527511 | - | Recruiting | May 14, 2020 | France ... 展开 >> Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques - Hôpital Femme Mère Enfant - Bron. Recruiting Bron, France, 69677 Contact: Justine BACCHETTA, Pr 04 27 85 61 30 ext +33 justine.bacchetta@chu-lyon.fr Principal Investigator: Justine BACCHETTA, Pr Sub-Investigator: Bruno RANCHIN, Dr Sub-Investigator: Anne-Laure SELIER-LECLERC, Dr Sub-Investigator: Aurélia BERTHOLET-THOMAS, Dr Sub-Investigator: Elodie CHEYSSAC, Dr Sub-Investigator: Corentin TANNE, Dr 收起 << | |
NCT01729728 | Postoperative Pain ... 展开 >> Acute Pain 收起 << | Phase 2 | Completed | - | United States, Utah ... 展开 >> Jean Brown Research Salt Lake City, Utah, United States, 84124 收起 << |
NCT01673178 | Diabetes Melliuts, Type 2 | Phase 1 | Completed | - | United States, California ... 展开 >> Anaheim Clinical Trials, LLC Anaheim, California, United States, 92801 Profil Institute for Clinical Research, Inc. Chula Vista, California, United States, 91911 Diablo Clinical Research, Inc. Walnut Creek, California, United States, 94598 United States, Florida Avail Clinical Research, LLC DeLand, Florida, United States, 32720 Elite Research Institute Miami, Florida, United States, 33169 Miami Research Associates, Inc. South Miami, Florida, United States, 33143 MRA Clinical Research, LLC South Miami, Florida, United States, 33143 United States, Kentucky Central Kentucky Research Associates, Inc. Lexington, Kentucky, United States, 40509 L-MARC Research Center Louisville, Kentucky, United States, 40213 United States, Minnesota Prism Research Saint Paul, Minnesota, United States, 55114 United States, North Carolina High Point Clinical Trials Center, LLC High Point, North Carolina, United States, 27265 Carolina Phase 1 Research Raleigh, North Carolina, United States, 27612 Wake Internal Medicine Consultants Raleigh, North Carolina, United States, 27612 United States, Ohio Medpace Clinical Pharmacology Unit Cincinnati, Ohio, United States, 45227 Community Research Cincinnati, Ohio, United States, 45255 Mercy Hospital Pharmacy Cincinnati, Ohio, United States, 45255 United States, Texas Covance Clinical Research Unit Dallas, Texas, United States, 75247 收起 << |
NCT01729728 | - | Completed | - | - | |
NCT00566020 | Bipolar Disorder | Phase 3 | Completed | - | - |
NCT00043186 | - | Completed | - | - | |
NCT00566020 | - | Completed | - | - | |
NCT00664430 | Secondary Hyperparathyroidism ... 展开 >> Dialysis 收起 << | Phase 4 | Terminated(Low enrollment rate... 展开 >>) 收起 << | - | Brazil ... 展开 >> Site Reference ID/Investigator# 7118 Sao Paulo, Brazil, 04039-001 Site Reference ID/Investigator# 7114 Sao Paulo, Brazil, 05403-000 收起 << |
NCT01857284 | Primary Biliary Cirrhosis | Phase 3 | Completed | - | China, Beijing ... 展开 >> Beijing 302 Hospital Beijing, Beijing, China Beijing Ditan Hospital Beijing, Beijing, China Beijing Friendship Hospital Beijing, Beijing, China Beijing Youan Hospital Beijing, Beijing, China Chinese PLA General Hospital Beijing, Beijing, China Peiking University First Hosptial Beijing, Beijing, China Peking University People's Hospital Beijing, Beijing, China China, Guangdong First Affiliated Hospital,SunYat-Sen University Guangzhou, Guangdong, China Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China Third Affiliated Hospital,SunYat-Sen University Guangzhou, Guangdong, China China, Hunan Tongji Hospital Wuhan, Hunan, China China, Shanghai 85 Military Hospital Shanghai, Shanghai, China Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China Huashan Hospital Shanghai, Shanghai, China NO.3 People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China RenJi Hospital Shanghai, Shanghai, China RuiJin Hospital Shanghai, Shanghai, China ShangHai Changzheng Hospital Shanghai, Shanghai, China Shanghai Public Health Clinical Center Shanghai, Shanghai, China Shanghai Zhongshan Hospital Shanghai, Shanghai, China China, Shanxi Xijing Hospital Xian, Shanxi, China China, Sichuan West China Hospital Chengdu, Sichuan, China China, Yunnan First Affiliated Hospital Of KunMing Medical College Kunming, Yunnan, China China, Zhejiang The Sixth People's Hospital of Hangzhou Hangzhou, Zhejiang, China First Affiliated Hospital of Zhejiang University Zhejiang, Zhejiang, China 收起 << |
NCT02064946 | Prostatic Neoplasms ... 展开 >> Bone Mineral Density Quantitative Trait Locus 3 收起 << | Not Applicable | Active, not recruiting | January 2019 | United States, New York ... 展开 >> Wilmot Cancer Center, University of Rochester Rochester, New York, United States, 14624 收起 << |
NCT01904058 | PBC Primary B... 展开 >>iliary Cirrhosis 收起 << | Phase 2 | Completed | - | - |
NCT00664430 | - | Terminated(Low enrollment rate... 展开 >>) 收起 << | - | - | |
NCT01904058 | - | Completed | - | - | |
NCT00095498 | Rheumatoid Arthritis | Phase 2 | Completed | - | - |
NCT02491684 | Asthma | Phase 2 | Completed | - | Argentina ... 展开 >> Research Site Buenos Aires, Argentina Research Site C.a.b.a., Argentina Research Site Ciudad Autonomade Buenos Aires, Argentina Research Site Quilmes, Argentina Australia Research Site Bedford Park, Australia Research Site New Lambton, Australia Research Site Westmead, Australia Research Site Woolloongabba, Australia Colombia Research Site Bogota, Colombia Research Site Bogotá, Colombia Research Site Floridablanca, Colombia France Research Site Brest Cedex, France Research Site Dijon, France Research Site Lyon Cedex 04, France Research Site Marseille, France Research Site Montpellier Cedex 5, France Research Site Paris Cedex 18, France Research Site Pessac, France Korea, Republic of Research Site Bucheon-si, Korea, Republic of Research Site Jeonju-si, Korea, Republic of Research Site Seoul, Korea, Republic of Spain Research Site Barcelona, Spain Research Site Marbella (Málaga), Spain Research Site Málaga, Spain Research Site Sevilla, Spain Research Site Valencia, Spain United Kingdom Research Site Blackpool, United Kingdom Research Site Bradford, United Kingdom Research Site Lancaster, United Kingdom Research Site Leeds, United Kingdom Research Site Manchester, United Kingdom Research Site Nottingham, United Kingdom Research Site Southampton, United Kingdom 收起 << |
NCT01673178 | - | Completed | - | - | |
NCT02251275 | Autosomal Dominant Polycystic ... 展开 >>Kidney Disease 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT03195075 | Malignant Hepatobiliary Neopla... 展开 >>sm 收起 << | Not Applicable | Not yet recruiting | September 2020 | - |
NCT02011789 | Hypercholesterolemia | Not Applicable | Completed | - | United States, California ... 展开 >> USDA Western Human Nutrition Research Center Davis, California, United States, 95616 收起 << |
NCT02130635 | - | Completed | - | - | |
NCT02130635 | Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 << | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT00095498 | - | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!